10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D. C. 20549  

FORM 10-Q

(Mark One)

☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended March 31, 2025

OR

☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from _________ to _________.

Commission File Number: 1-6028  

_______________________________________________________________________________________________________

LINCOLN NATIONAL CORPORATION

(Exact name of registrant as specified in its charter)

_______________________________________________________________________________________________________  

Indiana	35-1140070
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
150 N. Radnor-Chester Road, Suite A305, Radnor, Pennsylvania	19087
(Address of principal executive offices)	(Zip Code)

(484) 583-1400  

(Registrant’s telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

_____________________________________________________________________________________________________

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading symbol(s)	Name of each exchange on which registered
Common Stock	LNC	New York Stock Exchange
Depositary Shares, each representing a 1/1000th interest in a share of 9.000% Non-Cumulative Preferred Stock, Series D	LNC PRD	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes  ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. 

Large Accelerated Filer	☒	Accelerated Filer	☐
Non-accelerated Filer	☐	Smaller Reporting Company	☐
		Emerging Growth Company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐   No  ☒  

As of May 2, 2025, there were 170,733,897 shares of the registrant’s common stock outstanding.

—————————————————————————————————————————————————————

Lincoln National Corporation

Table of Contents

		Page
PART I
Item 1.	Financial Statements:
	Consolidated Balance Sheets as of March 31, 2025 (Unaudited) and December 31, 2024	1
	Unaudited Consolidated Statements of Comprehensive Income (Loss) for the three months
	ended March 31, 2025 and 2024	2
	Unaudited Consolidated Statements of Stockholders’ Equity for the three months
	ended March 31, 2025 and 2024	3
	Unaudited Consolidated Statements of Cash Flows for the three months
	ended March 31, 2025 and 2024	4
	Notes to Unaudited Consolidated Financial Statements:
	Note 1 – Nature of Operations and Basis of Presentation	5
	Note 2 – New Accounting Standards	6
	Note 3 – Investments	7
	Note 4 – Variable Interest Entities	16
	Note 5 – Derivative Instruments	16
	Note 6 – DAC, VOBA, DSI and DFEL	26
	Note 7 – Reinsurance	29
	Note 8 – MRBs	29
	Note 9 – Separate Accounts	31
	Note 10 – Policyholder Account Balances	32
	Note 11 – Future Contract Benefits	36
	Note 12 – Fair Value of Financial Instruments	41
	Note 13 – Contingencies and Commitments	54
	Note 14 – Shares and Stockholders’ Equity	59
	Note 15 – Segment Information	62
	Note 16 – Realized Gain (Loss)	67
	Note 17 – Federal Income Taxes	67
	Note 18 – Subsequent Event	68
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	69
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	116
Item 4.	Controls and Procedures	116
PART II
Item 1.	Legal Proceedings	118
Item1A.	Risk Factors	118
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	119
Item 5.	Other Information	119
Item 6.	Exhibits	119
	Exhibit Index for the Report on Form 10-Q	120
	Signatures	121

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements

LINCOLN NATIONAL CORPORATION

CONSOLIDATED BALANCE SHEETS

(in millions, except share data)

	As of		As of
	March 31,		December 31,
	2025		2024
	(Unaudited)
ASSETS
Investments:
Fixed maturity available-for-sale securities, at fair value
(amortized cost: 2025 - $97,795; 2024 - $97,415; allowance for credit losses: 2025 - $74; 2024 - $46)	$	88,297	$	87,111
Trading securities	1,984		2,025
Equity securities	345		294
Mortgage loans on real estate, net of allowance for credit losses
(portion at fair value: 2025 - $232; 2024 - $232)	21,558		21,083
Policy loans	2,529		2,476
Derivative investments	7,849		9,677
Other investments	6,653		6,588
Total investments	129,215		129,254
Cash and invested cash	4,284		5,801
Deferred acquisition costs, value of business acquired and deferred sales inducements	12,563		12,537
Reinsurance recoverables, net of allowance for credit losses	28,580		28,750
Deposit assets, net of allowance for credit losses	31,048		30,776
Market risk benefit assets	4,157		4,860
Accrued investment income	1,134		1,108
Goodwill	1,144		1,144
Other assets	8,267		8,163
Separate account assets	162,506		168,438
Total assets	$	382,898	$	390,831
LIABILITIES AND STOCKHOLDERS’ EQUITY
Liabilities
Policyholder account balances	$	125,262	$	126,197
Future contract benefits	40,665		39,807
Funds withheld reinsurance liabilities	16,838		16,907
Market risk benefit liabilities	1,306		1,046
Deferred front-end loads	6,910		6,730
Payables for collateral on investments	8,282		10,020
Short-term debt	–		300
Long-term debt	5,868		5,856
Other liabilities	7,068		7,261
Separate account liabilities	162,506		168,438
Total liabilities	374,705		382,562
Contingencies and Commitments (See Note 13)
Stockholders’ Equity
Preferred stock – 10,000,000 shares authorized:
Series C preferred stock – 20,000 shares authorized, issued and outstanding
as of March 31, 2025, and December 31, 2024	493		493
Series D preferred stock – 20,000 shares authorized, issued and outstanding
as of March 31, 2025, and December 31, 2024	493		493
Common stock – 800,000,000 shares authorized; 170,695,166 and 170,380,646 shares
issued and outstanding as of March 31, 2025, and December 31, 2024, respectively	4,703		4,674
Retained earnings	6,810		7,645
Accumulated other comprehensive income (loss)	(4,306)		(5,036)
Total stockholders’ equity	8,193		8,269
Total liabilities and stockholders’ equity	$	382,898	$	390,831

See accompanying Notes to Consolidated Financial Statements

1

Table of Contents

LINCOLN NATIONAL CORPORATION

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(Unaudited, in millions, except per share data)

	For the Three Months Ended March 31,
	2025		2024
Revenues
Insurance premiums	$	1,676	$	1,601
Fee income	1,365		1,324
Net investment income	1,457		1,346
Realized gain (loss)	11		(434)
Other revenues	182		279
Total revenues	4,691		4,116
Expenses
Benefits	2,068		2,003
Interest credited	890		822
Market risk benefit (gain) loss	1,293		(1,907)
Policyholder liability remeasurement (gain) loss	(59)		(12)
Commissions and other expenses	1,368		1,601
Interest and debt expense	80		81
Total expenses	5,640		2,588
Income (loss) before taxes	(949)		1,528
Federal income tax expense (benefit)	(227)		306
Net income (loss)	(722)		1,222
Other comprehensive income (loss), net of tax:
Unrealized investment gain (loss)	523		(127)
Market risk benefit non-performance risk gain (loss)	318		(464)
Policyholder liability discount rate remeasurement gain (loss)	(111)		116
Foreign currency translation adjustment	5		(1)
Funded status of employee benefit plans	(5)		1
Total other comprehensive income (loss), net of tax	730		(475)
Comprehensive income (loss)	$	8	$	747
Net Income (Loss) Available to Common Stockholders
Net income (loss)	$	(722)	$	1,222
Preferred stock dividends declared	(34)		(34)
Net income (loss) available to common stockholders	$	(756)	$	1,188
Net Income (Loss) Per Common Share
Basic	$	(4.41)	$	6.98
Diluted	(4.41)		6.93
Cash Dividends Declared Per Common Share	$	0.45	$	0.45

See accompanying Notes to Consolidated Financial Statements

2

Table of Contents

LINCOLN NATIONAL CORPORATION

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(Unaudited, in millions)

	For the Three Months Ended March 31,
	2025		2024
Preferred Stock
Balance as of beginning-of-year	$	986	$	986
Balance as of end-of-period	986		986
Common Stock
Balance as of beginning-of-year	4,674		4,605
Stock compensation/issued for benefit plans	29		19
Balance as of end-of-period	4,703		4,624
Retained Earnings
Balance as of beginning-of-year	7,645		4,778
Net income (loss)	(722)		1,222
Preferred stock dividends declared	(34)		(34)
Common stock dividends declared	(79)		(79)
Balance as of end-of-period	6,810		5,887
Accumulated Other Comprehensive Income (Loss)
Balance as of beginning-of-year	(5,036)		(3,476)
Other comprehensive income (loss), net of tax	730		(475)
Balance as of end-of-period	(4,306)		(3,951)
Total stockholders’ equity as of end-of-period	$	8,193	$	7,546

See accompanying Notes to Consolidated Financial Statements

3

Table of Contents

LINCOLN NATIONAL CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited, in millions)

	For the Three Months Ended March 31,
	2025		2024
Cash Flows from Operating Activities
Net income (loss)	$	(722)	$	1,222
Adjustments to reconcile net income (loss) to net cash provided by (used in)
operating activities:
Realized (gain) loss	(11)		434
Market risk benefit (gain) loss	1,293		(1,907)
Sales and maturities (purchases) of trading securities, net	71		129
Change in:
Deferred acquisition costs, value of business acquired, deferred sales inducements
and deferred front-end loads	156		190
Accrued investment income	(16)		(32)
Insurance liabilities and reinsurance-related balances	(216)		(1,035)
Accrued expenses	(227)		(41)
Federal income tax accruals	(227)		306
Other	(373)		(609)
Net cash provided by (used in) operating activities	(272)		(1,343)
Cash Flows from Investing Activities
Purchases of available-for-sale securities and equity securities	(3,722)		(2,360)
Sales of available-for-sale securities and equity securities	509		677
Maturities of available-for-sale securities	2,689		1,694
Purchases of alternative investments	(397)		(315)
Sales and repayments of alternative investments	213		16
Issuance of mortgage loans on real estate	(919)		(571)
Repayment and maturities of mortgage loans on real estate	502		267
Repayment (issuance) of policy loans, net	(54)		(1)
Net change in collateral on investments, certain derivatives and related settlements	(799)		2,232
Other	(68)		–
Net cash provided by (used in) investing activities	(2,046)		1,639
Cash Flows from Financing Activities
Payment of long-term debt, including current maturities	(300)		(47)
Issuance of long-term debt, net of issuance costs	–		347
Payment related to sale-leaseback transactions	(2)		(4)
Payment related to certain financing arrangements	(14)		(16)
Policyholder account balances:
Deposits	4,434		3,602
Withdrawals	(3,129)		(3,215)
Transfers from (to) separate accounts, net	(73)		(90)
Common stock issued for benefit plans	(4)		(5)
Dividends paid to preferred stockholders	(34)		(34)
Dividends paid to common stockholders	(77)		(77)
Net cash provided by (used in) financing activities	801		461
Net increase (decrease) in cash, invested cash and restricted cash	(1,517)		757
Cash, invested cash and restricted cash as of beginning-of-year	5,801		3,365
Cash, invested cash and restricted cash as of end-of-period	$	4,284	$	4,122

See accompanying Notes to Consolidated Financial Statements

4

Table of Contents

LINCOLN NATIONAL CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1. Nature of Operations and Basis of Presentation

Nature of Operations

Lincoln National Corporation and its subsidiaries (“LNC” or the “Company,” which also may be referred to as “we,” “our” or “us”) operate multiple insurance businesses through four business segments: Annuities, Life Insurance, Group Protection and Retirement Plan Services. In addition, we include financial results for operations that are not directly related to our business segments in Other Operations. The collective group of businesses uses “Lincoln Financial” as its marketing identity. Through our business segments, we sell a wide range of wealth accumulation, wealth protection, group protection and retirement products and solutions. These products primarily include variable annuities, fixed annuities (including indexed), registered index-linked annuities (“RILA”), universal life insurance (“UL”), variable universal life insurance (“VUL”), linked-benefit UL and VUL, indexed universal life insurance (“IUL”), term life insurance, group life, disability and dental and employer-sponsored retirement plans and services. For more information on our segments and the products and solutions we provide, see Note 15.

Basis of Presentation

The accompanying unaudited consolidated financial statements are prepared in accordance with United States of America generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions for the Securities and Exchange Commission (“SEC”) Quarterly Report on Form 10-Q, including Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. The information contained in the Notes to Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended December 31, 2024 (“2024 Form 10-K”), should be read in connection with the reading of these interim unaudited consolidated financial statements.

Certain GAAP policies, which significantly affect the determination of financial condition, results of operations and cash flows, are summarized in our 2024 Form 10-K.

In the opinion of management, these statements include all normal recurring adjustments necessary for a fair presentation of the Company’s results. Interim results for the three months ended March 31, 2025, are not necessarily indicative of the results that may be expected for the full year ending December 31, 2025. All material inter-company accounts and transactions have been eliminated in consolidation.

We present disaggregated disclosures in the Notes below for long-duration insurance balances, applying the level of aggregation by business segment as follows:

Business Segment	Level of Aggregation
Annuities	Variable Annuities
	Fixed Annuities
	Payout Annuities
Life Insurance	Traditional Life
	UL and Other
Group Protection	Group Protection
Retirement Plan Services	Retirement Plan Services

The variable annuities level of aggregation includes RILA products, which are indexed variable annuities. The fixed annuities level of aggregation represents deferred fixed annuities. We have excluded amounts reported in Other Operations from our disaggregated disclosures that are attributable to the indemnity reinsurance agreements with Protective Life Insurance Company (“Protective”) and Swiss Re Life & Health America, Inc (“Swiss Re”) as these contracts are fully reinsured, run-off institutional pension business in the form of group annuity and the results of certain disability income business.

5

Table of Contents

2. New Accounting Standards

Adoption of New Accounting Standards

The following table provides a description of current period adoptions of new Accounting Standards Updates (“ASUs”).

Standard	Description	Effective Date	Effect on Financial Statements or Other Significant Matters
ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures	This ASU aims to enhance reportable segment disclosure requirements. It requires that a public entity disclose significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”), disclose and describe other segment items and report additional measures of a segment’s profit or loss if used by the CODM.	January 1, 2024 (Annual Filings) and January 1, 2025 (Quarterly Filings)	We adopted this ASU on the applicable effective dates, incorporating the required disclosures in Note 15 to the consolidated financial statements, along with retrospectively updating the applicable tabular disclosures.

Future Adoption of New Accounting Standards

The following table provides a description of future adoptions of new ASUs that may have an impact on the consolidated financial statements when adopted. ASUs not listed below were assessed and determined to be either not applicable or insignificant in presentation or amount.

Standard	Description	Effective Date	Effect on Financial Statements or Other Significant Matters
ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures	This ASU establishes new income tax disclosure requirements, as well as adjusts certain existing requirements. It specifically requires expanded and disaggregated disclosures around the tax rate reconciliation.	January 1, 2025 (Annual Filings)	We are evaluating the impact of this ASU to disclosures within the Federal Income Taxes Note to the consolidated financial statements.
ASU 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40)	This ASU requires disclosure of specified information about certain costs and expenses, including employee compensation, depreciation and intangible asset amortization.	January 1, 2027	We are evaluating the impact of this ASU to the consolidated financial statements.

6

Table of Contents

3. Investments

Fixed Maturity AFS Securities

The amortized cost, gross unrealized gains and losses, allowance for credit losses and fair value of fixed maturity available-for-sale (“AFS”) securities (in millions) were as follows:

	As of March 31, 2025
	Amortized Cost		Gross Unrealized				Allowance for Credit Losses		Fair Value
			Gains		Losses
Fixed maturity AFS securities:
Corporate bonds	$	75,363	$	630	$	9,085	$	23	$	66,885
U.S. government bonds	567		5		34		–		538
State and municipal bonds	2,744		21		415		–		2,350
Foreign government bonds	282		13		56		–		239
RMBS	2,104		29		186		6		1,941
CMBS	1,961		6		137		–		1,830
ABS	14,515		110		340		44		14,241
Hybrid and redeemable preferred securities	259		25		10		1		273
Total fixed maturity AFS securities	$	97,795	$	839	$	10,263	$	74	$	88,297

	As of December 31, 2024
	Amortized Cost		Gross Unrealized				Allowance for Credit Losses		Fair Value
			Gains		Losses
Fixed maturity AFS securities:
Corporate bonds	$	75,556	$	563	$	9,655	$	14	$	66,450
U.S. government bonds	429		3		41		–		391
State and municipal bonds	2,798		18		445		–		2,371
Foreign government bonds	282		11		56		–		237
RMBS	2,066		24		220		7		1,863
CMBS	1,817		4		156		–		1,665
ABS	14,226		99		421		24		13,880
Hybrid and redeemable preferred securities	241		25		11		1		254
Total fixed maturity AFS securities	$	97,415	$	747	$	11,005	$	46	$	87,111

The amortized cost and fair value of fixed maturity AFS securities by contractual maturities (in millions) as of March 31, 2025, were as follows:

	Amortized Cost		Fair Value
Due in one year or less	$	4,353	$	4,332
Due after one year through five years	18,500		18,050
Due after five years through ten years	13,107		12,271
Due after ten years	43,255		35,632
Subtotal	79,215		70,285
Structured securities (RMBS, CMBS, ABS)	18,580		18,012
Total fixed maturity AFS securities	$	97,795	$	88,297

Actual maturities may differ from contractual maturities because issuers may have the right to call or pre-pay obligations.

7

Table of Contents

The fair value and gross unrealized losses of fixed maturity AFS securities (dollars in millions) for which an allowance for credit losses has not been recorded, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position, were as follows:

	As of March 31, 2025
	Less Than or Equal to Twelve Months				Greater Than Twelve Months				Total
	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses (1)
Fixed maturity AFS securities:
Corporate bonds	$	23,140	$	3,798	$	29,434	$	5,287	$	52,574	$	9,085
U.S. government bonds	67		2		230		32		297		34
State and municipal bonds	940		214		766		201		1,706		415
Foreign government bonds	32		6		119		50		151		56
RMBS	660		58		786		128		1,446		186
CMBS	610		43		785		94		1,395		137
ABS	3,820		94		3,522		246		7,342		340
Hybrid and redeemable
preferred securities	24		2		92		8		116		10
Total fixed maturity AFS securities	$	29,293	$	4,217	$	35,734	$	6,046	$	65,027	$	10,263
Total number of fixed maturity AFS securities in an unrealized loss position											6,835

	As of December 31, 2024
	Less Than or Equal to Twelve Months				Greater Than Twelve Months				Total
	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses (1)
Fixed maturity AFS securities:
Corporate bonds	$	24,657	$	4,054	$	29,786	$	5,601	$	54,443	$	9,655
U.S. government bonds	86		3		224		38		310		41
State and municipal bonds	1,087		228		760		217		1,847		445
Foreign government bonds	32		5		118		51		150		56
RMBS	795		76		760		144		1,555		220
CMBS	579		50		777		106		1,356		156
ABS	2,907		118		3,827		303		6,734		421
Hybrid and redeemable
preferred securities	23		3		93		8		116		11
Total fixed maturity AFS securities	$	30,166	$	4,537	$	36,345	$	6,468	$	66,511	$	11,005
Total number of fixed maturity AFS securities in an unrealized loss position											6,985

(1) As of March 31, 2025, and December 31, 2024, we recognized $12 million and $23 million of gross unrealized losses, respectively, in other comprehensive income (loss) (“OCI”) for fixed maturity AFS securities for which an allowance for credit losses has been recorded.

8

Table of Contents

The fair value, gross unrealized losses (in millions) and number of fixed maturity AFS securities where the fair value had declined and remained below amortized cost by greater than 20% were as follows:

	As of March 31, 2025
	Fair Value		Gross Unrealized Losses		Number of Securities (1)
Less than six months	$	3,053	$	900	522
Six months or greater, but less than nine months	1,600		518		324
Nine months or greater, but less than twelve months	369		187		208
Twelve months or greater	4,381		2,149		737
Total	$	9,403	$	3,754	1,791

	As of December 31, 2024
	Fair Value		Gross Unrealized Losses		Number of Securities (1)
Less than six months	$	5,405	$	1,621	799
Six months or greater, but less than nine months	371		198		216
Nine months or greater, but less than twelve months	71		28		37
Twelve months or greater	4,440		2,218		741
Total	$	10,287	$	4,065	1,793

(1) We may reflect a security in more than one aging category based on various purchase dates.

Our gross unrealized losses on fixed maturity AFS securities decreased by $742 million for the three months ended March 31, 2025. As discussed further below, we do not believe the unrealized loss position as of March 31, 2025, required an impairment recognized in earnings as: (i) we did not intend to sell these fixed maturity AFS securities; (ii) it is not more likely than not that we will be required to sell the fixed maturity AFS securities before recovery of their amortized cost basis; and (iii) the difference in the fair value compared to the amortized cost was due to factors other than credit loss. Based upon this evaluation as of March 31, 2025, management believes we have the ability to generate adequate amounts of cash from our normal operations (e.g., insurance premiums, fee income and investment income) to meet cash requirements with a prudent margin of safety without requiring the sale of our impaired securities.

As of March 31, 2025, the unrealized losses associated with our corporate bond, U.S. government bond, state and municipal bond and foreign government bond securities were attributable primarily to rising interest rates and widening credit spreads since purchase. We performed a detailed analysis of the financial performance of the underlying issuers and determined that we expected to recover the entire amortized cost of each impaired security.

Credit ratings express opinions about the credit quality of a security. Securities rated investment grade (those rated BBB- or higher by S&P Global Ratings (“S&P”) or Baa3 or higher by Moody’s Investors Service (“Moody’s”)) are generally considered by the rating agencies and market participants to be low credit risk. As of March 31, 2025, and December 31, 2024, 96% of the fair value of our corporate bond portfolio was rated investment grade. As of March 31, 2025, and December 31, 2024, the portion of our corporate bond portfolio rated below investment grade had an amortized cost of $2.8 billion and $2.9 billion, respectively, and a fair value of $2.7 billion and $2.8 billion, respectively. Based upon the analysis discussed above, we believe that as of March 31, 2025, and December 31, 2024, we would have recovered the amortized cost of each corporate bond.

As of March 31, 2025, the unrealized losses associated with our mortgage-backed securities (“MBS”) and asset-backed securities (“ABS”) were attributable primarily to rising interest rates and widening credit spreads since purchase. We assessed for credit impairment using a cash flow model that incorporates key assumptions including default rates, severities and prepayment rates. We estimated losses for a security by forecasting the underlying loans in each transaction. The forecasted loan performance was used to project cash flows to the various tranches in the structure, as applicable. Our forecasted cash flows also considered, as applicable, independent industry analyst reports and forecasts and other independent market data. Based upon our assessment of the expected credit losses of the security given the performance of the underlying collateral compared to our subordination or other credit enhancement, we expected to recover the entire amortized cost of each impaired security.

9

Table of Contents

As of March 31, 2025, the unrealized losses associated with our hybrid and redeemable preferred securities were attributable primarily to wider credit spreads caused by illiquidity in the market and subordination within the capital structure, as well as credit risk of underlying issuers. For our hybrid and redeemable preferred securities, we evaluated the financial performance of the underlying issuers based upon credit performance and investment ratings and determined that we expected to recover the entire amortized cost of each impaired security.

Credit Loss Impairment on Fixed Maturity AFS Securities

We regularly review our fixed maturity AFS securities for declines in fair value that we determine to be impairment-related, including those attributable to credit risk factors that may require an allowance for credit losses. Changes in the allowance for credit losses on fixed maturity AFS securities (in millions), aggregated by investment category, were as follows:

	For the Three Months Ended March 31, 2025
	Corporate Bonds		RMBS		ABS		Hybrids		Total
Balance as of beginning-of-year	$	14	$	7	$	24	$	1	$	46
Additions from purchases of PCD debt securities (1)	–		–		–		–		–
Additions for securities for which credit losses were
not previously recognized	7		–		8		–		15
Additions (reductions) for securities for which
credit losses were previously recognized	2		(1)		12		–		13
Reductions for securities charged off	–		–		–		–		–
Balance as of end-of-period (2)	$	23	$	6	$	44	$	1	$	74

	For the Three Months Ended March 31, 2024
	Corporate Bonds		RMBS		ABS		Hybrids		Total
Balance as of beginning-of-year	$	8	$	6	$	4	$	1	$	19
Additions from purchases of PCD debt securities (1)	–		–		–		–		–
Additions for securities for which credit losses were
not previously recognized	1		–		–		–		1
Additions (reductions) for securities for which
credit losses were previously recognized	2		–		–		–		2
Reductions for disposed securities	(1)		–		–		–		(1)
Reductions for securities charged off	–		–		–		–		–
Balance as of end-of-period (2)	$	10	$	6	$	4	$	1	$	21

(1) Represents purchased credit-deteriorated (“PCD”) fixed maturity AFS securities.

(2) As of March 31, 2025 and 2024, accrued investment income on fixed maturity AFS securities totaled $911 million and $943 million, respectively, and was excluded from the estimate of credit losses.

Losses from debt instrument modifications were $5 million and zero for the three months ended March 31, 2025 and 2024, respectively.

10

Table of Contents

Mortgage Loans on Real Estate

The following provides the current and past due composition of our mortgage loans on real estate (in millions):

	As of March 31, 2025						As of December 31, 2024
	Commercial		Residential		Total		Commercial		Residential		Total
Current	$	17,602	$	3,795	$	21,397	$	17,567	$	3,387	$	20,954
30 to 59 days past due	13		84		97		6		71		77
60 to 89 days past due	3		26		29		–		33		33
90 or more days past due	31		104		135		35		90		125
Allowance for credit losses	(98)		(56)		(154)		(99)		(53)		(152)
Unamortized premium (discount)	(5)		91		86		(6)		83		77
Mark-to-market gains (losses) (1)	(32)		–		(32)		(31)		–		(31)
Total carrying value	$	17,514	$	4,044	$	21,558	$	17,472	$	3,611	$	21,083

(1) Represents the mark-to-market on certain mortgage loans on real estate that support our modified coinsurance agreements, where the investment results are passed directly to the reinsurers, and for which we have elected the fair value option. As of March 31, 2025, and December 31, 2024, the amortized cost and fair value of such mortgage loans on real estate that were in nonaccrual status was $30 million and $21 million, respectively. As of March 31, 2025, and December 31, 2024, there were no such mortgage loans on real estate that were more than 90 days past due and still accruing interest. See Note 12 for additional information.

The amortized cost of mortgage loans on real estate on nonaccrual status (in millions) was as follows, excluding certain mortgage loans on real estate that support our modified coinsurance agreements, where the investment results are passed directly to the reinsurers:

	As of March 31, 2025		As of December 31, 2024
Commercial mortgage loans on real estate	$	1	$	4
Residential mortgage loans on real estate	106		92
Total	$	107	$	96

We use loan-to-value (“LTV”) and debt-service coverage ratios as credit quality indicators for our commercial mortgage loans on real estate. The amortized cost of commercial mortgage loans on real estate (dollars in millions) by year of origination and credit quality indicator was as follows:

	As of March 31, 2025
	LTV Less Than 65%		Debt-Service Coverage Ratio	LTV 65% to 75%		Debt-Service Coverage Ratio	LTV Greater Than 75%		Debt-Service Coverage Ratio	Total
Origination Year
2025	$	267	1.63	$	18	1.33	$	–	–	$	285
2024	1,551		1.73	74		1.42	1		1.69	1,626
2023	1,346		1.76	40		1.37	2		1.51	1,388
2022	1,718		2.07	87		1.52	8		1.24	1,813
2021	2,247		3.21	46		1.73	9		1.26	2,302
2020 and prior	10,103		2.48	114		1.56	13		1.13	10,230
Total	$	17,232		$	379		$	33		$	17,644

11

Table of Contents

	As of December 31, 2024
	LTV Less Than 65%		Debt-Service Coverage Ratio	LTV 65% to 75%		Debt-Service Coverage Ratio	LTV Greater Than 75%		Debt-Service Coverage Ratio	Total
Origination Year
2024	$	1,548	1.73	$	83	1.41	$	–	–	$	1,631
2023	1,348		1.78	44		1.36	–		–	1,392
2022	1,724		2.11	94		1.55	4		1.30	1,822
2021	2,267		3.50	47		1.52	–		–	2,314
2020	1,167		3.33	4		1.53	–		–	1,171
2019 and prior	9,138		2.38	126		1.58	8		1.30	9,272
Total	$	17,192		$	398		$	12		$	17,602

We use loan performance status as the primary credit quality indicator for our residential mortgage loans on real estate. The amortized cost of residential mortgage loans on real estate (in millions) by year of origination and credit quality indicator was as follows:

	As of March 31, 2025
	Performing		Nonperforming		Total
Origination Year
2025	$	167	$	–	$	167
2024	2,223		29		2,252
2023	495		19		514
2022	471		31		502
2021	415		12		427
2020 and prior	223		15		238
Total	$	3,994	$	106	$	4,100

	As of December 31, 2024
	Performing		Nonperforming		Total
Origination Year
2024	$	1,895	$	14	$	1,909
2023	557		16		573
2022	492		33		525
2021	427		11		438
2020	65		4		69
2019 and prior	136		14		150
Total	$	3,572	$	92	$	3,664

Credit Losses on Mortgage Loans on Real Estate

In connection with our recognition of an allowance for credit losses for mortgage loans on real estate, we perform a quantitative analysis using a probability of default/loss given default/exposure at default approach to estimate expected credit losses in our mortgage loan portfolio as well as unfunded commitments related to commercial mortgage loans, exclusive of certain mortgage loans held at fair value.

12

Table of Contents

Changes in the allowance for credit losses on mortgage loans on real estate (in millions) were as follows:

	For the Three Months Ended March 31, 2025
	Commercial		Residential		Total
Balance as of beginning-of-year	$	99	$	53	$	152
Additions (reductions) from provision for credit loss
expense (1)	(1)		3		2
Additions from purchases of PCD mortgage loans on
real estate	–		–		–
Balance as of end-of-period (2)	$	98	$	56	$	154

	For the Three Months Ended March 31, 2024
	Commercial		Residential		Total
Balance as of beginning-of-year	$	86	$	28	$	114
Additions (reductions) from provision for credit loss
expense (1)	(2)		3		1
Additions from purchases of PCD mortgage loans on
real estate	–		–		–
Balance as of end-of-period (2)	$	84	$	31	$	115

(1) We recognized $1 million of credit loss benefit (expense) related to unfunded commitments for mortgage loans on real estate for the three months ended March 31, 2025 and 2024.

(2) Accrued investment income on mortgage loans on real estate totaled $101 million and $69 million as of March 31, 2025 and 2024, respectively, and was excluded from the estimate of credit losses.

Alternative Investments 

As of March 31, 2025, and December 31, 2024, alternative investments included investments in 370 and 371 different partnerships, respectively, and represented approximately 3% of total investments.

Impairments on Fixed Maturity AFS Securities

Details underlying credit loss benefit (expense) incurred as a result of impairments that were recognized in net income (loss) and included in realized gain (loss) on fixed maturity AFS securities (in millions) were as follows:

	For the Three Months Ended March 31,
	2025		2024
Credit Loss Benefit (Expense)
Fixed maturity AFS securities:
Corporate bonds	$	(9)	$	(2)
RMBS	1		–
ABS	(20)		–
Total credit loss benefit (expense)	$	(28)	$	(2)

13

Table of Contents

Payables for Collateral on Investments

The carrying value of the payables for collateral on investments included on the Consolidated Balance Sheets and the fair value of the related investments or collateral (in millions) consisted of the following:

	As of March 31, 2025				As of December 31, 2024
	Carrying Value		Fair Value		Carrying Value		Fair Value
Collateral payable for derivative investments (1)	$	5,558	$	5,558	$	7,213	$	7,213
Securities pledged under securities lending agreements (2)	167		161		157		151
Securities pledged under repurchase agreements (3)	57		59		–		–
Investments pledged for FHLBI (4)	2,500		3,480		2,650		3,657
Total payables for collateral on investments	$	8,282	$	9,258	$	10,020	$	11,021

(1) We obtain collateral based upon contractual provisions with our counterparties. These agreements take into consideration the counterparties’ credit rating as compared to ours, the fair value of the derivative investments and specified thresholds that if exceeded result in the receipt of cash that is typically invested in cash and invested cash or fixed maturity AFS securities. This also includes interest payable on collateral. See Note 5 for additional information.

(2) Our pledged securities under securities lending agreements are included in fixed maturity AFS securities on the Consolidated Balance Sheets. We generally obtain collateral in an amount equal to 102% and 105% of the fair value of the domestic and foreign securities, respectively. We value collateral daily and obtain additional collateral when deemed appropriate. The cash received in our securities lending program is typically invested in cash and invested cash or fixed maturity AFS securities.

(3) Our pledged securities under repurchase agreements are included in fixed maturity AFS securities on the Consolidated Balance Sheets. The collateral requirements are generally 80% to 95% of the fair value of the securities, and our agreements with third parties contain contractual provisions to allow for additional collateral to be obtained when necessary. The cash received in our repurchase program is typically invested in cash and invested cash or fixed maturity AFS securities.

(4) Our pledged investments for Federal Home Loan Bank (“FHLB”) of Indianapolis (“FHLBI”) are included in fixed maturity AFS securities and mortgage loans on real estate on the Consolidated Balance Sheets. The collateral requirements are generally 105% to 115% of the fair value for fixed maturity AFS securities and 155% to 175% of the fair value for mortgage loans on real estate. The cash received in these transactions is primarily invested in cash and invested cash or fixed maturity AFS securities.

Increase (decrease) in payables for collateral on investments (in millions) consisted of the following:

	For the Three Months Ended March 31,
	2025		2024
Collateral payable for derivative investments	$	(1,655)	$	1,684
Securities pledged under securities
lending agreements	10		78
Securities pledged under repurchase agreements	57		–
Investments pledged for FHLBI	(150)		250
Total increase (decrease) in payables for
collateral on investments	$	(1,738)	$	2,012

14

Table of Contents

We have elected not to offset our securities lending transactions in the consolidated financial statements. The remaining contractual maturities of securities lending transactions accounted for as secured borrowings (in millions) were as follows:

	As of March 31, 2025
	Overnight  and  Continuous		Up to 30 Days		30-90 Days		Greater Than 90 Days		Total
Securities Lending
Corporate bonds	$	157	$	–	$	–	$	–	$	157
Equity securities	10		–		–		–		10
Total gross secured borrowings	$	167	$	–	$	–	$	–	$	167

	As of December 31, 2024
	Overnight  and  Continuous		Up to 30 Days		30-90 Days		Greater Than 90 Days		Total
Securities Lending
Corporate bonds	$	144	$	–	$	–	$	–	$	144
U.S. government bonds	1		–		–		–		1
Equity securities	12		–		–		–		12
Total gross secured borrowings	$	157	$	–	$	–	$	–	$	157

We accept collateral in the form of securities in connection with repurchase agreements. In instances where we are permitted to sell or re-pledge the securities received, we report the fair value of the collateral received and a related obligation to return the collateral in the consolidated financial statements. In addition, we receive securities in connection with securities borrowing agreements that we are permitted to sell or re-pledge. As of March 31, 2025, we had not received any collateral and, therefore, had not sold or repledged any

collateral under these agreements.

We also accept collateral from derivative counterparties in the form of securities that we are permitted to sell or re-pledge. As of March 31, 2025, the fair value of this collateral received that we are permitted to sell or re-pledge was $2.2 billion, and we had re-pledged $64 million of this collateral to cover our collateral requirements.

We had not pledged any fixed maturity AFS securities to derivative counterparties as of March 31, 2025.

Investment Commitments

As of March 31, 2025, our investment commitments were $4.6 billion, which included $3.5 billion of limited partnerships (“LPs”), $828 million of mortgage loans on real estate and $277 million of private placement securities.

Concentrations of Financial Instruments

As of March 31, 2025, and December 31, 2024, our most significant investments in one issuer were our investments in securities issued by the Federal National Mortgage Association with a fair value of $892 million and $851 million, respectively, or 1% of total investments, and our investments in securities issued by the Federal Home Loan Mortgage Corporation with a fair value of $604 million and $566 million, respectively, or less than 1% of total investments. These concentrations include fixed maturity AFS, trading and equity securities.

As of March 31, 2025, and December 31, 2024, our most significant investments in one industry were our investments in securities in the financial services industry with a fair value of $13.5 billion and $13.4 billion, respectively, or 10% of total investments, and our investments in securities in the consumer non-cyclical industry with a fair value of $13.0 billion and $12.9 billion, respectively, or 10% of total investments. These concentrations include fixed maturity AFS, trading and equity securities.

15

Table of Contents

4. Variable Interest Entities

Consolidated VIEs

Asset information (dollars in millions) for the consolidated variable interest entities (“VIEs”) included on the Consolidated Balance Sheets was as follows:

	As of March 31, 2025					As of December 31, 2024
	Number of Instruments	Notional Amounts		Carrying Value		Number of Instruments		Notional Amounts		Carrying Value
Assets
Total return swap	1	$	504	$	–	$	1	$	522	$	–

There were no gains or losses for consolidated VIEs recognized on the Consolidated Statements of Comprehensive Income (Loss) for the three months ended March 31, 2025 and 2024.

Unconsolidated VIEs

Structured Securities

Through our investment activities, we make passive investments in structured securities issued by VIEs for which we are not the manager. These structured securities include our ABS, residential mortgage-backed securities (“RMBS”) and commercial mortgage-backed securities (“CMBS”). We have not provided financial or other support with respect to these VIEs other than our original investment. We have determined that we are not the primary beneficiary of these VIEs due to the relative size of our investment in comparison to the principal amount of the structured securities issued by the VIEs and the level of credit subordination that reduces our obligation to absorb losses or right to receive benefits. Our maximum exposure to loss on these structured securities is limited to the amortized cost for these investments. We recognize our variable interest in these VIEs at fair value on the Consolidated Balance Sheets. For information about these structured securities, see Note 3.

Limited Partnerships and Limited Liability Companies

We invest in certain LPs and limited liability companies (“LLCs”) that we have concluded are VIEs. Our exposure to loss is limited to the capital we invest in the LPs and LLCs. We do not hold any substantive kick-out or participation rights in the LPs and LLCs, and we do not receive any performance fees or decision maker fees from the LPs and LLCs. Based on our analysis of the LPs and LLCs, we are not the primary beneficiary of the VIEs as we do not have the power to direct the most significant activities of the LPs and LLCs. The carrying amounts of our investments in the LPs and LLCs are recognized in other investments on the Consolidated Balance Sheets and were $5.6 billion and $5.3 billion as of March 31, 2025, and December 31, 2024, respectively.

5. Derivative Instruments

We maintain an overall risk management strategy that incorporates the use of derivative instruments to minimize significant unplanned fluctuations in earnings that are caused by interest rate risk, foreign currency exchange risk, equity market risk, basis risk, commodity risk and credit risk. We assess these risks by continually identifying and monitoring changes in our exposures that may adversely affect expected future cash flows and by evaluating hedging opportunities.

Derivative activities are monitored by various management committees. The committees are responsible for overseeing the implementation of various hedging strategies that are developed through the analysis of financial simulation models and other internal and industry sources. The resulting hedging strategies are incorporated into our overall risk management strategies.

See Note 13 for additional disclosures related to the fair value of our derivative instruments.

Interest Rate Contracts

We use derivative instruments as part of our interest rate risk management strategy. These instruments are economic hedges unless otherwise noted and include:

Forward-Starting Interest Rate Swaps

We use forward-starting interest rate swaps to hedge the interest rate exposure within our annuity, life insurance and retirement products.

16

Table of Contents

Interest Rate Cap Corridors

We use interest rate cap corridors to provide a level of protection from the effect of rising interest rates for certain annuity contracts and life insurance products. Interest rate cap corridors involve purchasing an interest rate cap at a specific cap rate and selling an interest rate cap with a higher cap rate. For each corridor, the amount of quarterly payments, if any, is determined by the rate at which the underlying index rate resets above the original capped rate. The corridor limits the benefit the purchaser can receive as the related interest rate index rises above the higher capped rate. There is no additional liability to us other than the purchase price associated with the interest rate cap corridor.

Interest Rate Futures

We use interest rate futures contracts to hedge the liability exposure on certain options in variable annuity and RILA products. These futures contracts require payment between our counterparty and us on a daily basis for changes in the futures index price.

Interest Rate Swap Agreements

We use interest rate swap agreements to hedge the liability exposure on certain options in variable annuity and RILA products.

We also use interest rate swap agreements designated and qualifying as cash flow hedges to hedge the interest rate risk of floating-rate bond coupon payments on certain variable-rate long-term debt and other variable-rate bonds held by replicating a fixed-rate bond.

Finally, we use interest rate swap agreements designated and qualifying as fair value hedges to hedge against changes in the fair value of certain fixed-rate long-term debt and fixed maturity securities due to interest rate risks.

Bond Forwards and Treasury and Reverse Treasury Locks

We use treasury locks designated and qualifying as cash flow hedges to hedge the interest rate exposure related to our issuance of fixed-rate securities or the anticipated future cash flows of floating-rate fixed maturity securities due to changes in interest rates. In addition, we use bond forwards and reverse treasury locks designated and qualifying as cash flow hedges to hedge the interest rate exposure related to the anticipated purchase of fixed-rate securities or the anticipated future cash flows of floating-rate fixed maturity securities due to changes in interest rates. These derivatives are primarily structured to hedge interest rate risk inherent in the assumptions used to price certain liabilities.

Foreign Currency Contracts

We use derivative instruments as part of our foreign currency risk management strategy. These instruments are economic hedges unless otherwise noted and include:

Currency Futures

We use currency futures to hedge foreign exchange risk associated with certain options in variable annuity products. Currency futures exchange one currency for another at a specified date in the future at a specified exchange rate.

Foreign Currency Swaps

We use foreign currency swaps to hedge foreign exchange risk of investments in fixed maturity securities denominated in foreign currencies. A foreign currency swap is a contractual agreement to exchange one currency for another at specified dates in the future at a specified exchange rate.

We also use foreign currency swaps designated and qualifying as cash flow and fair value hedges to hedge foreign exchange risk of investments in fixed maturity securities denominated in foreign currencies.

Foreign Currency Forwards

We use foreign currency forwards to hedge foreign exchange risk of investments in fixed maturity securities denominated in foreign currencies. A foreign currency forward is a contractual agreement to exchange one currency for another at specified dates in the future at a specified current exchange rate.

17

Table of Contents

Equity Market Contracts

We use derivative instruments as part of our equity market risk management strategy that are economic hedges and include:

Call Options Based on the S&P 500® Index and Other Indices

We use call options to hedge the liability exposure on certain options in variable annuity, RILA, fixed indexed annuity, IUL and VUL products.

Our RILA, fixed indexed annuity and IUL contracts permit the holder to elect an interest rate return or an equity market component, where interest credited to the contracts is linked to the performance of the S&P 500 Index or other indices. Policyholders may elect to rebalance index options at renewal dates. At the end of each indexed term, which can be up to six years, we have the opportunity to re-price the indexed component by establishing participation rates, caps, spreads and specified rates, subject to contractual guarantees. We use call options that are highly correlated to the portfolio allocation decisions of our policyholders, such that we are economically hedged with respect to equity returns for the current reset period.

Consumer Price Index Swaps

We use consumer price index swaps to hedge the liability exposure on certain options in fixed annuity products. Consumer price index swaps are contracts entered into at no cost and whose payoff is the difference between the consumer price index inflation rate and the fixed-rate determined as of inception.

Equity Futures

We use equity futures contracts to hedge the liability exposure on certain options in variable annuity and RILA products. These futures contracts require payment between our counterparty and us on a daily basis for changes in the futures index price.

Put Options

We use put options to hedge the liability exposure on certain options in variable annuity, RILA and VUL products. Put options are contracts that require the buyers to pay at a specified future date the amount, if any, by which a specified equity index is less than the strike rate stated in the agreement, applied to a notional amount.

Total Return Swaps

We use total return swaps to hedge the liability exposure on certain options in variable annuity, RILA and VUL products.

In addition, we use total return swaps to hedge a portion of the liability related to our deferred compensation plans. We receive the total return on a portfolio of indexes and pay a floating-rate of interest.

Commodity Contracts

We use commodity contracts to economically hedge certain investments that are closely tied to the changes in commodity values. The commodity contract is an over-the-counter contract that combines a purchase put/sold call to lock in a commodity price within a predetermined range in exchange for a net premium.

Credit Contracts

We use derivative instruments as part of our credit risk management strategy that are economic hedges and include:

Credit Default Swaps – Buying Protection

We use credit default swaps (“CDSs”) to hedge the liability exposure on certain options in variable annuity products.

We buy CDSs to hedge against a drop in bond prices due to credit concerns of certain bond issuers. A CDS allows us to put the bond back to the counterparty at par upon a default event by the bond issuer. A default event is defined as bankruptcy, failure to pay, obligation acceleration or restructuring.

CDSs – Selling Protection

We use CDSs to hedge the liability exposure on certain options in variable annuity products.

18

Table of Contents

We sell CDSs to offer credit protection to policyholders and investors. The CDSs hedge the policyholders and investors against a drop in bond prices due to credit concerns of certain bond issuers. A CDS allows the investor to put the bond back to us at par upon a default event by the bond issuer. A default event is defined as bankruptcy, failure to pay, obligation acceleration or restructuring.

Embedded Derivatives

We have embedded derivatives that include:

RILA, Fixed Indexed Annuity and IUL Contracts Embedded Derivatives

Our RILA, fixed indexed annuity and IUL contracts permit the holder to elect an interest rate return or an equity market component, where interest credited to the contracts is linked to the performance of the S&P 500® Index or other indices. Policyholders may elect to rebalance index options at renewal dates. At the end of each indexed term, which can be up to six years, we have the opportunity to re-price the indexed component by establishing participation rates, caps, spreads and specified rates, subject to contractual guarantees. We use options that are highly correlated to the portfolio allocation decisions of our policyholders, such that we are economically hedged with respect to equity returns for the current reset period.

Reinsurance-Related Embedded Derivatives

We have certain modified coinsurance and coinsurance with funds withheld reinsurance agreements with embedded derivatives related to the withheld assets of the related funds. These derivatives are considered total return swaps with contractual returns that are attributable to various assets and liabilities associated with these reinsurance agreements.

19

Table of Contents

Primary Risks Managed by Derivatives

We have derivative instruments with off-balance-sheet risks whose notional or contract amounts exceed the related credit exposure. Outstanding derivative instruments with off-balance-sheet risks (in millions) were as follows:

	As of March 31, 2025						As of December 31, 2024
	Notional Amounts		Fair Value				Notional Amounts		Fair Value
			Asset		Liability				Asset		Liability
Qualifying Hedges
Cash flow hedges:
Interest rate contracts (1)	$	1,275	$	154	$	6	$	1,230	$	156	$	16
Foreign currency contracts (1)	4,805		552		44		4,738		556		44
Total cash flow hedges	6,080		706		50		5,968		712		60
Fair value hedges:
Interest rate contracts (1)	1,066		2		29		1,066		10		16
Foreign currency contracts (1)	25		–		–		25		1		–
Total fair value hedges	1,091		2		29		1,091		11		16
Non-Qualifying Hedges
Interest rate contracts (1)	81,364		40		334		75,445		63		439
Foreign currency contracts (1)	332		23		2		348		30		2
Equity market contracts (1)	168,433		10,477		3,081		191,666		13,072		3,879
Credit contracts (1)	242		–		–		57		–		–
Embedded derivatives:
Reinsurance-related (2)	–		–		138		–		–		30
RILA, fixed indexed annuity and IUL
contracts (3)	–		1,092		10,807		–		1,115		12,449
Total derivative instruments	$	257,542	$	12,340	$	14,441	$	274,575	$	15,003	$	16,875

(1) These asset and liability balances are presented on a gross basis. Amounts are reported in derivative investments and other liabilities on the Consolidated Balance Sheets after the evaluation for right of offset subject to master netting agreements.

(2) Reported in funds withheld reinsurance liabilities on the Consolidated Balance Sheets.

(3) Reported in policyholder account balances and deposit assets on the Consolidated Balance Sheets.

The maturity of the notional amounts of derivative instruments (in millions) was as follows:

	Remaining Life as of March 31, 2025
	Less Than 1 Year		1 - 5 Years		6 - 10 Years		11 - 30 Years		Over 30 Years		Total
Interest rate contracts (1)	$	12,810	$	18,418	$	23,981	$	27,898	$	598	$	83,705
Foreign currency contracts (2)	199		1,292		1,776		1,853		42		5,162
Equity market contracts	127,307		30,374		8,696		7		2,049		168,433
Credit contracts	–		172		70		–		–		242
Total derivative instruments with
notional amounts	$	140,316	$	50,256	$	34,523	$	29,758	$	2,689	$	257,542

(1) As of March 31, 2025, the latest maturity date for which we were hedging our exposure to the variability in future cash flows for these instruments was April 20, 2067.

(2) As of March 31, 2025, the latest maturity date for which we were hedging our exposure to the variability in future cash flows for these instruments was June 16, 2061.

20

Table of Contents

The following amounts (in millions) were recorded on the Consolidated Balance Sheets related to cumulative basis adjustments for fair value hedges:

	Amortized Cost of the Hedged Assets (Liabilities)				Cumulative Fair Value Hedging Adjustment Included in the Amortized Cost of the Hedged Assets (Liabilities)
	As of March 31,  2025		As of  December 31, 2024		As of March 31,  2025		As of  December 31, 2024
Line Item in the Consolidated Balance Sheets in
which the Hedged Item is Included
Fixed maturity AFS securities, at fair value	$	497	$	484	$	19	$	7
Long-term debt (1)	(691)		(676)		184		199

(1) Includes $(306) million and $(310) million of unamortized adjustments from discontinued hedges as of March 31, 2025, and December 31, 2024, respectively.

The change in our unrealized gain (loss) on derivative instruments within accumulated other comprehensive income (loss) (“AOCI”) (in millions) was as follows:

	For the Three Months Ended March 31,
	2025		2024
Unrealized Gain (Loss) on Derivative Instruments
Balance as of beginning-of-year	$	638	$	375
Other comprehensive income (loss):
Unrealized holding gains (losses) arising during the period:
Cash flow hedges:
Interest rate contracts	5		89
Foreign currency contracts	168		(25)
Change in foreign currency exchange rate adjustment	(153)		101
Income tax benefit (expense)	(4)		(35)
Less:
Reclassification adjustment for gains (losses)
included in net income (loss):
Cash flow hedges:
Foreign currency contracts (1)	15		15
Interest rate contracts (2)	3		9
Foreign currency contracts (3)	3		–
Income tax benefit (expense)	(4)		(5)
Balance as of end-of-period	$	637	$	486

(1) The OCI offset is reported within net investment income on the Consolidated Statements of Comprehensive Income (Loss).

(2) The OCI offset is reported within interest and debt expense on the Consolidated Statements of Comprehensive Income (Loss).

(3) The OCI offset is reported within realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss).

21

Table of Contents

The effects of qualifying and non-qualifying hedges (in millions) on the Consolidated Statements of Comprehensive Income (Loss) were as follows:

Gain (Loss) Recognized in Income For the Three Months Ended March 31,

2025

2024

Realized Gain (Loss)

Net Investment Income

Interest and Debt Expense

Realized Gain (Loss)

Net Investment Income

Interest and Debt Expense

Total Line Items in which the

Effects of Fair Value or Cash

Flow Hedges are Recorded

$

11

$

1,457

$

80

$

(434)

$

1,346

$

81

Qualifying Hedges

Gain or (loss) on fair value hedging

relationships:

Interest rate contracts:

Hedged items

–

11

(15)

–

(18)

17

Derivatives designated as hedging

instruments

–

(11)

15

–

18

(17)

Foreign currency contracts:

Hedged items

–

1

–

–

(1)

–

Derivatives designated as hedging

instruments

–

(1)

–

–

1

–

Gain or (loss) on cash flow hedging

relationships:

Interest rate contracts:

Amount of gain or (loss) reclassified

from AOCI into income

–

–

3

–

–

9

Foreign currency contracts:

Amount of gain or (loss) reclassified

from AOCI into income

3

15

–

–

15

–

Non-Qualifying Hedges

Interest rate contracts

82

–

–

(163)

–

–

Foreign currency contracts

(1)

–

–

–

–

–

Equity market contracts

(1,143)

–

–

2,134

–

–

Credit contracts

1

–

–

–

–

–

Embedded derivatives:

Reinsurance-related

(108)

–

–

197

–

–

RILA, fixed indexed annuity and IUL

contracts

1,654

–

–

(1,642)

–

–

As of March 31, 2025, $76 million of the deferred net gains (losses) on derivative instruments in AOCI were expected to be reclassified to earnings during the next 12 months. This reclassification would be due primarily to interest rate variances related to our interest rate swap agreements.

For the three months ended March 31, 2025 and 2024, there were no material reclassifications to earnings due to hedged firm commitments no longer deemed probable or due to hedged forecasted transactions that had not occurred by the end of the originally specified time period.

As of March 31, 2025, and December 31, 2024, we did not have any exposure related to CDSs for which we are the seller.

22

Table of Contents

Credit Risk

We are exposed to credit losses in the event of non-performance by our counterparties on various derivative contracts and reflect assumptions regarding the credit or non-performance risk. The non-performance risk is based upon assumptions for each counterparty’s credit spread over the estimated weighted average life of the counterparty exposure, less collateral held. As of March 31, 2025, the non-performance risk adjustment was zero. The credit risk associated with such agreements is minimized by entering into agreements with financial institutions with long-standing, superior performance records. Additionally, we maintain a policy of requiring derivative contracts to be governed by an International Swaps and Derivatives Association (“ISDA”) Master Agreement. We are required to maintain minimum ratings as a matter of routine practice in negotiating ISDA agreements. Under nearly all of our ISDA agreements, our insurance subsidiaries have agreed to maintain certain financial strength ratings. A downgrade below these levels could result in termination of derivative contracts, at which time any amounts payable by us would be dependent on the market value of the underlying derivative contracts. In certain transactions, we and the counterparty have entered into a credit support annex requiring either party to post collateral when net exposures exceed pre-determined thresholds. These thresholds vary by counterparty and credit rating. The amount of such exposure is essentially the net replacement cost or market value less collateral held for such agreements with each counterparty if the net market value is in our favor. We did not have any exposure as of March 31, 2025, or December 31, 2024.

The amounts recognized (in millions) by S&P credit rating of counterparty, for which we had the right to reclaim cash collateral or were obligated to return cash collateral, were as follows:

	As of March 31, 2025				As of December 31, 2024
S&P Credit Rating of Counterparty	Collateral Posted by Counterparty		Collateral Posted to Counterparty		Collateral Posted by Counterparty		Collateral Posted to Counterparty
AA-	$	3,314	$	(12)	$	4,043	$	(21)
A+	1,741		(28)		2,460		(89)
A	32		–		47		–
A-	449		–		632		–
Total cash collateral	$	5,536	$	(40)	$	7,182	$	(110)

23

Table of Contents

Balance Sheet Offsetting

Information related to the effects of offsetting on the Consolidated Balance Sheets (in millions) was as follows:

	As of March 31, 2025
	Derivative Instruments		Embedded Derivative Instruments		Total
Financial Assets
Gross amount of recognized assets	$	11,173	$	1,092	$	12,265
Gross amounts offset	(3,324)		–		(3,324)
Net amount of assets	7,849		1,092		8,941
Gross amounts not offset:
Cash collateral	(5,536)		–		(5,536)
Non-cash collateral (1)	(2,313)		–		(2,313)
Net amount	$	–	$	1,092	$	1,092
Financial Liabilities
Gross amount of recognized liabilities	$	197	$	10,945	$	11,142
Gross amounts offset	(100)		–		(100)
Net amount of liabilities	97		10,945		11,042
Gross amounts not offset:
Cash collateral	(40)		–		(40)
Non-cash collateral (2)	(57)		–		(57)
Net amount	$	–	$	10,945	$	10,945

(1) Excludes excess non-cash collateral received of $941 million, as the collateral offset is limited to the net estimated fair value of derivatives after application of netting arrangements.

(2) Excludes excess non-cash collateral pledged of $1 million, as the collateral offset is limited to the net estimated fair value of derivatives after application of netting arrangements.

24

Table of Contents

	As of December 31, 2024
	Derivative Instruments		Embedded Derivative Instruments		Total
Financial Assets
Gross amount of recognized assets	$	13,483	$	1,115	$	14,598
Gross amounts offset	(3,806)		–		(3,806)
Net amount of assets	9,677		1,115		10,792
Gross amounts not offset:
Cash collateral	(7,182)		–		(7,182)
Non-cash collateral (1)	(2,495)		–		(2,495)
Net amount	$	–	$	1,115	$	1,115
Financial Liabilities
Gross amount of recognized liabilities	$	617	$	12,479	$	13,096
Gross amounts offset	(432)		–		(432)
Net amount of liabilities	185		12,479		12,664
Gross amounts not offset:
Cash collateral	(110)		–		(110)
Non-cash collateral (2)	(75)		–		(75)
Net amount	$	–	$	12,479	$	12,479

(1) Excludes excess non-cash collateral received of $817 million, as the collateral offset is limited to the net estimated fair value of derivatives after application of netting arrangements.

(2) Excludes excess non-cash collateral pledged of $39 million, as the collateral offset is limited to the net estimated fair value of derivatives after application of netting arrangements.

25

Table of Contents

6. DAC, VOBA, DSI and DFEL

The following table reconciles deferred acquisition costs (“DAC”), value of business acquired (“VOBA”) and deferred sales inducements (“DSI”) (in millions) to the Consolidated Balance Sheets:

	As of March 31,		As of December 31,
	2025		2024
DAC, VOBA and DSI
Variable Annuities	$	4,001	$	3,964
Fixed Annuities	416		423
Traditional Life	1,352		1,370
UL and Other	6,323		6,318
Group Protection	181		178
Retirement Plan Services	288		284
Other Operations	2		–
Total DAC, VOBA and DSI	$	12,563	$	12,537

The following table reconciles deferred front-end loads (“DFEL”) (in millions) to the Consolidated Balance Sheets:

	As of March 31,		As of December 31,
	2025		2024
DFEL
Variable Annuities	$	270	$	273
UL and Other	6,587		6,406
Other Operations (1)	53		51
Total DFEL	$	6,910	$	6,730

(1) Represents DFEL reported in Other Operations attributable to the indemnity reinsurance agreement with Protective that is excluded from the following tables. We reported $53 million and $51 million of ceded DFEL in reinsurance recoverables on the Consolidated Balance Sheets as of March 31, 2025, and December 31, 2024, respectively.

26

Table of Contents

The following tables summarize the changes in DAC (in millions):

	For the Three Months Ended March 31, 2025
	Variable Annuities		Fixed Annuities		Traditional Life		UL and Other		Group Protection		Retirement Plan Services
Balance as of beginning-of-year	$	3,851	$	394	$	1,335	$	5,916	$	178	$	242
Deferrals	136		10		21		94		32		5
Amortization	(97)		(16)		(37)		(79)		(29)		(5)
Balance as of end-of-period	$	3,890	$	388	$	1,319	$	5,931	$	181	$	242

	For the Three Months Ended March 31, 2024
	Variable Annuities		Fixed Annuities		Traditional Life		UL and Other		Group Protection		Retirement Plan Services
Balance as of beginning-of-year	$	3,751	$	421	$	1,376	$	5,791	$	154	$	239
Deferrals	89		9		32		100		29		5
Amortization	(89)		(16)		(37)		(76)		(26)		(5)
Balance as of end-of-period	$	3,751	$	414	$	1,371	$	5,815	$	157	$	239

DAC amortization expense of $263 million and $249 million was recorded in commissions and other expenses on the Consolidated Statements of Comprehensive Income (Loss) for the three months ended March 31, 2025 and 2024, respectively.

The following tables summarize the changes in VOBA (in millions):

	For the Three Months Ended March 31, 2025
	Fixed Annuities		Traditional Life		UL and Other
Balance as of beginning-of-year	$	13	$	35	$	375
Amortization	(1)		(2)		(9)
Balance as of end-of-period	$	12	$	33	$	366

	For the Three Months Ended March 31, 2024
	Fixed Annuities		Traditional Life		UL and Other
Balance as of beginning-of-year	$	15	$	42	$	413
Amortization	(1)		(2)		(10)
Balance as of end-of-period	$	14	$	40	$	403

VOBA amortization expense of $12 million and $13 million was recorded in commissions and other expenses on the Consolidated Statements of Comprehensive Income (Loss) for the three months ended March 31, 2025 and 2024, respectively. No additions or write-offs were recorded for each respective period.

27

Table of Contents

The following tables summarize the changes in DSI (in millions):

	For the Three Months Ended March 31, 2025
	Variable Annuities		Fixed Annuities		UL and Other		Retirement Plan Services
Balance as of beginning-of-year	$	113	$	16	$	27	$	42
Deferrals	–		–		–		4
Amortization	(2)		–		(1)		–
Balance as of end-of-period	$	111	$	16	$	26	$	46

	For the Three Months Ended March 31, 2024
	Variable Annuities		Fixed Annuities		UL and Other		Retirement Plan Services
Balance as of beginning-of-year	$	122	$	19	$	28	$	26
Deferrals	1		–		–		8
Amortization	(3)		–		–		–
Balance as of end-of-period	$	120	$	19	$	28	$	34

DSI amortization expense of $3 million was recorded in interest credited on the Consolidated Statements of Comprehensive Income (Loss) for the three months ended March 31, 2025 and 2024.

The following tables summarize the changes in DFEL (in millions):

	For the Three Months Ended March 31, 2025				For the Three Months Ended March 31, 2024
	Variable Annuities		UL and Other		Variable Annuities		UL and Other
Balance as of beginning-of-year	$	273	$	6,406	$	278	$	5,579
Deferrals	3		279		5		267
Amortization	(6)		(98)		(6)		(68)
Balance as of end-of-period	270		6,587		277		5,778
Less: Ceded DFEL	–		237		–		258
Balance as of end-of-period, net of reinsurance	$	270	$	6,350	$	277	$	5,520

DFEL amortization of $104 million and $74 million was recorded in fee income on the Consolidated Statements of Comprehensive Income (Loss) for the three months ended March 31, 2025 and 2024, respectively.

28

Table of Contents

7. Reinsurance

Fortitude Re

Effective October 1, 2023, we entered into two reinsurance agreements with Fortitude Reinsurance Company Ltd. (“Fortitude Re”), an authorized Bermuda reinsurer with reciprocal jurisdiction reinsurer status in Indiana, to reinsure certain blocks of in-force UL with secondary guarantees (“ULSG”), MoneyGuard® and fixed annuity products, including group pension annuities. Fortitude Re represents our largest reinsurance exposure as of March 31, 2025, and December 31, 2024.

The first agreement was structured as a coinsurance treaty between us and Fortitude Re for the ULSG and fixed annuities blocks. As significant insurance risk was transferred for ULSG products and life-contingent annuities, amounts recoverable from Fortitude Re were $10.6 billion as of March 31, 2025, and December 31, 2024. We reported a deferred loss on the transaction of $2.6 billion as of March 31, 2025, and December 31, 2024. We amortized $23 million and $22 million of the deferred loss during the three months ended March 31, 2025 and 2024, respectively. Annuities that are not life-contingent do not contain significant insurance risk; therefore, we reported deposit assets for these contracts of $2.8 billion and $3.0 billion as of March 31, 2025, and December 31, 2024, respectively.

The second agreement was structured as coinsurance with funds withheld for the MoneyGuard block; however, as we retained significant insurance risk under the agreement, we reported deposit assets of $8.2 billion and $8.1 billion as of March 31, 2025, and December 31, 2024, respectively. In this coinsurance with funds withheld reinsurance agreement, we as the ceding company withhold, and therefore retain, the assets backing the deposit assets. We held investments with a carrying value of $9.2 billion and $9.3 billion in support of reserves associated with the Fortitude Re transaction in a funds withheld arrangement as of March 31, 2025, and December 31, 2024, respectively, which consisted of the following (in millions):

	As of March 31,		As of December 31,
	2025		2024
Fixed maturity AFS securities	$	7,549	$	7,764
Derivative investments	19		30
Other investments	1,465		1,419
Cash and invested cash	104		28
Accrued investment income	93		96
Total	$	9,230	$	9,337

8. MRBs

The following table reconciles market risk benefits (“MRBs”) (in millions) to MRB assets and MRB liabilities on the Consolidated Balance Sheets:

	As of March 31, 2025						As of December 31, 2024
	Assets		Liabilities		Net (Assets) Liabilities		Assets		Liabilities		Net (Assets) Liabilities
Variable Annuities	$	4,041	$	1,165	$	(2,876)	$	4,737	$	933	$	(3,804)
Fixed Annuities	73		137		64		78		110		32
Retirement Plan Services	43		4		(39)		45		3		(42)
Total MRBs	$	4,157	$	1,306	$	(2,851)	$	4,860	$	1,046	$	(3,814)

29

Table of Contents

The following table summarizes the balances of and changes in net MRB (assets) liabilities (in millions):

	As of or For the Three Months Ended March 31, 2025						As of or For the Three Months Ended March 31, 2024
	Variable Annuities		Fixed Annuities		Retirement Plan Services		Variable Annuities		Fixed Annuities		Retirement Plan Services
Balance as of beginning-of-year	$	(3,804)	$	32	$	(42)	$	(2,180)	$	32	$	(30)
Less: Effect of cumulative changes in
non-performance risk	(153)		(33)		–		(1,299)		(58)		(4)
Balance as of beginning-of-year, before the effect
of changes in non-performance risk	(3,651)		65		(42)		(881)		90		(26)
Issuances	5		–		–		3		–		–
Attributed fees collected	373		8		1		380		9		2
Benefit payments	(6)		–		–		(11)		–		–
Effect of changes in interest rates	396		39		1		(1,081)		(17)		(6)
Effect of changes in equity markets	456		2		2		(1,343)		(11)		(4)
Effect of changes in equity index volatility	31		–		–		4		(2)		–
In-force updates and other changes in MRBs (1)	59		(2)		1		51		1		1
Balance as of end-of-period, before the effect of
changes in non-performance risk	(2,337)		112		(37)		(2,878)		70		(33)
Effect of cumulative changes in
non-performance risk	(539)		(48)		(2)		(726)		(43)		(2)
Balance as of end-of-period	(2,876)		64		(39)		(3,604)		27		(35)
Less: Ceded MRB assets (liabilities)	(312)		–		–		(358)		–		–
Balance as of end-of-period, net of reinsurance	$	(2,564)	$	64	$	(39)	$	(3,246)	$	27	$	(35)
Weighted-average age of policyholders (years)	73		70		63		72		69		63
Net amount at risk (2)	$	2,518	$	255	$	4	$	2,056	$	210	$	3

(1)     Consists primarily of changes in MRB assets and liabilities related to differences between separate account fund performance and modeled indices and other changes such as actual to expected policyholder behavior.

(2)     Net amount at risk (“NAR”) is the current guaranteed minimum benefit in excess of the current account balance as of the balance sheet date. For guaranteed living benefits (“GLBs”), the guaranteed minimum benefit is calculated based on the present value of GLB payments. Our variable annuity products may offer more than one type of guaranteed benefit rider to a policyholder. In instances where more than one guaranteed benefit feature exists in a contract, the guaranteed benefit rider that provides the highest NAR is used in the calculation.

See “MRBs” in Note 12 for details related to our fair value judgments, assumptions, inputs and valuation methodology.

30

Table of Contents

9. Separate Accounts

The following table presents the fair value of separate account assets (in millions) reported on the Consolidated Balance Sheets by major investment category:

	As of March 31,		As of December 31,
	2025		2024
Mutual funds and collective investment trusts	$	161,823	$	167,759
Exchange-traded funds	249		336
Fixed maturity AFS securities	168		161
Cash and invested cash	77		12
Other investments	189		170
Total separate account assets	$	162,506	$	168,438

The following table reconciles separate account liabilities (in millions) to the Consolidated Balance Sheets:

	As of March 31,		As of December 31,
	2025		2024
Variable Annuities	$	113,635	$	117,998
UL and Other	28,106		28,841
Retirement Plan Services	20,708		21,541
Other Operations (1)	57		58
Total separate account liabilities	$	162,506	$	168,438

(1) Represents separate account liabilities reported in Other Operations primarily attributable to the indemnity reinsurance agreements with Protective ($47 million and $49 million as of March 31, 2025, and December 31, 2024, respectively) that are excluded from the following tables.

The following table summarizes the balances of and changes in separate account liabilities (in millions):

	As of or For the Three Months Ended March 31, 2025						As of or For the Three Months Ended March 31, 2024
	Variable Annuities		UL and Other		Retirement Plan Services		Variable Annuities		UL and Other		Retirement Plan Services
Balance as of beginning-of-year	$	117,998	$	28,841	$	21,541	$	113,356	$	25,150	$	19,699
Gross deposits	1,557		353		627		904		358		570
Withdrawals	(3,915)		(204)		(902)		(3,208)		(103)		(732)
Policyholder assessments	(656)		(246)		(46)		(648)		(246)		(44)
Change in market performance	(1,798)		(624)		(478)		7,503		1,885		1,475
Net transfers from (to) general account	449		(14)		(34)		269		(37)		18
Balance as of end-of-period	$	113,635	$	28,106	$	20,708	$	118,176	$	27,007	$	20,986
Cash surrender value	$	112,239	$	23,577	$	20,695	$	116,771	$	24,606	$	20,971

31

Table of Contents

10. Policyholder Account Balances

The following table reconciles policyholder account balances (in millions) to the Consolidated Balance Sheets:

	As of March 31,		As of December 31,
	2025		2024
Variable Annuities	$	34,370	$	35,267
Fixed Annuities	26,039		25,963
UL and Other	36,220		36,599
Retirement Plan Services	23,479		23,619
Other (1)	5,154		4,749
Total policyholder account balances	$	125,262	$	126,197

(1) Represents policyholder account balances reported primarily in Other Operations attributable to the indemnity reinsurance agreements with Protective ($4.3 billion and $4.4 billion as of March 31, 2025, and December 31, 2024, respectively) and funding agreements, that are excluded from the following tables. See “Funding Agreements” below for more information.

The following table summarizes the balances and changes in policyholder account balances (in millions):

	As of or For the Three Months Ended March 31, 2025
	Variable Annuities		Fixed Annuities		UL and Other		Retirement Plan Services
Balance as of beginning-of-year	$	35,267	$	25,963	$	36,599	$	23,619
Gross deposits	1,369		873		865		811
Withdrawals	(612)		(947)		(445)		(1,330)
Policyholder assessments	–		(15)		(1,104)		(4)
Net transfers from (to) separate account	(287)		–		14		211
Interest credited	199		210		356		172
Change in fair value of embedded derivative
instruments and other	(1,566)		(45)		(65)		–
Balance as of end-of-period	$	34,370	$	26,039	$	36,220	$	23,479
Weighted-average crediting rate	2.3%		3.2%		3.9%		2.9%
Net amount at risk (1) (2)	$	2,518	$	255	$	299,107	$	4
Cash surrender value	33,108		24,935		32,645		23,443

32

Table of Contents

	As of or For the Three Months Ended March 31, 2024
	Variable Annuities			Fixed Annuities			UL and Other			Retirement Plan Services
Balance as of beginning-of-year	$	29,141		$	25,355		$	37,180		$	23,784
Gross deposits	973			973			850			790
Withdrawals	(224)			(1,410)			(364)			(1,203)
Policyholder assessments	–			(17)			(1,124)			(3)
Net transfers from (to) separate account	(178)			–			38			50
Interest credited	158			183			365			168
Change in fair value of embedded derivative
instruments and other	1,538			78			61			–
Balance as of end-of-period	$	31,408		$	25,162		$	37,006		$	23,586
Weighted-average crediting rate	2.1		%	2.9		%	3.9		%	2.8		%
Net amount at risk (1) (2)	$	2,056		$	210		$	300,740		$	3
Cash surrender value	30,228			24,139			33,314			23,560

(1) NAR is the current guaranteed minimum benefit in excess of the current account balance as of the balance sheet date. For GLBs, the guaranteed minimum benefit is calculated based on the present value of GLB payments. Our variable annuity products may offer more than one type of guaranteed benefit rider to a policyholder. In instances where more than one guaranteed benefit rider exists in a contract, the guaranteed benefit rider that provides the highest NAR is used in the calculation.

(2) Calculation is based on total account balances and includes both policyholder account balances and separate account balances.

Funding Agreements

FABN Program

The Lincoln National Life Insurance Company (“LNL”) established a $5.0 billion funding agreement-backed notes (“FABN”) program in 2024 pursuant to which LNL may issue unsecured funding agreements to an unaffiliated and unconsolidated special purpose statutory trust (the “Trust”) that will then issue medium-term notes for which payment of interest and principal is secured by such funding agreement. Funding agreements issued to the Trust are reported in policyholder account balances on the Consolidated Balance Sheets, and the associated interest is reported within interest credited on the Consolidated Statements of Comprehensive Income (Loss). We had funding agreements issued under the program of $500 million as of March 31, 2025, compared to none as of December 31, 2024.

33

Table of Contents

The following table presents policyholder account balances (in millions) by range of guaranteed minimum crediting rates and the related range of difference, in basis points, between the interest being credited to policyholders and the respective guaranteed contract minimums:

	As of March 31, 2025
	At Guaranteed Minimum		1-50 Basis Points Above		51-100 Basis Points Above		101-150 Basis Points Above		Greater Than 150 Basis Points Above		Total
Range of Guaranteed
Minimum Crediting Rate
Variable Annuities
Up to 1.00%	$	9	$	–	$	–	$	–	$	–	$	9
1.01% - 2.00%	3		–		–		–		7		10
2.01% - 3.00%	495		–		–		–		–		495
3.01% - 4.00%	1,197		–		–		–		–		1,197
4.01% and above	7		–		–		–		–		7
Other (1)	–		–		–		–		–		32,652
Total	$	1,711	$	–	$	–	$	–	$	7	$	34,370
Fixed Annuities
Up to 1.00%	$	201	$	855	$	459	$	229	$	2,266	$	4,010
1.01% - 2.00%	223		202		146		161		5,908		6,640
2.01% - 3.00%	1,499		33		1		2		38		1,573
3.01% - 4.00%	930		–		–		–		–		930
4.01% and above	166		–		–		–		–		166
Other (1)	–		–		–		–		–		12,720
Total	$	3,019	$	1,090	$	606	$	392	$	8,212	$	26,039
UL and Other
Up to 1.00%	$	261	$	–	$	231	$	31	$	453	$	976
1.01% - 2.00%	541		–		–		–		2,976		3,517
2.01% - 3.00%	6,483		9		152		–		–		6,644
3.01% - 4.00%	14,972		–		1		–		–		14,973
4.01% and above	3,525		–		–		–		–		3,525
Other (1)	–		–		–		–		–		6,585
Total	$	25,782	$	9	$	384	$	31	$	3,429	$	36,220
Retirement Plan Services
Up to 1.00%	$	573	$	312	$	725	$	3,498	$	5,766	$	10,874
1.01% - 2.00%	477		996		1,847		451		662		4,433
2.01% - 3.00%	1,680		542		48		18		1		2,289
3.01% - 4.00%	4,194		107		8		11		–		4,320
4.01% and above	1,426		137		–		–		–		1,563
Total	$	8,350	$	2,094	$	2,628	$	3,978	$	6,429	$	23,479

34

Table of Contents

	As of March 31, 2024
	At Guaranteed Minimum		1-50 Basis Points Above		51-100 Basis Points Above		101-150 Basis Points Above		Greater Than 150 Basis Points Above		Total
Range of Guaranteed
Minimum Crediting Rate
Variable Annuities
Up to 1.00%	$	–	$	–	$	–	$	–	$	–	$	–
1.01% - 2.00%	5		–		–		–		6		11
2.01% - 3.00%	560		–		–		–		–		560
3.01% - 4.00%	1,319		–		–		–		–		1,319
4.01% and above	9		–		–		–		–		9
Other (1)	–		–		–		–		–		29,509
Total	$	1,893	$	–	$	–	$	–	$	6	$	31,408
Fixed Annuities
Up to 1.00%	$	679	$	605	$	560	$	493	$	2,466	$	4,803
1.01% - 2.00%	360		99		285		500		3,231		4,475
2.01% - 3.00%	1,749		39		5		1		25		1,819
3.01% - 4.00%	916		–		–		–		–		916
4.01% and above	177		–		–		–		–		177
Other (1)	–		–		–		–		–		12,972
Total	$	3,881	$	743	$	850	$	994	$	5,722	$	25,162
UL and Other
Up to 1.00%	$	264	$	–	$	219	$	119	$	30	$	632
1.01% - 2.00%	548		–		–		–		3,208		3,756
2.01% - 3.00%	6,848		10		149		–		–		7,007
3.01% - 4.00%	15,596		–		1		–		–		15,597
4.01% and above	3,722		–		–		–		–		3,722
Other (1)	–		–		–		–		–		6,292
Total	$	26,978	$	10	$	369	$	119	$	3,238	$	37,006
Retirement Plan Services
Up to 1.00%	$	437	$	500	$	740	$	3,706	$	4,320	$	9,703
1.01% - 2.00%	527		1,660		1,413		1,345		14		4,959
2.01% - 3.00%	2,342		21		63		17		1		2,444
3.01% - 4.00%	4,842		31		3		3		–		4,879
4.01% and above	1,458		143		–		–		–		1,601
Total	$	9,606	$	2,355	$	2,219	$	5,071	$	4,335	$	23,586

(1) Consists of indexed account balances that include the fair value of embedded derivative instruments, non-life contingent payout annuity account balances, short-term dollar cost averaging annuities business and policy loans.

35

Table of Contents

11. Future Contract Benefits

The following table reconciles future contract benefits (in millions) to the Consolidated Balance Sheets:

	As of March 31,		As of December 31,
	2025		2024
Payout Annuities (1)	$	2,033	$	2,009
Traditional Life (1)	3,821		3,774
Group Protection (2)	5,712		5,628
UL and Other (3)	16,702		16,062
Other Operations (4)	9,062		9,070
Other (5)	3,335		3,264
Total future contract benefits	$	40,665	$	39,807

(1) See “Liability for Future Policy Benefits” below for further information.

(2) See “Liability for Future Claims” below for further information.

(3) See “Additional Liabilities for Other Insurance Benefits” below for further information.

(4) Represents future contract benefits reported in Other Operations primarily attributable to the indemnity reinsurance agreements with Protective ($5.4 billion as of March 31, 2025, and December 31, 2024) and Swiss Re ($1.8 billion as of March 31, 2025, and December 31, 2024) that are excluded from the following tables.

(5) Represents other miscellaneous reserves that are not representative of long-duration contracts and are excluded from the following tables.

36

Table of Contents

Liability for Future Policy Benefits

The following table summarizes the balances of and changes in the present values of expected net premiums and liability for future policy benefits (“LFPB”) (in millions, except years):

	As of or For the Three Months Ended March 31, 2025				As of or For the Three Months Ended March 31, 2024
	Payout Annuities		Traditional Life		Payout Annuities		Traditional Life
Present Value of Expected Net Premiums
Balance as of beginning-of-year	$	–	$	5,873	$	–	$	6,200
Less: Effect of cumulative changes in discount
rate assumptions	–		(275)		–		(148)
Beginning balance at original discount rate	–		6,148		–		6,348
Effect of actual variances from expected experience	–		(48)		–		2
Adjusted balance as of beginning-of-year	–		6,100		–		6,350
Issuances	–		64		–		108
Interest accrual	–		62		–		63
Net premiums collected	–		(192)		–		(202)
Flooring impact of LFPB	–		(5)		–		3
Ending balance at original discount rate	–		6,029		–		6,322
Effect of cumulative changes in discount
rate assumptions	–		(196)		–		(254)
Balance as of end-of-period	$	–	$	5,833	$	–	$	6,068
Present Value of Expected LFPB
Balance as of beginning-of-year	$	2,009	$	9,647	$	2,085	$	10,041
Less: Effect of cumulative changes in discount
rate assumptions	(251)		(438)		(187)		(189)
Beginning balance at original discount rate (1)	2,260		10,085		2,272		10,230
Effect of actual variances from expected experience	(1)		(55)		1		7
Adjusted balance as of beginning-of-year	2,259		10,030		2,273		10,237
Issuances	22		64		15		108
Interest accrual	22		99		22		100
Benefit payments	(49)		(234)		(49)		(206)
Ending balance at original discount rate (1)	2,254		9,959		2,261		10,239
Effect of cumulative changes in discount
rate assumptions	(221)		(305)		(227)		(378)
Balance as of end-of-period	$	2,033	$	9,654	$	2,034	$	9,861
Net balance as of end-of-period	$	2,033	$	3,821	$	2,034	$	3,793
Less: Reinsurance recoverables	1,478		360		1,562		421
Net balance as of end-of-period, net of reinsurance	$	555	$	3,461	$	472	$	3,372
Weighted-average duration of future policyholder
benefit liability (years)	9		9		9		9

(1) Includes deferred profit liability within Payout Annuities of $65 million and $60 million as of March 31, 2025 and 2024, respectively.

For the three months ended March 31, 2025 and 2024, Payout Annuities and Traditional Life did not have any significantly different actual experience compared to expected.

37

Table of Contents

The following table summarizes the discounted and undiscounted expected future gross premiums and expected future benefit payments (in millions):

	As of March 31, 2025				As of March 31, 2024
	Undiscounted		Discounted		Undiscounted		Discounted
Payout Annuities
Expected future gross premiums	$	–	$	–	$	–	$	–
Expected future benefit payments	3,408		2,033		3,438		2,034
Traditional Life
Expected future gross premiums	13,807		9,447		13,896		9,570
Expected future benefit payments	14,129		9,654		14,582		9,861

The following table summarizes the gross premiums and interest accretion (in millions) recognized in insurance premiums and benefits, respectively, on the Consolidated Statements of Comprehensive Income (Loss):

	For the Three Months Ended March 31,
	2025		2024
Payout Annuities
Gross premiums	$	23	$	21
Interest accretion	22		22
Traditional Life
Gross premiums	314		314
Interest accretion	37		37

The following table summarizes the weighted-average interest rates:

	For the Three Months Ended March 31,
	2025		2024
Payout Annuities
Interest accretion rate	4.0	%	3.9	%
Current discount rate	5.2	%	5.2	%
Traditional Life
Interest accretion rate	5.0	%	5.0	%
Current discount rate	4.9	%	5.0	%

38

Table of Contents

Liability for Future Claims

The following table summarizes the balances of and changes in liability for future claims (in millions, except years):

	Group Protection
	As of or For the Three Months Ended March 31,
	2025		2024
Balance as of beginning-of-year	$	5,628	$	5,689
Less: Effect of cumulative changes in discount
rate assumptions	(550)		(490)
Beginning balance at original discount rate	6,178		6,179
Effect of actual variances from expected experience	(72)		(67)
Adjusted beginning-of-year balance	6,106		6,112
New incidence	402		408
Interest	50		48
Benefit payments	(371)		(382)
Ending balance at original discount rate	6,187		6,186
Effect of cumulative changes in discount
rate assumptions	(475)		(546)
Balance as of end-of-period	5,712		5,640
Less: Reinsurance recoverables	121		123
Balance as of end-of-period, net of reinsurance	$	5,591	$	5,517
Weighted-average duration of liability for future
claims (years)	5		5

For the three months ended March 31, 2025, we experienced more favorable reported incidence and claim terminations than assumed.

For the three months ended March 31, 2024, we experienced more favorable claim terminations than assumed.

The following table summarizes the discounted and undiscounted expected future benefit payments (in millions):

	As of March 31, 2025				As of March 31, 2024
	Undiscounted		Discounted		Undiscounted		Discounted
Group Protection
Expected future benefit payments	$	7,413	$	5,712	$	7,296	$	5,640

The following table summarizes the gross premiums and interest accretion (in millions) recognized in insurance premiums and benefits, respectively, on the Consolidated Statements of Comprehensive Income (Loss):

	For the Three Months Ended March 31,
	2025		2024
Group Protection
Gross premiums	$	933	$	896
Interest accretion	50		48

39

Table of Contents

The following table summarizes the weighted-average interest rates:

	For the Three Months Ended March 31,
	2025		2024
Group Protection
Interest accretion rate	3.4	%	3.2	%
Current discount rate	4.9	%	5.0	%

Additional Liabilities for Other Insurance Benefits

The following table summarizes the balances of and changes in additional liabilities for other insurance benefits (in millions, except years):

	UL and Other
	As of or For the Three Months Ended March 31,
	2025		2024
Balance as of beginning-of-year	$	16,062	$	15,000
Less: Effect of cumulative changes in shadow
balance in AOCI	(2,673)		(2,222)
Balance as of beginning-of-year, excluding
shadow balance in AOCI	18,735		17,222
Effect of actual variances from expected experience	23		106
Adjusted beginning-of-year balance	18,758		17,328
Interest accrual	228		209
Net assessments collected	293		303
Benefit payments	(200)		(313)
Balance as of end-of-period, excluding shadow
balance in AOCI	19,079		17,527
Effect of cumulative changes in shadow
balance in AOCI	(2,377)		(3,083)
Balance as of end-of-period	16,702		14,444
Less: Reinsurance recoverables	5,316		4,776
Balance as of end-of-period, net of reinsurance	$	11,386	$	9,668
Weighted-average duration of additional liabilities
for other insurance benefits (years)	16		17

For the three months ended March 31, 2025, we did not have any significantly different actual experience compared to expected.

For the three months ended March 31, 2024, we had unfavorable actual mortality experience compared to expected on reinsured and retained business.

40

Table of Contents

The following table summarizes the gross assessments and interest accretion (in millions) recognized in insurance premiums and benefits, respectively, on the Consolidated Statements of Comprehensive Income (Loss):

	For the Three Months Ended March 31,
	2025		2024
UL and Other
Gross assessments	$	700	$	766
Interest accretion	228		209

The following table summarizes the weighted-average interest rates:

	For the Three Months Ended March 31,
	2025		2024
UL and Other
Interest accretion rate	5.4	%	5.3	%

12. Fair Value of Financial Instruments

Financial Instruments Carried at Fair Value

The following summarizes our financial instruments carried at fair value (in millions) on a recurring basis by the fair value hierarchy levels:

41

Table of Contents

	As of March 31, 2025
	Quoted
	Prices
	in Active
	Markets for		Significant		Significant
	Identical		Observable		Unobservable		Total
	Assets		Inputs		Inputs		Fair
	(Level 1)		(Level 2)		(Level 3)		Value
Assets
Investments:
Fixed maturity AFS securities:
Corporate bonds	$	–	$	63,911	$	2,974	$	66,885
U.S. government bonds	518		20		–		538
State and municipal bonds	–		2,350		–		2,350
Foreign government bonds	–		239		–		239
RMBS	–		1,922		19		1,941
CMBS	–		1,800		30		1,830
ABS	–		11,610		2,631		14,241
Hybrid and redeemable preferred securities	47		145		81		273
Trading securities	–		1,697		287		1,984
Equity securities	–		310		35		345
Mortgage loans on real estate	–		–		232		232
Derivative investments (1)	–		11,238		10		11,248
Other investments – short-term investments	–		468		15		483
MRB assets	–		–		4,157		4,157
Other assets:
Ceded MRBs	–		–		2		2
Indexed annuity ceded embedded derivatives	–		–		1,092		1,092
Separate account assets	373		162,133		–		162,506
Total assets	$	938	$	257,843	$	11,565	$	270,346
Liabilities
Policyholder account balances – RILA, fixed annuity
and IUL contracts	$	–	$	–	$	(10,807)	$	(10,807)
Funds withheld reinsurance liabilities – reinsurance-related
embedded derivatives	–		185		(323)		(138)
MRB liabilities	–		–		(1,306)		(1,306)
Other liabilities:
Ceded MRBs	–		–		(314)		(314)
Derivative liabilities (1)	–		(3,377)		(119)		(3,496)
Total liabilities	$	–	$	(3,192)	$	(12,869)	$	(16,061)

42

Table of Contents

	As of December 31, 2024
	Quoted
	Prices
	in Active
	Markets for		Significant		Significant
	Identical		Observable		Unobservable		Total
	Assets		Inputs		Inputs		Fair
	(Level 1)		(Level 2)		(Level 3)		Value
Assets
Investments:
Fixed maturity AFS securities:
Corporate bonds	$	–	$	63,585	$	2,865	$	66,450
U.S. government bonds	371		20		–		391
State and municipal bonds	–		2,371		–		2,371
Foreign government bonds	–		237		–		237
RMBS	–		1,851		12		1,863
CMBS	–		1,657		8		1,665
ABS	–		11,781		2,099		13,880
Hybrid and redeemable preferred securities	48		133		73		254
Trading securities	–		1,760		265		2,025
Equity securities	–		260		34		294
Mortgage loans on real estate	–		–		232		232
Derivative investments (1)	–		13,884		3		13,887
Other investments – short-term investments	–		369		23		392
MRB assets	–		–		4,860		4,860
Other assets:
Ceded MRBs	–		–		2		2
Indexed annuity ceded embedded derivatives	–		–		1,115		1,115
Separate account assets	391		168,047		–		168,438
Total assets	$	810	$	265,955	$	11,591	$	278,356
Liabilities
Policyholder account balances – RILA, fixed annuity
and IUL contracts	$	–	$	–	$	(12,449)	$	(12,449)
Funds withheld reinsurance liabilities – reinsurance-related
embedded derivatives	–		204		(234)		(30)
MRB liabilities	–		–		(1,046)		(1,046)
Other liabilities:
Ceded MRBs	–		–		(381)		(381)
Derivative liabilities (1)	–		(4,256)		(139)		(4,395)
Total liabilities	$	–	$	(4,052)	$	(14,249)	$	(18,301)

(1) Derivative investment assets and liabilities are presented within the fair value hierarchy on a gross basis by derivative type and not on a master netting basis by counterparty.

43

Table of Contents

The following summarizes changes to our financial instruments carried at fair value (in millions) and classified within Level 3 of the fair value hierarchy. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology. The summary schedule excludes changes to MRB assets and MRB liabilities as these balances are rolled forward in Note 8.

	For the Three Months Ended March 31, 2025
					Gains		Issuances,		Transfers
			Items		(Losses)		Sales,		Into or
			Included		in		Maturities,		Out
	Beginning		in		OCI		Settlements,		of		Ending
	Fair		Net		and		Calls,		Level 3,		Fair
	Value		Income		Other (1)		Net		Net		Value
Assets
Investments: (2)
Fixed maturity AFS securities:
Corporate bonds	$	2,865	$	(13)	$	1	$	99	$	22	$	2,974
RMBS	12		–		–		7		–		19
CMBS	8		–		–		22		–		30
ABS	2,099		(21)		18		478		57		2,631
Hybrid and redeemable preferred
securities	73		–		–		18		(10)		81
Trading securities	265		1		–		4		17		287
Equity securities	34		(6)		–		7		–		35
Mortgage loans on real estate	232		(1)		2		(1)		–		232
Other investments	23		–		–		(8)		–		15
Other assets:
Ceded MRBs (3)	2		–		–		–		–		2
Indexed annuity ceded embedded
derivatives (4)	1,115		(24)		–		1		–		1,092
Liabilities
Policyholder account balances –
RILA, fixed annuity and
IUL contracts (4)	(12,449)		1,676		–		(34)		–		(10,807)
Funds withheld reinsurance
liabilities – reinsurance-related
embedded derivatives (4)	(234)		(89)		–		–		–		(323)
Other liabilities:
Ceded MRBs (3)	(381)		67		–		–		–		(314)
Derivative liabilities	(136)		27		–		–		–		(109)
Total, net	$	(6,472)	$	1,617	$	21	$	593	$	86	$	(4,155)

44

Table of Contents

	For the Three Months Ended March 31, 2024
					Gains		Issuances,		Transfers
			Items		(Losses)		Sales,		Into or
			Included		in		Maturities,		Out
	Beginning		in		OCI		Settlements,		of		Ending
	Fair		Net		and		Calls,		Level 3,		Fair
	Value		Income		Other (1)		Net		Net		Value
Assets
Investments: (2)
Fixed maturity AFS securities:
Corporate bonds	$	2,497	$	2	$	(10)	$	22	$	(22)	$	2,489
State and municipal bonds	5		–		–		–		(5)		–
RMBS	13		–		(1)		–		–		12
CMBS	8		–		–		–		–		8
ABS	1,484		–		(1)		201		8		1,692
Hybrid and redeemable preferred
securities	48		–		3		–		–		51
Trading securities	284		–		–		(13)		–		271
Equity securities	42		(3)		–		–		–		39
Mortgage loans on real estate	288		–		1		–		–		289
Derivative investments	36		12		–		4		(51)		1
Other assets:
Ceded MRBs (3)	2		–		–		–		–		2
Indexed annuity ceded embedded
derivatives (4)	940		33		–		–		–		973
Liabilities
Policyholder account balances –
RILA, fixed annuity and
IUL contracts (4)	(9,077)		(1,677)		–		(142)		–		(10,896)
Funds withheld reinsurance
liabilities – reinsurance-related
embedded derivatives (4)	(789)		206		–		–		–		(583)
Other liabilities – ceded MRBs (3)	(239)		(121)		–		–		–		(360)
Total, net	$	(4,458)	$	(1,548)	$	(8)	$	72	$	(70)	$	(6,012)

(1) The changes in fair value of the interest rate swaps are offset by an adjustment to derivative investments (see Note 5).

(2) Amortization and accretion of premiums and discounts are included in net investment income on the Consolidated Statements of Comprehensive Income (Loss). Gains (losses) from sales, maturities, settlements and calls and credit loss expense are included in realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss).

(3) Gains (losses) from the changes in fair value are included in market risk benefit gain (loss) on the Consolidated Statements of Comprehensive Income (Loss).

(4) Gains (losses) from the changes in fair value are included in realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss).

45

Table of Contents

The following provides the components of the items included in issuances, sales, maturities, settlements and calls, net, (in millions) as reported above:

	For the Three Months Ended March 31, 2025
	Issuances		Sales		Maturities		Settlements		Calls		Total
Investments:
Fixed maturity AFS securities:
Corporate bonds	$	246	$	(45)	$	–	$	(102)	$	–	$	99
RMBS	7		–		–		–		–		7
CMBS	22		–		–		–		–		22
ABS	594		–		(10)		(90)		(16)		478
Hybrid and redeemable preferred
securities	20		(2)		–		–		–		18
Trading securities	50		(42)		–		(4)		–		4
Equity securities	8		(1)		–		–		–		7
Mortgage loans on real estate	–		(1)		–		–		–		(1)
Other investments	2		–		(10)		–		–		(8)
Other assets – indexed annuity ceded
embedded derivatives	27		–		–		(26)		–		1
Policyholder account balances –
RILA, fixed annuity and
IUL contracts	(234)		–		–		200		–		(34)
Total, net	$	742	$	(91)	$	(20)	$	(22)	$	(16)	$	593

	For the Three Months Ended March 31, 2024
	Issuances		Sales		Maturities		Settlements		Calls		Total
Investments:
Fixed maturity AFS securities:
Corporate bonds	$	277	$	(141)	$	(2)	$	(111)	$	(1)	$	22
ABS	264		–		–		(63)		–		201
Trading securities	–		(2)		–		(11)		–		(13)
Mortgage loans on real estate	1		(1)		–		–		–		–
Derivative investments	7		–		(3)		–		–		4
Other assets – indexed annuity ceded
embedded derivatives	26		–		–		(26)		–		–
Policyholder account balances –
RILA, fixed annuity and
IUL contracts	(249)		–		–		107		–		(142)
Total, net	$	326	$	(144)	$	(5)	$	(104)	$	(1)	$	72

46

Table of Contents

The following summarizes changes in unrealized gains (losses) included in net income related to financial instruments carried at fair value classified within Level 3 that we still held (in millions):

	For the Three Months Ended March 31,
	2025		2024
Investments:
Trading securities (1)	$	(3)	$	–
Equity securities (1)	(6)		(3)
Mortgage loans on real estate (1)	(1)		–
Derivative investments (1)	12		16
MRBs (2)	(1,299)		1,896
Funds withheld reinsurance liabilities –
reinsurance-related embedded derivatives (1)	(89)		206
Embedded derivatives – indexed annuity
and IUL contracts (1)	169		241
Total, net	$	(1,217)	$	2,356

(1) Included in realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss).

(2) Included in market risk benefit gain (loss) on the Consolidated Statements of Comprehensive Income (Loss).

The following summarizes changes in unrealized gains (losses) included in OCI, net of tax, related to financial instruments carried at fair value classified within Level 3 that we still held (in millions):

	For the Three Months Ended March 31,
	2025		2024
Investments:
Fixed maturity AFS securities:
Corporate bonds	$	(7)	$	(11)
ABS	16		(1)
Hybrid and redeemable preferred
securities	–		2
Mortgage loans on real estate	2		1
Total, net	$	11	$	(9)

47

Table of Contents

The following provides the components of the transfers into and out of Level 3 (in millions) as reported above:

	For the Three Months Ended March 31, 2025						For the Three Months Ended March 31, 2024
	Transfers		Transfers				Transfers		Transfers
	Into		Out of				Into		Out of
	Level 3		Level 3		Total		Level 3		Level 3		Total
Investments:
Fixed maturity AFS securities:
Corporate bonds	$	22	$	–	$	22	$	22	$	(44)	$	(22)
State and municipal bonds	–		–		–		–		(5)		(5)
ABS	57		–		57		31		(23)		8
Hybrid and redeemable preferred
securities	–		(10)		(10)		–		–		–
Trading securities	17		–		17		–		–		–
Derivative investments	–		–		–		–		(51)		(51)
Total, net	$	96	$	(10)	$	86	$	53	$	(123)	$	(70)

Transfers into and out of Level 3 are generally the result of observable market information on financial instruments no longer being available or becoming available to our pricing vendors. For the three months ended March 31, 2025 and 2024, transfers in and out of Level 3 were attributable primarily to the financial instruments’ observable market information no longer being available or becoming available.

48

Table of Contents

The following summarizes the fair value (in millions), valuation techniques and significant unobservable inputs of the Level 3 fair value measurements as of March 31, 2025:

										Weighted
										Average
	Fair		Valuation	Significant	Assumption or					Input
	Value		Technique	Unobservable Inputs	Input Ranges					Range (1)
Assets
Investments:
Fixed maturity AFS
securities:
Corporate bonds	$	190	Discounted cash flow	Liquidity/duration adjustment (2)	0.0	%	–	4.3	%	1.9	%
ABS	10		Discounted cash flow	Liquidity/duration adjustment (2)	1.4	%	–	1.4	%	1.4	%
CMBS	8		Discounted cash flow	Liquidity/duration adjustment (2)	2.0	%	—	2.0	%	2.0	%
Hybrid and redeemable
preferred securities	39		Discounted cash flow	Liquidity/duration adjustment (2)	1.2	%	–	2.1	%	1.8	%
Equity securities	5		Discounted cash flow	Liquidity/duration adjustment (2)	4.5	%	–	4.5	%	4.5	%
MRB assets	4,157		Discounted cash flow	Lapse (3)	1.0	%	—	30.0	%	(10)
				Utilization of GLB withdrawals (4)	85.0	%	—	100.0	%	92.0	%
				Claims utilization factor (5)	60.0	%	—	100.0	%	(10)
				Premiums utilization factor (5)	80.0	%	—	115.0	%	(10)
				Non-performance risk (6)	0.3	%	—	2.2	%	1.8	%
				Mortality (7)				(9)		(10)
				Volatility (8)	1.0	%	—	29.0	%	14.3	%
Other assets:
Ceded MRBs (11)	2
Indexed annuity
ceded embedded
derivatives	1,092		Discounted cash flow	Lapse (3)	0.0	%	–	9.0	%	(10)
				Mortality (7)				(9)		(10)
Liabilities
Policyholder account
balances – indexed annuity
contracts embedded
derivatives	$	(10,860)	Discounted cash flow	Lapse (3)	0.0	%	–	9.0	%	(10)
				Mortality (7)				(9)		(10)
MRB liabilities	(1,306)		Discounted cash flow	Lapse (3)	1.0	%	—	30.0	%	(10)
				Utilization of GLB withdrawals (4)	85.0	%	—	100.0	%	92.0	%
				Claims utilization factor (5)	60.0	%	—	100.0	%	(10)
				Premiums utilization factor (5)	80.0	%	—	115.0	%	(10)
				Non-performance risk (6)	0.3	%	—	2.2	%	1.8	%
				Mortality (7)				(9)		(10)
				Volatility (8)	1.0	%	—	29.0	%	14.3	%
Other liabilities – ceded
MRBs (11)	(314)

49

Table of Contents

The following summarizes the fair value (in millions), valuation techniques and significant unobservable inputs of the Level 3 fair value measurements as of December 31, 2024:

										Weighted
										Average
	Fair		Valuation	Significant	Assumption or					Input
	Value		Technique	Unobservable Inputs	Input Ranges					Range (1)
Assets
Investments:
Fixed maturity AFS
securities:
Corporate bonds	$	187	Discounted cash flow	Liquidity/duration adjustment (2)	0.0	%	–	3.1	%	1.7	%
ABS	10		Discounted cash flow	Liquidity/duration adjustment (2)	1.3	%	–	1.3	%	1.3	%
CMBS	8		Discounted cash flow	Liquidity/duration adjustment (2)	1.9	%	–	1.9	%	1.9	%
Hybrid and redeemable
preferred securities	19		Discounted cash flow	Liquidity/duration adjustment (2)	1.4	%	–	1.9	%	1.8	%
Equity securities	5		Discounted cash flow	Liquidity/duration adjustment (2)	4.5	%	–	4.5	%	4.5	%
MRB assets	4,860		Discounted cash flow	Lapse (3)	1.0	%	—	30.0	%	(10)
				Utilization of GLB withdrawals (4)	85.0	%	–	100.0	%	92.0	%
				Claims utilization factor (5)	60.0	%	–	100.0	%	(10)
				Premiums utilization factor (5)	80.0	%	–	115.0	%	(10)
				Non-performance risk (6)	0.3	%	–	2.0	%	1.6	%
				Mortality (7)				(9)		(10)
				Volatility (8)	1.0	%	–	29.0	%	14.5	%
Other assets:
Ceded MRBs (11)	2
Indexed annuity
ceded embedded
derivatives	1,115		Discounted cash flow	Lapse (3)	0.0	%	—	9.0	%	(10)
				Mortality (7)				(9)		(10)
Liabilities
Policyholder account
balances – indexed annuity
contracts embedded
derivatives	$	(12,402)	Discounted cash flow	Lapse (3)	0.0	%	–	9.0	%	(10)
				Mortality (7)				(9)		(10)
MRB liabilities	(1,046)		Discounted cash flow	Lapse (3)	1.0	%	–	30.0	%	(10)
				Utilization of GLB withdrawals (4)	85.0	%	–	100.0	%	92.0	%
				Claims utilization factor (5)	60.0	%	–	100.0	%	(10)
				Premiums utilization factor (5)	80.0	%	–	115.0	%	(10)
				Non-performance risk (6)	0.3	%	—	2.0	%	1.6	%
				Mortality (7)				(9)		(10)
				Volatility (8)	1.0	%	–	29.0	%	14.5	%
Other liabilities – ceded
MRBs (11)	(381)

(1) Unobservable inputs were weighted by the relative fair value of the instruments, unless otherwise noted.

(2) The liquidity/duration adjustment input represents an estimated market participant composite of adjustments attributable to liquidity premiums, expected durations, structures and credit quality that would be applied to the market observable information of an investment.

(3) The lapse input represents the estimated probability of a contract surrendering during a year, and thereby forgoing any future benefits. The range for indexed annuity contracts represents the lapses during the surrender charge period.

(4) The utilization of GLB withdrawals input represents the estimated percentage of policyholders that utilize the GLB withdrawal riders.

50

Table of Contents

(5) The utilization factors are applied to the present value of claims or premiums, as appropriate, in the MRB calculation to estimate the impact of inefficient GLB withdrawal behavior, including taking less than or more than the maximum GLB withdrawal.

(6) The non-performance risk input represents the estimated additional credit spread that market participants would apply to the market observable discount rate when pricing a contract. The non-performance risk input was weighted by the absolute value of the sensitivity of the reserve to the non-performance risk assumption.

(7) The mortality input represents the estimated probability of when an individual belonging to a particular group, categorized according to age or some other factor such as gender, will die.

(8) The volatility input represents overall volatilities assumed for the underlying variable annuity funds, which include a mixture of equity and fixed-income assets. Volatility assumptions vary by fund due to the benchmarking of different indices. The volatility input was weighted by the relative account balance assigned to each index.

(9) The mortality is based on a combination of company and industry experience, adjusted for improvement factors.

(10) A weighted average input range is not a meaningful measurement for lapse, utilization factors or mortality.

(11) The fair value inputs for ceded MRBs are consistent with those used to value MRB assets and liabilities.

From the table above, we have excluded Level 3 fair value measurements obtained from independent, third-party pricing sources. We do not develop the significant inputs used to measure the fair value of these assets and liabilities, and the information regarding the significant inputs is not readily available to us. Independent broker-quoted fair values are non-binding quotes developed by market makers or broker-dealers obtained from third-party sources recognized as market participants. The fair value of a broker-quoted asset or liability is based solely on the receipt of an updated quote from a single market maker or a broker-dealer recognized as a market participant as we do not adjust broker quotes when used as the fair value measurement for an asset or liability. Significant increases or decreases in any of the quotes received from a third-party broker-dealer may result in a significantly higher or lower fair value measurement.

The embedded derivative liability associated with Fortitude Re was excluded from the above table. As discussed in Note 7, this embedded derivative liability was created through a coinsurance with funds withheld reinsurance agreement where the investments supporting the reinsurance agreement were withheld by and continue to be reported on the Consolidated Balance Sheets. This reinsurance-related embedded derivative is valued as a total return swap with reference to the fair value of the investments held by us. Accordingly, the unobservable inputs utilized in the valuation of the reinsurance-related embedded derivative are a component of the investments supporting the reinsurance agreement that are reported on the Consolidated Balance Sheets.

Changes in any of the significant inputs presented in the table above would have resulted in a significant change in the fair value measurement of the asset or liability as follows:

•Investments – An increase in the liquidity/duration adjustment input would have resulted in a decrease in the fair value measurement.

•Indexed annuity contracts embedded derivatives – For direct embedded derivatives, an increase in the lapse or mortality inputs would have resulted in a decrease in the fair value measurement.

•MRBs – Assuming our MRBs are in a liability position: an increase in our lapse, non-performance risk or mortality inputs would have resulted in a decrease in the fair value measurement, except for policies with guaranteed death benefit (“GDB”) riders only, in which case an increase in mortality inputs would have resulted in an increase in the fair value measurement.

For each category discussed above, the unobservable inputs are not inter-related; therefore, a directional change in one input would not have affected the other inputs.

As part of our ongoing valuation process, we assess the reasonableness of our valuation techniques or models and make adjustments as necessary.

Fair Value Option

Mortgage loans on real estate, net of allowance for credit losses, as reported on the Consolidated Balance Sheets, includes mortgage loans on real estate for which the fair value option was elected. The fair value option allows us to elect fair value as an alternative measurement for mortgage loans not otherwise reported at fair value. We have made these elections for certain mortgage loans associated with modified coinsurance agreements to help mitigate the inconsistency in earnings that would otherwise result from the use of embedded derivatives included with these loans. Changes in fair value are reflected in realized gain (loss) on the Consolidated Statement of Comprehensive Income (Loss). Changes in fair value due to instrument-specific credit risk are estimated using changes in credit spreads and quality ratings for the period reported. Mortgage loans on real estate for which the fair value option was elected are valued using third-party pricing services. We have procedures in place to review the valuations each quarter to ensure they are reasonable, including utilizing a separate third party to reperform the valuation for a selection of mortgage loans on an annual basis. Due to lack of observable inputs, mortgage loans electing the fair value option are classified as Level 3 within the fair value hierarchy.

51

Table of Contents

The fair value and aggregate contractual principal for mortgage loans on real estate where the fair value option was elected (in millions) were as follows:

	As of March 31,		As of December 31,
	2025		2024
Fair value	$	232	$	232
Aggregate contractual principal	263		263

For information on current and past due composition and accruing status for loans where we have elected the fair value option, see Note 3.

Financial Instruments Not Carried at Fair Value

The following summarizes the fair value by the fair value hierarchy levels and the carrying amount of our financial instruments not carried at fair value (in millions):

	As of March 31, 2025
	Quoted
	Prices
	in Active
	Markets for		Significant		Significant
	Identical		Observable		Unobservable		Total
	Assets		Inputs		Inputs		Fair		Carrying
	(Level 1)		(Level 2)		(Level 3)		Value		Amount
Assets
Investments:
Mortgage loans on real estate	$	–	$	20,373	$	–	$	20,373	$	21,326
Other investments	–		513		5,657		6,170		6,170
Policy loans	–		2,529		–		2,529		2,529
Cash and invested cash	–		4,284		–		4,284		4,284
Liabilities
Policyholder account balances – certain investment
contracts and other liabilities	$	–	$	–	$	(30,876)	$	(30,876)	$	(41,005)
Policyholder account balances – funding agreements	–		(508)		–		(508)		(500)
Long-term debt	–		(5,356)		–		(5,356)		(5,868)
Funds withheld reinsurance-related liabilities – excluding
embedded derivatives	–		–		(16,700)		(16,700)		(16,700)

52

Table of Contents

	As of December 31, 2024
	Quoted
	Prices
	in Active
	Markets for		Significant		Significant
	Identical		Observable		Unobservable		Total
	Assets		Inputs		Inputs		Fair		Carrying
	(Level 1)		(Level 2)		(Level 3)		Value		Amount
Assets
Investments:
Mortgage loans on real estate	$	–	$	19,647	$	–	$	19,647	$	21,083
Other investments	–		1,119		5,469		6,588		6,588
Policy loans	–		2,476		–		2,476		2,476
Cash and invested cash	–		5,801		–		5,801		5,801
Liabilities
Policyholder account balances – certain investment
contracts and other liabilities	$	–	$	–	$	(30,505)	$	(30,505)	$	(40,394)
Short-term debt	–		(299)		–		(299)		(300)
Long-term debt	–		(5,304)		–		(5,304)		(5,856)
Funds withheld reinsurance-related liabilities – excluding
embedded derivatives	–		–		(16,877)		(16,877)		(16,877)

The following discussion outlines the methodologies and assumptions used to determine the fair value of our financial instruments not carried at fair value on the Consolidated Balance Sheets. Considerable judgment is required to develop these assumptions used to measure fair value. Accordingly, the estimates shown above are not necessarily indicative of the amounts that would be realized in a one-time, current market exchange of all of our financial instruments.

Mortgage Loans on Real Estate

The fair value of mortgage loans on real estate, excluding mortgage loans accounted for using the fair value option, is established using a discounted cash flow method based on credit rating, maturity and future income. The ratings for mortgages in good standing are based on property type, location, market conditions, occupancy, debt-service coverage, LTV, quality of tenancy, borrower and payment record. The fair value for impaired mortgage loans is based on the present value of expected future cash flows discounted at the loan’s effective interest rate, the loan’s market price or the fair value of the collateral if the loan is collateral dependent. The inputs used to measure the fair value of our mortgage loans on real estate, excluding mortgage loans accounted for using the fair value option, are classified as Level 2 within the fair value hierarchy.

Other Investments

The carrying value of our assets classified as other investments, excluding short-term investments, approximates fair value. Other investments includes primarily LPs and other privately held investments that are accounted for using the equity method of accounting and the carrying value is based on our proportional share of the net assets of the LPs. Other investments also includes FHLB stock carried at cost and periodically evaluated for impairment based on ultimate recovery of par value. The inputs used to measure the fair value of our LPs, other privately held investments and FHLB stock are classified as Level 3 within the fair value hierarchy. The remaining assets in other investments include cash collateral receivables and securities that are not LPs or other privately held investments. The inputs used to measure the fair value of these assets are classified as Level 2 within the fair value hierarchy.

Policy Loans

The carrying value for policy loans are the unpaid principal balances. Policy loans are fully collateralized by the cash surrender value of underlying insurance policies. As a result, the carrying value of the policy loans approximates the fair value. The inputs used to measure the fair value of these assets are classified as Level 2 within the fair value hierarchy.

53

Table of Contents

Cash and Invested Cash

Cash and invested cash is carried at cost. The inputs used to measure its fair value are classified as Level 2 within the fair value hierarchy.

Policyholder Account Balances – Certain Investment Contracts and Other Liabilities

Policyholder account balances and other liabilities include account balances of certain investment contracts that exclude significant mortality or morbidity risk. The fair value of the account balances of certain investment contracts is based on a discounted cash flow model as of the balance sheet date. The inputs used to measure the fair value of these policyholder account balances are classified as Level 3 within the fair value hierarchy.

Policyholder Account Balances – Funding Agreements

The fair value of funding agreements is based on quoted market prices and is measured using inputs that are classified as Level 2 within the fair value hierarchy. For more information on funding agreements, see Note 10.

Short-Term and Long-Term Debt

The fair value of short-term and long-term debt is based on quoted market prices. The inputs used to measure the fair value of our short-term and long-term debt are classified as Level 2 within the fair value hierarchy.

Funds Withheld Reinsurance Liabilities

Funds withheld reinsurance liabilities includes our obligation to pay reinsurers under coinsurance with funds withheld and modified coinsurance arrangements where the Company is the cedant. This liability includes embedded derivatives, which are total return swaps with contractual returns that are attributable to the Company’s reinsurance agreements. The embedded derivatives are carried at fair value and thus excluded from the preceding table. The inputs used to measure the remaining balance are classified as Level 3 within the fair value hierarchy.

13. Contingencies and Commitments

Contingencies

Regulatory and Litigation Matters

Regulatory bodies, such as state insurance departments, the SEC, the Financial Industry Regulatory Authority, tax authorities and other regulatory bodies regularly make inquiries and conduct examinations, investigations or audits concerning our compliance with, among other things, insurance laws, securities laws, tax laws, laws governing the activities of broker-dealers and registered investment advisers and unclaimed property laws. Tax-related matters can include disputes with taxing authorities, ongoing audits, evaluation of filing positions and any potential assessments related thereto.

LNC is involved in various pending or threatened legal or regulatory proceedings, including purported class actions, arising from the conduct of business both in the ordinary course and otherwise. In some of the matters, very large and/or indeterminate amounts, including punitive and treble damages, are sought. Modern pleading practice in the U.S. permits considerable variation in the assertion of monetary damages or other relief. Jurisdictions may permit claimants not to specify the monetary damages sought or may permit claimants to state only that the amount sought is sufficient to invoke the jurisdiction of the trial court. In addition, jurisdictions may permit plaintiffs to allege monetary damages in amounts well exceeding verdicts obtained in the jurisdiction for similar matters. This variability in pleadings, together with the actual experiences of LNC in litigating or resolving through settlement numerous claims over an extended period of time, demonstrates to management that the monetary relief which may be specified in a lawsuit or claim bears little relevance to its merits or disposition value.

Due to the unpredictable nature of litigation, the outcome of a litigation matter and the amount or range of potential loss at particular points in time is normally difficult to ascertain. Uncertainties can include how fact finders will evaluate documentary evidence and the credibility and effectiveness of witness testimony, and how trial and appellate courts will apply the law in the context of the pleadings or evidence presented, whether by motion practice, or at trial or on appeal. Disposition valuations are also subject to the uncertainty of how opposing parties and their counsel will themselves view the relevant evidence and applicable law.

We establish liabilities for litigation and regulatory loss contingencies when information related to the loss contingencies shows both that it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. It is possible that some matters could require us to pay damages or make other expenditures or establish accruals in amounts that could not be estimated as of March 31, 2025.

54

Table of Contents

For some matters, the Company is able to estimate a reasonably possible range of loss. For such matters in which a loss is probable, an accrual has been made. For such matters where a loss is believed to be reasonably possible, but not probable, no accrual has been made. Accordingly, the estimate contained in this paragraph reflects two types of matters. For some matters included within this estimate, an accrual has been made, but there is a reasonable possibility that an exposure exists in excess of the amount accrued. In these cases, the estimate reflects the reasonably possible range of loss in excess of the accrued amount. For other matters included within this estimation, no accrual has been made because a loss, while potentially estimable, is believed to be reasonably possible but not probable. In these cases, the estimate reflects the reasonably possible loss or range of loss. As of March 31, 2025, we estimate the aggregate range of reasonably possible losses, including amounts in excess of amounts accrued for these matters as of such date, to be up to approximately $150 million, after-tax. Any estimate is not an indication of expected loss, if any, or of the Company’s maximum possible loss exposure on such matters.

For other matters, we are not currently able to estimate the reasonably possible loss or range of loss. We are often unable to estimate the possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from other parties and investigation of factual allegations, rulings by the court on motions or appeals, analysis by experts and the progress of settlement negotiations. On a quarterly and annual basis, we review relevant information with respect to litigation contingencies and update our accruals, disclosures and estimates of reasonably possible losses or ranges of loss based on such reviews.

Among other matters, we are presently engaged in litigation, including relating to cost of insurance rates (“Cost of Insurance and Other Litigation”), as described below. No accrual has been made for some of these matters. Although a loss is believed to be reasonably possible for these matters, for some of these matters, we are not able to estimate a reasonably possible amount or range of potential liability. An adverse outcome in one or more of these matters may have a material impact on the consolidated financial statements, but, based on information currently known, management does not believe those cases are likely to have such an impact.

Cost of Insurance and Other Litigation

Cost of Insurance Litigation

Glover v. Connecticut General Life Insurance Company and The Lincoln National Life Insurance Company, filed in the U.S. District Court for the District of Connecticut, No. 3:16-cv-00827, is a putative class action that was served on LNL on June 8, 2016. Plaintiff is the owner of a universal life insurance policy who alleges that LNL charged more for non-guaranteed cost of insurance than permitted by the policy. Plaintiff seeks to represent all universal life and variable universal life policyholders who owned policies containing non-guaranteed cost of insurance provisions that are similar to those of plaintiff’s policy and seeks damages on behalf of all such policyholders. On January 11, 2019, the court dismissed plaintiff’s complaint in its entirety. In response, plaintiff filed a motion for leave to amend the complaint, which, on September 25, 2023, the court granted in part and denied in part. Plaintiff filed an amended complaint on October 10, 2023. On March 7, 2024, the parties entered into a provisional settlement agreement that encompasses policies that are at issue in this case, which also includes all policies at issue in the lawsuits captioned Iwanski v. First Penn-Pacific Life Insurance Company, TVPX ARS INC., as Securities Intermediary for Consolidated Wealth Management, LTD. v. The Lincoln National Life Insurance Company and Vida Longevity Fund, LP v. Lincoln Life & Annuity Company of New York, each of which are described below. The Glover plaintiffs’ motion for preliminary approval of the provisional settlement was filed on March 8, 2024, and on September 4, 2024, the court granted preliminary approval of the provisional settlement. On December 16, 2024, the court heard oral argument on the issue of whether to grant final approval of the provisional settlement. The provisional settlement, which is still subject to final approval of the court, consists of a $147.5 million pre-tax cash payment for Glover class members (inclusive of all policyholders in Iwanski, TVPX ARS INC. and Vida). As of March 31, 2025, the total provisional settlement amount of $147.5 million, pre-tax, remains accrued.

Iwanski v. First Penn-Pacific Life Insurance Company (“FPP”), No. 2:18-cv-01573, filed in the U.S. District Court for the Eastern District of Pennsylvania is a putative class action that was filed on April 13, 2018. Plaintiff alleges that defendant FPP breached the terms of his life insurance policy by deducting non-guaranteed cost of insurance charges in excess of what is permitted by the policies. Plaintiff seeks to represent all owners of universal life insurance policies issued by FPP containing non-guaranteed cost of insurance provisions that are similar to those of Plaintiff’s policy and seeks damages on their behalf. Breach of contract is the only cause of action asserted. On March 7, 2024, the parties in Glover v. Connecticut General Life Insurance Company and The Lincoln National Life Insurance Company (discussed above) entered into a provisional settlement agreement that encompasses all policies at issue in this case, as the Glover case is inclusive of all policies in this case, as well as in the lawsuits captioned TVPX ARS INC., as Securities Intermediary for Consolidated Wealth Management, LTD. v. The Lincoln National Life Insurance Company and Vida Longevity Fund, LP v. Lincoln Life & Annuity Company of New York (both discussed below). The Glover plaintiffs’ motion for preliminary approval of the provisional settlement was filed on March 8, 2024, and on September 4, 2024, the court granted preliminary approval of the provisional settlement. On December 16, 2024, the court heard oral argument on the issue of whether to grant final approval of the provisional settlement. The provisional settlement, which is still subject to final approval of the court, consists of a $147.5 million pre-tax cash payment for Glover class members (inclusive of all policyholders in Iwanski, TVPX ARS INC. and Vida). A motion has been filed to stay the proceedings in this matter pending the completion of the settlement approval process in Glover.

55

Table of Contents

TVPX ARS INC., as Securities Intermediary for Consolidated Wealth Management, LTD. v. The Lincoln National Life Insurance Company, filed in the U.S. District Court for the Eastern District of Pennsylvania, No. 2:18-cv-02989, is a putative class action that was filed on July 17, 2018. Plaintiff alleges that LNL charged more for non-guaranteed cost of insurance than permitted by the policy. Plaintiff seeks to represent all universal life and variable universal life policyholders who own policies issued by LNL or its predecessors containing non-guaranteed cost of insurance provisions that are similar to those of Plaintiff’s policy and seeks damages on behalf of all such policyholders. On March 7, 2024, the parties in Glover v. Connecticut General Life Insurance Company and The Lincoln National Life Insurance Company (discussed above) entered into a provisional settlement agreement that encompasses all policies at issue in this case, as the Glover case is inclusive of all policies in this case, as well as in the lawsuits captioned Iwanski v. First Penn-Pacific Life Insurance Company (discussed above) and Vida Longevity Fund, LP v. Lincoln Life & Annuity Company of New York (discussed below). The Glover plaintiffs’ motion for preliminary approval of the provisional settlement was filed on March 8, 2024, and on September 4, 2024, the court granted preliminary approval of the provisional settlement. On December 16, 2024, the court heard oral argument on the issue of whether to grant final approval of the provisional settlement. The provisional settlement, which is still subject to final approval of the court, consists of a $147.5 million pre-tax cash payment for Glover class members (inclusive of all policyholders in Iwanski, TVPX ARS INC. and Vida). A motion has been filed to stay the proceedings in this matter pending the completion of the settlement approval process in Glover.

Vida Longevity Fund, LP v. Lincoln Life & Annuity Company of New York, pending in the U.S. District Court for the Southern District of New York, No. 1:19-cv-06004, is a putative class action that was filed on June 27, 2019. Plaintiff alleges that Lincoln Life & Annuity Company of New York (“LLANY”) charged more for non-guaranteed cost of insurance than was permitted by the policies. On March 31, 2022, the court issued an order granting plaintiff’s motion for class certification and certified a class of all current or former owners of six universal life insurance products issued by LLANY that were assessed a cost of insurance charge any time on or after June 27, 2013. Plaintiff seeks damages on behalf of the class. On April 19, 2023, LLANY filed a motion for summary judgment. On March 7, 2024, the parties in Glover v. Connecticut General Life Insurance Company and The Lincoln National Life Insurance Company (discussed above) entered into a provisional settlement agreement that encompasses all policies at issue in this case, as the Glover case is inclusive of all policies in this case, as well as in the lawsuits captioned Iwanski v. First Penn-Pacific Life Insurance Company and TVPX ARS INC., as Securities Intermediary for Consolidated Wealth Management, LTD. v. The Lincoln National Life Insurance Company (both discussed above). The Glover plaintiffs’ motion for preliminary approval of the provisional settlement was filed on March 8, 2024, and on September 4, 2024, the court granted preliminary approval of the provisional settlement. On December 16, 2024, the court heard oral argument on the issue of whether to grant final approval of the provisional settlement. The provisional settlement, which is still subject to final approval of the court, consists of a $147.5 million pre-tax cash payment for Glover class members (inclusive of all policyholders in Iwanski, TVPX ARS INC. and Vida). On March 29, 2024, the court issued its summary judgment decision, granting LLANY’s motion in part and denying it in part, and entering summary judgment against twenty-two policyholders that the court determined were not economically harmed. On June 25, 2024, the court granted LLANY’s April 12, 2024, motion to stay proceedings in this matter pending the completion of the approval process in Glover.

Angus v. The Lincoln National Life Insurance Company, pending in the U.S. District Court for the Eastern District of Pennsylvania, No. 2:22-cv-01878, is a putative class action filed on May 13, 2022. Plaintiff alleges that defendant LNL breached the terms of her life insurance policy by deducting non-guaranteed cost of insurance charges in excess of what is permitted by the policies. Plaintiff seeks to represent all owners of universal life insurance policies issued or insured by LNL or its predecessors containing non-guaranteed cost of insurance provisions that are similar to those of plaintiff’s policy and seeks damages on their behalf. Breach of contract is the only cause of action asserted. On August 26, 2022, LNL filed a motion to dismiss. We are vigorously defending this matter.

EFG Bank AG, Cayman Branch, et al. v. The Lincoln National Life Insurance Company, No. 17-cv-02592-GJP (E.D. Pa.), filed on February 1, 2017; Conestoga Trust, et al, v. Lincoln National Corp., et al., No. 18-cv-02379-GJP (E.D. Pa.), filed on June 6, 2018; Brighton Trustees, LLC, et al. v. The Lincoln National Life Insurance Company, No. 2:23-cv-2251-GJP (E.D. Pa.), filed on April 20, 2023 (and transferred to the U.S. District Court for the Eastern District of Pennsylvania on June 12, 2023); and Ryan K. Crayne, on behalf of and as trustee for Carlton Peak Trust v. The Lincoln National Life Insurance Company, No. 2:24-cv-00053-GJP, filed on November 17, 2023 (and transferred to the U.S. District Court for the Eastern District of Pennsylvania on January 4, 2024) are consolidated civil actions pending in the Eastern District of Pennsylvania. In each case other than Crayne, plaintiffs purport to own universal life insurance policies or interests in universal life insurance policies originally issued by Jefferson-Pilot (now LNL). In Crayne, plaintiffs purport to own litigation claims concerning universal life policies originally issued by Jefferson-Pilot (now LNL). Among other things, plaintiffs in each case allege that LNL (or, in Conestoga, LNL and LNC) breached the terms of policyholders’ contracts when it increased non-guaranteed cost of insurance rates beginning in 2016 (or, in Brighton Trustees, in 2016 and 2017). We are vigorously defending these consolidated matters.

Wells Fargo Bank, N.A, solely in its capacity as securities intermediary v. The Lincoln National Life Insurance Company, pending in the U.S. District Court for the Eastern District of Pennsylvania, No. 25-cv-00152-GJP (E.D. Pa.), is a civil action initially filed on December 4, 2024, in the U.S. District Court for the Northern District of Indiana. On January 9, 2025, this case was transferred to the Eastern District of Pennsylvania. Plaintiff, purporting to act solely in its capacity as securities intermediary for the beneficial owner of universal life insurance policies originally issued by Jefferson-Pilot (now LNL), alleges, among other things, that LNL breached the terms of Plaintiff’s contracts when it increased non-guaranteed cost of insurance rates beginning in 2016 and 2017. We are vigorously defending this matter.

56

Table of Contents

Other Litigation

Henry Morgan et al. v. Lincoln National Corporation d/b/a Lincoln Financial Group, et al, filed in the District Court of the 14th Judicial District of Dallas County, Texas, No. DC-23-02492, is a putative class action that was filed on February 22, 2023. Plaintiffs Henry Morgan, Susan Smith, Charles Smith, Laura Seale, Terri Cogburn, Laura Baesel, Kathleen Walton, Terry Warner, and Toni Hale (“Plaintiffs”) allege on behalf of a putative class that Lincoln National Corporation d/b/a Lincoln Financial Group, LNL and LLANY (together, “Lincoln”), FMR, LLC, and Fidelity Product Services, LLC (“Fidelity”) created and marketed misleading and deceptive insurance products with attributes of investment products. The putative class comprises all individuals and entities who purchased Lincoln OptiBlend products that allocated account monies to the 1-Year Fidelity AIM Dividend Participation Account, between January 1, 2020, to December 31, 2022. Plaintiffs assert the following claims individually and on behalf of the class, (1) violations of the Texas Deceptive Trade Practices Act against Lincoln; (2) common-law fraud against Lincoln; (3) negligent misrepresentation against Lincoln and Fidelity; and (4) aiding and abetting fraud against Fidelity. Plaintiffs allege they suffered damages from “a missed investment return of approximately 5-6%” and mitigation damages. They seek actual, consequential and punitive damages, as well as pre-judgment and post-judgment interest, attorney’s fees and litigation costs. On March 31, 2023, the Lincoln defendants filed a notice of removal removing the action from the 14th Judicial District of Dallas County, Texas, to the United States District Court for the Northern District of Texas, Dallas Division. On May 8, 2023, the Lincoln defendants and the Fidelity defendants filed motions to dismiss, which remain pending. We are vigorously defending this matter.

Donald C. Meade v. Lincoln National Corporation, Ellen Cooper, Dennis Glass, and Randal Freitag (“Defendants”), No. 2:24-cv-01704, pending in the U.S. District Court for the Eastern District of Pennsylvania, is a putative class action that was filed on April 23, 2024. On June 24, 2024, Local 295 IBT Employer Group Pension Trust Fund (“Local 295”) filed a motion for appointment as lead plaintiff. On October 23, 2024, the court granted this motion. Local 295 seeks to represent persons and entities that purchased or otherwise acquired Lincoln National Corporation common stock between December 8, 2021, and November 2, 2022, inclusive (the “Class Period”). On December 23, 2024, plaintiff filed an amended complaint. Plaintiff alleges claims under Section 10(b) and Section 20(a) of the Securities Exchange Act of 1934, and under SEC Rule 10b-5. Plaintiff alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts that plaintiff alleges Defendants knew, or recklessly disregarded, at the time the statements were made, about the Company’s business, operations and prospects with respect to its Guaranteed Universal Life policies and their lapse rates. The action seeks unspecified compensatory damages and reasonable costs and expenses incurred in this action, including counsel fees and expert fees, together with equitable/injunctive relief or such other relief as the court may deem just and proper. On February 21, 2025, Defendants filed a motion to dismiss. We are vigorously defending this matter.

In Re Lincoln National Corporation Stockholder Derivative Litigation, No. 2:24-cv-02713, is the matter name for the following two civil actions that were consolidated for all purposes on September 26, 2024, by the U.S. District Court for the Eastern District of Pennsylvania: Lawrence Hollin, derivatively on behalf of Nominal Defendant Lincoln National Corporation v. Ellen G. Cooper, Dennis R. Glass, Randal J. Freitag, Deirdre P Connelly, William H. Cunningham, Reginald E. Davis, Eric G. Johnson, Gary C. Kelly, M. Leanne Lachman, Dale LeFebvre, Janet Liang, Michael F. Mee, Lynn M. Utter and Patrick S. Pittard (“Individual Defendants”) and Lincoln National Corporation (“Nominal Defendant”), No. 2:24-cv-02713 (E.D. Pa.), filed on June 20, 2024; and Robert R. Wiersum, derivatively on behalf of Lincoln National Corporation v. Ellen G. Cooper, Dennis R. Glass, Randal J. Freitag, Deirdre P Connelly, William H. Cunningham, Reginald E. Davis, Eric G. Johnson, Gary C. Kelly, M. Leanne Lachman, Dale LeFebvre, Janet Liang, Michael F. Mee, Lynn M. Utter and Patrick S. Pittard (“Individual Defendants”) and Lincoln National Corporation (“Nominal Defendant”), No. 2:24-cv-03251 (E.D. Pa.), filed on July 23, 2024. By the same September 26, 2024, order, the court directed, among other things, that all proceedings and deadlines in this consolidated case be stayed until 30 days after resolution of all motions to dismiss (including the exhaustion of all related appeals) in the Meade matter discussed above. Plaintiffs bring this complaint for, inter alia, alleged breaches of fiduciary duties between November 4, 2020, at latest, through the date of filing and allege violations of the federal securities laws caused by the issuance of allegedly materially false and misleading statements issued, or caused to be issued, by the Individual Defendants in the Company’s SEC filings and other public statements. Plaintiffs allege that the Company thereby suffered loss, injury and damage. Among other relief, plaintiffs seek, in favor of the Company, damages sustained by the Company, punitive damages and attorney’s fees, an accounting for all damages to the Company and an unspecified order directing the Company to improve existing corporate governance and internal procedures. The Individual Defendants are vigorously defending these consolidated matters.

In Re Lincoln National Corporation Shareholder Derivative Litigation, No. CV-2024-0011319, is the matter name for the following two civil actions that were consolidated for all purposes on February 28, 2025, by the Court of Common Pleas of Delaware County, Pennsylvania: Anthony Morgan, derivatively on behalf of Nominal Defendant Lincoln National Corporation v. Ellen G. Cooper, Deirdre P. Connelly, William H. Cunningham, Reginald Davis, Eric C. [G.] Johnson, Gary C. Kelly, M. Leanne Lachman, Dale LeFebvre, Janet Liang, Lynn M. Utter, Dennis Glass and Randal Freitag (“Individual Defendants”) and Lincoln National Corporation (“Nominal Defendant”), No. CV-2024-011319 (Court of Common Pleas of Delaware County, Pennsylvania) filed on December 31, 2024; and Harry Rosenthal, derivatively on behalf of Nominal Defendant Lincoln National Corporation v. Ellen G. Cooper, Deirdre P Connelly, William H. Cunningham, Reginald Davis, Eric C. [G.] Johnson, Gary C. Kelly, M. Leanne Lachman, Dale LeFebvre, Janet Liang, Lynn M. Utter, Dennis Glass and Randal Freitag (“Individual Defendants”) and Lincoln National Corporation (“Nominal Defendant”), No. CV-2025-00146 (Court of Common Pleas of Delaware County, Pennsylvania) filed on January 3, 2025. By the same February 28, 2025, order, the court directed, among other things, that all proceedings and deadlines in this consolidated case be stayed until 30 days after resolution of all motions to dismiss (including the exhaustion of all related appeals) in the Meade matter discussed above. Plaintiffs bring this verified stockholder derivative complaint purportedly on behalf of Nominal Defendant

57

Table of Contents

Lincoln National Corporation against the Individual Defendants, inter alia, for alleged breaches of fiduciary duties for allegedly failing to comply with federal securities laws, by the issuance of allegedly materially false and misleading statements in the Company’s SEC filings and other public statements. Plaintiffs allege claims against the Individual Defendants for breach of fiduciary duties and for unjust enrichment. Plaintiffs allege, inter alia, that the Individual Defendants failed to disclose to investors: (i) that the Company was experiencing a decline in its VUL business; (ii) that, as a result, the goodwill associated with the life insurance business was overstated; (iii) that, as a result, the Company’s policy lapse assumptions were outdated; (iv) that, as a result, the Company’s reserves were overstated; (v) that, as a result, the Company’s reported financial results and financial statements were misstated; and (vi) that, as a result, the Individual Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. Plaintiffs allege that the Company thereby suffered loss, injury and damage. Among other relief, the action seeks specifically, in favor of the Company: damages sustained by the Company; a direction by the court for the Company to take all necessary actions to reform and improve its corporate governance and internal procedures to comply with all applicable laws and to protect the Company and its shareholders; restitution from the Individual Defendants, and each of them, and an order for the disgorgement of all profits, benefits and other compensation obtained by the Individual Defendants; the costs and disbursements of the action, including reasonable attorneys’ fees, accountants’ and experts’ fees, costs and expenses; and such other and further relief as the court deems just and proper. The Individual Defendants are vigorously defending this matter.

Kelly Grink v. Virtua Health and Lincoln National Corporation et al., No. 1:24-cv-09919, is a putative class action filed on October 18, 2024, in the U.S. District Court for the District of New Jersey. On March 7, 2025, Plaintiffs filed an amended complaint which, inter alia, added an additional named plaintiff (Steven Molnar) and additional named defendants, including Lincoln Retirement Services Company, LLC, and [The] Lincoln National Life Insurance Company. Plaintiffs Kelly Grink, Diane Trump and Steven Molnar are participants in Virtua Health’s defined contribution plans. Plaintiffs seek to represent all current and former participants or beneficiaries of Virtua’s 401(k) savings plan and 403(b) retirement program (together, the “Plans”) who invested in the Plans’ fixed annuity option in the six years prior to the filing of this lawsuit. Lincoln offers a fixed annuity investment option to plan participants through its group annuity contract with the Plans. Lincoln also provides recordkeeping and administration services to the Plans. Plaintiffs allege that the Virtua defendants acted in breach of their fiduciary duty including by maintaining the Plans’ investment in the Lincoln stable value fund when other investment providers are alleged to have provided superior alternatives at substantially lower cost. Plaintiffs allege that the Lincoln defendants were at all relevant times fiduciaries to the Plans and were parties in interest to a prohibited transaction under ERISA. The action seeks relief against the Lincoln defendants including the disgorgement of any profits they received as a result of the alleged breaches of fiduciary duty, together with plaintiffs’ attorney’s fees and costs, prejudgment and post-judgment interest and such other equitable or remedial relief as the court deems appropriate. On April 4, 2025, the Lincoln defendants filed a motion to dismiss. We are vigorously defending this matter.

Tax Assessment Proceeding

Lincoln National Life Insurance Company v. Township of Radnor, pending in the Court of Common Pleas of Delaware County, Pennsylvania Civil Division, No. 2022-001894, is a de novo appeal filed by LNL on March 21, 2022, regarding a September 30, 2021, Notice of Tax Assessment issued by the Township of Radnor to LNL for additional business privilege tax (“BPT”) for the years 2014-2019/2020 estimate. The assessment was based on an audit undertaken by a third-party auditor and consultant to the Township of Radnor, following a periodic business review of LNL undertaken by the same individual in 2018. The assessment is comprised of taxes, interest and penalties for the period in question. LNL filed a motion for summary judgment that was denied by the court. The trial of this matter was held in the fourth quarter of 2024. The court’s ruling remains pending. We are vigorously defending this matter.

Reinsurance Disputes

Certain reinsurers have in the past sought, and may in the future seek, rate increases on certain yearly renewable term agreements. We may initiate legal proceedings, as necessary, under these agreements in order to protect our contractual rights. Additionally, reinsurers have in the past initiated, and may in the future initiate, legal proceedings against us.

State Guaranty Fund Assessments

State guaranty associations levy assessments on insurance companies doing business within their jurisdictions to cover policyholder losses from insolvent or impaired insurance companies. Mandatory assessments may be partially recovered through a reduction in future premium taxes in some states. We accrue the cost of future guaranty fund assessments based on estimates of insurance company insolvencies provided by the National Organization of Life & Health Insurance Guaranty Associations and the amount of premiums written in each state. We reported the undiscounted expected state guaranty fund assessment liability within other liabilities on the Consolidated Balance Sheets of $63 million as of March 31, 2025, and December 31, 2024. The actual amount of assessments levied against us in connection with insurance company insolvencies may vary from this estimate. Future guaranty fund assessments are expected to be paid based on anticipated funding periods for each guaranty association obligation. In addition, we reported the related receivable for expected future state premium tax recoveries within other assets on the Consolidated Balance Sheets of $100 million and $99 million as of March 31, 2025, and December 31, 2024, respectively. Premium tax recoveries are expected to be realized based on regulations set forth by the various state taxing authorities. The balance sheet position as of March 31, 2025, and December 31, 2024, nets to recoveries of $37 million and $36 million, respectively.

58

Table of Contents

14. Shares and Stockholders’ Equity

Preferred Shares

Preferred stock authorized, issued and outstanding (number of shares) was as follows:

	As of March 31, 2025			As of December 31, 2024
	Shares Authorized	Shares Issued	Shares Outstanding	Shares Authorized	Shares Issued	Shares Outstanding
9.250% Fixed Rate Reset Non-Cumulative
Preferred Stock, Series C	20,000	20,000	20,000	20,000	20,000	20,000
9.000% Non-Cumulative Preferred Stock,   Series D	20,000	20,000	20,000	20,000	20,000	20,000
Not designated	9,960,000	–	–	9,960,000	–	–
Total preferred shares	10,000,000	40,000	40,000	10,000,000	40,000	40,000

The per share and aggregate dividends declared for preferred stock by series (in millions except per share data) was as follows:

	For the Three Months Ended March 31,
	2025				2024
	Dividend		Aggregate		Dividend		Aggregate
Series	Per Share		Dividend		Per Share		Dividend
Series C	$	1,156.25	$	23	$	1,156.25	$	23
Series D	562.50		11		562.50		11
Total	$	1,718.75	$	34	$	1,718.75	$	34

Common Shares

The changes in our common stock (number of shares) were as follows:

	For the Three Months Ended March 31,
	2025	2024
Common Stock
Balance as of beginning-of-year	170,380,646	169,666,137
Stock compensation/issued for benefit   plans	314,520	350,750
Balance as of end-of-period	170,695,166	170,016,887

Our common stock is without par value.

59

Table of Contents

Earnings Per Share

The calculation of earnings per share (“EPS”) was as follows (in millions except per share data):

	For the Three Months Ended March 31,
	2025		2024
Net income (loss) available to common stockholders – basic	$	(756)	$	1,188
Deferred units of LNC stock in our
deferred compensation plans (1)	–		3
Net income (loss) available to common
stockholders – diluted	$	(756)	$	1,191
Weighted-average shares, as used in basic calculation	171,321,440		170,049,994
Incremental common shares from assumed exercise or
issuance of stock-based incentive compensation awards	2,765,580		1,096,272
Average deferred compensation shares (1)	–		688,480
Weighted-average shares, as used in diluted calculation (2)	174,087,020		171,834,746
Net income (loss) per share:
Basic	$	(4.41)	$	6.98
Diluted	(4.41)		6.93

(1)    We have participants in our deferred compensation plans who selected LNC stock as the measure for the investment return attributable to all or a portion of their deferral amounts. This obligation is settled in either cash or LNC stock pursuant to the applicable plan document. We exclude deferred units of LNC stock that are antidilutive from our diluted EPS calculation.

(2)     Due to reporting a net loss for the three months ended March 31, 2025, basic shares were used in the diluted EPS calculation for this period as the use of diluted shares would have resulted in a lower loss per share.

In the event the average market price of LNC common stock exceeds the issue price of stock options and the options have a dilutive effect to our EPS, such options will be shown in the table above.

60

Table of Contents

AOCI

The following summarizes the components and changes in AOCI (in millions):

	For the Three Months Ended March 31,
	2025		2024
Unrealized Gain (Loss) on Fixed Maturity AFS Securities and Certain
Other Investments
Balance as of beginning-of-year	$	(6,239)	$	(5,188)
Unrealized holding gains (losses)	744		(1,140)
Change in foreign currency exchange rate adjustment	156		(103)
Change in future contract benefits and policyholder account balances,
net of reinsurance	(326)		891
Income tax benefit (expense)	(121)		71
Less:
Reclassification adjustment for gains (losses) included in net income (loss)	(90)		(55)
Income tax benefit (expense)	19		12
Balance as of end-of-period	$	(5,715)	$	(5,426)
Unrealized Gain (Loss) on Derivative Instruments
Balance as of beginning-of-year	$	638	$	375
Unrealized holding gains (losses)	173		64
Change in foreign currency exchange rate adjustment	(153)		101
Income tax benefit (expense)	(4)		(35)
Less:
Reclassification adjustment for gains (losses) included in net income (loss)	21		24
Income tax benefit (expense)	(4)		(5)
Balance as of end-of-period	$	637	$	486
Market Risk Benefit Non-Performance Risk Gain (Loss)
Balance as of beginning-of-year	$	146	$	1,070
OCI before reclassification	403		(590)
Income tax benefit (expense)	(85)		126
Balance as of end-of-period	$	464	$	606
Policyholder Liability Discount Rate Remeasurement Gain (Loss)
Balance as of beginning-of-year	$	744	$	587
OCI before reclassification	(141)		147
Income tax benefit (expense)	30		(31)
Balance as of end-of-period	$	633	$	703
Foreign Currency Translation Adjustment
Balance as of beginning-of-year	$	(29)	$	(26)
OCI before reclassification	5		(1)
Balance as of end-of-period	$	(24)	$	(27)
Funded Status of Employee Benefit Plans
Balance as of beginning-of-year	$	(296)	$	(294)
OCI before reclassification	(5)		1
Balance as of end-of-period	$	(301)	$	(293)

61

Table of Contents

The following summarizes the reclassifications out of AOCI (in millions) and the associated line item on the Consolidated Statements of Comprehensive Income (Loss):

	For the Three Months Ended March 31,
	2025		2024
Unrealized Gain (Loss) on Fixed Maturity AFS
Securities and Certain Other Investments
Reclassification	$	(118)	$	(54)	Realized gain (loss)
Associated change in future contract benefits	28		(1)		Benefits
Reclassification before income tax benefit (expense)	(90)		(55)		Income (loss) before taxes
Income tax benefit (expense)	19		12		Federal income tax expense (benefit)
Reclassification, net of income tax	$	(71)	$	(43)	Net income (loss)
Unrealized Gain (Loss) on Derivative Instruments
Interest rate contracts	$	3	$	9	Interest and debt expense
Foreign currency contracts	15		15		Net investment income
Foreign currency contracts	3		–		Realized gain (loss)
Reclassification before income tax benefit (expense)	21		24		Income (loss) before taxes
Income tax benefit (expense)	(4)		(5)		Federal income tax expense (benefit)
Reclassification, net of income tax	$	17	$	19	Net income (loss)

15. Segment Information

We provide products and services and report results through our Annuities, Life Insurance, Group Protection and Retirement Plan Services business segments. The accounting policies of the business segments and Other Operations are the same as those described in

Note 1 in our 2024 Form 10-K. We also have Other Operations, which includes the financial data for operations that are not directly related to the business segments. Our business segments and Other Operations reflect the manner by which our CODM views and manages the business. Our CODM is the Chief Executive Officer. A discussion of these segments and Other Operations is found in Note 19 in our 2024 Form 10-K.

Income (loss) from operations is the internal measure used by our CODM that explains the results of our ongoing operations in a manner that allows for a better understanding of the underlying trends by excluding items that are unpredictable and not necessarily indicative of current operating fundamentals or future performance, and, in many instances, decisions regarding these adjustments do not necessarily relate to the operations of the individual business segments. Income (loss) from operations is used by our CODM to evaluate financial performance, to assess the budgeting and forecasting process and to determine future resource allocation. In the third quarter of 2024, we revised our definition of income (loss) from operations to exclude the impact of certain additional items that are not indicative of the ongoing operations of the business and may obscure trends in the underlying performance of the Company. The presentation of prior period income (loss) from operations was recast for such third quarter 2024 revisions to conform to the current period presentation.

Income (loss) from operations is GAAP net income excluding the following items, as applicable:

•Items related to annuity product features, which include changes in MRBs, including gains and losses and benefit payments, changes in the fair value of the derivative instruments we hold to hedge GLB and GDB riders, net of fee income allocated to support the cost of hedging them, and changes in the fair value of the embedded derivative liabilities of our indexed annuity contracts and the associated index options we hold to hedge them, including collateral expense associated with the hedge program (collectively, “net annuity product features”);

•Items related to life insurance product features, which include changes in the fair value of derivatives we hold as part of VUL hedging, changes in reserves resulting from benefit ratio unlocking associated with the impact of capital markets, and changes in the fair value of the embedded derivative liabilities of our IUL contracts and the associated index options we hold to hedge them (collectively, “net life insurance product features”);

•Credit loss-related adjustments on fixed maturity AFS securities, mortgage loans on real estate and reinsurance-related assets (“credit loss-related adjustments”);

•Changes in the fair value of equity securities, certain derivatives, certain other investments and realized gains (losses) on sales, disposals and impairments of financial assets (collectively, “investment gains (losses)”);

62

Table of Contents

•Changes in the fair value of reinsurance-related embedded derivatives, trading securities and mortgage loans on real estate electing the fair value option (“changes in the fair value of reinsurance-related embedded derivatives, trading securities and certain mortgage loans”);

•Income (loss) from the initial adoption of new accounting standards, accounting policy changes and new regulations, including changes in tax law;

•Income (loss) from reserve changes, net of related amortization, on business sold through reinsurance;

•Losses from the impairment of intangible assets and gains (losses) on other non-financial assets;

•Income (loss) from discontinued operations;

•Other items, which include the following: certain legal and regulatory accruals; severance expense related to initiatives that realign the workforce; transaction and integration costs related to mergers and acquisitions including the acquisition or divestiture, through reinsurance or other means, of businesses or blocks of business; mark-to-market adjustment related to the LNC stock component of our deferred compensation plans (“deferred compensation mark-to-market adjustment”); gains (losses) on modification or early extinguishment of debt; and impacts from settlement or curtailment of defined benefit obligations; and

•Income tax benefit (expense) related to the above pre-tax items, including the effect of tax adjustments such as changes to deferred tax valuation allowances.

We use our prevailing corporate federal income tax rate of 21% and an estimated state income tax rate, where applicable, net of the impacts related to dividends-received deduction and foreign tax credits and any other permanent differences for events recognized differently in the consolidated financial statements and federal income tax returns.

We do not report total assets by segment because this is not a metric used by the CODM to allocate resources or evaluate segment performance.

63

Table of Contents

The tables below reconcile our internal measure of performance to the GAAP measure presented in the Consolidated Statements of Comprehensive Income (Loss) (in millions):

	For the Three Months Ended March 31, 2025
	Annuities		Life Insurance		Group Protection		Retirement Plan Services		Other Operations		Total
Operating Revenues (1)	$	1,198	$	1,587	$	1,521	$	327	$	52	$	4,685
Operating Expenses (2)
Benefits and policyholder liability
remeasurement (gain) loss	28		1,002		994		–		4		2,028
Interest credited	419		287		–		170		14		890
Commissions	298		99		133		27		–		557
General and administrative expenses	125		131		222		84		68		630
Interest and debt expense	–		–		–		–		80		80
Other (3)	(12)		100		44		8		(2)		138
Total operating expenses	858		1,619		1,393		289		164		4,323
Total federal income tax expense (benefit)	50		(16)		27		4		(17)		48
Total income (loss) from operations	290		(16)		101		34		(95)		314
Reconciliation of total income (loss) from
operations to net income (loss):
Net annuity product features, pre-tax											(1,092)
Net life insurance product features, pre-tax											42
Credit loss-related adjustments, pre-tax											(28)
Investment gains (losses), pre-tax											(103)
Changes in the fair value of
reinsurance-related embedded
derivatives, trading securities and
certain mortgage loans, pre-tax (4)											(90)
Other items, pre-tax (5) (6) (7)											(35)
Income tax benefit (expense) related to
the above pre-tax items											270
Total net income (loss)											$	(722)

(1)    See table below for reconciliation of total operating revenues to the GAAP measure presented in the Consolidated Statements of Comprehensive Income (Loss).

(2)    The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM. Inter-segment expenses are included within the amounts shown.

(3)    Other operating expenses include: Annuities: DAC and VOBA capitalization and amortization; taxes, licenses and fees; expenses associated with reserve financing and letters of credit (“LOCs”) and amortization of deferred loss on business sold through reinsurance. Life Insurance: DAC and VOBA capitalization and amortization; taxes, licenses and fees; expenses associated with reserve financing and LOCs; amortization of deferred loss on business sold through reinsurance and other intangible amortization. Group Protection: Taxes, licenses and fees; DAC capitalization and amortization; other intangible amortization and expenses associated with LOCs. Retirement Plan Services: Taxes, licenses and fees; DAC capitalization and amortization and expenses associated with LOCs. Other Operations: DAC capitalization and amortization; taxes, licenses and fees and reimbursements to Other Operations from the Life Insurance segment for the use of proceeds from certain issuances of senior notes that were used as long-term structured solutions, net of expenses incurred by Other Operations for its access to a financing facility and issuance of LOCs.

(4)    Includes primarily changes in the fair value of the embedded derivative related to the fourth quarter 2023 reinsurance transaction. For more information, see Note 7.

(5)    Includes severance expense related to initiatives to realign the workforce of $(6) million.

(6)    Includes transaction and integration costs related to mergers, acquisitions and divestitures of $(20) million.

(7)    Includes deferred compensation mark-to-market adjustment of $(9) million.

64

Table of Contents

	For the Three Months Ended March 31, 2024
	Annuities		Life Insurance		Group Protection		Retirement Plan Services		Other Operations		Total
Operating Revenues (1)	$	1,269	$	1,541	$	1,425	$	322	$	27	$	4,584
Operating Expenses (2)
Benefits and policyholder liability
remeasurement (gain) loss	27		987		963		–		7		1,984
Interest credited	354		294		1		166		7		822
Commissions	254		113		109		23		–		499
General and administrative expenses	120		143		208		86		57		613
Interest and debt expense	–		–		–		–		81		81
Other (3)	197		54		43		6		(6)		295
Total operating expenses	952		1,591		1,324		281		146		4,294
Total federal income tax expense (benefit)	58		(15)		21		5		(23)		46
Total income (loss) from operations	259		(35)		80		36		(96)		244
Reconciliation of total income (loss) from
operations to net income (loss) (4):
Net annuity product features, pre-tax											1,450
Net life insurance product features, pre-tax											(130)
Credit loss-related adjustments, pre-tax											(1)
Investment gains (losses), pre-tax											(81)
Changes in the fair value of
reinsurance-related embedded
derivatives, trading securities and
certain mortgage loans, pre-tax (5)											194
Other items, pre-tax (6) (7) (8) (9)											(186)
Income tax benefit (expense) related to
the above pre-tax items											(268)
Total net income (loss)											$	1,222

(1)    See table below for reconciliation of total operating revenues to the GAAP measure presented in the Consolidated Statements of Comprehensive Income (Loss).

(2)    The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM. Inter-segment expenses are included within the amounts shown.

(3)    Other operating expenses include: Annuities: Broker-dealer expenses; DAC and VOBA capitalization and amortization; taxes, licenses and fees and expenses associated with reserve financing and LOCs. Life Insurance: DAC and VOBA capitalization and amortization; taxes, licenses and fees; expenses associated with reserve financing and LOCs and other intangible amortization. Group Protection: Taxes, licenses and fees; DAC capitalization and amortization; other intangible amortization and expenses associated with LOCs. Retirement Plan Services: DAC capitalization and amortization; taxes, licenses and fees and expenses associated with LOCs. Other Operations: Taxes, licenses and fees and reimbursements to Other Operations from the Life Insurance segment for the use of proceeds from certain issuances of senior notes that were used as long-term structured solutions, net of expenses incurred by Other Operations for its access to a financing facility and issuance of LOCs.

(4)    The prior period presentation was recast to conform to the revised definition of income (loss) from operations.

(5)    Includes primarily changes in the fair value of the embedded derivative related to the fourth quarter 2023 reinsurance transaction. For more information, see Note 7.

(6)    Includes $(114) million primarily related to the settlement of cost of insurance litigation in the first quarter of 2024.

(7)    Includes severance expense related to initiatives to realign the workforce of $(49) million.

(8)    Includes transaction and integration costs related to mergers, acquisitions and divestitures of $(10) million.

(9)    Includes deferred compensation mark-to-market adjustment of $(13) million.

65

Table of Contents

The tables below reconcile our total operating revenues to the GAAP measure presented in the Consolidated Statements of Comprehensive Income (Loss) (in millions):

	For the Three Months Ended March 31, 2025
	Annuities		Life Insurance		Group Protection		Retirement Plan Services		Other Operations		Total
Operating revenues	$	1,198	$	1,587	$	1,521	$	327	$	52	$	4,685
Revenue adjustments from annuity and life
insurance product features	209		18		–		–		–		227
Credit loss-related adjustments	(17)		1		(2)		(2)		(8)		(28)
Investment gains (losses)	(6)		(109)		–		(2)		14		(103)
Changes in the fair value of reinsurance-
related embedded derivatives, trading
securities and certain mortgage loans	10		(89)		–		–		(11)		(90)
Total revenues	$	1,394	$	1,408	$	1,519	$	323	$	47	$	4,691

	For the Three Months Ended March 31, 2024
	Annuities		Life Insurance		Group Protection		Retirement Plan Services		Other Operations		Total
Operating revenues	$	1,269	$	1,541	$	1,425	$	322	$	27	$	4,584
Revenue adjustments from annuity and life
insurance product features	(446)		(134)		–		–		–		(580)
Credit loss-related adjustments	(4)		5		–		–		(2)		(1)
Investment gains (losses)	19		(29)		–		(5)		(66)		(81)
Changes in the fair value of reinsurance-
related embedded derivatives, trading
securities and certain mortgage loans	(3)		205		–		–		(8)		194
Total revenues	$	835	$	1,588	$	1,425	$	317	$	(49)	$	4,116

Other business segment and Other Operations information (in millions) was as follows:

	For the Three Months Ended March 31,
	2025		2024
Net Investment Income
Annuities	$	452	$	379
Life Insurance	624		622
Group Protection	89		85
Retirement Plan Services	251		244
Other Operations	41		16
Total net investment income	$	1,457	$	1,346

66

Table of Contents

16. Realized Gain (Loss)

Realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss) includes realized gains and losses from the sale of investments, write-downs for impairments of investments and changes in the allowance for credit losses for financial assets, changes in fair value for mortgage loans on real estate accounted for under the fair value option, changes in fair value of equity securities, VUL derivative and embedded derivative gains and losses, gains and losses on the sale of subsidiaries and businesses and net gains and losses on reinsurance-related embedded derivatives and trading securities. Realized gains and losses on the sale of investments are determined using the specific identification method. Realized gain (loss) is also net of allocations of investment gains and losses to certain policyholders, certain funds withheld on reinsurance arrangements and certain modified coinsurance arrangements for which we have a contractual obligation. Details underlying realized gain (loss) (in millions) were as follows:

	For the Three Months Ended March 31,
	2025		2024
Fixed maturity AFS securities:
Gross gains	$	4	$	7
Gross losses	(122)		(61)
Credit loss benefit (expense) (1)	(28)		(2)
Realized gain (loss) on equity securities (2)	(5)		11
Credit loss benefit (expense) on mortgage loans on real estate (1)	(1)		–
Credit loss benefit (expense) on reinsurance-related assets	1		1
Realized gain (loss) on the mark-to-market on certain
instruments (3)(4)	(55)		12
Indexed product derivative results (5)	(69)		145
Derivative results (6)	287		(548)
Other realized gain (loss)	(1)		1
Total realized gain (loss)	$	11	$	(434)

(1) Includes changes in the allowance for credit losses as well as direct write-downs to amortized cost as a result of negative credit events.

(2) Includes mark-to-market adjustments on equity securities still held of $(5) million and $11 million for the three months ended March 31, 2025 and 2024, respectively.

(3) Represents changes in the fair values of derivatives we hold as part of VUL hedging, reinsurance-related embedded derivatives and trading securities.

(4) Includes gains and losses from fair value changes on mortgage loans on real estate accounted for under the fair value option of $(1) million and less than $1 million for the three months ended March 31, 2025 and 2024, respectively.

(5) Represents the change in fair value of the index options that we hold and the change in the fair value of the embedded derivative liabilities of our indexed annuity and IUL contracts, and the associated index options to hedge policyholder index allocations applicable to future reset periods for our indexed annuity products.

(6) Includes the change in the fair value of the derivative instruments we own to support capital needs associated with our GLB and GDB riders net of fee income allocated to support the cost of purchasing the hedging instruments.

17. Federal Income Taxes

The effective tax rate is the ratio of tax expense (benefit) over pre-tax income (loss). The effective tax rate was 24% and 20% for the three months ended March 31, 2025 and 2024, respectively. The effective tax rate on pre-tax income is typically lower than the prevailing corporate federal income tax rate of 21% due to benefits from preferential tax items including the separate account dividends-received deduction and tax credits.

For the three months ended March 31, 2025, the effective tax rate differed from the prevailing corporate federal income tax rate due primarily to a tax benefit at 21% from pre-tax losses in addition to the effects of preferential tax items.

For the three months ended March 31, 2024, the effective tax rate differed from the prevailing corporate federal income tax rate due primarily to the effects of preferential tax items.

67

Table of Contents

18. Subsequent Event

On April 9, 2025, we announced our entry into a stock purchase agreement (the “Purchase Agreement”) with Bain Capital Prairie, LLC (the “Buyer”), a newly formed subsidiary of Bain Capital, pursuant to which we will sell shares (the “Shares”) representing approximately 9.9% of our outstanding Common Stock (“Common Stock) on a post-issuance basis, to the Buyer for aggregate consideration of approximately $825 million in cash (the “Transaction”). The closing of the Transaction is subject to the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and the satisfaction of customary closing conditions.

The Purchase Agreement provides for, among other things, certain limitations on the Buyer’s and certain of its affiliates’ ability to transfer Common Stock, purchase additional Common Stock, and take certain other actions with respect to the Company and its Common Stock, and an agreement that the Buyer and certain of its affiliates will, subject to certain limitations, vote Common Stock they beneficially own in favor of the matters recommended for approval by the Company’s board of directors (the “Board”). The Purchase Agreement also grants the Buyer the right to designate one observer to be present in a nonvoting capacity at all meetings of the Board and, following the first anniversary of the closing of the Transaction, the right to replace such observer with a voting member of the Board, in each case subject to the Buyer’s satisfaction of certain conditions and approval of the Board.

68

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Index to Management’s Discussion and Analysis of Financial Condition and Results of Operations

	Page
Forward-Looking Statements – Cautionary Language	70
Introduction	71
Executive Summary	71
Summary of Critical Accounting Estimates	72
Results of Consolidated Operations	78
Results of Annuities	80
Results of Life Insurance	85
Results of Group Protection	91
Results of Retirement Plan Services	94
Results of Other Operations	98
Consolidated Investments	100
Liquidity and Capital Resources	112

69

Table of Contents

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is intended to help the reader understand the financial condition as of March 31, 2025, compared with December 31, 2024, and the results of operations for the three months ended March 31, 2025, compared with the corresponding period in 2024 of Lincoln National Corporation and its consolidated subsidiaries. Unless otherwise stated or the context otherwise requires, “LNC,” “Company,” “we,” “our” or “us” refers to Lincoln National Corporation and its consolidated subsidiaries.

The MD&A is provided as a supplement to, and should be read in conjunction with, the consolidated financial statements and the accompanying notes to the consolidated financial statements (“Notes”) presented in “Part I – Item 1. Financial Statements” and our Annual Report on Form 10-K for the year ended December 31, 2024 (“2024 Form 10-K”). For more detailed information on the risks and uncertainties associated with the Company’s business activities, see the risks described in “Part I – Item 1A. Risk Factors” in our 2024 Form 10-K.

FORWARD-LOOKING STATEMENTS – CAUTIONARY LANGUAGE

Certain statements made in this report and in other written or oral statements made by us or on our behalf are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (“PSLRA”). A forward-looking statement is a statement that is not a historical fact and, without limitation, includes any statement that may predict, forecast, indicate or imply future results, performance or achievements. Forward-looking statements may contain words like: “anticipate,” “believe,” “estimate,” “expect,” “project,” “shall,” “will” and other words or phrases with similar meaning in connection with a discussion of future operating or financial performance. In particular, these include statements relating to future actions, trends in our businesses, prospective services or products, future performance or financial results and the outcome of contingencies, such as legal proceedings. We claim the protection afforded by the safe harbor for forward-looking statements provided by the PSLRA.

Forward-looking statements are subject to risks and uncertainties. Actual results could differ materially from those expressed in or implied by such forward-looking statements due to a variety of factors, including:

•Weak general economic and business conditions that may affect demand for our products, account balances, investment results, guaranteed benefit liabilities, premium levels and claims experience;

•Adverse global capital and credit market conditions that may affect our ability to raise capital, if necessary, and may cause us to realize impairments on investments and certain intangible assets, including goodwill and the valuation allowance against deferred tax assets, which may reduce future earnings and/or affect our financial condition and ability to raise additional capital or refinance existing debt as it matures;

•The inability of our subsidiaries to pay dividends to the holding company in sufficient amounts, which could harm the holding company’s ability to meet its obligations;

•Legislative, regulatory or tax changes, both domestic and foreign, that affect: the cost of, or demand for, our subsidiaries’ products; the required amount of reserves and/or surplus; our ability to conduct business; our affiliate reinsurance arrangements; and restrictions on the payment of revenue sharing and 12b-1 distribution fees;

•Changes in tax law or the interpretation of or application of existing tax laws that could impact our tax costs and the products that we sell;

•The impact of regulations adopted by the Securities and Exchange Commission (“SEC”), the Department of Labor or other federal or state regulators or self-regulatory organizations that could adversely affect our distribution model and sales of our products and result in additional disclosure and other requirements related to the sale and delivery of our products;

•The impact of new and emerging rules, laws and regulations relating to privacy, cybersecurity and artificial intelligence that may lead to increased compliance costs, reputation risk and/or changes in business practices;

•Increasing scrutiny and evolving expectations and regulations regarding environmental, social and governance matters that may adversely affect our reputation and our investment portfolio;

•Actions taken by reinsurers to raise rates on in-force business;

•Declines in or sustained low interest rates causing a reduction in investment income, the interest margins of our businesses and demand for our products;

•Rapidly increasing or sustained high interest rates that may negatively affect our profitability, value of our investment portfolio and capital position and may cause policyholders to surrender annuity and life insurance policies, thereby causing realized investment losses;

•The impact of the implementation of the provisions of the European Market Infrastructure Regulation relating to the regulation of derivatives transactions;

•The initiation of legal or regulatory proceedings against us, and the outcome of any legal or regulatory proceedings, such as: adverse actions related to present or past business practices common in businesses in which we compete; adverse decisions in significant actions including, but not limited to, actions brought by federal and state authorities and class action cases; new decisions that result in changes in law; and unexpected trial court rulings;

•A decline or continued volatility in the equity markets causing a reduction in the sales of our subsidiaries’ products; a reduction of asset-based fees that our subsidiaries charge on various investment and insurance products; and an increase in liabilities related to guaranteed benefit riders, which are accounted for as market risk benefits (“MRBs”), of our subsidiaries’ variable annuity products;

70

Table of Contents

•Ineffectiveness of our risk management policies and procedures, including our various hedging strategies;

•A deviation in actual experience regarding future policyholder behavior, mortality, morbidity, interest rates or equity market returns from the assumptions used in pricing our subsidiaries’ products and in establishing related insurance reserves, which may reduce future earnings;

•Changes in accounting principles that may affect our consolidated financial statements;

•Lowering of one or more of our debt ratings issued by nationally recognized statistical rating organizations and the adverse effect such action may have on our ability to raise capital and on our liquidity and financial condition;

•Lowering of one or more of the insurer financial strength ratings of our insurance subsidiaries and the adverse effect such action may have on the premium writings, policy retention, and profitability of our insurance subsidiaries and liquidity;

•Significant credit, accounting, fraud, corporate governance or other issues that may adversely affect the value of certain financial assets, as well as counterparties to which we are exposed to credit risk, requiring that we realize losses on financial assets;

•Interruption in or failure of the telecommunication, information technology or other operational systems of the Company or the third parties on whom we rely or failure to safeguard the confidentiality or privacy of sensitive data on such systems, including from cyberattacks or other breaches in security of such systems;

•The effect of acquisitions and divestitures, including the inability to realize the anticipated benefits of acquisitions and dispositions of businesses and potential operating difficulties and unforeseen liabilities relating thereto, as well as the effect of restructurings, product withdrawals and other unusual items;

•The inability to complete our announced transaction with Bain Capital within the expected timeframe, or at all, and the possibility that the anticipated benefits related to the transaction may not materialize as expected;

•The inability to realize or sustain the benefits we expect from, greater than expected investments in, and the potential impact of efforts related to, our strategic initiatives;

•The adequacy and collectability of reinsurance that we have obtained;

•Pandemics, acts of terrorism, war or other man-made and natural catastrophes that may adversely impact liabilities for policyholder claims and adversely affect our businesses and the cost and availability of reinsurance;

•Competitive conditions, including pricing pressures, new product offerings and the emergence of new competitors, that may affect the level of premiums and fees that our subsidiaries can charge for their products;

•The unknown effect on our subsidiaries’ businesses resulting from evolving market preferences and the changing demographics of our client base; and

•The unanticipated loss of key management or wholesalers.

The risks and uncertainties included here are not exhaustive. Other sections of this report and other reports that we file with the SEC include additional factors that could affect our businesses and financial performance, including “Part I – Item 1A. Risk Factors” and “Part II – Item 7A. Quantitative and Qualitative Disclosures About Market Risk” in our 2024 Form 10-K. Moreover, we operate in a rapidly changing and competitive environment. New risk factors emerge from time to time, and it is not possible for management to predict all such risk factors.

Further, it is not possible to assess the effect of all risk factors on our businesses or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, investors should not place undue reliance on forward-looking statements as a prediction of actual results. In addition, we disclaim any obligation to correct or update any forward-looking statements to reflect events or circumstances that occur after the date of this report.

INTRODUCTION

Executive Summary

We are a holding company that operates multiple insurance and retirement businesses through subsidiary companies. We sell a wide range of wealth accumulation, wealth protection, group protection and retirement products and solutions through our four business segments:

•Annuities

•Life Insurance

•Group Protection

•Retirement Plan Services

We also have Other Operations, which includes the financial results for operations that are not directly related to the business segments. See “Part I – Item 1. Business” in our 2024 Form 10-K for a discussion of our business segments and products.

In this report, in addition to providing consolidated net income (loss), we also provide income (loss) from operations because we believe it is a meaningful measure of the profitability of our business segments and Other Operations. Income (loss) from operations is the financial performance measure we use to evaluate and assess the results of our segments and Other Operations. Accordingly, we define and report income (loss) from operations by segment in Note 15. Our management believes that income (loss) from operations explains

71

Table of Contents

the results of our ongoing businesses in a manner that allows for a better understanding of the underlying trends in and performance of our current businesses. Certain items are excluded from income (loss) from operations because they are unpredictable and not necessarily indicative of current operating fundamentals or future performance of the business segments, and, in many instances, decisions regarding these items do not necessarily relate to the operations of the individual segments.

We provide information about our business segments’ and Other Operations’ operating revenue and expense line items, key drivers of changes and historical details underlying the line items below. For factors that could cause actual results to differ materially from those set forth, see “Forward-Looking Statements – Cautionary Language” above and “Part I – Item 1A. Risk Factors” in our 2024 Form 10-K.

On April 9, 2025, we entered into a stock purchase agreement with Bain Capital Prairie, LLC, a newly formed subsidiary of Bain Capital, pursuant to which we will sell shares representing approximately 9.9% of our outstanding common stock on a post-issuance basis for aggregate consideration of approximately $825 million in cash. We expect the transaction will provide us with capital to deploy toward our strategic priorities, including growing spread-based earnings, advancing our portfolio management efforts and asset sourcing capabilities and optimizing our legacy life portfolio. For more information, see Note 18.

Industry trends and significant operational matters are described in “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Introduction – Executive Summary” of our 2024 Form 10-K.

Summary of Critical Accounting Estimates

The MD&A included in our 2024 Form 10-K contains a detailed discussion of our critical accounting estimates. The following information updates the “Summary of Critical Accounting Estimates” provided in our 2024 Form 10-K, and therefore, should be read in conjunction with that disclosure.

Investments

Investment Valuation

The following summarizes investments on the Consolidated Balance Sheets carried at fair value by pricing source and fair value hierarchy level (in millions) as of March 31, 2025:

	Quoted
	Prices
	in Active
	Markets for		Significant		Significant
	Identical		Observable		Unobservable
	Assets		Inputs		Inputs		Total
	(Level 1)		(Level 2)		(Level 3)		Fair Value
Priced by third-party pricing services	$	565	$	75,386	$	111	$	76,062
Priced by independent broker quotations	–		–		5,832		5,832
Priced by matrices	–		16,947		–		16,947
Priced by other methods (1)	–		–		252		252
Total	$	565	$	92,333	$	6,195	$	99,093
Percent of total	1%		93%		6%		100%

(1) Represents primarily securities for which pricing models were used to compute fair value.

For more information about the valuation of our financial instruments carried at fair value, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Introduction – Summary of Critical Accounting Estimates – Investments – Investment Valuation” in our 2024 Form 10-K and Note 12 herein.

Derivatives

Derivatives are primarily used for hedging purposes. We hedge certain portions of our exposure to interest rate risk, foreign currency exchange risk, equity market risk, basis risk, commodity risk and credit risk by entering into derivative transactions. We also purchase and issue financial instruments that contain embedded derivative instruments. See “Policyholder Account Balances” below for information on

72

Table of Contents

embedded derivatives. Assessing the effectiveness of hedging and evaluating the carrying values of the related derivatives often involve a variety of assumptions and estimates

We carry our derivative instruments at fair value, which we determine through valuation techniques or models that use market data inputs or independent broker quotations. The fair values fluctuate from period to period due to the volatility of the valuation inputs, including but not limited to swap interest rates, interest and equity volatility and equity index levels, foreign currency forward and spot rates, credit spreads and correlations, some of which are significantly affected by economic conditions. The effect to revenue is reported in realized gain (loss) and such amount along with the associated federal income taxes is excluded from income (loss) from operations of our segments.

For more information on derivatives, see Note 1 in our 2024 Form 10-K and Note 5 herein. For more information on market exposures associated with our derivatives, including sensitivities, see “Part II – Item 7A. Quantitative and Qualitative Disclosures About Market Risk” in our 2024 Form 10-K.

Future Contract Benefits

Future contract benefits represent liability reserves that we have established and carry based on estimates of how much we will need to pay for future benefits and claims.

Liability for Future Policy Benefits

Liability for future policy benefits (“LFPB”) represents the reserve amounts associated with non-participating traditional life insurance contracts and limited payment life-contingent annuity contracts that are calculated to meet the various policy and contract obligations as they mature. Establishing adequate reserves for our obligations to policyholders requires assumptions to be made that are intended to represent an estimation of experience for the period that policy benefits are payable. If actual experience is better than or equal to the assumptions, then reserves should be adequate to provide for future benefits and expenses. If experience is worse than the assumptions, additional reserves may be required. Significant assumptions include mortality rates, morbidity and policyholder behavior (e.g., persistency) and withdrawals. During the third quarter of each year, we conduct our comprehensive review of the actuarial assumptions to best estimate future premium and benefit cash flows (“cash flow assumptions”) and projection models used in estimating these liabilities and update these assumptions as needed (excluding the claims settlement expense assumption that is locked-in at inception) in the calculation of the net premium ratio. We may also update these assumptions in other quarters as we become aware of information that is indicative of the need for such an update. In measuring our LFPB, we establish cohorts, which are groupings of long-duration contracts. On a quarterly basis, we retrospectively update the net premium ratio at the cohort level for actual experience. For all contract cohorts issued after January 1, 2021, interest is accrued on LFPB at the single-A interest rate on the contract cohort inception date. For contract cohorts issued prior to January 1, 2021, interest remains accruing at the original discount rate in effect on the contract cohort inception date due to the modified retrospective transition method. We also remeasure the LFPB using the single-A interest rate as of the end of each reporting period.

Liability for Future Claims

Future contract benefits include reserves for long-term life and disability claims associated with our Group Protection segment. These reserves use actuarial assumptions primarily based on claim termination rates, offsets for other insurance including social security and long-term disability incidence and severity assumptions. Such cash flow assumptions are subject to the comprehensive review process discussed above. We remeasure the liability for future claims using a single-A interest rate as of the end of each reporting period.

Additional Liabilities for Other Insurance Benefits

We previously issued UL-type contracts where we provided a secondary guarantee to the policyholder. The policy can remain in force, even if the base policy account balance is zero, as long as contractual secondary guarantee requirements have been met. These guaranteed benefits require an additional liability that is calculated based on the application of a benefit ratio (calculated as the present value of total expected benefit payments over the life of the contract from inception divided by the present value of total expected assessments over the life of the contract). These secondary guarantees are reported within future contract benefits on the Consolidated Balance Sheets. The level and direction of the change in reserves will vary over time based on the emergence of the benefit ratio and the level of assessments associated with the contracts. Cash flow assumptions incorporated in a benefit ratio in measuring these additional liabilities for other insurance benefits include mortality rates, morbidity, policyholder behavior (e.g., persistency) and withdrawals based principally on generally accepted actuarial methods and assumptions. During the third quarter of each year, we conduct our comprehensive review of the cash flow assumptions and projection models used in estimating these liabilities and update these assumptions in the calculation of the benefit ratio. We may also update these assumptions in other quarters as we become aware of information that is indicative of the need for such an update.

For additional information on future contract benefits, see Note 11.

73

Table of Contents

Market Risk Benefits

MRBs are contracts or contract features that provide protection to the policyholder from other-than-nominal capital market risk and expose us to other-than-nominal capital market risk upon the occurrence of a specific event or circumstance, such as death, annuitization or periodic withdrawal. An MRB can be in either an asset or a liability position. Our MRB assets and MRB liabilities are reported at fair value separately on the Consolidated Balance Sheets.

We issue variable and fixed annuity contracts that may include various types of guaranteed living benefit (“GLB”) and guaranteed death benefit (“GDB”) riders that we have accounted for as MRBs. For contracts that contain multiple riders that qualify as MRBs, the MRBs are valued on a combined basis using an integrated model. We have entered into reinsurance agreements to cede certain GLB and GDB riders where the reinsurance agreements themselves are accounted for as MRBs or contain MRBs. We therefore record ceded MRB assets and ceded MRB liabilities associated with these reinsurance agreements. We report ceded MRBs associated with these reinsurance agreements in other assets or other liabilities on the Consolidated Balance Sheets.

Net amount at risk (“NAR”) represents the amount of GLB or GDB in excess of a policyholder’s account balance at the balance sheet date. Underperforming markets increase our exposure to potential benefits with the GLB and GDB riders. A contract with a GDB rider is “in the money” if the policyholder’s account balance falls below the GDB. As of March 31, 2025 and 2024, 12% and 9%, respectively, of all in-force contracts with a GDB rider were “in the money.” A contract with a GLB rider is “in the money” if the policyholder’s account balance falls below the present value of GLB payments, assuming no full surrenders. As of March 31, 2025 and 2024, 19% and 16%, respectively, of all in-force contracts with a GLB rider were “in the money.” However, the only way the policyholder can realize the excess of the present value of benefits over the account balance of the contract is through a series of withdrawals or income payments that do not exceed a maximum amount. If, after the series of withdrawals or income payments, the account balance is exhausted, the policyholder will continue to receive a series of annuity payments. The account balance can also fluctuate with market returns on a daily basis resulting in increases or decreases in the excess of the present value of benefits over account balance.

Many policyholders have both a GLB and GDB present on the same policy. The total NAR represents the greater of GLB NAR and GDB NAR for each policy as only one benefit can be exercised in practice. Details underlying the NAR, net of reinsurance, (in millions) were as follows:

	Annuities				Retirement Plan Services
	As of March 31,				As of March 31,
	2025		2024		2025		2024
GLB NAR	$	1,756	$	1,454	$	1	$	1
GDB NAR	1,027		842		2		2
Total NAR	2,681		2,197		4		3

The change in the fair value of MRB assets and liabilities is reported in market risk benefit gain (loss) on the Consolidated Statements of Comprehensive Income (Loss), except for the portion attributable to the change in non-performance risk, which is recognized in other comprehensive income (loss) (“OCI”). The change in the fair value of ceded MRB assets and liabilities, including the changes in our counterparties’ non-performance risks, is reported in market risk benefit gain (loss) on the Consolidated Statements of Comprehensive Income (Loss).

MRBs are valued based on a stochastic projection of risk-neutral scenarios that incorporate a spread reflecting our non-performance risk. Ceded MRBs are valued based on a stochastic projection of risk-neutral scenarios that incorporate a spread reflecting our counterparties’ non-performance risk. The scenario assumptions, at each valuation date, are those we view to be appropriate for a hypothetical market participant and include assumptions for capital markets, lapse, benefit utilization, mortality, risk margin and administrative expenses. These assumptions are based on a combination of historical data and actuarial judgments. The assumption for our own non-performance risk and our counterparties’ non-performance risk for MRBs and ceded MRBs, respectively, are determined at each valuation date and reflect our risk and our counterparties’ risks of not fulfilling the obligations of the underlying liability. The spread for the non-performance risk is added to the discount rates used in determining the fair value from the net cash flows. We believe these assumptions are consistent with those that would be used by a market participant; however, as the related markets develop, we will continue to reassess our assumptions. During the third quarter of each year, we conduct our comprehensive review of the assumptions used in calculating the fair value of these MRBs and update these assumptions on a prospective basis as needed. We may also update these assumptions in other quarters as we become aware of information that is indicative of the need for such an update. For information on fair value inputs, see Note 12.

74

Table of Contents

For illustrative purposes, the following presents hypothetical effects to MRBs attributable to changes to key assumptions / inputs, assuming all other factors remain constant:

		Hypothetical	Hypothetical
		Effect	Effect
Assumption / Input	Actual Experience	to MRB Liability	to Net Income	Description of Assumption / Input
Equity market return	Increase / (Decrease)	(Decrease) / Increase	Increase / (Decrease)	Equity market return input represents impact based on movements in equity markets.
Interest rate	Higher /  Lower	(Decrease) / Increase	Increase / (Decrease)	Interest rate input represents impact based on movements in interest rates and impact to fixed-income assets.
Volatility	Increase / (Decrease)	Increase / (Decrease)	(Decrease) / Increase	Volatility assumption represents overall volatilities assumed for the underlying variable annuity funds, which include a mixture of equity and fixed-income assets. Volatility assumptions vary by fund due to the benchmarking of difference indices.
Mortality	Increase / (Decrease)	(Decrease) / Increase	Increase / (Decrease)	Mortality represents the estimated probability of when an individual belonging to a particular group, categorized according to age or some other factor such as gender, will die.
Mortality contracts with only GDB rider	Increase / (Decrease)	Increase / (Decrease)	(Decrease) / Increase	Mortality represents the estimated probability of when an individual belonging to a particular group, categorized according to age or some other factor such as gender, will die.
Lapse	Higher / Lower	(Decrease) / Increase	Increase / (Decrease)	Lapse assumption represents the estimated probability of a contract surrendering during a year, thereby forgoing any future benefits.
Benefit utilization	Higher /  Lower	Increase / (Decrease)	(Decrease) / Increase	Benefit utilization assumption of guaranteed withdrawals represents the estimated percentage of policyholders that utilize the guaranteed withdrawal feature.

We use derivative instruments to hedge our exposure to selected risk caused by changes in equity markets and interest rates associated with GLB and GDB riders that are available in our variable annuity products and accounted for as MRBs. Our hedge program focuses on generating sufficient income to fund future claims with a goal of maximizing distributable earnings and explicitly protecting capital. We utilize options and total return swaps on U.S.-based equity indices, and futures on U.S.-based and international equity indices, as well as interest rate futures, interest rate swaps and currency futures. For additional information on our derivatives, see Note 5.

As part of our hedge program, equity market and interest rate conditions are monitored on a daily basis. We rebalance our hedge positions based upon changes in these factors as needed. While we actively manage our hedge positions, these positions may not completely offset changes in the fair value of our GLB and GDB riders caused by movements in these factors due to, among other things, differences in timing between when a market exposure changes and corresponding changes to the hedge positions, extreme swings in the equity markets, interest rates and market-implied volatilities, realized market volatility, policyholder behavior, divergence between the performance of the underlying funds and the hedging indices, divergence between the actual and expected performance of the hedge instruments or our ability to purchase hedging instruments at prices consistent with our desired risk and return trade-off.

The following table presents our after-tax estimates of the potential instantaneous effect to net income (loss) that could result from sudden changes that may occur in equity markets and interest rates (in millions) and excludes the net cost of operating the hedge program. The amounts represent the difference between the change in GLB and GDB riders and the change in the fair value of the underlying hedge instruments. These estimates are based upon the balance as of March 31, 2025, net of reinsurance, and the related hedge instruments in place as of that date.

75

Table of Contents

The effects presented in the table below are not representative of the aggregate impacts that could result if a combination of such changes to equity market returns and interest rates occurred.

	In-Force Sensitivities
Equity Market Return	-10%		+10%
Hypothetical effect to net income	$	(600)	$	600
Interest Rates	-25 bps		+25 bps
Hypothetical effect to net income	$	(425)	$	400

The actual effects of the results illustrated in the table above could vary significantly depending on a variety of factors, many of which are out of our control, and consideration should be given to the following:

•The analysis is only valid as of March 31, 2025, due to changing market conditions, policyholder activity, hedge positions and other factors;

•The analysis assumes instantaneous shifts in the capital market factors and no ability to rebalance hedge positions prior to the market changes;

•The analysis assumes constant exchange rates and implied dividend yields;

•Assumptions regarding shifts in the market factors, such as assuming parallel shifts in interest rates, may be overly simplistic and not indicative of actual market behavior in stress scenarios;

•It is very unlikely that one capital market sector (e.g., equity markets) will sustain such a large instantaneous movement without affecting other capital market sectors; and

•The analysis assumes that there is no tracking or basis risk between the funds and/or indices affecting the GLB and GDB riders and the instruments utilized to hedge these exposures.

For additional information on MRBs, see Note 8.

Policyholder Account Balances

Policyholder account balances include the contract value that has accrued to the benefit of the policyholder as of the balance sheet date. This liability includes universal life insurance (“UL”), MoneyGuard®, variable universal life insurance (“VUL”), indexed universal life insurance (“IUL”), investment-type annuity (including registered index-linked annuities (“RILA”), individual and group fixed and fixed portion of variable annuities, fixed indexed deferred annuities and non-life contingent payout fixed annuities) and funding agreement products where account balances are equal to deposits plus interest credited less withdrawals, surrender charges, asset-based fees and policyholder administration charges (collectively known as “policyholder assessments”), as well as amounts representing the fair value of embedded derivative instruments associated with our fixed indexed annuity and IUL products. During the third quarter of each year, we conduct our comprehensive review of the assumptions and projection models underlying our reserves and embedded derivatives and update assumptions as needed. We may also update these assumptions in other quarters as we become aware of information that is indicative of the need for such an update.

Our indexed annuity and IUL contracts permit the holder to elect a fixed interest rate return or a return where interest credited to the contracts is linked to the performance of the S&P 500® Index or other indices. The value of the variable portion of the policyholder’s account balance varies with the performance of the underlying variable funds chosen by the policyholder. Policyholders may elect to rebalance among the various accounts within the product at renewal dates. At the end of each indexed term, which can be up to six years, we have the opportunity to re-price the indexed component by establishing different participation rates, caps, spreads or specified rates, subject to contractual guarantees. We purchase and sell index options that are highly correlated to the portfolio allocation decisions of our policyholders, such that we are economically hedged with respect to equity returns for the current reset period. The mark-to-market of the options held generally offsets the change in value of the embedded derivative within the contract, both of which are recorded as a component of realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss). The Derivatives and Hedging and the Fair Value Measurements and Disclosures Topics of the Financial Accounting Standards Board Accounting Standards CodificationTM

require that we calculate fair values of index options we may purchase or sell in the future to hedge policyholder index allocations in future reset periods. These fair values represent an estimate of the cost of the options we will purchase or sell in the future, discounted back to the date of the balance sheet, using current market indicators of volatility and interest rates. Changes in the fair values of these liabilities are included as a component of realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss). For more information on indexed product derivative results, see Note 16.

For additional information on the liability for policyholder account balances, see Note 10.

76

Table of Contents

Reinsurance Recoverables

Reinsurance recoverables are generally measured and recognized consistent with the assumptions and methodologies used to project the future performance of the underlying direct business as discussed in the “Future Contract Benefits” and “Policyholder Account Balances” sections above. During the third quarter of each year, we conduct our comprehensive review of the assumptions and projection models and update assumptions as needed. In addition, we consider the potential impact of counterparty credit risks related to the reinsurance recoverable by estimating an allowance for credit losses using a probability of loss model approach to estimate expected credit losses for reinsurance recoverables. For additional information on our allowance for credit losses on reinsurance-related assets, see Note 7 in our 2024 Form 10-K.

Income Taxes

Management uses certain assumptions and estimates in determining the income taxes payable or refundable for the current year, the deferred income tax assets and liabilities for items recognized differently in its financial statements from amounts shown on its income tax returns and the federal income tax expense. Determining these amounts requires analysis and interpretation of current tax laws and regulations. Management exercises judgment in evaluating the amount and timing of recognition of the resulting income tax assets and liabilities. These judgments and estimates are re-evaluated on a continual basis as regulatory and business factors change. Legislative changes to the Internal Revenue Code of 1986, as amended, modifications or new regulations, administrative rulings, or court decisions could increase or decrease our effective tax rate.

The application of GAAP requires us to evaluate the recoverability of our deferred tax assets and establish a valuation allowance, if necessary, to reduce our deferred tax asset to an amount that is more likely than not to be realizable. Judgment and the use of estimates are required in determining whether a valuation allowance is necessary, and if so, the amount of such valuation allowance. In evaluating the need for a valuation allowance, we consider many factors, including: the nature and character of the deferred tax assets and liabilities; taxable income in prior carryback years; future reversals of existing temporary differences; the length of time carryovers can be utilized; and any future prudent and feasible tax planning strategies.

As of March 31, 2025, we had an approximate $2.1 billion deferred tax asset related to net unrealized losses on fixed maturity available-for-sale (“AFS”) securities. In the assessment of the future realizability of this deferred tax asset, management concluded that its tax planning strategies, including holding these securities to recovery, were prudent and feasible as these unrealized losses were caused by factors other than credit loss, and we have the intent and ability to hold these securities to recovery and collect all of the contractual cash flows.

Although realization is not assured, management believes it is more likely than not that the deferred tax assets, will be realized.

For risks related to establishing a valuation allowance against our deferred tax assets, see “Part I – Item 1A. Risk Factors – Assumptions and Estimates – We may be required to recognize an impairment of our goodwill or to establish a valuation allowance against our deferred tax assets” in our 2024 Form 10-K.

For additional information on income taxes, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Introduction – Summary of Critical Accounting Estimates – Income Taxes” and Note 22 in our 2024 Form 10-K and Note 17 herein.

77

Table of Contents

RESULTS OF CONSOLIDATED OPERATIONS

Details underlying the consolidated results (in millions) were as follows:

	For the Three Months Ended March 31,
	2025		2024 (1)
Net Income (Loss)
Income (loss) from operations:
Annuities	$	290	$	259
Life Insurance	(16)		(35)
Group Protection	101		80
Retirement Plan Services	34		36
Other Operations	(95)		(96)
Net annuity product features, pre-tax	(1,092)		1,450
Net life insurance product features, pre-tax	42		(130)
Credit loss-related adjustments, pre-tax	(28)		(1)
Investment gains (losses), pre-tax	(103)		(81)
Changes in the fair value of reinsurance-related
embedded derivatives, trading securities and
certain mortgage loans, pre-tax (2)	(90)		194
Other items, pre-tax (3) (4) (5) (6)	(35)		(186)
Income tax benefit (expense) related to the
above pre-tax items	270		(268)
Net income (loss)	$	(722)	$	1,222

(1)    The prior period presentation was recast to conform to the revised definition of income (loss) from operations. See Note 15 for additional information.

(2)    Includes primarily changes in the fair value of the embedded derivative related to the fourth quarter 2023 reinsurance transaction. The coinsurance with funds withheld investment portfolio includes fixed maturity securities classified as AFS with changes in fair value recorded in OCI. Since the corresponding and offsetting changes in fair value of the embedded derivative related to the coinsurance with funds withheld investment portfolio are recorded in realized gain (loss), volatility can occur within net income (loss). See Note 7 for more information.

(3)    Includes $(114) million primarily related to the settlement of cost of insurance litigation for the three months ended March 31, 2024.

(4)    Includes severance expense related to initiatives to realign the workforce of $(6) million and $(49) million for the three months ended March 31, 2025 and 2024, respectively.

(5)    Includes transaction and integration costs related to mergers, acquisitions and divestitures of $(20) million and $(10) million for the three months ended March 31, 2025 and 2024, respectively.

(6)    Includes deferred compensation mark-to-market adjustment of $(9) million and $(13) million for the three months ended March 31, 2025 and 2024, respectively.

78

Table of Contents

Comparison of the Three Months Ended March 31, 2025 to 2024

Net income decreased due primarily to the following:

•Loss in net annuity product features in 2025 compared to gain in 2024 driven by loss in MRB-related impacts in 2025 compared to gain in 2024 due to unfavorable changes from equity markets and interest rates, partially offset by improvement in the fair value of GLB hedge instruments attributable to the impact of capital markets.

•Unfavorable changes in the fair value of reinsurance-related embedded derivatives, trading securities and certain mortgage loans in 2025 compared to favorable changes in 2024 driven by the fair value of the embedded derivative related to the fourth quarter 2023 reinsurance transaction.

•Higher credit loss-related adjustments on fixed maturity AFS securities.

The decrease in net income was partially offset by the following:

•Gain in net life insurance product features in 2025 compared to loss in 2024 driven by improvement in the fair value of hedges associated with VUL products attributable to the impact of capital markets.

•Lower expenses in other items.

•Growth in average account balances and improvement in our total loss ratio in our Group Protection segment.

79

Table of Contents

RESULTS OF ANNUITIES

Income (Loss) from Operations

Details underlying the results for Annuities (in millions) were as follows:

	For the Three Months Ended March 31,
	2025		2024
Operating Revenues
Insurance premiums (1)	$	21	$	26
Fee income	591		580
Net investment income	466		420
Other revenues (2)	120		243
Total operating revenues	1,198		1,269
Operating Expenses
Benefits (1)	29		27
Interest credited	419		354
Policyholder liability remeasurement (gain) loss	(1)		–
Commissions and other expenses	411		571
Total operating expenses	858		952
Income (loss) from operations before taxes	340		317
Federal income tax expense (benefit)	50		58
Income (loss) from operations	$	290	$	259

(1) Insurance premiums include primarily our income annuities that have a corresponding offset in benefits. Benefits include primarily changes in income annuity reserves driven by insurance premiums.

(2) Consists primarily of revenues attributable to broker-dealer services, which are subject to market volatility and have a comparable offset in commissions and other expenses; and the net settlement related to certain reinsurance transactions, which has a corresponding offset in net investment income and interest credited. During the second quarter of 2024, we closed the sale of our wealth management business. For more information, see Note 1 in our 2024 Form 10-K.

Comparison of the Three Months Ended March 31, 2025 to 2024

Income from operations for this segment increased due primarily to the following:

•Higher fee income driven by higher average daily separate account balances.

•Lower federal income tax expense due to unfavorable separate account dividends-received deduction true-ups in 2024.

The increase in income from operations was partially offset by the following:

•Lower net investment income, net of interest credited, which more than offset impacts from higher average general account balances, improving portfolio yields from the current interest rate environment and higher investment income within our surplus portfolio. The lower net investment income, net of interest credited, was experienced in certain reinsured portfolios that have a corresponding increase in other revenues and decrease in benefits.

•Higher commissions and other expenses, net of broker-dealer expenses, driven by higher deferred acquisition costs (“DAC”) amortization.

The increase in income from operations was also due to higher commissions and other expenses in the first quarter of 2024 related to a balance sheet true-up in preparation for the close of the sale of the wealth management business.

Additional Information

New deposits are an important component of net flows and key to our efforts to grow our business. Although deposits do not significantly affect current period income from operations, they can significantly impact future income from operations.

80

Table of Contents

The other component of net flows relates to the retention of new business and account balances. An important measure of retention is the reduction in account balances caused by full surrenders, deaths and other contract benefits. These outflows as a percentage of average gross account balances were 11% for the three months ended March 31, 2025 and 2024.

Our fixed annuities and RILA have discretionary fixed and indexed crediting rates that reset on an annual or periodic basis and may be subject to surrender charges. Our ability to retain these annuities will be subject to current competitive conditions at the time crediting rates for these products reset. We expect to manage the effects of spreads on near-term income from operations through portfolio management and, to a lesser extent, crediting rate actions, which assumes no significant changes in net flows or other changes that may cause interest rate spreads to differ from our expectations. For information on interest rate spreads and interest rate risk, see “Part I – Item 1A. Risk Factors – Market Conditions – Changes in interest rates and sustained low interest rates may cause interest rate spreads to decrease, impacting our profitability, and make it more challenging to meet certain statutory requirements,” “Part I – Item 1A. Risk Factors – Market Conditions – Increases in interest rates and sustained high interest rates may negatively affect our profitability, capital position and the value of our investment portfolio and may also result in increased contract withdrawals and surrenders” and “Part II – Item 7A. Quantitative and Qualitative Disclosures About Market Risk – Interest Rate Risk” in our 2024 Form 10-K. For information on the interest rate environment, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Introduction – Executive Summary – Industry Trends – Interest Rate Environment” in our 2024 Form 10-K.

Fee Income

Details underlying fee income (in millions) were as follows:

	For the Three Months Ended March 31,
	2025		2024
Fee Income
Mortality, expense and other assessments (1)	$	576	$	564
Surrender charges	13		15
DFEL:
Deferrals	(4)		(5)
Amortization	6		6
Total fee income	$	591	$	580

(1) Presented net of GLB and GDB hedge allowance.

We charge policyholders mortality and expense assessments on variable annuity accounts to cover insurance and administrative expenses. These assessments are a function of the rates priced into the product and the average daily separate account balances. Average daily separate account balances are driven by net flows and variable fund returns. Charges on GLB riders are assessed based on a contractual rate that is applied either to the account balance or the guaranteed amount. We allocate a portion of these fees to support the cost of hedging GLB and GDB riders. For more information, see Note 15. We may collect surrender charges when our fixed and variable annuity policyholders surrender their contracts during the surrender charge period to protect us from premature withdrawals.

81

Table of Contents

Net Investment Income and Interest Credited

Details underlying net investment income and interest credited (in millions) were as follows:

	For the Three Months Ended March 31,
	2025		2024
Net Investment Income
Fixed maturity AFS securities, mortgage loans on real
estate and other, net of investment expenses	$	431	$	383
Commercial mortgage loan prepayment and bond
make-whole premiums (1)	–		1
Surplus investments (2)	35		31
Net investment income pertaining to broker-dealer services	–		5
Total net investment income	$	466	$	420
Interest Credited
Amount provided to policyholders	$	416	$	351
DSI deferrals	–		(1)
Interest credited before DSI amortization	416		350
DSI amortization	3		4
Total interest credited	$	419	$	354

(1) See “Consolidated Investments – Commercial Mortgage Loan Prepayment and Bond Make-Whole Premiums” below for additional information.

(2) Represents net investment income on the required statutory surplus for this segment and includes the effect of investment income on alternative investments for such assets that are held in the portfolios supporting statutory surplus versus the portfolios supporting product liabilities. See “Consolidated Investments – Alternative Investments” below for more information on alternative investments.

A portion of our investment income earned is credited to the policyholders of our deferred fixed annuities, the fixed portion of our variable annuities and our RILA contracts. We expect to earn a spread between what we earn on the underlying general account investments supporting the fixed annuities, fixed portion of the variable annuities and RILA contracts and what we credit to our policyholders’ accounts. Changes in commercial mortgage loan prepayments and bond make-whole premiums, investment income on alternative investments and surplus investment income can vary significantly from period to period due to a number of factors and, therefore, may contribute to investment income results that are not indicative of the underlying trends.

82

Table of Contents

Account Balances

Details underlying account balances (dollars in millions) were as follows:

	For the Three Months Ended March 31,
	2025		2024
Separate Account Balance Information (1)
Separate account deposits	$	1,557	$	904
Separate account net flows	(2,359)		(2,304)
Separate account balances	113,635		118,176
Average daily separate account balances	118,294		114,943
Average daily S&P 500® Index (2)	5,900		4,996
General Account Balance Information
General account deposits	$	2,242	$	1,945
General account net flows	683		311
General account balances (3)	44,779		41,617
Average general account balances (3)	45,394		40,348

(1) Excludes the fixed portion of variable annuities and RILA indexed account balances.

(2) We generally use the S&P 500 Index as a benchmark for the performance of our separate account balances. The account balances of our variable annuity contracts are invested by our policyholders in a variety of investment options including, but not limited to, domestic and international equity securities and fixed income, which do not necessarily align with S&P 500 Index performance.

(3) Net of reinsurance.

For more information on account balances, see Notes 9 and 10.

83

Table of Contents

Commissions and Other Expenses

Details underlying commissions and other expenses (in millions) were as follows:

	For the Three Months Ended March 31,
	2025		2024
Commissions and Other Expenses
Commissions:
Deferrable	$	128	$	84
Non-deferrable	170		170
General and administrative expenses	125		120
Expenses associated with reserve financing
and LOC expenses	6		6
Taxes, licenses and fees	14		14
Total expenses incurred, excluding broker-dealer	443		394
DAC deferrals	(147)		(98)
Total pre-broker-dealer expenses incurred,
excluding amortization	296		296
DAC, VOBA and other amortization	115		106
Broker-dealer expenses incurred (1)	–		169
Total commissions and other expenses	$	411	$	571

DAC Deferrals
As a percentage of sales/deposits	3.9	%	3.4	%

(1) During the second quarter of 2024, we closed the sale of our wealth management business. For more information, see Note 1 in our 2024 Form 10-K.

Commissions and other expenses that result directly from and are essential to the successful acquisition of new or renewal business are deferred to the extent recoverable and are amortized on a constant level basis over the expected term of the related contracts using the groupings and actuarial assumptions consistent with those used for calculating the related policyholder liability balances. Certain types of commissions, such as trail commissions that are based on account balances, are expensed as incurred rather than deferred and amortized.

84

Table of Contents

RESULTS OF LIFE INSURANCE

Income (Loss) from Operations

Details underlying the results for Life Insurance (in millions) were as follows:

	For the Three Months Ended March 31,
	2025		2024
Operating Revenues
Insurance premiums (1)	$	283	$	288
Fee income	698		672
Net investment income	571		581
Operating realized gain (loss)	(2)		(2)
Other revenues (2)	37		2
Total operating revenues	1,587		1,541
Operating Expenses
Benefits	994		928
Interest credited	287		294
Policyholder liability remeasurement (gain) loss	8		59
Commissions and other expenses (2)	330		310
Total operating expenses	1,619		1,591
Income (loss) from operations before taxes	(32)		(50)
Federal income tax expense (benefit)	(16)		(15)
Income (loss) from operations	$	(16)	$	(35)

(1)    Includes term insurance premiums, which have a corresponding partial offset in benefits for changes in reserves.

(2)    For information on amortization of deferred gain (loss) on business sold through reinsurance, see Note 1 in our 2024 Form 10-K.

Comparison of the Three Months Ended March 31, 2025 to 2024

Loss from operations for this segment decreased due primarily to the following:

•Higher fee income driven by higher deferred front-end loads (“DFEL”) amortization.

•Lower commissions and other expenses, net of amortization of deferred loss on business sold through reinsurance, due to expense management.

The decrease in loss from operations for this segment was partially offset by the following:

•Higher benefits and policyholder liability remeasurement loss driven by aging of the block, partially offset by improved mortality due to lower claims incidence.

•Lower net investment income, net of interest credited, driven by lower investment income on alternative investments.

Additional Information

For information on interest rate spreads and interest rate risk, see “Part I – Item 1A. Risk Factors – Market Conditions – Changes in interest rates and sustained low interest rates may cause interest rate spreads to decrease, impacting our profitability, and make it more challenging to meet certain statutory requirements,” “Part I – Item 1A. Risk Factors – Market Conditions – Increases in interest rates and sustained high interest rates may negatively affect our profitability, capital position and the value of our investment portfolio and may also result in increased contract withdrawals and surrenders” and “Part II – Item 7A. Quantitative and Qualitative Disclosures About Market Risk – Interest Rate Risk” in our 2024 Form 10-K. For information on the interest rate environment, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Introduction – Executive Summary – Industry Trends – Interest Rate Environment” in our 2024 Form 10-K.

85

Table of Contents

Insurance Premiums

Insurance premiums relate to traditional products and are a function of the rates priced into the product and insurance in force. Insurance in force, in turn, is driven by sales, persistency and mortality claims.

Fee Income

Details underlying fee income, sales, net flows, account balances and in-force face amount (in millions) were as follows:

	For the Three Months Ended March 31,
	2025		2024
Fee Income
Cost of insurance assessments	$	546	$	523
Expense assessments	343		338
Surrender charges	10		10
DFEL:
Deferrals	(279)		(267)
Amortization	78		68
Total fee income	$	698	$	672

	For the Three Months Ended March 31,
	2025		2024
Sales by Product
IUL/UL	$	24	$	18
MoneyGuard®	28		24
VUL	15		23
Term	13		19
Executive Benefits	17		7
Total sales	$	97	$	91
Net Flows
Deposits	$	1,218	$	1,208
Withdrawals and deaths	(649)		(467)
Net flows	$	569	$	741
Policyholder Assessments	$	1,350	$	1,370

86

Table of Contents

	As of March 31,
	2025		2024
Account Balances (1)
General account	$	21,255	$	21,399
Separate account	22,752		21,669
Total account balances	$	44,007	$	43,068
In-Force Face Amount
UL and other	$	361,480	$	365,507
Term insurance	709,924		720,745
Total in-force face amount	$	1,071,404	$	1,086,252
	For the Three Months Ended March 31,
	2025		2024
Average General Account Balances (1)	$	21,353	$	21,401

(1) Net of reinsurance ceded.

Fee income relates only to interest-sensitive products and includes cost of insurance assessments, expense assessments and surrender charges. Both cost of insurance and expense assessments can have deferrals and amortization related to DFEL. Cost of insurance and expense assessments are deducted from our policyholders’ account balances. These amounts are a function of the rates priced into the product and premiums received, face amount in force and account balances.

Sales are not recorded as a component of revenues (other than for traditional products) and do not have a significant effect on current quarter income from operations but are indicators of future profitability. Generally, we have higher sales during the second half of the year with the fourth quarter being our strongest.

Sales in the table above and as discussed above were reported as follows:

•UL, IUL and VUL – first-year commissionable premiums plus 5% of excess premiums received;

•MoneyGuard® linked-benefit products – MoneyGuard (UL) and MoneyGuard Market AdvantageSM (VUL), 150% of commissionable premiums;

•Executive Benefits – insurance and corporate-owned UL and VUL, first-year commissionable premiums plus 5% of excess premium received, and single premium bank-owned UL and VUL, 15% of single premium deposits; and

•Term – 100% of annualized first-year premiums.

We monitor the business environment, including but not limited to the regulatory and interest rate environments, and make changes to our product offerings and in-force products as needed, and as permitted under the terms of the policies, to sustain the future profitability of our segment.

87

Table of Contents

Net Investment Income and Interest Credited

Details underlying net investment income and interest credited (in millions) were as follows:

	For the Three Months Ended March 31,
	2025		2024
Net Investment Income
Fixed maturity AFS securities, mortgage loans on real estate
and other, net of investment expenses	$	460	$	476
Commercial mortgage loan prepayment and bond
make-whole premiums (1)	1		–
Alternative investments (2)	70		74
Surplus investments (3)	40		31
Total net investment income	$	571	$	581
Interest Credited	$	287	$	294

(1) See “Consolidated Investments – Commercial Mortgage Loan Prepayment and Bond Make-Whole Premiums” below for additional information.

(2) See “Consolidated Investments – Alternative Investments” below for additional information.

(3) Represents net investment income on the required statutory surplus for this segment and includes the effect of investment income on alternative investments for such assets that are held in the portfolios supporting statutory surplus versus the portfolios supporting product liabilities.

A portion of the investment income earned for this segment is credited to policyholder accounts. Statutory reserves will typically grow at a faster rate than account balances because of reserve requirements. Investments allocated to this segment are based upon the statutory reserve liabilities and are affected by various reserve adjustments, including financing transactions providing relief from reserve requirements. These financing transactions lead to a transfer of investments from this segment to Other Operations. We expect to earn a spread between what we earn on the underlying general account investments and what we credit to our policyholders’ accounts. Investment income partially offsets the earnings effect of the associated growth of our policy reserves. Commercial mortgage loan prepayments and bond make-whole premiums and investment income on alternative investments can vary significantly from period to period due to a number of factors, and, therefore, may contribute to investment income results that are not indicative of the underlying trends.

88

Table of Contents

Benefits and Policyholder Remeasurement (Gain) Loss

Details underlying benefits and policyholder remeasurement (gain) loss (dollars in millions) were as follows:

	For the Three Months Ended March 31,
	2025		2024
Benefits and Policyholder Remeasurement (Gain) Loss
Death claims direct and assumed	$	1,484	$	1,568
Death claims ceded	(610)		(758)
Reserves released on death	(190)		(146)
Net death benefits	684		664
Change in secondary guarantee life insurance product
reserves	111		97
Change in MoneyGuard® reserves	152		142
Change in traditional product reserves	–		37
Other benefits (1)	55		47
Total benefits and policyholder remeasurement
(gain) loss	$	1,002	$	987
Death claims per $1,000 of in-force	2.55		2.44

(1) Includes primarily long-term care claims and life surrender benefits.

Benefits for this segment include claims incurred during the period in excess of the associated reserves for its interest-sensitive and traditional products. In addition, benefits include the change in secondary guarantee, linked-benefit and term life insurance product reserves. These reserves are affected by changes in expected future trends of assessments and benefits causing remeasurements. Generally, we experience higher mortality in the first quarter of the year due to the seasonality of claims.

89

Table of Contents

Commissions and Other Expenses

Details underlying commissions and other expenses (in millions) were as follows:

	For the Three Months Ended March 31,
	2025		2024
Commissions and Other Expenses
Commissions	$	99	$	113
General and administrative expenses	131		143
Expenses associated with reserve financing	26		23
Taxes, licenses and fees	37		38
Total expenses incurred	293		317
DAC and VOBA deferrals	(115)		(133)
Total expenses recognized before amortization	178		184
DAC and VOBA amortization	127		125
Amortization of deferred loss on business sold
through reinsurance (1)	24		–
Other intangible amortization	1		1
Total commissions and other expenses	$	330	$	310

DAC and VOBA Deferrals
As a percentage of sales	118.6	%	146.2	%

(1) The amortization of deferred loss on business sold through reinsurance pertains to the fourth quarter 2023 reinsurance transaction.         See Note 1 in our 2024 Form 10-K for additional information.

Commissions and other expenses that result directly from and are essential to the successful acquisition of new or renewal business are deferred to the extent recoverable. For our interest-sensitive and traditional products, DAC and value of business acquired (“VOBA”) are amortized on a constant level basis over the expected term of the related contracts using the groupings and actuarial assumptions consistent with those used for calculating the related policyholder liability balances.

90

Table of Contents

RESULTS OF GROUP PROTECTION

Income (Loss) from Operations

Details underlying the results for Group Protection (in millions) were as follows:

	For the Three Months Ended March 31,
	2025		2024
Operating Revenues
Insurance premiums	$	1,371	$	1,285
Net investment income	89		85
Other revenues (1)	61		55
Total operating revenues	1,521		1,425
Operating Expenses
Benefits	1,064		1,030
Interest credited	–		1
Policyholder liability remeasurement (gain) loss	(70)		(67)
Commissions and other expenses	399		360
Total operating expenses	1,393		1,324
Income (loss) from operations before taxes	128		101
Federal income tax expense (benefit)	27		21
Income (loss) from operations	$	101	$	80

(1) Consists of revenue from third parties for administrative services performed, which has a corresponding partial offset in commissions and other expenses.

	For the Three Months Ended March 31,
	2025		2024
Income (Loss) from Operations by Product Line
Life	$	8	$	9
Disability	95		73
Dental	(2)		(2)
Income (loss) from operations	$	101	$	80

Comparison of the Three Months Ended March 31, 2025 to 2024

Income from operations for this segment increased due primarily to higher insurance premiums due to growth in business in force and persistency.

The increase in income from operations was partially offset by the following:

•Higher commissions and other expenses due to incentive compensation as a result of increased production performance and higher other costs pertaining to business operations.

•Higher benefits, net of policyholder liability remeasurement gain, driven by growth in business in force and higher claims experience in our life business, partially offset by lower incidence in our disability business.

Additional Information

For information about the effect of the loss ratio sensitivity on our income (loss) from operations, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Results of Group Protection – Additional Information” in our 2024 Form 10-K.

91

Table of Contents

For information on the effects of current interest rates on our long-term disability claim reserves, see “Item 3. Quantitative and Qualitative Disclosures About Market Risk – Interest Rate Risk – Effect of Interest Rate Sensitivity” in our 2024 Form 10-K. For information on the interest rate environment, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Introduction – Executive Summary” in our 2024 Form 10-K.

Insurance Premiums

Details underlying insurance premiums (in millions) were as follows:

	For the Three Months Ended March 31,
	2025		2024
Insurance Premiums by Product Line
Life	$	542	$	499
Disability	783		740
Dental	46		46
Total insurance premiums	$	1,371	$	1,285
Sales by Product Line
Life	$	101	$	85
Disability	48		51
Dental	8		8
Total sales	$	157	$	144

Premiums are a function of the rates priced into the product and our business in force. Business in force, in turn, is driven by sales and persistency experience.

Sales relate to new policyholders and new coverages sold to existing policyholders. We believe that the trend in sales is an important indicator of development of business in force over time. Sales in the table above are the combined annualized premiums for our products. Generally, we have higher sales during the fourth quarter of the year.

Net Investment Income

We use our investment income to offset the earnings effect of the associated build of our reserves, which are a function of our insurance premiums and the yields on our investments. Details underlying net investment income (in millions) were as follows:

	For the Three Months Ended March 31,
	2025		2024
Net Investment Income
Fixed maturity AFS securities, mortgage loans on real estate
and other, net of investment expenses	$	70	$	68
Surplus investments (2)	19		17
Total net investment income	$	89	$	85

(1) See “Consolidated Investments – Commercial Mortgage Loan Prepayment and Bond Make-Whole Premiums” below for additional information.

(2) Represents net investment income on the required statutory surplus for this segment and includes the effect of investment income on alternative investments for such assets that are held in the portfolios supporting statutory surplus versus the portfolios supporting product liabilities. See “Consolidated Investments – Alternative Investments” below for more information on alternative investments.

92

Table of Contents

Benefits, Interest Credited and Policyholder Liability Remeasurement (Gain) Loss

Details underlying benefits, interest credited, policyholder liability remeasurement (gain) loss (in millions) and loss ratios by product line were as follows:

	For the Three Months Ended March 31,
	2025			2024
Benefits, Interest Credited and Policyholder
Liability Remeasurement (Gain) Loss by
Product Line
Life	$	407		$	380
Disability	550			549
Dental	37			35
Total benefits, interest credited and policyholder
liability remeasurement (gain) loss	$	994		$	964
Loss Ratios by Product Line
Life	75.2		%	76.1		%
Disability	70.1		%	74.2		%
Dental	79.0		%	76.5		%
Total	72.4		%	75.0		%

Generally, we experience higher mortality in the first quarter of the year and higher disability claims in the fourth quarter of the year due to the seasonality of claims. For additional information on our loss ratios, see “Additional Information” above.

Commissions and Other Expenses

Details underlying commissions and other expenses (in millions) were as follows:

	For the Three Months Ended March 31,
	2025		2024
Commissions and Other Expenses
Commissions	$	133	$	109
General and administrative expenses	222		208
Taxes, licenses and fees	38		37
Other	1		1
Total expenses incurred	394		355
DAC deferrals	(32)		(29)
Total expenses recognized before amortization	362		326
DAC and other intangible amortization	37		34
Total commissions and other expenses	$	399	$	360

DAC Deferrals
As a percentage of insurance premiums	2.3	%	2.3	%

Commissions and other expenses that result directly from and are essential to the successful acquisition of new or renewal business are deferred to the extent recoverable and are amortized on a constant level basis over the expected term of the related contracts using the groupings and actuarial assumptions consistent with those used for calculating the related policyholder liability balances. Certain broker commissions that vary with and are related to paid premiums are expensed as incurred rather than deferred and amortized.

93

Table of Contents

RESULTS OF RETIREMENT PLAN SERVICES

Income (Loss) from Operations

Details underlying the results for Retirement Plan Services (in millions) were as follows:

	For the Three Months Ended March 31,
	2025		2024
Operating Revenues
Fee income	$	72	$	70
Net investment income	251		244
Other revenues (1)	4		8
Total operating revenues	327		322
Operating Expenses
Interest credited	170		166
Commissions and other expenses	119		115
Total operating expenses	289		281
Income (loss) from operations before taxes	38		41
Federal income tax expense (benefit)	4		5
Income (loss) from operations	$	34	$	36

(1) Consists primarily of mutual fund account program revenues from mid to large employers.

Comparison of the Three Months Ended March 31, 2025 to 2024

Income from operations for this segment decreased due primarily to:

•Lower other revenues driven by a plan termination during the fourth quarter of 2024.

•Higher commissions and other expenses driven by higher trail commissions resulting from higher average daily separate account balances.

The decrease in income from operations was partially offset by the following:

•Higher net investment income, net of interest credited, driven by higher investment income on surplus investments, partially offset by lower average general account balances.

•Higher fee income driven by higher average daily separate account balances.

Additional Information

Net flows in this business fluctuate based on the timing of larger plans being implemented and terminating over the course of the year.

New deposits are an important component of net flows and key to our efforts to grow our business. Although deposits do not significantly affect current period income from operations, they can significantly impact future income from operations. The other component of net flows relates to the retention of the business. An important measure of retention is the reduction in account balances caused by plan sponsor terminations and participant withdrawals. These outflows as a percentage of average account balances were 22% and 13% for the three months ended March 31, 2025 and 2024, respectively. The increase in the outflow rate was attributable primarily to a large plan termination during the first quarter of 2025.

Our net flows are negatively affected by the continued net outflows from our oldest blocks of annuities business (as presented on our Net Flows By Market table below as “Multi-Fund® and other”), which are among our higher margin product lines in this segment, due to the fact that they are mature blocks with low distribution and servicing costs. The proportion of these products to our total account balances was 13% and 14% as of March 31, 2025 and 2024, respectively. Due to this overall shift in business mix toward products with lower returns, new deposit production continues to be necessary to maintain earnings at current levels.

Our fixed annuity business includes products with discretionary and index-based crediting rates that are reset on either a quarterly or semi-annual basis. Our ability to retain quarterly or semi-annual reset annuities will be subject to current competitive conditions at the

94

Table of Contents

time crediting rates for these products reset. We expect to manage the effects of spreads on near-term income from operations through portfolio management and, to a lesser extent, crediting rate actions, which assumes no significant changes in net flows into or out of our fixed accounts or other changes that may cause interest rate spreads to differ from our expectations. For information on interest rate spreads and interest rate risk, see “Part I – Item 1A. Risk Factors – Market Conditions – Changes in interest rates and sustained low interest rates may cause interest rate spreads to decrease, impacting our profitability, and make it more challenging to meet certain statutory requirements,” “Part I – Item 1A. Risk Factors – Market Conditions – Increases in interest rates and sustained high interest rates may negatively affect our profitability, capital position and the value of our investment portfolio and may also result in increased contract withdrawals and surrenders” and “Part II – Item 7A. Quantitative and Qualitative Disclosures About Market Risk – Interest Rate Risk” in our 2024 Form 10-K. For information on the interest rate environment, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Introduction – Executive Summary – Industry Trends – Interest Rate Environment” in our 2024 Form 10-K.

Fee Income

Details underlying fee income (in millions) were as follows:

	For the Three Months Ended March 31,
	2025		2024
Fee Income
Annuity expense assessments	$	53	$	51
Mutual fund fees	18		18
Total expense assessments	71		69
Surrender charges	1		1
Total fee income	$	72	$	70

Our fee income is primarily composed of expense assessments that we charge to cover insurance and administrative expenses, and mutual fund fees earned for services we provide to our mutual fund programs. Fee income is primarily based on average account balances, both general and separate, which are driven by net flows and the equity markets. Fee income is also driven by non-account balance-related items such as participant counts. We may collect surrender charges when our policyholders surrender their contracts during the surrender charge period to protect us from premature withdrawals.

Net Investment Income and Interest Credited

Details underlying net investment income and interest credited (in millions) were as follows:

	For the Three Months Ended March 31,
	2025		2024
Net Investment Income
Fixed maturity AFS securities, mortgage loans on real estate
and other, net of investment expenses	$	231	$	226
Commercial mortgage loan prepayment and
bond make-whole premiums (1)	–		1
Surplus investments (2)	20		17
Total net investment income	$	251	$	244
Interest Credited	$	170	$	166

(1) See “Consolidated Investments – Commercial Mortgage Loan Prepayment and Bond Make-Whole Premiums” below for additional information.

(2) Represents net investment income on the required statutory surplus for this segment and includes the effect of investment income on alternative investments for such assets that are held in the portfolios supporting statutory surplus versus the portfolios supporting product liabilities. See “Consolidated Investments – Alternative Investments” below for more information on alternative investments.

95

Table of Contents

A portion of our investment income earned is credited to the policyholders of our fixed annuity products, including the fixed portion of variable annuity contracts. We expect to earn a spread between what we earn on the underlying general account investments supporting the fixed annuity product line, including the fixed portion of variable annuity contracts, and what we credit to our policyholders’ accounts. Commercial mortgage loan prepayments and bond make-whole premiums, investment income on alternative investments and surplus investment income can vary significantly from period to period due to a number of factors and, therefore, may contribute to investment income results that are not indicative of the underlying trends.

Account Balances

Details underlying account balances (dollars in millions) were as follows:

	As of or For the Three Months Ended March 31,
	2025		2024
Separate Account Balance Information (1)
Separate account deposits	$	617	$	551
Separate account net flows	(270)		(177)
Separate account balances	20,673		20,958
Average daily separate account balances	21,575		20,132
Average daily S&P 500® Index (2)	5,900		4,996
General Account Balance Information
General account deposits	$	811	$	790
General account net flows	(519)		(413)
General account balances	23,479		23,586
Average general account balances	23,552		23,655
Mutual Fund Account Balance Information
Mutual fund deposits	$	2,687	$	2,461
Mutual fund net flows	(1,395)		981
Mutual fund account balances (3)	65,081		62,268

(1) Excludes the fixed portion of variable annuities.

(2) We generally use the S&P 500 Index as a benchmark for the performance of our separate account balances. The account balances of our variable annuity contracts are invested by our policyholders in a variety of investment options including, but not limited to, domestic and international equity securities and fixed income, which do not necessarily align with S&P 500 Index performance.

(3) Mutual funds are not included in the separate accounts reported on the Consolidated Balance Sheets as we do not have any ownership interest in them.

	For the Three Months Ended March 31,
	2025		2024
Net Flows By Market
Small market	$	(79)	$	(32)
Mid – large market	(1,732)		847
Multi-Fund® and other	(373)		(424)
Total net flows	$	(2,184)	$	391

For more information on account balances, see Notes 9 and 10.

96

Table of Contents

Commissions and Other Expenses

Details underlying commissions and other expenses (in millions) were as follows:

	For the Three Months Ended March 31,
	2025		2024
Commissions and Other Expenses
Commissions:
Deferrable	$	1	$	1
Non-deferrable	26		22
General and administrative expenses	84		86
Taxes, licenses and fees	7		6
Total expenses incurred	118		115
DAC deferrals	(4)		(5)
Total expenses recognized before amortization	114		110
DAC amortization	5		5
Total commissions and other expenses	$	119	$	115
DAC Deferrals
As a percentage of annuity sales/deposits	0.3%		0.4%

Commissions and other expenses that result directly from and are essential to the successful acquisition of new or renewal business are deferred to the extent recoverable and are amortized on a constant level basis over the expected term of the related contracts using the groupings and actuarial assumptions consistent with those used for calculating the related policyholder liability balances. Certain types of commissions, such as trail commissions that are based on account balances, are expensed as incurred rather than deferred and amortized. Distribution expenses associated with the sale of mutual fund products are expensed as incurred.

97

Table of Contents

RESULTS OF OTHER OPERATIONS

Income (Loss) from Operations

Details underlying the results for Other Operations (in millions) were as follows:

	For the Three Months Ended March 31,
	2025		2024 (1)
Operating Revenues
Insurance premiums (2)	$	–	$	2
Net investment income (3)	41		16
Other revenues (4)	11		9
Total operating revenues	52		27
Operating Expenses
Benefits	5		6
Interest credited	13		9
Policyholder liability remeasurement (gain) loss	–		(1)
Other expenses	66		51
Interest and debt expense	80		81
Total operating expenses	164		146
Income (loss) from operations before taxes	(112)		(119)
Federal income tax expense (benefit)	(17)		(23)
Income (loss) from operations	$	(95)	$	(96)

(1)    The prior period presentation was recast to conform to the revised definition of income (loss) from operations. See Note 15 for additional information.

(2)    Includes our disability income business, which has a corresponding offset in benefits for changes in reserves.

(3)    Includes our institutional pension business, which has a corresponding offset in premiums and benefits for changes in reserves, and funding agreements, which has a partial offset in interest credited. For information on funding agreements, see Note 10.

(4)    Includes certain third-party advisory fees, which has a partial offset in other expenses.

Comparison of the Three Months Ended March 31, 2025 to 2024

Loss from operations for Other Operations modestly decreased due primarily to higher net investment income, net of interest credited, related to higher allocated investments driven by an increase in excess capital retained by Other Operations. The decrease in loss from operations was partially offset by lower other revenues due to the effect of market fluctuations on assets held as part of certain compensation plans.

Net Investment Income and Interest Credited

We utilize an internal formula to determine the amount of capital that is allocated to our business segments. Investment income on capital in excess of the calculated amounts is reported in Other Operations. If our business segments require increases in statutory reserves, surplus or investments, the amount of excess capital that is retained by Other Operations would decrease and net investment income would be negatively affected.

Write-downs for impairments decrease the recorded value of investments owned by the business segments. These write-downs are not included in the income from operations of our business segments. When impairment occurs, assets are transferred to the business segments’ portfolios and will reduce the future net investment income for Other Operations. Statutory reserve adjustments for our business segments can also cause allocations of investments between the business segments and Other Operations.

The majority of our interest credited relates to our reinsurance operations sold to Swiss Re Life & Health America, Inc. (“Swiss Re”) in 2001. A substantial amount of the business was sold through indemnity reinsurance transactions, which is still recorded in the consolidated financial statements. The interest credited corresponds to investment income earnings on the assets we continue to hold for this business. There is no effect to income or loss in Other Operations or on a consolidated basis for these amounts because interest earned on the blocks that continue to be reinsured is passed through to Swiss Re in the form of interest credited.

98

Table of Contents

Benefits

Benefits are recognized when incurred for institutional pension products and disability income business.

Other Expenses

Details underlying other expenses (in millions) were as follows:

	For the Three Months Ended March 31,
	2025		2024 (1)
General and administrative expenses:
Legal	$	1	$	1
Branding	8		12
Other (2)	59		44
Total general and administrative expenses	68		57
DAC and VOBA deferrals	(2)		–
Other (3)	–		(6)
Total other expenses	$	66	$	51

(1)    The prior period presentation was recast to conform to the revised definition of income (loss) from operations. See Note 15 for additional information.

(2)    Includes expenses that are corporate in nature and not allocated to our business segments.

(3)    Consists primarily of reimbursements to Other Operations from the Life Insurance segment for the use of proceeds from certain issuances of senior notes that were used as long-term structured solutions, net of expenses incurred by Other Operations for its access to a financing facility and issuance of letters of credit (“LOCs”) and taxes, licenses and fees.

Interest and Debt Expense

Our current level of interest expense may not be indicative of the future due to, among other things, the timing of the use of cash and the future cost of capital. For additional information on our financing activities, see “Liquidity and Capital Resources – Holding Company Sources and Uses of Liquidity and Capital – Debt” below.

99

Table of Contents

CONSOLIDATED INVESTMENTS

Details underlying consolidated investment balances (in millions) were as follows:

					Percentage of
					Total Investments
	As of March 31,		As of  December 31,		As of March 31,		As of  December 31,
	2025		2024		2025		2024
Investments
Fixed maturity AFS securities	$	88,297	$	87,111	68.3	%	67.4	%
Trading securities	1,984		2,025		1.5	%	1.6	%
Equity securities	345		294		0.3	%	0.2	%
Mortgage loans on real estate	21,558		21,083		16.7	%	16.3	%
Policy loans	2,529		2,476		2.0	%	1.9	%
Derivative investments	7,849		9,677		6.1	%	7.5	%
Alternative investments	4,006		3,836		3.1	%	3.0	%
Other investments	2,647		2,752		2.0	%	2.1	%
Total investments	$	129,215	$	129,254	100.0	%	100.0	%

Investment Objective

Investments are an integral part of our operations. We follow a balanced approach to investing for both current income and prudent risk management, with an emphasis on generating sufficient current income, net of income tax, to meet our obligations to customers, as well as other general liabilities. This balanced approach requires the evaluation of expected return and risk of each asset class utilized, while still meeting our income objectives. This approach is important to our asset-liability management because decisions can be made based upon both the economic and current investment income considerations affecting assets and liabilities. For a discussion of our risk management process, see “Part II – Item 7A. Quantitative and Qualitative Disclosures About Market Risk” in our 2024 Form 10-K.

Investment Portfolio Composition and Diversification

Fundamental to our investment policy is diversification across asset classes. Our investment portfolio, excluding cash and invested cash, is composed of fixed maturity securities, mortgage loans on real estate, real estate (either wholly owned or in joint ventures) and other long-term investments. We purchase investments for our segmented portfolios that have yield, duration and other characteristics that take into account the liabilities of the products being supported.

We have the ability to maintain our investment holdings throughout credit cycles because of our capital position, the long-term nature of our liabilities and the matching of our portfolios of investment assets with the liabilities of our various products.

100

Table of Contents

Fixed Maturity and Equity Securities Portfolios

Fixed maturity securities consist of portfolios classified as AFS and trading. Details underlying our fixed maturity AFS securities by industry classification (in millions) are presented in the tables below. These tables agree in total with the presentation of fixed maturity AFS securities in Note 3; however, the categories below represent a more detailed breakout of the fixed maturity AFS portfolio. Therefore, the investment classifications listed below do not agree to the investment categories provided in Note 3.

	As of March 31, 2025
	Net								%
	Amortized		Gross Unrealized				Fair		Fair
	Cost (1)		Gains		Losses		Value		Value
Fixed Maturity AFS Securities
Industry corporate bonds:
Financial services	$	14,269	$	110	$	1,267	$	13,112	14.8	%
Basic industry	3,375		42		372		3,045		3.4	%
Capital goods	6,170		59		696		5,533		6.3	%
Communications	3,208		49		416		2,841		3.2	%
Consumer cyclical	5,786		44		553		5,277		6.0	%
Consumer non-cyclical	14,988		124		2,210		12,902		14.7	%
Energy	2,981		29		314		2,696		3.1	%
Technology	4,759		21		567		4,213		4.8	%
Transportation	3,456		32		357		3,131		3.5	%
Industrial other	2,481		9		448		2,042		2.3	%
Utilities	12,530		92		1,663		10,959		12.4	%
Government-related entities	1,337		19		222		1,134		1.3	%
Collateralized mortgage and other obligations (“CMOs”):
Agency backed	1,191		3		142		1,052		1.2	%
Non-agency backed	324		24		4		344		0.4	%
Mortgage pass through securities (“MPTS”):
Agency backed	583		2		40		545		0.6	%
Commercial mortgage-backed securities (“CMBS”):
Non-agency backed	1,961		6		137		1,830		2.1	%
Asset-backed securities (“ABS”):
Collateralized loan obligations (“CLOs”)	8,004		14		233		7,785		8.8	%
Other (2)	6,467		96		107		6,456		7.3	%
Municipals:
Taxable	2,710		21		412		2,319		2.6	%
Tax-exempt	34		–		3		31		0.0	%
Government:
United States	567		5		34		538		0.6	%
Foreign	282		13		56		239		0.3	%
Hybrid and redeemable preferred securities	258		25		10		273		0.3	%
Total fixed maturity AFS securities	97,721		839		10,263		88,297		100.0	%
Trading Securities (3)	2,105		40		161		1,984
Equity Securities	368		7		30		345
Total fixed maturity AFS, trading and equity securities	$	100,194	$	886	$	10,454	$	90,626

101

Table of Contents

	As of December 31, 2024
	Net								%
	Amortized		Gross Unrealized				Fair		Fair
	Cost (1)		Gains		Losses		Value		Value
Fixed Maturity AFS Securities
Industry corporate bonds:
Financial services	$	14,276	$	97	$	1,396	$	12,977	14.9	%
Basic industry	3,395		40		381		3,054		3.5	%
Capital goods	6,223		51		745		5,529		6.4	%
Communications	3,242		49		437		2,854		3.3	%
Consumer cyclical	5,899		38		593		5,344		6.1	%
Consumer non-cyclical	15,042		115		2,356		12,801		14.7	%
Energy	3,000		27		341		2,686		3.1	%
Technology	4,708		19		620		4,107		4.7	%
Transportation	3,451		28		370		3,109		3.6	%
Industrial other	2,450		7		445		2,012		2.3	%
Utilities	12,494		76		1,750		10,820		12.4	%
Government-related entities	1,362		16		221		1,157		1.3	%
CMOs:
Agency backed	1,202		3		168		1,037		1.2	%
Non-agency backed	328		21		4		345		0.4	%
MPTS:
Agency backed	529		–		48		481		0.6	%
CMBS:
Non-agency backed	1,817		4		156		1,665		1.9	%
ABS:
CLOs	8,307		21		277		8,051		9.2	%
Other (2)	5,895		78		144		5,829		6.6	%
Municipals:
Taxable	2,765		18		443		2,340		2.7	%
Tax-exempt	33		–		2		31		0.0	%
Government:
United States	429		3		41		391		0.5	%
Foreign	282		11		56		237		0.3	%
Hybrid and redeemable preferred securities	240		25		11		254		0.3	%
Total fixed maturity AFS securities	97,369		747		11,005		87,111		100.0	%
Trading Securities (3)	2,168		35		178		2,025
Equity Securities	310		6		22		294
Total fixed maturity AFS, trading and equity securities	$	99,847	$	788	$	11,205	$	89,430

(1) Represents amortized cost, net of the allowance for credit losses.

(2) Includes securities collateralized by consumer loans, equipment loans and other asset types.

(3) Certain of our trading securities support our reinsurance funds withheld and modified coinsurance agreements and the investment results are passed directly to the reinsurers. See “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Consolidated Investments – Fixed Maturity and Equity Securities Portfolios – Trading Securities” in our 2024 Form 10-K for more information.

102

Table of Contents

Fixed Maturity AFS Securities

In accordance with the fixed maturity AFS accounting guidance, we reflect stockholders’ equity as if unrealized gains and losses were actually recognized and consider all related accounting adjustments that would occur upon such a hypothetical recognition of unrealized gains and losses. Such related balance sheet effects include adjustments to future contract benefits, policyholder account balances and deferred income taxes. Adjustments to each of these balances are charged or credited to accumulated other comprehensive income (loss) (“AOCI”). For instance, deferred income tax balances are adjusted because unrealized gains or losses do not affect actual taxes currently paid.

The quality of our fixed maturity AFS securities portfolio, as measured at estimated fair value and by the percentage of fixed maturity AFS securities invested in various ratings categories, relative to the entire fixed maturity AFS security portfolio (in millions) was as follows:

		As of March 31, 2025						As of December 31, 2024
	Rating Agency	Net						Net
NAIC	Equivalent	Amortized		Fair		% of		Amortized		Fair		% of
Designation (1)	Designation (1)	Cost		Value		Total		Cost		Value		Total
Investment Grade Securities
1	AAA / AA / A	$	58,615	$	52,575	59.6	%	$	58,103	$	51,596	59.2	%
2	BBB	36,157		32,854		37.2	%	36,224		32,583		37.4	%
Total investment grade securities		94,772		85,429		96.8	%	94,327		84,179		96.6	%
Below Investment Grade Securities
3	BB	875		825		0.9	%	960		910		1.0	%
4	B	1,878		1,856		2.1	%	1,857		1,826		2.1	%
5	CCC and lower	122		112		0.1	%	138		124		0.2	%
6	In or near default	74		75		0.1	%	87		72		0.1	%
Total below investment grade securities		2,949		2,868		3.2	%	3,042		2,932		3.4	%
Total fixed maturity AFS securities		$	97,721	$	88,297	100.0	%	$	97,369	$	87,111	100.0	%

Total securities below investment
grade as a percentage of total
fixed maturity AFS securities	3.0	%	3.2	%	3.1	%	3.4	%

(1) Based upon the rating designations determined and provided by the National Association of Insurance Commissioners (“NAIC”) or the major credit rating agencies (Fitch Ratings (“Fitch”), Moody’s Investors Service (“Moody’s”) and S&P Global Ratings (“S&P”)). For securities where the ratings assigned by the major credit rating agencies are not equivalent, the second lowest rating assigned is used. For those securities where ratings by the major credit rating agencies are not available, which does not represent a significant amount of our total fixed maturity AFS securities, we base the ratings disclosed upon internal ratings. The average credit quality was A- as of March 31, 2025.

Comparisons between the NAIC designations and rating agency designations are published by the NAIC. The NAIC assigns securities quality designations and uniform valuations, which are used by insurers when preparing their annual statements. The NAIC designations are similar to the rating agency designations of the Nationally Recognized Statistical Rating Organizations for marketable bonds. NAIC designations 1 and 2 include bonds generally considered investment grade (rated Baa3 or higher by Moody’s, or rated BBB- or higher by S&P and Fitch) by such ratings organizations. However, securities designated NAIC 1 and 2 could be deemed below investment grade by the rating agencies as a result of the current risk-based capital (“RBC”) rules for residential mortgage-backed securities (“RMBS”) and CMBS for statutory reporting. NAIC designations 3 through 6 include bonds generally considered below investment grade (rated Ba1 or lower by Moody’s, or rated BB+ or lower by S&P and Fitch).

As of March 31, 2025, and December 31, 2024, 97% of the total fixed maturity AFS securities in an unrealized loss position were investment grade. Our gross unrealized losses recognized in OCI on fixed maturity AFS securities as of March 31, 2025, decreased by $742 million since December 31, 2024. For the three months ended March 31, 2025, we recognized $122 million of gross losses, on fixed maturity AFS securities, which were primarily related to sales that support our reinsurance funds withheld agreements where the

103

Table of Contents

investment results are passed directly to the reinsurers. For the three months ended March 31, 2024, we recognized $61 million of gross losses on fixed maturity AFS securities, which were primarily related to portfolio rebalancing.

We regularly review our fixed maturity AFS securities for declines in fair value that we determine to be impairment-related, including those attributable to credit risk factors that may require a credit allowance. We do not believe the unrealized loss position as of March 31, 2025, required an impairment recognized in earnings as: (i) we did not intend to sell these fixed maturity AFS securities; (ii) it is not more likely than not that we will be required to sell the fixed maturity AFS securities before recovery of their amortized cost basis; and (iii) the difference in the fair value compared to the amortized cost was due to factors other than credit loss. This conclusion is consistent with our asset-liability management process. Management considered the following as part of the evaluation:

•The current economic environment and market conditions;

•Our business strategy and current business plans;

•The nature and type of security, including expected maturities and exposure to general credit, liquidity, market and interest rate risk;

•Our analysis of data from financial models and other internal and industry sources to evaluate the current effectiveness of our hedging and overall risk management strategies;

•The current and expected timing of contractual maturities of our assets and liabilities, expectations of prepayments on investments and expectations for surrenders and withdrawals of annuity contracts and life insurance policies;

•The capital risk limits approved by management; and

•Our current financial condition and liquidity demands.

We recognized $(28) million of credit loss benefit (expense) on our fixed maturity AFS securities for the three months ended March 31, 2025, and $(2) million for the corresponding period in 2024. In order to determine the amount of credit loss, we calculated the recovery value by performing a discounted cash flow analysis based on the current cash flows and future cash flows we expect to recover. To determine the recoverability, we considered the facts and circumstances surrounding the underlying issuer including, but not limited to, the following:

•Historical and implied volatility of the security;

•The extent to which the fair value has been less than amortized cost;

•Adverse conditions specifically related to the security or to specific conditions in an industry or geographic area;

•Failure, if any, of the issuer of the security to make scheduled payments; and

•Recoveries or additional declines in fair value subsequent to the balance sheet date.

For information on credit loss impairment on fixed maturity AFS securities, see Notes 3 and 16 herein and Note 1 in our 2024 Form 10-K.

As reported on the Consolidated Balance Sheets, we had $133.5 billion of investments and cash and invested cash, which exceeded the liabilities for our future obligations under insurance policies and contracts, net of amounts recoverable from reinsurers and amounts on deposit with reinsurers, which totaled $110.4 billion as of March 31, 2025. If it were necessary to liquidate fixed maturity AFS securities prior to maturity or call to meet cash flow needs, we would first look to those fixed maturity AFS securities that are in an unrealized gain position, which had a fair value of $23.3 billion as of March 31, 2025, rather than selling fixed maturity AFS securities in an unrealized loss position. The amount of cash that we have on hand at any point in time takes into account our liquidity needs in the future, other sources of cash, such as the maturities of investments, interest and dividends we earn on our investments and the ongoing cash flows from new and existing business. For additional information, see “Liquidity and Capital Resources” below.

As of March 31, 2025, and December 31, 2024, the estimated fair value for all private placement securities was $21.5 billion and $20.9 billion, respectively, representing 17% and 16% of total investments, respectively.

Mortgage-Backed Securities (Included in Fixed Maturity AFS and Trading Securities)

See “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Consolidated Investments – Mortgage-Backed Securities” in our 2024 Form 10-K for a discussion of our mortgage-backed securities.

104

Table of Contents

The market value of fixed maturity AFS and trading securities backed by subprime loans was $180 million and represented less than 1% of our total investment portfolio as of March 31, 2025. Fixed maturity AFS securities represented $173 million, or 96%, and trading securities represented $7 million, or 4%, of the subprime exposure as of March 31, 2025. The table below summarizes our investments in fixed maturity AFS securities backed by pools of residential mortgages (in millions) as of March 31, 2025:

	Agency				Non-Agency				Total
	Net Amortized Cost		Fair Value		Net Amortized Cost		Fair Value		Net Amortized Cost		Fair Value
Type
RMBS	$	1,774	$	1,598	$	324	$	343	$	2,098	$	1,941
ABS home equity	–		–		157		191		157		191
Total by type (1)(2)	$	1,774	$	1,598	$	481	$	534	$	2,255	$	2,132
NAIC Designation
1	$	1,774	$	1,598	$	454	$	502	$	2,228	$	2,100
2	–		–		5		5		5		5
3	–		–		10		9		10		9
4	–		–		10		16		10		16
5	–		–		2		2		2		2
6	–		–		–		–		–		–
Total by NAIC designation (1)(2)(3)	$	1,774	$	1,598	$	481	$	534	$	2,255	$	2,132

Total fixed maturity AFS securities backed by pools of
residential mortgages as a percentage of total fixed maturity AFS securities	2.3	%	2.4	%
Total non-agency backed as a percentage of total fixed maturity AFS securities	0.5	%	0.6	%

(1) Does not include the amortized cost of trading securities totaling $71 million that primarily support our reinsurance funds withheld and modified coinsurance agreements because investment results for these agreements are passed directly to the reinsurers. The $71 million in trading securities consisted of $14 million agency and $57 million non-agency.

(2) Does not include the fair value of trading securities totaling $63 million that primarily support our reinsurance funds withheld and modified coinsurance agreements because investment results for these agreements are passed directly to the reinsurers. The $63 million in trading securities consisted of $13 million agency and $50 million non-agency.

(3) Based upon the rating designations determined and provided by the NAIC.

None of these investments included any direct investments in subprime lenders or mortgages. We are not aware of material exposure to subprime loans in our alternative investment portfolio.

105

Table of Contents

The following summarizes our investments in fixed maturity AFS securities backed by pools of commercial mortgages (in millions) as of March 31, 2025:

	Multiple Property					Single Property					Total
	Net Amortized Cost		Fair Value			Net Amortized Cost		Fair Value			Net Amortized Cost		Fair Value
Type
CMBS (1)(2)	$	1,879	$	1,754		$	82	$	76		$	1,961	$	1,830
NAIC Designation
1	$	1,874	$	1,749		$	82	$	76		$	1,956	$	1,825
2	5		5			–		–			5		5
3	–		–			–		–			–		–
4	–		–			–		–			–		–
5	–		–			–		–			–		–
6	–		–		—	–		–		—	–		–
Total by NAIC designation (1)(2)(3)	$	1,879	$	1,754		$	82	$	76		$	1,961	$	1,830

Total fixed maturity AFS securities backed by pools of
commercial mortgages as a percentage of total fixed maturity AFS securities	2.0	%	2.1	%

(1) Does not include the amortized cost of trading securities totaling $125 million that primarily support our reinsurance funds withheld and modified coinsurance agreements because investment results for these agreements are passed directly to the reinsurers. The $125 million in trading securities consisted of $76 million of multiple property CMBS and $49 million of single property CMBS.

(2) Does not include the fair value of trading securities totaling $108 million that primarily support our reinsurance funds withheld and modified coinsurance agreements because investment results for these agreements are passed directly to the reinsurers. The $108 million in trading securities consisted of $69 million of multiple property CMBS and $39 million of single property CMBS.

(3) Based upon the rating designations determined and provided by the NAIC.

The following summarizes our investments in asset-backed securities within fixed maturity AFS securities (in millions) as of March 31, 2025:

	CLOs					Other					Total
	Net Amortized Cost		Fair Value			Net Amortized Cost		Fair Value			Net Amortized Cost		Fair Value
Type
ABS (1)(2)	$	8,004	$	7,785		$	6,467	$	6,456		$	14,471	$	14,241
NAIC Designation
1	$	7,755	$	7,537		$	4,850	$	4,847		$	12,605	$	12,384
2	249		248			1,543		1,527			1,792		1,775
3	–		–			–		–			–		–
4	–		–			6		14			6		14
5	–		–			–		–			–		–
6	–		–		–	68		68		–	68		68
Total by NAIC designation (1)(2)(3)	$	8,004	$	7,785		$	6,467	$	6,456		$	14,471	$	14,241

(1) Does not include the amortized cost of trading securities totaling $416 million that primarily support our reinsurance funds withheld and modified coinsurance agreements because investment results for these agreements are passed directly to the reinsurers. The $416 million in trading securities consisted of $287 million of CLOs and $129 million of Other ABS.

106

Table of Contents

(2) Does not include the fair value of trading securities totaling $409 million that primarily support our reinsurance funds withheld and modified coinsurance agreements because investment results for these agreements are passed directly to the reinsurers. The $409 million in trading securities consisted of $287 million of CLOs and $122 million of Other ABS.

(3) Based upon the rating designations determined and provided by the NAIC.

Composition by Industry Categories of our Unrealized Losses on Fixed Maturity AFS Securities

When considering unrealized gain and loss information, it is important to recognize that the information relates to the position of securities at a particular point in time and may not be indicative of the position of our investment portfolios subsequent to the balance sheet date. Further, because the timing of the recognition of realized investment gains and losses through the selection of which securities are sold is largely at management’s discretion, it is important to consider the information provided below within the context of the overall unrealized gain or loss position of our investment portfolios. These are important considerations that should be included in any evaluation of the potential effect of securities in an unrealized loss position on our future earnings. The composition by industry categories of all fixed maturity AFS securities in an unrealized loss position (in millions) as of March 31, 2025, was as follows:

	Net Amortized Cost		%  Net Amortized Cost		Gross Unrealized Losses		% Gross Unrealized Losses		Fair Value		% Fair Value
Healthcare	$	5,765	7.7	%	$	1,219	11.9	%	$	4,546	7.0	%
Electric	6,994		9.3	%	1,125		11.0	%	5,869		9.0	%
Technology	3,793		5.0	%	567		5.5	%	3,226		5.0	%
Food and beverage	3,599		4.8	%	526		5.1	%	3,073		4.7	%
Industrial – other	2,093		2.8	%	455		4.4	%	1,638		2.4	%
Local authorities	2,159		2.9	%	420		4.1	%	1,739		2.7	%
Banking	4,642		6.2	%	360		3.5	%	4,282		6.6	%
ABS	7,328		9.7	%	327		3.2	%	7,001		10.8	%
Pharmaceuticals	2,124		2.8	%	308		3.0	%	1,816		2.8	%
Diversified manufacturing	2,185		2.9	%	301		2.9	%	1,884		2.9	%
Natural gas	1,542		2.0	%	273		2.7	%	1,269		2.0	%
Retail	1,549		2.1	%	249		2.4	%	1,300		2.0	%
Chemicals	1,833		2.4	%	243		2.4	%	1,590		2.4	%
Brokerage asset management	1,610		2.1	%	218		2.1	%	1,392		2.1	%
Transportation services	1,859		2.5	%	205		2.0	%	1,654		2.5	%
Property and casualty	1,351		1.8	%	205		2.0	%	1,146		1.8	%
Aerospace and defense	1,310		1.7	%	199		1.9	%	1,111		1.7	%
Life insurance	1,220		1.6	%	198		1.9	%	1,022		1.6	%
Utility – other	1,138		1.5	%	186		1.8	%	952		1.5	%
Government-sponsored	468		0.6	%	154		1.5	%	314		0.5	%
Midstream	1,344		1.8	%	151		1.5	%	1,193		1.8	%
Wirelines	847		1.1	%	150		1.5	%	697		1.1	%
Railroads	835		1.1	%	147		1.4	%	688		1.1	%
Non-agency CMBS	1,524		2.0	%	136		1.3	%	1,388		2.1	%
Consumer products	903		1.2	%	127		1.2	%	776		1.2	%
Integrated	657		0.9	%	118		1.1	%	539		0.8	%
Wireless	676		0.9	%	117		1.1	%	559		0.9	%
Automotive	1,339		1.8	%	114		1.1	%	1,225		1.9	%
Industries with unrealized losses
less than $100 million	12,603		16.8	%	1,465		14.5	%	11,138		17.1	%
Total by industry	$	75,290	100.0	%	$	10,263	100.0	%	$	65,027	100.0	%

Total by industry as a percentage of
total fixed maturity AFS securities	77.0	%	100.0	%	73.6	%

107

Table of Contents

Mortgage Loans on Real Estate

The following tables summarize key information on mortgage loans on real estate (in millions):

	As of March 31, 2025
	Commercial		Residential		Total		%
Credit Quality Indicator
Current	$	17,587	$	3,994	$	21,581	99.4	%
Delinquent (1)	25		47		72		0.3	%
Foreclosure	–		59		59		0.3	%
Total mortgage loans on real estate before allowance	17,612		4,100		21,712		100.0	%
Allowance for credit losses	(98)		(56)		(154)
Total mortgage loans on real estate	$	17,514	$	4,044	$	21,558

	As of December 31, 2024
	Commercial		Residential		Total		%
Credit Quality Indicator
Current	$	17,546	$	3,572	$	21,118	99.4	%
Delinquent (1)	25		33		58		0.3	%
Foreclosure	–		59		59		0.3	%
Total mortgage loans on real estate before allowance	17,571		3,664		21,235		100.0	%
Allowance for credit losses	(99)		(53)		(152)
Total mortgage loans on real estate	$	17,472	$	3,611	$	21,083

(1) Includes certain mortgage loans on real estate that support our modified coinsurance agreements, where the investment results are passed directly to the reinsurers. As of March 31, 2025, and December 31, 2024, the fair value of such commercial mortgage loans on real estate that were in delinquent status was $21 million.

As of March 31, 2025, there were specifically identified impaired commercial and residential mortgage loans with an aggregate carrying value of $34 million and $66 million, respectively, or less than 1% of total mortgage loans on real estate. As of December 31, 2024, there were specifically identified impaired commercial and residential mortgage loans with an aggregate carrying value of $36 million and $58 million, respectively, or less than 1% of total mortgage loans on real estate.

The total outstanding principal and interest on commercial mortgage loans that were two or more payments delinquent, excluding foreclosures, as of March 31, 2025, and December 31, 2024, was $34 million, or less than 1% of total mortgage loans on real estate. The total outstanding principal and interest on residential mortgage loans that were three or more payments delinquent, excluding foreclosures, as of March 31, 2025, and December 31, 2024, was $46 million and $32 million, respectively, or less than 1% of total mortgage loans on real estate.

The carrying value of mortgage loans on real estate by business segment and Other Operations (in millions) was as follows:

	As of March 31, 2025		As of  December 31, 2024
Segment
Annuities	$	9,212	$	8,783
Life Insurance	3,490		3,527
Group Protection	1,607		1,608
Retirement Plan Services	5,413		5,380
Other Operations	1,836		1,785
Total mortgage loans on real estate	$	21,558	$	21,083

108

Table of Contents

The composition of commercial mortgage loans (in millions) by property type, geographic region and state is shown below as of March 31, 2025:

	Carrying Value		%			Carrying Value		%
Property Type					State
Apartment	$	5,455	31.1	%	CA	$	4,712	26.9	%
Industrial	5,124		29.3	%	TX	1,694		9.7	%
Office building	3,123		17.8	%	FL	1,007		5.7	%
Retail	2,764		15.8	%	AZ	904		5.2	%
Other commercial	798		4.6	%	NY	895		5.2	%
Mixed use	144		0.8	%	PA	890		5.1	%
Hotel/motel	106		0.6	%	WA	670		3.9	%
Total	$	17,514	100.0	%	MD	670		3.8	%
Geographic Region					GA	605		3.5	%
Pacific	5,688		32.5	%	TN	528		3.0	%
South Atlantic	3,666		20.8	%	NC	498		2.8	%
Middle Atlantic	2,188		12.5	%	VA	424		2.4	%
West South Central	1,831		10.5	%	UT	404		2.3	%
Mountain	1,605		9.2	%	NJ	403		2.3	%
East North Central	1,104		6.3	%	IL	340		1.9	%
East South Central	641		3.7	%	OH	318		1.8	%
West North Central	444		2.5	%	OR	305		1.7	%
New England	347		2.0	%	All other states	2,247		12.8	%
Total	$	17,514	100.0	%	Total	$	17,514	100.0	%

The following table shows the principal amount (in millions) of our commercial and residential mortgage loans by year in which the principal is contractually obligated to be repaid:

	As of March 31, 2025
	Commercial		Residential		Total		%
Principal Repayment Year
2025	$	848	$	405	$	1,253	5.8	%
2026	1,399		285		1,684		7.8	%
2027	1,850		50		1,900		8.8	%
2028	2,194		47		2,241		10.3	%
2029	1,884		50		1,934		8.9	%
2030 and thereafter	9,474		3,172		12,646		58.4	%
Total	$	17,649	$	4,009	$	21,658	100.0	%

See Note 3 for information regarding our loan-to-value and debt-service coverage ratios and our allowance for credit losses.

109

Table of Contents

Alternative Investments

Investment income (loss) on alternative investments by business segment (in millions) was as follows:

	For the Three Months Ended March 31,
	2025		2024
Annuities	$	2	$	2
Life Insurance	70		74
Group Protection	1		1
Retirement Plan Services	2		1
Total (1)	$	75	$	78

(1) Includes net investment income on the alternative investments supporting the required statutory surplus of our insurance businesses.

As of March 31, 2025, and December 31, 2024, alternative investments included investments in 370 and 371 different partnerships, respectively, and the portfolio represented approximately 3% of total investments. The partnerships do not represent off-balance sheet financing and generally involve several third-party partners. Some of our partnerships contain capital calls, which require us to contribute capital upon notification by the general partner. These capital calls are contemplated during the initial investment decision and are planned for well in advance of the call date. The capital calls are not material in size and are not material to our liquidity. Alternative investments are accounted for using the equity method of accounting and are included in other investments on the Consolidated Balance Sheets.

Net Investment Income

Details underlying net investment income (in millions) and our investment yield were as follows:

	For the Three Months Ended March 31,
	2025		2024
Net Investment Income
Fixed maturity AFS securities	$	1,059	$	1,051
Trading securities	26		32
Equity securities	3		4
Mortgage loans on real estate	251		196
Policy loans	26		25
Cash and invested cash	59		37
Commercial mortgage loan prepayment
and bond make-whole premiums (1)	2		2
Alternative investments (2)	75		78
Other investments	23		15
Investment income	1,524		1,440
Investment expense	(67)		(94)
Net investment income	$	1,457	$	1,346

(1) See “Commercial Mortgage Loan Prepayment and Bond Make-Whole Premiums” below for additional information.

(2) See “Alternative Investments” above for additional information.

110

Table of Contents

	For the Three Months Ended March 31,
	2025		2024
Interest Rate Yield
Fixed maturity AFS securities, mortgage loans on
real estate and other, net of investment expenses	4.23	%	4.00	%
Commercial mortgage loan prepayment and
bond make-whole premiums	0.01	%	0.00	%
Alternative investments	0.23	%	0.26	%
Net investment income yield on invested assets	4.47	%	4.26	%

We earn investment income on our general account investments supporting our liabilities associated with investment-type annuities (including RILA, individual and group fixed and fixed portion of variable annuities, fixed indexed deferred annuities and non-life contingent payout fixed annuities), UL, MoneyGuard(R), VUL, IUL and funding agreement products. The profitability of our products is affected by our ability to achieve target spreads, or margins, between the interest income earned on the general account assets and the interest credited to the policyholder account balance. The net investment income and the interest rate yield tables above each include commercial mortgage loan prepayments and bond make-whole premiums, alternative investments and contingent interest and standby real estate equity commitments. These items can vary significantly from period to period due to a number of factors and, therefore, can provide results that are not indicative of the underlying trends.

Commercial Mortgage Loan Prepayment and Bond Make-Whole Premiums

Prepayment and make-whole premiums are collected when borrowers elect to call or prepay their debt prior to the stated maturity. A prepayment or make-whole premium allows investors to attain the same yield as if the borrower made all scheduled interest payments until maturity. These premiums are designed to make investors indifferent to prepayment.

111

Table of Contents

LIQUIDITY AND CAPITAL RESOURCES

Overview

Liquidity

Liquidity refers to our ability to generate adequate amounts of cash from our normal operations to meet cash requirements with a prudent margin of safety. Our ability to generate and maintain sufficient liquidity depends on the profitability of our businesses, general economic conditions and access to the capital markets and other sources of liquidity and capital as described below.

When considering our liquidity, it is important to distinguish between the needs of our insurance subsidiaries and the needs of the holding company, LNC. As a holding company with no operations of its own, LNC is largely dependent upon the dividend capacity of its insurance and other subsidiaries as well as their ability to advance or repay funds to it through inter-company borrowing arrangements, which may be affected by factors influencing the subsidiaries’ capital position, as discussed further below. Based on the sources of liquidity available to us as discussed below, we currently expect to be able to meet the holding company’s ongoing cash needs.

Capital

Capital refers to our long-term financial resources to support the operations of our businesses, to fund long-term growth strategies and to support our operations during adverse conditions. Our ability to generate and maintain sufficient capital depends on the profitability of our businesses, general economic conditions and access to the capital markets and other sources of liquidity and capital as described below.

Disruptions, uncertainty or volatility in the capital and credit markets may materially affect our business operations and results of operations and may adversely affect our subsidiaries’ capital position, which may cause them to retain more capital. This in turn may pressure our subsidiaries’ ability to pay dividends to LNC, which may lead us to take steps to preserve or raise additional capital. We believe we have appropriate capital to operate our business in accordance with our strategy. For more information, see “Subsidiaries’ Capital” below.

For factors that could cause actual results to differ materially from those set forth in this section and that could affect our expectations for liquidity and capital, see “Forward-Looking Statements – Cautionary Language” above and “Part I – Item 1A. Risk Factors” in our 2024 Form 10-K.

Consolidated Sources and Uses of Liquidity and Capital

Our primary sources of liquidity and capital are insurance premiums and fees, investment income, maturities and sales of investments, issuance of debt or other types of securities and policyholder deposits. We also have access to alternative sources of liquidity as discussed below. Our primary uses are to pay policy claims and benefits, to fund commissions and other general operating expenses, to purchase investments, to fund policy surrenders and withdrawals, to pay dividends to our common and preferred stockholders, to repurchase our common stock and to repay debt. Our operating activities provided (used) cash of $(272) million and $(1.3) billion for the three months ended March 31, 2025 and 2024, respectively. Cash flows from operating activities will fluctuate based on the timing of insurance premiums received and benefit payments to policyholders, as well as other business activities including cash payments on certain derivatives used to hedge exposure to product-related risks.

Holding Company Sources and Uses of Liquidity and Capital

The primary sources of liquidity and capital at the holding company level are dividends, return of capital and interest payments from subsidiaries, augmented by holding company short-term investments, bank lines of credit and the ongoing availability of long-term public financing under an effective shelf registration statement, which allows us to issue, in unlimited amounts, securities, including debt securities, preferred stock, common stock, warrants, stock purchase contracts, stock purchase units and depository shares. These sources support the general corporate needs of the holding company, including its common and preferred stock dividends, common stock repurchases, interest and debt service, funding of callable securities, acquisitions and investment in core businesses.

112

Table of Contents

Details underlying the primary sources of the holding company’s liquidity (in millions) were as follows:

	For the Three Months Ended March 31,
	2025		2024
Cash Dividends and Return of Capital from Subsidiaries
The Lincoln National Life Insurance Company	$	230	$	180
Total cash dividends and return of capital from subsidiaries	$	230	$	180
Interest from Subsidiaries
Interest on inter-company notes	$	35	$	40

The table above focuses on significant and recurring cash flow items and excludes the effects of certain financing activities, including the periodic issuance and retirement of debt, issuance of preferred stock, cash flows related to our inter-company cash management program and certain investing activities, including capital contributions to subsidiaries. These activities are discussed below. Taxes have been eliminated from the analysis due to a tax sharing agreement among our primary subsidiaries resulting in a modest effect on net cash flows at the holding company. Also excluded from this analysis is the modest amount of investment income on short-term investments of the holding company and employee stock exercise activity related to our stock-based incentive compensation plans. See “Part IV – Item 15(a)(2) Financial Statement Schedules – Schedule II – Condensed Financial Information of Registrant” in our 2024 Form 10-K for the holding company cash flow statement. For information regarding limits on the dividends that our insurance subsidiaries may pay without prior approval, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Liquidity and Capital Resources – Holding Company Sources and Uses of Liquidity and Capital – Restrictions on Subsidiaries’ Dividends” in our 2024 Form 10-K.

Subsidiaries’ Capital

Our insurance subsidiaries must maintain certain regulatory capital levels. We utilize the RBC ratio as a primary measure of the capital adequacy of our insurance subsidiaries. The RBC ratio is an important factor in the determination of the credit and financial strength ratings of LNC and its subsidiaries, as a reduction in our insurance subsidiaries’ surplus will affect their RBC ratios and dividend-paying capacity. For additional information on RBC ratios, see “Part I – Item 1. Business – Regulatory – Insurance Regulation – Risk-Based Capital” in our 2024 Form 10-K.

Our insurance subsidiaries’ regulatory capital levels are affected by statutory accounting rules, which are subject to change by each applicable insurance regulator. For instance, our term products and UL products containing secondary guarantees subject to the NAIC RBC framework require reserves calculated pursuant to the Valuation of Life Insurance Policies Model Regulation (“XXX”) and Actuarial Guideline XXXVIII (“AG38”), respectively. Our insurance subsidiaries employ strategies to reduce the strain caused by XXX and AG38 by reinsuring the business to reinsurance captives or reinsurance subsidiaries. Our captive reinsurance and reinsurance subsidiaries provide a mechanism for financing a portion of the excess reserve amounts in a more efficient manner and free up capital the insurance subsidiaries can use for any number of purposes, including paying dividends to the holding company. We use long-dated LOCs and debt financing as well as other financing strategies to finance those reserves. Included in the LOCs issued as of March 31, 2025, was $1.7 billion of long-dated LOCs issued to support inter-company reinsurance agreements for term products and UL products containing secondary guarantees. For information on the LOCs, see the credit facilities table in Note 13 in our 2024 Form 10-K. Our captive reinsurance and reinsurance subsidiaries have also issued long-term notes of $3.7 billion to finance a portion of the excess reserves associated with our term and UL products with secondary guarantees as of March 31, 2025; of this amount, $3.0 billion involve exposure to variable interest entities. For information on these long-term notes issued by our captive reinsurance and reinsurance subsidiaries, see Note 4 in our 2024 Form 10-K. We have also used the proceeds from senior note issuances of $875 million to execute long-term structured solutions primarily supporting reinsurance of UL products containing secondary guarantees. LOCs and related capital market solutions lower the capital effect of term products and UL products containing secondary guarantees.

Statutory reserves for variable annuity guaranteed benefit riders and guaranteed benefits on VUL policies, as well as certain components of the NAIC RBC calculation that are impacted by such guaranteed benefits, are sensitive to changes in the equity markets and interest rates, and such statutory reserves and our RBC levels are also affected by the level of account balances relative to the level of any guarantees, product design and reinsurance arrangements. As a result, the relationship between reserve changes and equity market performance is non-linear during any given reporting period. Our insurance subsidiaries cede a portion of the variable annuity guaranteed benefit riders to Lincoln National Reinsurance Company (Barbados) Limited (“LNBAR”) through a modified coinsurance agreement. Our variable annuity hedge program mitigates the risk to LNBAR from guaranteed benefit riders and continues to focus on generating sufficient income to fund future claims with a goal of maximizing distributable earnings and explicitly protecting capital. LNL also uses a partial hedge that mitigates potential capital volatility from guaranteed benefits on VUL policies. Market conditions greatly influence the

113

Table of Contents

ultimate capital required due to its effect on the valuation of reserves and supporting derivatives. For more information, see Note 4 in our 2024 Form 10-K.

Changes in equity markets may also affect the capital position of our insurance subsidiaries. We may decide to reallocate available capital among our insurance subsidiaries, as well as our captive reinsurance or reinsurance subsidiaries, which would result in different RBC ratios for our insurance subsidiaries. In addition, changes in the equity markets can affect the value of our variable annuity and VUL separate accounts. When the market value of our separate account assets increases, the statutory surplus within our insurance subsidiaries also increases, all else equal. Contrarily, when the market value of our separate account assets decreases, the statutory surplus within our insurance subsidiaries also decreases, all else equal, which will affect RBC ratios, and in the case of our separate account assets becoming less than the related product liabilities, we must allocate additional capital to fund the difference.

LNC made no capital contributions in cash to subsidiaries for the three months ended March 31, 2025 and 2024.

Debt

Although our subsidiaries currently generate adequate cash flow to meet the needs of our normal operations, periodically LNC may issue debt to maintain ratings and increase liquidity, as well as to fund internal growth, acquisitions and the retirement of its debt.

Details underlying our debt activities (in millions) for the three months ended March 31, 2025, were as follows:

	Beginning Balance		Issuance		Maturities, Repayments and Refinancing		Change in Fair Value Hedges		Other Changes (1)		Ending Balance
Short-Term Debt
Current maturities of long-term debt (2)	$	300	$	–	$	(300)	$	–	$	–	$	–
Long-Term Debt
Senior notes	4,498		–		–		15		(3)		4,510
Term loans	150		–		–		–		–		150
Subordinated notes (3)	995		–		–		–		–		995
Capital securities (3)	213		–		–		–		–		213
Total long-term debt	$	5,856	$	–	$	–	$	15	$	(3)	$	5,868

(1) Includes the non-cash reclassification of long-term debt to current maturities of long-term debt, accretion (amortization) of discounts and premiums, amortization of debt issuance costs and amortization of adjustments from discontinued hedges, as applicable.

(2) We repaid our 3.35% Senior Notes that matured on March 9, 2025.

(3) We use interest rate swaps to partially hedge the variability in rates.

LNC made interest payments to service debt to third parties of $82 million and $62 million for the three months ended March 31, 2025 and 2024, respectively.

For additional information about our short-term and long-term debt and our credit facilities, see Note 13 in our 2024 Form 10-K.

Preferred Stock

Details underlying preferred stock dividends paid (in millions) were as follows:

	For the Three Months Ended March 31,
	2025		2024
Series C preferred stock dividends	$	23	$	23
Series D preferred stock dividends	11		11
Total preferred stock dividends	$	34	$	34

For additional information on preferred stock, see Note 14 herein and Note 18 in our 2024 Form 10-K.

114

Table of Contents

Return of Capital to Common Stockholders

One of our primary goals is to provide a return to our common stockholders through share price accretion, dividends and stock repurchases. In determining dividends, the Board of Directors takes into consideration items such as current and expected earnings, capital needs, rating agency considerations and requirements for financial flexibility. The amount and timing of share repurchases depends on key capital ratios, rating agency expectations, the generation of dividends from our subsidiaries and an evaluation of the costs and benefits associated with alternative uses of capital. We did not repurchase any shares of common stock under our buyback program for the three months ended March 31, 2025 and 2024. For additional information regarding share repurchases, see “Part II – Item 2(c)” below.

Details underlying return of capital to common stockholders (in millions) were as follows:

	For the Three Months Ended March 31,
	2025		2024
Dividends to common stockholders	$	77	$	76
Total cash returned to common stockholders	$	77	$	76

Alternative Sources of Liquidity

Inter-Company Cash Management Program

To meet short-term liquidity needs that arise in the ordinary course of business, we utilize an inter-company cash management program between LNC and participating subsidiaries whereby participating subsidiaries can borrow cash from or lend cash to LNC. Loans under the inter-company cash management program are permitted under applicable insurance laws subject to certain restrictions. For our Indiana-domiciled insurance subsidiary, the borrowing and lending limit is currently 3% of the insurance company’s admitted assets as of its most recent year end. For our New York-domiciled insurance subsidiary, it may borrow from LNC less than 2% of its admitted assets as of its most recent year end but may not lend any amounts to LNC. As of March 31, 2025, LNC had $76 million of outstanding

borrowings from the cash management program related primarily to collateral posting requirements on derivatives. As of

March 31, 2025, LNC did not have outstanding lending into the cash management program.

Facility Agreement for Senior Notes Issuance

LNC entered into a facility agreement in 2020 with a Delaware trust that gives LNC the right over a 10-year period to issue, from time to time, up to $500 million of 2.330% senior notes to the trust in exchange for a corresponding amount of U.S. Treasury securities held by the trust. By agreeing to purchase the 2.330% senior notes in exchange for U.S. Treasury securities upon exercise of the issuance right, the trust will provide a source of liquid assets for the Company. The issuance right will be exercised automatically in full upon our failure to make certain payments to the trust, if the failure to pay is not cured within 30 days, or upon certain bankruptcy events involving LNC. We are also required to exercise the issuance right in full if consolidated stockholders’ equity (excluding AOCI) falls below a minimum threshold (which was $2.75 billion as of March 31, 2025, and is subject to adjustment from time to time in certain cases) and upon certain other events described in the facility agreement. For additional information, see Note 13 in our 2024 Form 10-K.

Federal Home Loan Bank

Our primary insurance subsidiary, LNL, is a member of the Federal Home Loan Bank (“FHLB”) of Indianapolis (“FHLBI”). Membership allows LNL access to the FHLBI’s financial services, including the ability to obtain loans and to issue funding agreements as an alternative source of liquidity that are collateralized by qualifying mortgage-related assets, agency securities or U.S. Treasury securities. Borrowings under this facility are subject to the FHLBI’s discretion and require the availability of qualifying assets at LNL. As of March 31, 2025, LNL had an estimated maximum borrowing capacity of $7.0 billion under the FHLBI facility and maximum available borrowing based on qualifying assets of $4.9 billion. As of March 31, 2025, LNL had outstanding borrowings of $2.5 billion under this facility reported within payables for collateral on investments on the Consolidated Balance Sheets. Lincoln Life & Annuity Company of New York (“LLANY”) is a member of the Federal Home Loan Bank of New York (“FHLBNY”) with an estimated maximum borrowing capacity of $750 million. Borrowings under this facility are subject to the FHLBNY’s discretion and require the availability of qualifying assets at LLANY. As of March 31, 2025, LLANY had no outstanding borrowings under this facility. For additional information, see “Payables for Collateral on Investments” in Note 3.

115

Table of Contents

Repurchase Agreements and Securities Lending Programs

Our insurance and reinsurance subsidiaries had access to $2.6 billion through committed repurchase agreements, of which none was utilized as of March 31, 2025. Our insurance subsidiaries, by virtue of their general account fixed-income investment holdings, can also access liquidity through securities lending programs and uncommitted repurchase agreements. As of March 31, 2025, our insurance subsidiaries had securities pledged under securities lending agreements and uncommitted repurchase agreements with a carrying value of $167 million and $57 million, respectively. For additional information, see “Payables for Collateral on Investments” in Note 3.

Collateral on Derivative Contracts

Our cash flows associated with collateral received from counterparties (when we are in a net collateral payable position) and posted with counterparties (when we are in a net collateral receivable position) change as the market value of the underlying derivative contract changes. The net collateral position depends on changes in interest rates and equity markets related to the amount of the exposures hedged. As of March 31, 2025, we were in a net collateral payable position of $5.5 billion compared to $7.1 billion as of December 31, 2024. In the event of adverse changes in fair value of our derivative instruments, we may need to return, post or pledge collateral to counterparties. If we do not have sufficient high quality securities or cash to provide as collateral to counterparties, we have alternative sources of liquidity. In addition to the liquidity from repurchase agreements and FHLB facilities discussed above, we also have a five-year revolving credit facility discussed in Note 13 in our 2024 Form 10-K. For additional information, see “Credit Risk” in Note 5.

Ratings

Financial Strength Ratings

See “Part I – Item 1. Business – Financial Strength Ratings” in our 2024 Form 10-K for information on our financial strength ratings.

Credit Ratings

See “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Liquidity and Capital Resources – Ratings” in our 2024 Form 10-K for information on our credit ratings.

If our current financial strength ratings or credit ratings were downgraded in the future, terms in our derivative agreements and/or certain repurchase agreements may be triggered, which could negatively affect overall liquidity. For the majority of our derivative counterparties, there is a termination event if the long-term credit ratings of LNC drop below BBB-/Baa3 (S&P/Moody’s) or if the financial strength ratings of LNL drop below BBB-/Baa3 (S&P/Moody’s). For certain repurchase agreements, there is a termination event if the long-term credit ratings of LNC drop below BBB-/Baa3 (S&P/Moody’s) or if the financial strength ratings of LNL drop below BBB+/Baa1 (S&P/Moody’s). In addition, contractual selling agreements with intermediaries could be negatively affected, which could have an adverse effect on overall sales of annuities, life insurance and investment products. See “Part I – Item 1A. Risk Factors – Covenants and Ratings – A downgrade in our financial strength or credit ratings could limit our ability to market products, increase the number or value of policies being surrendered and/or hurt our relationships with creditors” in our 2024 Form 10-K for more information.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We analyze and manage the risks arising from market exposures of financial instruments, as well as other risks, in an integrated asset-liability management process that considers diversification. We have exposures to several market risks including interest rate risk, equity market risk, credit risk and, to a lesser extent, foreign currency exchange risk. For information on these market risks, see “Part II – Item 7A. Quantitative and Qualitative Disclosures About Market Risk” in our 2024 Form 10-K.

Item 4. Controls and Procedures

Conclusions Regarding Disclosure Controls and Procedures

We maintain disclosure controls and procedures, which are designed to ensure that information required to be disclosed in the reports we file or submit under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to the Company’s management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. As of the end of the period required by this report, we, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act).

116

Table of Contents

Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective in timely alerting them to material information relating to us and our consolidated subsidiaries required to be disclosed in our periodic reports under the Exchange Act.

Changes in Internal Control Over Financial Reporting

There was no change in the Company’s internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the Exchange Act) during the quarter ended March 31, 2025, that has materially affected, or is reasonably likely to materially affect, its internal control over financial reporting.

A control system, no matter how well designed and operated, can provide only reasonable assurance that the control system’s objectives will be met. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the Company have been detected. Projections of any evaluation of control effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

117

Table of Contents

PART II – OTHER INFORMATION

Item 1. Legal Proceedings

Reference is made to the lawsuit captioned Donald C. Meade v. Lincoln National Corporation, Ellen Cooper, Dennis Glass, and Randal Freitag (“Defendants”), previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2024 (“2024 Form 10-K”). On February 21, 2025, Defendants filed a motion to dismiss.

Reference is made to the lawsuits captioned Anthony Morgan, derivatively on behalf of Nominal Defendant Lincoln National Corporation v. Ellen G. Cooper, Deirdre P. Connelly, William H. Cunningham, Reginald Davis, Eric C. [G.] Johnson, Gary C. Kelly, M. Leanne Lachman, Dale LeFebvre, Janet Liang, Lynn M. Utter, Dennis Glass and Randal Freitag and Lincoln National Corporation and Harry Rosenthal, derivatively on behalf of Nominal Defendant Lincoln National Corporation v. Ellen G. Cooper, Deirdre P Connelly, William H. Cunningham, Reginald Davis, Eric C. [G.] Johnson, Gary C. Kelly, M. Leanne Lachman, Dale LeFebvre, Janet Liang, Lynn M. Utter, Dennis Glass and Randal Freitag and Lincoln National Corporation, both of which were previously disclosed in the 2024 Form 10-K. On February 28, 2025, the Court of Common Pleas of Delaware County, Pennsylvania, entered an order consolidating these two civil actions for all purposes under the matter name In Re Lincoln National Corporation Shareholder Derivative Litigation, No. CV-2024-0011319. By the same February 28, 2025, order, the court directed, among other things, that all proceedings and deadlines in this consolidated case be stayed until 30 days after resolution of all motions to dismiss (including the exhaustion of all related appeals) in the Donald C. Meade v. Lincoln National Corporation, Ellen Cooper, Dennis Glass, and Randal Freitag matter, discussed above and previously disclosed in the 2024 Form 10-K.

Reference is made to the lawsuit captioned Kelly Grink v. Virtua Health and Lincoln National Corporation et al., previously disclosed in the 2024 Form 10-K. On March 7, 2025, Plaintiffs filed an amended complaint which, inter alia, added an additional named plaintiff (Steven Molnar) and additional named defendants, including Lincoln Retirement Services Company, LLC, and [The] Lincoln National Life Insurance Company. The action seeks relief against the Lincoln defendants including the disgorgement of any profits they received as a result of the alleged breaches of fiduciary duty, together with plaintiffs’ attorney’s fees and costs, prejudgment and post-judgment interest and such other equitable or remedial relief as the court deems appropriate. On April 4, 2025, the Lincoln defendants filed a motion to dismiss.

See Note 13 in “Part I – Item 1. Financial Statements” for further discussion regarding these matters and other contingencies.

Item 1A. Risk Factors

In addition to the factors set forth in “Part I – Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Forward-Looking Statements – Cautionary Language,” you should carefully consider the risks described under “Part I – Item 1A. Risk Factors” in our 2024 Form 10-K. Such risks and uncertainties are not the only ones facing our Company. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also impair our business operations. If any of these risks actually occur, our business, financial condition and results of operations could be materially affected. In that case, the value of our securities could decline substantially.

118

Table of Contents

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

(c) The following summarizes purchases of equity securities by the Company during the quarter ended March 31, 2025 (dollars in millions, except per share data):

				(c) Total Number	(d) Approximate Dollar
	(a) Total			of Shares	Value of Shares
	Number	(b) Average		Purchased as Part of	that May Yet Be
	of Shares	Price Paid		Publicly Announced	Purchased Under the
Period	Purchased	per Share		Plans or Programs (1)	Plans or Programs (1)
1/1/25 – 1/31/25	–	$	–	–	$	714
2/1/25 – 2/28/25	–	–		–	714
3/1/25 – 3/31/25	–	–		–	714

(1) On November 10, 2021, our Board of Directors authorized an increase in our securities repurchase authorization, bringing the total aggregate repurchase authorization to $1.5 billion. As of March 31, 2025, our remaining security repurchase authorization was $714 million. The security repurchase authorization does not have an expiration date. The amount and timing of share repurchases depends on key capital ratios, rating agency expectations, the generation of free cash flow and an evaluation of the costs and benefits associated with alternative uses of capital. Our stock repurchases may be effected from time to time through open market purchases or in privately negotiated transactions and may be made pursuant to an accelerated share repurchase agreement or Rule 10b5-1 plan.

Item 5. Other Information

Rule 10b5-1 and Non-Rule 10b5-1 Trading Arrangements

During the three months ended March 31, 2025, none of our directors or officers (as defined in Exchange Act Rule 16a-1(f)) adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.

Item 6. Exhibits

The Exhibits included in this report are listed in the Exhibit Index beginning on page 120, which is incorporated herein by reference.

119

Table of Contents

LINCOLN NATIONAL CORPORATION

Exhibit Index for the Report on Form 10-Q

For the Quarter Ended March 31, 2025

3.1	Amended and Restated Bylaws of Lincoln National Corporation (“LNC”), effective March 3, 2025, are incorporated by reference to Exhibit 3.1 to LNC’s Form 8-K (File No. 1-6028) filed with the Securities and Exchange Commission (“SEC”) on March 4, 2025.
10.1	Form of Long-Term Incentive Award Program Performance Cycle (“PSA”) Agreement for CEO (effective February 2025).*
10.2	Form of Restricted Stock Unit (“RSU”) Award Agreement for CEO (effective February 2025).*
10.3	Form of PSA Agreement for CEO (February 2025; alternate vesting).* ^
10.4	Form of RSU Award Agreement for CEO (February 2025; alternate vesting).*
10.5	Form of PSA Agreement for Senior Management Committee (“SMC”) (other than CEO) (effective February 2025).*
10.6	Form of RSU Award Agreement for SMC (other than CEO) (effective February 2025).*
31.1	Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH	XBRL Taxonomy Extension Schema Document.
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document.
101.LAB	XBRL Taxonomy Extension Label Linkbase Document.
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document.
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document.
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

* This exhibit is a management contract or compensatory plan or arrangement.

^ Schedules (or similar attachments) to this agreement have been omitted pursuant to Item 601(a) of Regulation S-K. LNC will furnish supplementally a copy of the schedule (or similar attachment) to the SEC, upon request.

120

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		LINCOLN NATIONAL CORPORATION
	By:	/s/ Christopher Neczypor
		Christopher Neczypor Executive Vice President and Chief Financial Officer
	By:	/s/ Adam Cohen
		Adam Cohen Senior Vice President, Chief Accounting Officer and Treasurer
Dated: May 8, 2025

121

EX-10.1

Exhibit 10.1

LINCOLN NATIONAL CORPORATION

LONG-TERM INCENTIVE AWARD PROGRAM

Performance Cycle Agreement

For CEO

This Award Agreement (“Agreement”), by and between Lincoln National Corporation (“LNC”) on behalf of itself and its affiliates, and the <First Name> <Last Name> (“Grantee”), evidences the grant by LNC on <Grant Date>, of a long-term incentive performance award to Grantee, and Grantee’s acceptance of the award, in accordance with and subject to the provisions of the Lincoln National Corporation 2020 Incentive Compensation Plan effective June 11, 2020 (the “Plan”) and this Agreement. LNC and Grantee agree as follows:

1.    Form of Award. This performance award grant is for <Granted Amount>shares of LNC common stock (“Shares”). During the Performance Cycle, this award shall consist of LNC stock units but any actual award that ultimately vests will be delivered in Shares.

The number of Shares that will vest and be delivered, if any, may range from 0-<XXX>% of the aforementioned target numberof Shares plus any accumulated dividend equivalents under Section 4, below. Shares will vest and be delivered only after certification by the Compensation Committee of the LNC Board of Directors (the “Committee”) of the achievement of company performance criteria previously established and approved by the Committee for the Performance Cycle; however in no event will Shares be delivered later than March 15th of the year following the completion of the Performance Cycle.

The Committee reserves the right to adjust the target number or amount of Shares delivered at any time to the extent permissible under the Plan.

In the event an adjustment pursuant to Section 10(c) of the Plan is required, the number of Shares that may ultimately vest under this Agreement, if any, shall be adjusted in accordance with Section 10(c) of the Plan. All Shares that may ultimately vest under this Agreement, if any, after such adjustment shall be subject to the same restrictions applicable any Shares that may have vested under this Agreement before the adjustment.

2.    Full or Pro-Rata Awards upon Certain Events.

(a)    Except as provided in this Paragraph 2 and in Paragraph 3, below, if Grantee has a Separation from Service (defined in Paragraph 10, below), for any reason before the Committee certifies the achievement of company performance criteria for the Performance Cycle, the award shall be forfeited and automatically transferred back to LNC. Upon forfeiture, Grantee shall have no further rights in such award or Shares issuable pursuant to an award granted hereunder.

(b) In the case of Grantee’s Retirement (defined in Paragraph 10, below), Grantee or Grantee’s estate, if applicable, shall receive a full, non-pro-rated award as if Grantee had provided Service for the entire Performance Cycle.

1

(c)    In the case of Grantee’s death or Separation from Service on account of Total Disability (defined in Paragraph 10, below), Grantee (or Grantee's estate, if applicable) shall receive a full, non-prorated award as if Grantee had provided Service for the entire Performance Cycle.

(d) In the case of a “change in control,” within the meaning of section 409A of the Internal Revenue Code of 1986 as amended, of an LNC Subsidiary or Affiliate employing the Grantee, Grantee shall receive a pro-rated award based on the pro-ration formula described below.

(e) In the case of Grantee’s involuntary Separation from Service other than for Cause (defined in Paragraph 10, below), Grantee (or Grantee's estate, if applicable) shall receive a prorated award based on the proration formula described below, provided Grantee executes a release of claims against LNC and its affiliates (in form and substances satisfactory to LNC) or prior to the 60th day following Grantee’s Separation from Service and such release has become effective.

    The number of Shares deliverable upon the pro-rata vesting event described in Subparagraph 2(d) or (e) shall be calculated by multiplying this award by the product resulting from multiplying a fraction where the denominator is equal to the number of days during the performance cycle, and the numerator is equal to the number of days that the Grantee provided Service during the Performance Cycle, by a factor based on the company’s attainment of performance criteria during the Performance Cycle. Thereafter, the number of Shares deliverable shall be rounded up to the nearest whole Share.

Any Shares deliverable under this Paragraph 2 shall be delivered at the same time long-term incentive awards are normally paid and/or delivered after the end of the Performance Cycle.

3.    Change of Control. In connection with a Change of Control, pursuant to the definition in effect on the day immediately preceding such Change of Control, the Committee shall determine what, if any, award under this Agreement shall vest. In making such determination, the Committee shall consider the nature of such Change of Control, whether continuation of the Plan and the awards for the Performance Cycle are feasible, and whether the resulting corporate entity, if any, offers or commits to offer awards of comparable economic value; provided, however, that the Committee’s determination shall be consistent with existing LNC plans, such as the Plan and the LNC Executives’ Severance Benefit Plan.

Shares deliverable pursuant to this Paragraph 3 shall be delivered as of the earlier of (a) the time this award would normally be paid after the end of the original performance cycle established by the Committee, or (b) within 90 days after the Grantee’s involuntary Separation from Service, other than for Cause, from LNC, its affiliates or any successor entity, provided such Separation from Service occurs within two years after such Change of Control.

Notwithstanding the foregoing, a Grantee who has a voluntary Separation from Service after a Change of Control but before delivery of Shares in settlement of this award shall forfeit this award.

4.    Dividend Equivalent Units. If an award vests, Grantee shall also receive an amount equal to the dividends that would have been paid on such Shares had Grantee held such

2

Shares from the date of grant through the date the Shares become deliverable. Such dividend equivalent amount shall be delivered in Shares based on the Fair Market Value of a Share on the date of the payment of the dividend.

5.    Tax Withholding. LNC will require Grantee to remit an amount equal to any tax withholding required under federal, state or local law on the value of the Shares deliverable under this Agreement at such time as LNC is required to withhold such amounts. In accordance with procedures established by the Committee, Grantee may satisfy any required tax withholding payments in any combination of cash, certified check, or Shares (including the surrender of Shares held by the Grantee or those that would otherwise be issued in settlement of this award). Any surrendered or withheld Shares will constitute satisfaction of any required tax withholding to the extent of their Fair Market Value.

6.    Voting Rights. Grantee shall have no voting rights with respect to LNC stock units.

7.    Transferability. This award may not be transferred, sold, pledged, hypothecated, margined or otherwise encumbered by Grantee, except by will or the laws of descent and distribution.

8.    Cancellation/Rescission of Award after Vesting or Distribution/Termination for Cause.

This award and any Shares distributed in settlement of this award will be subject to potential forfeiture, recoupment or other action in accordance with the terms of this Agreement and any applicable claw back or recoupment policies implemented by the Company, as it may be amended or restated from time to time, or in accordance with any rules or regulations adopted by the Securities and Exchange Commission and the New York Stock Exchange pursuant to Section 10D of the Securities Exchange Act of 1934 or other applicable law.

(a)    If Grantee’s Service is terminated for Cause, any Shares distributed in settlement of this award during the six (6) month period prior to such termination for Cause shall be rescinded and any such Shares not yet delivered in settlement of this award shall be cancelled without further action by the Committee or its delegate.

(b)    If Grantee fails to comply with the non-competition, non-solicitation, non-disparagement or non-disclosure provisions described in Subparagraphs 9(a) through 9(d) below, before Shares are delivered in settlement of this award, in addition to the remedies provided in Subparagraph 9(e) below, this award shall be cancelled without further action by the Committee or its delegate.

(c)    If requested by LNC, at the time Shares are to be delivered pursuant to this Agreement, Grantee shall certify in a form acceptable to LNC that Grantee is in compliance with the terms and conditions described in Subparagraphs 9(a) through 9(d), below. Grantee’s failure to comply with Subparagraphs 9(a) or 9(b) at any time from the Grant Date through the applicable time periods specified in Subparagraphs 9(a) or 9(b) shall cause such Shares to be rescinded. Grantee’s failure to comply with Subparagraphs 9(c) or 9(d) at any time on or after the Grant Date shall cause such Shares to be rescinded.

3

(d)    (1) LNC must notify Grantee in writing of any such rescission: (A) in the case of Subparagraph 8(a), not later than 90 days after such termination for Cause; and (B) not later than 180 days after LNC obtains knowledge of Grantee’s failure to comply with Subparagraphs 9(a) through 9(d) below.

(2) Within ten (10) days after receiving a rescission notice from LNC: (A) Grantee must surrender to LNC the Shares acquired upon settlement of the award, or (B) if such Shares have been sold or transferred, (i) Grantee must make a payment to LNC of the proceeds from such sale or transfer, or (ii) if there are no proceeds from such transfer, Grantee must make a payment to LNC equal to the Fair Market Value of such Shares on the date of such transfer.

In all cases, Grantee shall pay to LNC the gross amount of any gain realized or payment received (not net of any withholding or other taxes paid by Grantee) as a result of the award.

9.    Covenants.

Grantee recognizes and acknowledges that during the term of employment, Grantee has had, and will continue to have, access to confidential and proprietary business information and trade secrets belonging to LNC and LNC’s customers, including, but not limited to, customer information, customer lists, pricing, products, information relating to sales, sales leads, sales performance, sales volume, LNC business and financial strategy, LNC quarterly business reviews, and LNC data, all of which are of substantial value to LNC. Grantee therefore agrees that the restrictive covenants below are reasonable and necessary to protect LNC’s trade secrets and confidential information.

(a)Non-Competition. From the Grant Date through the six (6) month period after the date Shares are distributed in settlement of this award , Grantee may not become employed by, work on behalf of, consult with, or otherwise render services that are the same or similar to the services rendered by Grantee to the business unit(s) for which Grantee provided Service or otherwise had responsibilities for within six (6) months prior to his/her Separation from Service to any other business, firm, person, partnership, corporation or other organization that competes with or provides, or is planning to provide, the same or similar products and/or services. Grantee understands and agrees that due to the nature of LNC’s nationwide business and the nationwide scope of Grantee’s employment, this restriction is nationwide in scope.

(b)Non-Solicitation of Employees and Other Service Providers. During Grantee’s employment with LNC, and for a period of twelve (12) months following the date of Grantee’s Separation from Service, for any reason, Grantee shall not directly or indirectly hire, manage, solicit, or recruit, or aid in the hiring, soliciting, or recruiting of any persons who are at the time of the hire, or were at any time within the six (6) months prior to hire, employees, agents, representatives, or consultants of LNC whom Grantee had hired, managed, supervised, or otherwise became familiar with in any capacity as a result of his/her Service.

(c)Non-Disparagement. Grantee agrees not to defame LNC or any of its affiliates, products, employees, officers, directors or services, or make or solicit any comments, statement or the like to the media or others that may be considered to be derogatory or harmful to

4

the good name or business reputation of LNC or its affiliates, except that Grantee may testify truthfully in any legal proceeding where his testimony is compelled by subpoena under oath. This provision also applies to any comments or statements which Grantee may make on the internet, including but not limited to comments, statements and/or videos placed in email, and/or on YouTube, Instagram, Facebook, Twitter or any other social media site.

(d)Non-Disclosure & Ideas Provision. Grantee shall not, without prior written authorization from LNC, disclose to anyone outside LNC, or use in other than LNC’s business, any trade secrets or confidential and/or proprietary information received from or on behalf of, developed for, or otherwise relating to the business of, LNC. Any confidentiality or non-disclosure obligations in this Agreement does not prohibit or restrict Grantee (or Grantee’s attorney) from initiating communications directly with, or responding to any inquiry from, or providing testimony before, the SEC, FINRA, any other self-regulatory organization, or any other state, local, or federal regulatory, investigative, or enforcement entity, agency, or authority. For purposes of this Agreement, a confidential disclosure to government officials or attorneys solely for purposes of reporting or investigating a suspected violation of the law (or disclosures made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal) is immune from civil and criminal liabilities under federal and state trade secret laws. Furthermore, Grantee agrees to disclose and assign to LNC all rights and interest in any invention or idea that Grantee developed or helped develop for actual or related business, research, or development work during the period of Grantee’s Service.

(e)Consent to Injunction; Attorneys’ Fees and Costs. Grantee acknowledges that any violation of the non-competition, non-solicitation, non- disparagement, or non-disclosure provisions described in Subparagraphs 9(a) through 9(d) would entail irreparable injury to the business and goodwill of LNC and would jeopardize the competitive position in the marketplace held by LNC. Therefore, Grantee also acknowledges that, in the event of any violation of Subparagraphs 9(a) through 9(d) by Grantee, the cancellation/rescission of the award alone will be inadequate to compensate LNC, and LNC will be entitled, as a matter of right and without the obligation to post a bond or other security, to an injunction issued by any court of competent jurisdiction and other equitable relief to prevent any actual, intended or likely violation of this Agreement. If LNC brings legal action for injunctive relief, LNC shall have the benefit of the full periods of the post-employment covenants set forth above. The injunction shall run from the date injunctive relief is granted but reduced by the time period after the separation of employment that Grantee was not in violation of the applicable covenant(s). In the event LNC elects to seek any remedy by court action, rendered necessary as the result of any violation or threatened violation of the Agreement by Grantee, and LNC prevails in such action, Grantee shall be responsible to pay all costs and attorneys’ fees incurred by LNC in taking such action.

Notwithstanding anything to the contrary herein, LNC may, in its discretion, waive Grantee’s compliance with Subparagraphs 9(a) through 9(d) in whole or part in any individual case. Moreover, if Grantee’s Service is terminated by LNC other than for Cause, a failure by Grantee to comply with the provisions of Subparagraph 9(a) through 9(d), above, after such termination shall not in and of itself cause rescission if the Shares were delivered in settlement of this award before Grantee’s termination.

5

If any term, provision or paragraph of this Paragraph 9 shall be determined by a court to be invalid or unenforceable for any reason, the term, provision or paragraph shall be construed so as to be enforceable to the maximum extent compatible with the applicable laws in effect at the time; and such determination of invalidity shall not affect the remaining terms, provisions or paragraphs of this Agreement, which shall continue to be given full force and effect. If any term, provision or paragraph of this Paragraph 9 shall be determined by a court to be unenforceable because of the scope or duration thereof, the parties hereby expressly agree that the court making such determination shall have the power to reduce the scope or duration and/or restrict the geographical area of such term, provision or paragraph and/or to delete such specific words or phrases which the court shall deem necessary to permit enforcement of such term, provision or paragraph in restricted form. If any term, provision or paragraph of this Paragraph 9 is found to be in conflict with any state or local law or regulation, the applicable state or local law will control to the extent that such state or local law applies to the Grantee.

10.    Definitions. As used in this Agreement:

“Cause” means (a) a conviction of a crime that is job related or that may otherwise cause harm to the reputation of the Corporation; (b) any act or omission detrimental to the conduct of business of the Corporation; (c) inability to obtain or retain proper licenses; (d) theft, dishonesty, fraud or misrepresentation; (e) failure to cooperate or be truthful in connection with an investigation related to the Corporation; (f) violation of any rule or regulation of any regulatory agency or self-regulatory agency; or (g) violation of any policy or rule of the Corporation Cause shall be determined in the sole discretion of the Committee.

“Corporation” means LNC or any subsidiary.

“Performance Cycle” means the three-year period that commences on the first day of the calendar year in which the grant was awarded.

“Retirement” means Grantee’s Separation from Service, other than for Cause, from LNC or any Subsidiary at age 55 or older with at least five (5) years of Service.

    “Service” means Grantee’s continuous service as a common law employee of, or as a planner with a full-time agent’s contract with, LNC or any Subsidiary. Service as a common law employee is the period of time Grantee is on the payroll of LNC or a Subsidiary but prior to the time the Grantee has had a Separation from Service. Service as a planner is the period of time Grantee’s full-time agent’s contract is in effect but prior to the time the Grantee has had a Separation from Service.

“Separation from Service” has the meaning given such term in Code section 409A and the regulations issued thereunder.

“Subsidiary” means a corporation in which LNC has ownership of at least twenty-five percent.

“Total Disability” means (as determined by the Committee) a disability that results in Grantee being unable to engage in any occupation or employment for wage or profit for which

6

Grantee is, or becomes, reasonably qualified by training, education or experience. In addition, the disability must have lasted six (6) months and be expected to continue for at least six (6) more months or be expected to continue unto death.

11.    Compliance with Securities Laws. Shares shall not be issued with respect to this award unless the issuance and delivery of such Shares shall comply with all relevant provisions of state and federal laws, rules and regulations, and, in the discretion of LNC, shall be further subject to the approval of counsel for LNC with respect to that compliance.

12.Governing Law; Forum for Disputes. This Agreement shall be governed by the laws of the Commonwealth of Pennsylvania, without giving effect to any choice of law or conflict of law provision or rule (whether of the chosen state or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the Commonwealth of Pennsylvania. Venue for any dispute relating to the Agreement shall be in the state or federal court, as applicable, having jurisdiction over claims arising in Delaware County, Pennsylvania, or such other venue as determined by LNC to best enforce its rights under this Agreement. To the extent legally possible, Grantee expressly waives any objections to LNC’s choice of venue and waives any arguments based on the inconvenience of the selected venue.

13.Incorporation of Plan Terms. This award is subject to the terms and conditions of the Plan. Such terms and conditions of the Plan are incorporated into and made a part of this Agreement by reference. In the event of any conflicts between the provisions of this Agreement and the terms of the Plan, the terms of the Plan will control. Capitalized terms used but not defined in this Agreement shall have the meanings set forth in the Plan unless the context clearly requires an alternative meaning.

14.Severability. The provisions of this Agreement are severable.  If any provision is held to be invalid or unenforceable, it shall not affect the validity or enforceability of any other provision.

IN WITNESS WHEREOF, LNC, by its duly authorized officer has signed this Agreement as of the first date set forth above.

LINCOLN NATIONAL CORPORATION

By: /s/ Deirdre Connelly

Deirdre Connelly

Chair of the Compensation Committee

7

EX-10.2

Exhibit 10.2

LINCOLN NATIONAL CORPORATION

RESTRICTED STOCK UNIT AWARD AGREEMENT

For CEO

This Restricted Stock Unit Award Agreement (the “Agreement”) is by and between Lincoln National Corporation (“LNC”) on behalf of itself and its affiliates, and <First Name> <Last Name> (the “Grantee”), and evidences the grant on <Grant Date>(the “Grant Date”) of Restricted Stock Units (“RSUs”) to Grantee, and Grantee’s acceptance of the RSUs, in accordance with the terms and provisions of the Lincoln National Corporation 2020 Incentive Compensation Plan effective June 11, 2020 (the “Plan”) and this Agreement. LNC and Grantee agree as follows:

1.Number of Shares Granted. Grantee is awarded <Granted Amount>RSUs subject to the terms and restrictions as set forth in the Plan and in this Agreement. In the event an adjustment pursuant to Section 10(c) of the Plan is required, the number of RSUs awarded under this Agreement and/or the number of shares of LNC common stock (the “Shares”) delivered pursuant to RSUs granted under this Agreement shall be adjusted in accordance with Section 10(c) of the Plan. All RSUs after such adjustment (and/or Shares deliverable pursuant to RSUs granted under this Agreement) shall be subject to the same restrictions applicable to such RSUs (and/or Shares issuable pursuant to an RSU granted under this Agreement) before the adjustment.

2.Vesting of Restricted Stock Units. Subject to Paragraph 8, below, the RSUs shall vest upon the earliest to occur of the following dates (such date, the “Vesting Date”), provided Grantee remains in Service (defined in Paragraph 10, below) through such date:

(a)100% as ofthe third anniversary of the Grant Date; or

(b)100% as of the date on which the Grantee has a Separation from Service (defined in Paragraph 10, below) on account of Total Disability (defined in Paragraph 10, below); or

(c)100% as of the date of the Grantee’s death; or

(d)100% as of the date of the Grantee’s involuntary Separation from Service other than for Cause (defined in Paragraph 10, below), provided such Separation from Service occurs within two years after a Change of Control pursuant to the definition in effect on the day immediately preceding such Change of Control; or

(e)Pro-rata as of the date of a “change in control,” within the meaning of section 409A of the Internal Revenue Code of 1986 as amended, of an LNC Subsidiary or Affiliate employing the Grantee.

    The number of RSUs vesting pro-rata upon the event described in Subparagraph  2(e) and (g) shall be calculated by taking a fraction where the denominator is equal to the number of days

1

during the three-year period beginning on the Grant Date and ending on the third anniversary of the Grant Date (such three-year period, the “Vesting Period”), and the numerator is equal to the number of days that the Grantee provided Service during the Vesting Period, with this award multiplied by such fraction (rounding up the nearest whole RSU).

    Except as otherwise provided in Subparagraphs 2(f) and (g) below, in the event that Grantee has a Separation from Service prior to the vesting of RSUs as set forth above, other than under the circumstances described in Subparagraphs 2(b) through (e), the RSUs shall be forfeited and automatically transferred back to LNC. Upon forfeiture, Grantee shall have no further rights in such RSUs or Shares deliverable pursuant to an RSU granted hereunder.

Special Circumstances for Retirement and Involuntary Termination Not for Cause

(f)If Grantee Retires (defined in Paragraph 10, below) prior to the Vesting Date, (i) Grantee shall be deemed, solely for purposes of this Paragraph 2, to remain in Service through the Vesting Date, and (ii) the Vesting Date shall be the date set forth in Subparagraph 2(a) or Subparagraph 2(c), whichever is earlier. In the event Grantee is rehired by LNC after Retirement but prior to the Vesting Date described in (ii) above, Grantee shall resume actual Service, and the Vesting Date shall be determined in accordance with Subparagraphs 2(a) through 2(e).

(g)If, prior to the Vesting Date, Grantee is Involuntarily Terminated not for Cause (as such terms are defined under The Severance Plan for Officers of Lincoln National Corporation), incurs a Separation from Service, and executes a Severance Agreement and General Release in form and substance satisfactory to LNC and all revocation periods applicable to such release have expired without such release having been revoked (i) Grantee shall be deemed, solely for purposes of this Paragraph 2, to remain in Service through the Vesting Date but receive a pro-rata award as described above except that the denominator is equal to the number of days during the three-year period beginning on the Grant Date and ending on the date of Separation from Service, and (ii) the Vesting Date shall be the date set forth in Subparagraph 2(a) or Subparagraph 2(c), whichever is earlier. In the event Grantee is rehired by LNC after an Involuntary Termination not for Cause but prior to the Vesting Date described in (ii) above, Grantee shall resume actual Service, and the Vesting Date shall be determined in accordance with Subparagraphs 2(a) through 2(e).

3.Dividend Equivalent Rights. No cash dividends shall be payable with respect to the RSUs. Instead, for each RSU, Grantee shall have a dividend equivalent right (“DER”). The DER shall entitle the Grantee to additional RSUs on each date that dividends are paid on Shares while the RSU is outstanding. The number of RSUs to be credited on a dividend payment date based on each DER shall equal the number (or fraction thereof) obtained by dividing the aggregate dividend that would have been paid if the RSUs had been outstanding Shares by the Fair Market Value of a Share on the date of the payment of the dividend. DERs have the same restrictions as the underlying RSUs.

4.Distribution of Shares. Except as provided below, a Share shall be distributed to Grantee (or to Grantee’s estate) as follows: (i) for every RSU (including RSUs credited based on DERs) that vested in accordance with Subparagraphs 2(a) through 2(e), on or within 60 days after the Vesting Date.

2

Once a Share has been issued with respect to an RSU pursuant to this Agreement and the Plan, the Grantee shall have no further rights with respect to the RSU.

5.Tax Withholding. LNC will require Grantee to remit an amount equal to any tax withholding required by federal, state, or local law on the value of the RSUs at such time as LNC is required to withhold such amounts. In accordance with procedures established by the Committee, Grantee may satisfy any required tax withholding payments in any combination of cash, certified check, or Shares (including the surrender of Shares held by the Grantee or those that would otherwise be issued in settlement of this award). Any surrendered or withheld Shares will constitute satisfaction of any required tax withholding to the extent of their Fair Market Value.

6.Voting Rights. Grantee shall have no voting rights with respect to RSUs.

7.Transferability. Neither the RSUs granted under this Agreement, nor any interest or right therein or part thereof, shall be transferred, sold, pledged, hypothecated, margined or otherwise encumbered by the Grantee, except by will or the laws of descent and distribution.

8.Cancellation/Rescission of Award after Vesting or Distribution/Termination for Cause.

This award and any Shares distributed in settlement of this award will be subject to potential forfeiture, recoupment or other action in accordance with the terms of this Agreement and any applicable claw back or recoupment policies implemented by the Company, as it may be amended or restated from time to time, or in accordance with any rules or regulations adopted by the Securities and Exchange Commission and the New York Stock Exchange pursuant to Section 10D of the Securities Exchange Act of 1934 or other applicable law.

(a)    If Grantee’s Service is terminated for Cause, any Shares distributed in settlement of this award during the six (6) month period prior to such termination for Cause shall be rescinded and any such Shares not yet delivered in settlement of this award shall be cancelled without further action by the Compensation Committee of the LNC Board of Directors (the “Committee”) or its delegate.

(b)    If Grantee fails to comply with the non-competition, non-solicitation, non-disparagement, or non-disclosure provisions described in Subparagraphs 9(a) through 9(d), below, before Shares are distributed in settlement of this award, in addition to the remedies provided in Subparagraph 9(e) below, this award shall be cancelled without further action by the Committee or its delegate.

(c)    If requested by LNC, at the time Shares are to be distributed pursuant to this Agreement, Grantee shall certify in a form acceptable to LNC that Grantee is in compliance with the terms and conditions described in Subparagraphs 9(a) through 9(d) below. Grantee’s failure to comply with Subparagraphs 9(a) or 9(b) at any time from the Grant Date through the applicable time periods specified in Subparagraphs 9(a) or 9(b) shall cause such Shares to be rescinded. Grantee’s failure to comply with Subparagraphs 9(c) or 9(d) at any time on or after the Grant Date shall cause such Shares to be rescinded.

3

(d)    (1) LNC shall notify Grantee in writing of any such rescission: (A) in the case of Subparagraph 8(a), not later than 90 days after such termination for Cause; and (B) not later than 180 days after LNC obtains knowledge of Grantee’s failure to comply with Subparagraphs 9(a) through 9(d) below.

(2) Within ten (10) days after receiving a rescission notice from LNC: (A) Grantee must surrender to LNC the Shares acquired upon settlement of this award; or (B) if such Shares have been sold or transferred, (i) Grantee must make a payment to LNC of the proceeds from such sale or transfer, or (ii) if there are no proceeds from such transfer, Grantee must make a payment to LNC equal to the Fair Market Value of such Shares on the date of such transfer.

In all cases, Grantee shall pay to LNC the gross amount of any gain realized or payment received (not net of any withholding or other taxes paid by Grantee) as a result of the RSUs.

9.Covenants.

Grantee recognizes and acknowledges that during the term of employment, Grantee has had, and will continue to have, access to confidential and proprietary business information and trade secrets belonging to LNC and LNC’s customers, including, but not limited to, customer information, customer lists, pricing, products, information relating to sales, sales leads, sales performance, sales volume, LNC business and financial strategy, LNC quarterly business reviews, and LNC data, all of which are of substantial value to LNC. Grantee therefore agrees that the restrictive covenants below are reasonable and necessary to protect LNC’s trade secrets and confidential information.

(a)Non-Competition. From the Grant Date through the six (6) month period after the date Shares are distributed in settlement of the RSUs , Grantee may not become employed by, work on behalf of, consult with, or otherwise render services that are the same or similar to the services rendered by Grantee to the business unit(s) for which Grantee provided Service or otherwise had responsibilities for within six (6) months prior to his/her Separation from Service to any other business, firm, person, partnership, corporation or other organization that competes with or provides, or is planning to provide, the same or similar products and/or services. Grantee understands and agrees that due to the nature of LNC’s nationwide business and the nationwide scope of Grantee’s employment, this restriction is nationwide in scope.

(b)Non-Solicitation of Employees and Other Service Providers. During Grantee’s employment with LNC, and for a period of twelve (12) months following the date of Grantee’s Separation from Service, for any reason, Grantee shall not directly or indirectly hire, manage, solicit, or recruit, or aid in the hiring, soliciting, or recruiting of any persons who are at the time of hire, or were at any time within the six (6) months prior to hire, employees, agents, representatives, or consultants of LNC whom Grantee had hired, managed, supervised, or otherwise became familiar with in any capacity as a result of his/her Service.

(c)Non-Disparagement. Grantee agrees not to defame LNC or any of its affiliates, products, employees, officers, directors or services, or make or solicit any comments, statement or the like to the media or others that may be considered to be derogatory or harmful to

4

the good name or business reputation of LNC or its affiliates, except that Grantee may testify truthfully in any legal proceeding where his testimony is compelled by subpoena under oath. This provision also applies to any comments or statements which Grantee may make on the internet, including but not limited to comments, statements and/or videos placed in email, and/or on YouTube, Instagram, Facebook, Twitter or any other social media site.

(d)Non-Disclosure & Ideas Provision. Grantee shall not, without prior written authorization from LNC, disclose to anyone outside LNC, or use in other than LNC’s business, any trade secrets or confidential and/or proprietary information received from or on behalf of, developed for, or otherwise relating to the business of, LNC. Any confidentiality or non-disclosure obligations in this Agreement does not prohibit or restrict Grantee (or Grantee’s attorney) from initiating communications directly with, or responding to any inquiry from, or providing testimony before, the SEC, FINRA, any other self-regulatory organization, or any other state, local, or federal regulatory, investigative, or enforcement entity, agency, or authority. For purposes of this Agreement, a confidential disclosure to government officials or attorneys solely for purposes of reporting or investigating a suspected violation of the law (or disclosures made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal) is immune from civil and criminal liabilities under federal and state trade secret laws. Furthermore, Grantee agrees to disclose and assign to LNC all rights and interest in any invention or idea that Grantee developed or helped develop for actual or related business, research, or development work during the period of Grantee’s Service.

(e)Consent to Injunction; Attorneys’ Fees and Costs. Grantee acknowledges that any violation of the non-competition, non-solicitation, non- disparagement, or non-disclosure provisions described in Subparagraphs 9(a) through 9(d) would entail irreparable injury to the business and goodwill of LNC and would jeopardize the competitive position in the marketplace held by LNC. Therefore, Grantee also acknowledges that, in the event of any violation of Subparagraphs 9(a) through 9(d) by Grantee, the cancellation/rescission of the award alone will be inadequate to compensate LNC, and LNC will be entitled, as a matter of right and without the obligation to post a bond or other security, to an injunction issued by any court of competent jurisdiction and other equitable relief to prevent any actual, intended or likely violation of this Agreement. If LNC brings legal action for injunctive relief, LNC shall have the benefit of the full periods of the post-employment covenants set forth above. The injunction shall run from the date injunctive relief is granted but reduced by the time period after the separation of employment that Grantee was not in violation of the applicable covenant(s). In the event LNC elects to seek any remedy by court action, rendered necessary as the result of any violation or threatened violation of the Agreement by Grantee, and LNC prevails in such action, Grantee shall be responsible to pay all costs and attorneys’ fees incurred by LNC in taking such action.

Notwithstanding anything herein to the contrary, LNC may, in its discretion, waive Grantee’s compliance with Subparagraphs 9(a) through 9(d) in whole or part in any individual case. Moreover, if Grantee’s Service is terminated by LNC other than for Cause, a failure by Grantee to comply with the provisions of Subparagraph 9(a) through 9(d) above, after such termination shall not in and of itself cause rescission if the Shares were distributed in settlement of the RSUs prior to Grantee’s date of termination.

5

If any term, provision or paragraph of this Paragraph 9 shall be determined by a court to be invalid or unenforceable for any reason, the term, provision or paragraph shall be construed so as to be enforceable to the maximum extent compatible with the applicable laws in effect at the time; and such determination of invalidity shall not affect the remaining terms, provisions or paragraphs of this Agreement, which shall continue to be given full force and effect. If any term, provision or paragraph of this Paragraph 9 shall be determined by a court to be unenforceable because of the scope or duration thereof, the parties hereby expressly agree that the court making such determination shall have the power to reduce the scope or duration and/or restrict the geographical area of such term, provision or paragraph and/or to delete such specific words or phrases which the court shall deem necessary to permit enforcement of such term, provision or paragraph in restricted form. If any term, provision or paragraph of this Paragraph 9 is found to be in conflict with any state or local law or regulation, the applicable state or local law will control to the extent that such state or local law applies to the Grantee.

10.Definitions. As used in this Agreement:

    “Cause” means (a) a conviction of a crime that is job related or that may otherwise cause harm to the reputation of the Corporation; (b) any act or omission detrimental to the conduct of business of LNC the Corporation; (c) inability to obtain or retain proper licenses; (d) theft, dishonesty, fraud or misrepresentation; (e) failure to cooperate or be truthful in connection with an investigation related to the Corporation; (f) violation of any rule or regulation of any regulatory agency or self-regulatory agency; or (g) violation of any policy or rule of the Corporation. Cause shall be determined in the sole discretion of the Committee.

“Corporation” means LNC or any subsidiary.

    “Retires” or “Retirement” means Grantee’s Separation from Service, other than for Cause, from LNC or any Subsidiary at age 55 or older with at least five (5) years of Service.

    “Service” means Grantee’s continuous service as a common law employee of, or as a planner with a full-time agent’s contract with, LNC or any Subsidiary. Service as a common law employee is the period of time Grantee is on the payroll of LNC or a Subsidiary but prior to the time the Grantee has had a Separation from Service. Service as a planner is the period of time Grantee’s full-time agent’s contract is in effect but prior to the time the Grantee has had a Separation from Service.

    “Separation from Service” has the meaning given such term in Code section 409A and the regulations issued thereunder.

“Subsidiary” means a corporation in which LNC has ownership of at least twenty-five percent.

“Total Disability” means (as determined by the Committee) a disability that results in Grantee being unable to engage in any occupation or employment for wage or profit for which Grantee is, or becomes, reasonably qualified by training, education or experience. In addition, the disability must have lasted six (6) months and be expected to continue for at least six (6) more months or be expected to continue unto death.

6

11.Compliance with Securities Laws. Shares shall not be issued with respect to RSUs unless the issuance and delivery of such Shares shall comply with all relevant provisions of state and federal laws, rules and regulations, and, in the discretion of LNC, shall be further subject to the approval of counsel for LNC with respect to that compliance.

12.Governing Law; Forum for Disputes. This Agreement shall be governed by the laws of the Commonwealth of Pennsylvania, without giving effect to any choice of law or conflict of law provision or rule (whether of the chosen state or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the Commonwealth of Pennsylvania. Venue for any dispute relating to the Agreement shall be in the state or federal court, as applicable, having jurisdiction over claims arising in Delaware County, Pennsylvania, or such other venue as determined by LNC to best enforce its rights under this Agreement. To the extent legally possible, Grantee expressly waives any objections to LNC’s choice of venue and waives any arguments based on the inconvenience of the selected venue.

13.Incorporation of Plan Terms. This award is subject to the terms and conditions of the Plan. Such terms and conditions of the Plan are incorporated into and made a part of this Agreement by reference. In the event of any conflicts between the provisions of this Agreement and the terms of the Plan, the terms of the Plan will control. Capitalized terms used but not defined in this Agreement shall have the meanings set forth in the Plan unless the context clearly requires an alternative meaning.

14.Severability. The provisions of this Agreement are severable. If any provision is held to be invalid or unenforceable, it shall not affect the validity or enforceability of any other provision.

IN WITNESS WHEREOF, LNC, by its duly authorized officer has signed this Agreement as of the effective date set out above.

LINCOLN NATIONAL CORPORATION

By:/s/ Deirdre Connelly            

Deirdre Connelly

Chair of the Compensation Committee

7

EX-10.3

Exhibit 10.3

LINCOLN NATIONAL CORPORATION

LONG-TERM INCENTIVE AWARD PROGRAM

Performance Cycle Agreement

For CEO

Alternate Vesting

This Award Agreement (“Agreement”), by and between Lincoln National Corporation (“LNC”) on behalf of itself and its affiliates, and the <First Name> <Last Name> (“Grantee”), evidences the grant by LNC on <Grant Date>, of a long-term incentive performance award to Grantee, and Grantee’s acceptance of the award, in accordance with and subject to the provisions of the Lincoln National Corporation 2020 Incentive Compensation Plan effective June 11, 2020 (the “Plan”) and this Agreement. LNC and Grantee agree as follows:

1.    Form of Award. This performance award grant is for <Granted Amount>shares of LNC common stock (“Shares”). During the Performance Cycle, this award shall consist of LNC stock units but any actual award that ultimately vests will be delivered in Shares.

Shares will vest and be delivered, together with any accumulated dividend equivalents, in up to five equal tranches only after certification by the Compensation Committee of the LNC Board of Directors (the “Committee”) of the satisfaction of the service requirement with respect to an applicable tranche of the award (as set forth on Appendix A hereto) and the achievement of company performance criteria previously established and approved by the Committee (as set forth in Appendix A hereto) with respect to the award (or tranche thereof (as set forth on Appendix A hereto)) during the Performance Cycle; however in no event will any Shares be delivered later than March 15th of the year following the completion of the Performance Cycle.

The Committee reserves the right to adjust the target number or amount of Shares delivered at any time to the extent permissible under the Plan.

In the event an adjustment pursuant to Section 10(c) of the Plan is required, the number of Shares that may ultimately vest under this Agreement, if any, shall be adjusted in accordance with Section 10(c) of the Plan. All Shares that may ultimately vest under this Agreement, if any, after such adjustment shall be subject to the same restrictions applicable any Shares that may have vested under this Agreement before the adjustment.

2.    Full Awards upon Certain Events.

(a)    Except as provided in this Paragraph 2 and in Paragraph 3, below, if Grantee has a Separation from Service (defined in Paragraph 11, below), for any reason before the Committee certifies the achievement of the applicable service and company performance criteria for a tranche of Shares during the Performance Cycle, any portion of the award that is unvested shall be forfeited and automatically transferred back to LNC. Upon forfeiture, Grantee shall have no further rights in such award or any Shares issuable pursuant to an award granted hereunder.

1

(b)    In the case of Grantee’s death or Separation from Service on account of Total Disability (defined in Paragraph 11, below) before the end of the Performance Cycle, Grantee (or Grantee's estate, if applicable) shall receive a full, non-prorated award with respect to any remaining unvested portion of the award.

(c)     Grantee shall receive a full, non-prorated award with respect to any remaining unvested portion of the award if, before the end of the Performance Cycle, Grantee is Involuntarily Terminated not for Cause (as such terms are defined under The Severance Plan for Officers of Lincoln National Corporation), and Grantee incurs a Separation from Service; provided, however, that on or prior to the fifty-second (52nd) day following such Separation from Service, Grantee executes a Severance Agreement and General Release in form and substance satisfactory to LNC and all revocation periods applicable to such release have expired without such release having been revoked.

3.    Change of Control. In connection with a Change of Control, pursuant to the definition in effect on the day immediately preceding such Change of Control, the Committee shall determine what, if any, award under this Agreement shall vest. In making such determination, the Committee shall consider the nature of such Change of Control, whether continuation of the Plan and the awards for the Performance Cycle are feasible, and whether the resulting corporate entity, if any, offers or commits to offer awards of comparable economic value; provided, however, that the Committee’s determination shall be consistent with existing LNC plans, such as the Plan and the LNC Executives’ Severance Benefit Plan.

Shares deliverable pursuant to this Paragraph 3 shall be delivered within 60 days after the vesting date as determined by the Committee. Notwithstanding the foregoing, a Grantee who has a voluntary Separation from Service following a Change of Control but before delivery of Shares in settlement of this award shall forfeit any remaining unvested portion of this award.

4.    Dividend Equivalent Units. If any portion of the award vests, Grantee shall also receive an amount equal to the dividends that would have been paid on such Shares had Grantee held such Shares from the date of grant through the date the Shares become deliverable. Such dividend equivalent amount shall be delivered in Shares based on the Fair Market Value of a Share on the date of the payment of the dividend.

5.Distribution of Shares. Except as provided below, Shares shall be distributed to Grantee (or to Grantee’s estate), including dividend equivalent units credited, on or within 60 days after the Committee certifies the achievement of both the service and company performance criteria for the applicable tranche of Shares.

If Grantee’s award vests pursuant to Subparagraph 2(b) above, such Shares shall be distributed to Grantee as soon as administratively feasible but in no case more than 60 days following Separation from Service. Once such Shares have been issued with respect to this Agreement and the Plan, the Grantee shall have no further rights with respect to the award.

If Grantee’s award vests pursuant to Subparagraph 2(c) above, such Shares shall be distributed to Grantee on the business day on or first following the sixtieth (60th) day after such

2

involuntary Separation from Service. Once such shares have been issued with respect to this Agreement and the Plan, the Grantee shall have no further rights with respect to the award.

6.    Tax Withholding. LNC will require Grantee to remit an amount equal to any tax withholding required under federal, state or local law on the value of the Shares deliverable under this Agreement at such time as LNC is required to withhold such amounts. In accordance with procedures established by the Committee, Grantee may satisfy any required tax withholding payments in any combination of cash, certified check, or Shares (including the surrender of Shares held by the Grantee or those that would otherwise be issued in settlement of this award). Any surrendered or withheld Shares will constitute satisfaction of any required tax withholding to the extent of their Fair Market Value.

7.    Voting Rights. Grantee shall have no voting rights with respect to LNC stock units.

8.    Transferability. This award may not be transferred, sold, pledged, hypothecated, margined or otherwise encumbered by Grantee, except by will or the laws of descent and distribution.

9.    Cancellation/Rescission of Award after Vesting or Distribution/Termination for Cause.

This award and any Shares distributed in settlement of this award will be subject to potential forfeiture, recoupment or other action in accordance with the terms of this Agreement and any applicable claw back or recoupment policies implemented by the Company, as it may be amended or restated from time to time, or in accordance with any rules or regulations adopted by the Securities and Exchange Commission and the New York Stock Exchange pursuant to Section 10D of the Securities Exchange Act of 1934 or other applicable law.

(a)    If Grantee’s Service is terminated for Cause, any Shares distributed in settlement of this award during the six (6) month period prior to such termination for Cause shall be rescinded and any such Shares not yet delivered in settlement of this award shall be cancelled without further action by the Committee or its delegate.

(b)    If Grantee fails to comply with the non-competition, non-solicitation, non-disparagement or non-disclosure provisions described in Subparagraphs 9(a) through 9(d) below, before Shares are delivered in settlement of this award, in addition to the remedies provided in Subparagraph 9(e) below, this award shall be cancelled without further action by the Committee or its delegate.

(c)    If requested by LNC, at the time Shares are to be delivered pursuant to this Agreement, Grantee shall certify in a form acceptable to LNC that Grantee is in compliance with the terms and conditions described in Subparagraphs 9(a) through 9(d), below. Grantee’s failure to comply with Subparagraphs 9(a) or 9(b) at any time from the Grant Date through the applicable time periods specified in Subparagraphs 9(a) or 9(b) shall cause such Shares to be rescinded. Grantee’s failure to comply with Subparagraphs 9(c) or 9(d) at any time on or after the Grant Date shall cause such Shares to be rescinded.

3

(d)    (1) LNC must notify Grantee in writing of any such rescission: (A) in the case of Subparagraph 8(a), not later than 90 days after such termination for Cause; and (B) not later than 180 days after LNC obtains knowledge of Grantee’s failure to comply with Subparagraphs 9(a) through 9(d) below.

(2) Within ten (10) days after receiving a rescission notice from LNC: (A) Grantee must surrender to LNC the Shares acquired upon settlement of the award, or (B) if such Shares have been sold or transferred, (i) Grantee must make a payment to LNC of the proceeds from such sale or transfer, or (ii) if there are no proceeds from such transfer, Grantee must make a payment to LNC equal to the Fair Market Value of such Shares on the date of such transfer.

In all cases, Grantee shall pay to LNC the gross amount of any gain realized or payment received (not net of any withholding or other taxes paid by Grantee) as a result of the award.

10.    Covenants.

Grantee recognizes and acknowledges that during the term of employment, Grantee has had, and will continue to have, access to confidential and proprietary business information and trade secrets belonging to LNC and LNC’s customers, including, but not limited to, customer information, customer lists, pricing, products, information relating to sales, sales leads, sales performance, sales volume, LNC business and financial strategy, LNC quarterly business reviews, and LNC data, all of which are of substantial value to LNC. Grantee therefore agrees that the restrictive covenants below are reasonable and necessary to protect LNC’s trade secrets and confidential information.

(a)Non-Competition. From the Grant Date through the six (6) month period after the date Shares are distributed in settlement of this award , Grantee may not become employed by, work on behalf of, consult with, or otherwise render services that are the same or similar to the services rendered by Grantee to the business unit(s) for which Grantee provided Service or otherwise had responsibilities for within six (6) months prior to his/her Separation from Service to any other business, firm, person, partnership, corporation or other organization that competes with or provides, or is planning to provide, the same or similar products and/or services. Grantee understands and agrees that due to the nature of LNC’s nationwide business and the nationwide scope of Grantee’s employment, this restriction is nationwide in scope.

(b)Non-Solicitation of Employees and Other Service Providers. During Grantee’s employment with LNC, and for a period of twelve (12) months following the date of Grantee’s Separation from Service, for any reason, Grantee shall not directly or indirectly hire, manage, solicit, or recruit, or aid in the hiring, soliciting, or recruiting of any persons who are at the time of the hire, or were at any time within the six (6) months prior to hire, employees, agents, representatives, or consultants of LNC whom Grantee had hired, managed, supervised, or otherwise became familiar with in any capacity as a result of his/her Service.

(c)Non-Disparagement. Grantee agrees not to defame LNC or any of its affiliates, products, employees, officers, directors or services, or make or solicit any comments, statement

4

or the like to the media or others that may be considered to be derogatory or harmful to the good name or business reputation of LNC or its affiliates, except that Grantee may testify truthfully in any legal proceeding where his testimony is compelled by subpoena under oath. This provision also applies to any comments or statements which Grantee may make on the internet, including but not limited to comments, statements and/or videos placed in email, and/or on YouTube, Instagram, Facebook, Twitter or any other social media site.

(d)Non-Disclosure & Ideas Provision. Grantee shall not, without prior written authorization from LNC, disclose to anyone outside LNC, or use in other than LNC’s business, any trade secrets or confidential and/or proprietary information received from or on behalf of, developed for, or otherwise relating to the business of, LNC. Any confidentiality or non-disclosure obligations in this Agreement does not prohibit or restrict Grantee (or Grantee’s attorney) from initiating communications directly with, or responding to any inquiry from, or providing testimony before, the SEC, FINRA, any other self-regulatory organization, or any other state, local, or federal regulatory, investigative, or enforcement entity, agency, or authority. For purposes of this Agreement, a confidential disclosure to government officials or attorneys solely for purposes of reporting or investigating a suspected violation of the law (or disclosures made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal) is immune from civil and criminal liabilities under federal and state trade secret laws. Furthermore, Grantee agrees to disclose and assign to LNC all rights and interest in any invention or idea that Grantee developed or helped develop for actual or related business, research, or development work during the period of Grantee’s Service.

(e)Consent to Injunction; Attorneys’ Fees and Costs. Grantee acknowledges that any violation of the non-competition, non-solicitation, non- disparagement, or non-disclosure provisions described in Subparagraphs 9(a) through 9(d) would entail irreparable injury to the business and goodwill of LNC and would jeopardize the competitive position in the marketplace held by LNC. Therefore, Grantee also acknowledges that, in the event of any violation of Subparagraphs 9(a) through 9(d) by Grantee, the cancellation/rescission of the award alone will be inadequate to compensate LNC, and LNC will be entitled, as a matter of right and without the obligation to post a bond or other security, to an injunction issued by any court of competent jurisdiction and other equitable relief to prevent any actual, intended or likely violation of this Agreement. If LNC brings legal action for injunctive relief, LNC shall have the benefit of the full periods of the post-employment covenants set forth above. The injunction shall run from the date injunctive relief is granted but reduced by the time period after the separation of employment that Grantee was not in violation of the applicable covenant(s). In the event LNC elects to seek any remedy by court action, rendered necessary as the result of any violation or threatened violation of the Agreement by Grantee, and LNC prevails in such action, Grantee shall be responsible to pay all costs and attorneys’ fees incurred by LNC in taking such action.

Notwithstanding anything to the contrary herein, LNC may, in its discretion, waive Grantee’s compliance with Subparagraphs 9(a) through 9(d) in whole or part in any individual case. Moreover, if Grantee’s Service is terminated by LNC other than for Cause, a failure by Grantee to comply with the provisions of Subparagraph 9(a) through 9(d), above, after such termination shall not in and of itself cause rescission if the Shares were delivered in settlement of this award before Grantee’s termination.

5

If any term, provision or paragraph of this Paragraph 9 shall be determined by a court to be invalid or unenforceable for any reason, the term, provision or paragraph shall be construed so as to be enforceable to the maximum extent compatible with the applicable laws in effect at the time; and such determination of invalidity shall not affect the remaining terms, provisions or paragraphs of this Agreement, which shall continue to be given full force and effect. If any term, provision or paragraph of this Paragraph 9 shall be determined by a court to be unenforceable because of the scope or duration thereof, the parties hereby expressly agree that the court making such determination shall have the power to reduce the scope or duration and/or restrict the geographical area of such term, provision or paragraph and/or to delete such specific words or phrases which the court shall deem necessary to permit enforcement of such term, provision or paragraph in restricted form. If any term, provision or paragraph of this Paragraph 9 is found to be in conflict with any state or local law or regulation, the applicable state or local law will control to the extent that such state or local law applies to the Grantee.

11.    Definitions. As used in this Agreement:

“Cause” means (a) a conviction of a crime that is job related or that may otherwise cause harm to the reputation of the Corporation; (b) any act or omission detrimental to the conduct of business of the Corporation; (c) inability to obtain or retain proper licenses; (d) theft, dishonesty, fraud or misrepresentation; (e) failure to cooperate or be truthful in connection with an investigation related to the Corporation; (f) violation of any rule or regulation of any regulatory agency or self-regulatory agency; or (g) violation of any policy or rule of the Corporation Cause shall be determined in the sole discretion of the Committee.

“Corporation” means LNC or any subsidiary.

“Performance Cycle” means the seven-year period that commences on the first day of the calendar year in which the grant was awarded.

    “Service” means Grantee’s continuous service as a common law employee of, or as a planner with a full-time agent’s contract with, LNC or any Subsidiary. Service as a common law employee is the period of time Grantee is on the payroll of LNC or a Subsidiary but prior to the time the Grantee has had a Separation from Service. Service as a planner is the period of time Grantee’s full-time agent’s contract is in effect but prior to the time the Grantee has had a Separation from Service.

“Separation from Service” has the meaning given such term in Code section 409A and the regulations issued thereunder.

“Subsidiary” means a corporation in which LNC has ownership of at least twenty-five percent.

“Total Disability” means (as determined by the Committee) a disability that results in Grantee being unable to engage in any occupation or employment for wage or profit for which Grantee is, or becomes, reasonably qualified by training, education or experience. In addition, the disability must have lasted six (6) months and be expected to continue for at least six (6) more months or be expected to continue unto death.

6

12.    Compliance with Securities Laws. Shares shall not be issued with respect to this award unless the issuance and delivery of such Shares shall comply with all relevant provisions of state and federal laws, rules and regulations, and, in the discretion of LNC, shall be further subject to the approval of counsel for LNC with respect to that compliance.

13.     Governing Law; Forum for Disputes. This Agreement shall be governed by the laws of the Commonwealth of Pennsylvania, without giving effect to any choice of law or conflict of law provision or rule (whether of the chosen state or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the Commonwealth of Pennsylvania. Venue for any dispute relating to the Agreement shall be in the state or federal court, as applicable, having jurisdiction over claims arising in Delaware County, Pennsylvania, or such other venue as determined by LNC to best enforce its rights under this Agreement. To the extent legally possible, Grantee expressly waives any objections to LNC’s choice of venue and waives any arguments based on the inconvenience of the selected venue.

14. Incorporation of Plan Terms. This award is subject to the terms and conditions of the Plan. Such terms and conditions of the Plan are incorporated into and made a part of this Agreement by reference. In the event of any conflicts between the provisions of this Agreement and the terms of the Plan, the terms of the Plan will control. Capitalized terms used but not defined in this Agreement shall have the meanings set forth in the Plan unless the context clearly requires an alternative meaning.

15. Severability. The provisions of this Agreement are severable.  If any provision held to be invalid or unenforceable, it shall not affect the validity or enforceability of any other provision.

IN WITNESS WHEREOF, LNC, by its duly authorized officer has signed this Agreement as of the first date set forth above.

LINCOLN NATIONAL CORPORATION

By: /s/ Deirdre Connelly        

Deirdre Connelly

Chair of the Compensation Committee

7

EX-10.4

Exhibit 10.4

LINCOLN NATIONAL CORPORATION

RESTRICTED STOCK UNIT AWARD AGREEMENT

For CEO

Alternate Vesting

This Restricted Stock Unit Award Agreement (the “Agreement”) is by and between Lincoln National Corporation (“LNC”) on behalf of itself and its affiliates, and <First Name> <Last Name> (the “Grantee”), and evidences the grant on <Grant Date>(the “Grant Date”) of Restricted Stock Units (“RSUs”) to Grantee, and Grantee’s acceptance of the RSUs, in accordance with the terms and provisions of the Lincoln National Corporation 2020 Incentive Compensation Plan effective June 11, 2020 (the “Plan”) and this Agreement. LNC and Grantee agree as follows:

1.Number of Shares Granted. Grantee is awarded <Granted Amount>RSUs subject to the terms and restrictions as set forth in the Plan and in this Agreement. In the event an adjustment pursuant to Section 10(c) of the Plan is required, the number of RSUs awarded under this Agreement and/or the number of shares of LNC common stock (the “Shares”) delivered pursuant to RSUs granted under this Agreement shall be adjusted in accordance with Section 10(c) of the Plan. All RSUs after such adjustment (and/or Shares deliverable pursuant to RSUs granted under this Agreement) shall be subject to the same restrictions applicable to such RSUs (and/or Shares issuable pursuant to an RSU granted under this Agreement) before the adjustment.

2.Vesting of Restricted Stock Units. Subject to Paragraph 8, below, the RSUs shall vest upon the earliest to occur of the following dates (such date, the “Vesting Date”), provided Grantee remains in Service (defined in Paragraph 10, below) through such date:

(a)25% as ofthe third anniversary of the Grant Date. 25% as of the fourth anniversary of the Grant Date, and 50% as of the fifth anniversary of the Grant Date; or

(b)100% as of the date on which the Grantee has a Separation from Service (defined in Paragraph 10, below) on account of Total Disability (defined in Paragraph 10, below); or

(c)100% as of the date of the Grantee’s death; or

(d)100% as of the date of the Grantee’s involuntary Separation from Service other than for Cause (defined in Paragraph 10, below), provided that Grantee executes a Severance Agreement and General Release in form and substance satisfactory to LNC and all revocation periods applicable to such release have expired without such release having been revoked.

1

    In the event that Grantee has a Separation from Service prior to the vesting of RSUs as set forth above, other than under the circumstances described in Subparagraphs 2(b) through (d) above, the RSUs shall be forfeited and automatically transferred back to LNC. Upon forfeiture, Grantee shall have no further rights in such RSUs or Shares deliverable pursuant to an RSU granted hereunder.

3.Dividend Equivalent Rights. No cash dividends shall be payable with respect to the RSUs. Instead, for each RSU, Grantee shall have a dividend equivalent right (“DER”). The DER shall entitle the Grantee to additional RSUs on each date that dividends are paid on Shares while the RSU is outstanding. The number of RSUs to be credited on a dividend payment date based on each DER shall equal the number (or fraction thereof) obtained by dividing the aggregate dividend that would have been paid if the RSUs had been outstanding Shares by the Fair Market Value of a Share on the date of the payment of the dividend. DERs have the same restrictions as the underlying RSUs.

4.Distribution of Shares. Except as provided below, a Share shall be distributed to Grantee (or to Grantee’s estate) as follows: (i) for every RSU (including RSUs credited based on DERs) that vested in accordance with Subparagraphs 2(a) through 2(d), on or within 60 days after the Vesting Date.

If Grantee’s RSU’s vest pursuant to Subparagraph 2(d) above, such Shares shall be distributed to Grantee on the business day or first following the fifty-fifth (55th) day after such involuntary Separation from Service. Once a Share has been issued with respect to an RSU pursuant to this Agreement and the Plan, the Grantee shall have no further rights with respect to the RSU.

5.Tax Withholding. LNC will require Grantee to remit an amount equal to any tax withholding required by federal, state, or local law on the value of the RSUs at such time as LNC is required to withhold such amounts. In accordance with procedures established by the Committee, Grantee may satisfy any required tax withholding payments in any combination of cash, certified check, or Shares (including the surrender of Shares held by the Grantee or those that would otherwise be issued in settlement of this award). Any surrendered or withheld Shares will constitute satisfaction of any required tax withholding to the extent of their Fair Market Value.

6.Voting Rights. Grantee shall have no voting rights with respect to RSUs.

7.Transferability. Neither the RSUs granted under this Agreement, nor any interest or right therein or part thereof, shall be transferred, sold, pledged, hypothecated, margined or otherwise encumbered by the Grantee, except by will or the laws of descent and distribution.

8.Cancellation/Rescission of Award after Vesting or Distribution/Termination for Cause.

2

This award and any Shares distributed in settlement of this award will be subject to potential forfeiture, recoupment or other action in accordance with the terms of this Agreement and any applicable claw back or recoupment policies implemented by the Company, as it may be amended or restated from time to time, or in accordance with any rules or regulations adopted by the Securities and Exchange Commission and the New York Stock Exchange pursuant to Section 10D of the Securities Exchange Act of 1934 or other applicable law.

(a)    If Grantee’s Service is terminated for Cause, any Shares distributed in settlement of this award during the six (6) month period prior to such termination for Cause shall be rescinded and any such Shares not yet delivered in settlement of this award shall be cancelled without further action by the Compensation Committee of the LNC Board of Directors (the “Committee”) or its delegate.

(b)    If Grantee fails to comply with the non-competition, non-solicitation, non-disparagement, or non-disclosure provisions described in Subparagraphs 9(a) through 9(d), below, before Shares are distributed in settlement of this award, in addition to the remedies provided in Subparagraph 9(e) below, this award shall be cancelled without further action by the Committee or its delegate.

(c)    If requested by LNC, at the time Shares are to be distributed pursuant to this Agreement, Grantee shall certify in a form acceptable to LNC that Grantee is in compliance with the terms and conditions described in Subparagraphs 9(a) through 9(d) below. Grantee’s failure to comply with Subparagraphs 9(a) or 9(b) at any time from the Grant Date through the applicable time periods specified in Subparagraphs 9(a) or 9(b) shall cause such Shares to be rescinded. Grantee’s failure to comply with Subparagraphs 9(c) or 9(d) at any time on or after the Grant Date shall cause such Shares to be rescinded.

(d)    (1) LNC shall notify Grantee in writing of any such rescission: (A) in the case of Subparagraph 8(a), not later than 90 days after such termination for Cause; and (B) not later than 180 days after LNC obtains knowledge of Grantee’s failure to comply with Subparagraphs 9(a) through 9(d) below.

(2) Within ten (10) days after receiving a rescission notice from LNC: (A) Grantee must surrender to LNC the Shares acquired upon settlement of this award; or (B) if such Shares have been sold or transferred, (i) Grantee must make a payment to LNC of the proceeds from such sale or transfer, or (ii) if there are no proceeds from such transfer, Grantee must make a payment to LNC equal to the Fair Market Value of such Shares on the date of such transfer.

In all cases, Grantee shall pay to LNC the gross amount of any gain realized or payment received (not net of any withholding or other taxes paid by Grantee) as a result of the RSUs.

9.Covenants.

Grantee recognizes and acknowledges that during the term of employment, Grantee has had, and will continue to have, access to confidential and proprietary business information and

3

trade secrets belonging to LNC and LNC’s customers, including, but not limited to, customer information, customer lists, pricing, products, information relating to sales, sales leads, sales performance, sales volume, LNC business and financial strategy, LNC quarterly business reviews, and LNC data, all of which are of substantial value to LNC. Grantee therefore agrees that the restrictive covenants below are reasonable and necessary to protect LNC’s trade secrets and confidential information.

(a)Non-Competition. From the Grant Date through the six (6) month period after the date Shares are distributed in settlement of the RSUs , Grantee may not become employed by, work on behalf of, consult with, or otherwise render services that are the same or similar to the services rendered by Grantee to the business unit(s) for which Grantee provided Service or otherwise had responsibilities for within six (6) months prior to his/her Separation from Service to any other business, firm, person, partnership, corporation or other organization that competes with or provides, or is planning to provide, the same or similar products and/or services. Grantee understands and agrees that due to the nature of LNC’s nationwide business and the nationwide scope of Grantee’s employment, this restriction is nationwide in scope.

(b)Non-Solicitation of Employees and Other Service Providers. During Grantee’s employment with LNC, and for a period of twelve (12) months following the date of Grantee’s Separation from Service, for any reason, Grantee shall not directly or indirectly hire, manage, solicit, or recruit, or aid in the hiring, soliciting, or recruiting of any persons who are at the time of hire, or were at any time within the six (6) months prior to hire, employees, agents, representatives, or consultants of LNC whom Grantee had hired, managed, supervised, or otherwise became familiar with in any capacity as a result of his/her Service.

(c)Non-Disparagement. Grantee agrees not to defame LNC or any of its affiliates, products, employees, officers, directors or services, or make or solicit any comments, statement or the like to the media or others that may be considered to be derogatory or harmful to the good name or business reputation of LNC or its affiliates, except that Grantee may testify truthfully in any legal proceeding where his testimony is compelled by subpoena under oath. This provision also applies to any comments or statements which Grantee may make on the internet, including but not limited to comments, statements and/or videos placed in email, and/or on YouTube, Instagram, Facebook, Twitter or any other social media site.

(d)Non-Disclosure & Ideas Provision. Grantee shall not, without prior written authorization from LNC, disclose to anyone outside LNC, or use in other than LNC’s business, any trade secrets or confidential and/or proprietary information received from or on behalf of, developed for, or otherwise relating to the business of, LNC. Any confidentiality or non-disclosure obligations in this Agreement does not prohibit or restrict Grantee (or Grantee’s attorney) from initiating communications directly with, or responding to any inquiry from, or providing testimony before, the SEC, FINRA, any other self-regulatory organization, or any other state, local, or federal regulatory, investigative, or enforcement entity, agency, or authority. For purposes of this Agreement, a confidential disclosure to government officials or attorneys solely for purposes of reporting or investigating a suspected violation of the law (or disclosures made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal) is immune from civil and criminal liabilities under federal and state trade secret laws. Furthermore, Grantee agrees to disclose and assign to LNC all rights and interest in any

4

invention or idea that Grantee developed or helped develop for actual or related business, research, or development work during the period of Grantee’s Service.

(e)Consent to Injunction; Attorneys’ Fees and Costs. Grantee acknowledges that any violation of the non-competition, non-solicitation, non- disparagement, or non-disclosure provisions described in Subparagraphs 9(a) through 9(d) would entail irreparable injury to the business and goodwill of LNC and would jeopardize the competitive position in the marketplace held by LNC. Therefore, Grantee also acknowledges that, in the event of any violation of Subparagraphs 9(a) through 9(d) by Grantee, the cancellation/rescission of the award alone will be inadequate to compensate LNC, and LNC will be entitled, as a matter of right and without the obligation to post a bond or other security, to an injunction issued by any court of competent jurisdiction and other equitable relief to prevent any actual, intended or likely violation of this Agreement. If LNC brings legal action for injunctive relief, LNC shall have the benefit of the full periods of the post-employment covenants set forth above. The injunction shall run from the date injunctive relief is granted but reduced by the time period after the separation of employment that Grantee was not in violation of the applicable covenant(s). In the event LNC elects to seek any remedy by court action, rendered necessary as the result of any violation or threatened violation of the Agreement by Grantee, and LNC prevails in such action, Grantee shall be responsible to pay all costs and attorneys’ fees incurred by LNC in taking such action.

Notwithstanding anything herein to the contrary, LNC may, in its discretion, waive Grantee’s compliance with Subparagraphs 9(a) through 9(d) in whole or part in any individual case. Moreover, if Grantee’s Service is terminated by LNC other than for Cause, a failure by Grantee to comply with the provisions of Subparagraph 9(a) through 9(d) above, after such termination shall not in and of itself cause rescission if the Shares were distributed in settlement of the RSUs prior to Grantee’s date of termination.

If any term, provision or paragraph of this Paragraph 9 shall be determined by a court to be invalid or unenforceable for any reason, the term, provision or paragraph shall be construed so as to be enforceable to the maximum extent compatible with the applicable laws in effect at the time; and such determination of invalidity shall not affect the remaining terms, provisions or paragraphs of this Agreement, which shall continue to be given full force and effect. If any term, provision or paragraph of this Paragraph 9 shall be determined by a court to be unenforceable because of the scope or duration thereof, the parties hereby expressly agree that the court making such determination shall have the power to reduce the scope or duration and/or restrict the geographical area of such term, provision or paragraph and/or to delete such specific words or phrases which the court shall deem necessary to permit enforcement of such term, provision or paragraph in restricted form. If any term, provision or paragraph of this Paragraph 9 is found to be in conflict with any state or local law or regulation, the applicable state or local law will control to the extent that such state or local law applies to the Grantee.

10.Definitions. As used in this Agreement:

    “Cause” means (a) a conviction of a crime that is job related or that may otherwise cause harm to the reputation of the Corporation; (b) any act or omission detrimental to the conduct of

5

business of LNC the Corporation; (c) inability to obtain or retain proper licenses; (d) theft, dishonesty, fraud or misrepresentation; (e) failure to cooperate or be truthful in connection with an investigation related to the Corporation; (f) violation of any rule or regulation of any regulatory agency or self-regulatory agency; or (g) violation of any policy or rule of the Corporation. Cause shall be determined in the sole discretion of the Committee.

“Corporation” means LNC or any subsidiary.

        “Service” means Grantee’s continuous service as a common law employee of, or as a planner with a full-time agent’s contract with, LNC or any Subsidiary. Service as a common law employee is the period of time Grantee is on the payroll of LNC or a Subsidiary but prior to the time the Grantee has had a Separation from Service. Service as a planner is the period of time Grantee’s full-time agent’s contract is in effect but prior to the time the Grantee has had a Separation from Service.

    “Separation from Service” has the meaning given such term in Code section 409A and the regulations issued thereunder.

“Subsidiary” means a corporation in which LNC has ownership of at least twenty-five percent.

“Total Disability” means (as determined by the Committee) a disability that results in Grantee being unable to engage in any occupation or employment for wage or profit for which Grantee is, or becomes, reasonably qualified by training, education or experience. In addition, the disability must have lasted six (6) months and be expected to continue for at least six (6) more months or be expected to continue unto death.

11.Compliance with Securities Laws. Shares shall not be issued with respect to RSUs unless the issuance and delivery of such Shares shall comply with all relevant provisions of state and federal laws, rules and regulations, and, in the discretion of LNC, shall be further subject to the approval of counsel for LNC with respect to that compliance.

12.Governing Law; Forum for Disputes. This Agreement shall be governed by the laws of the Commonwealth of Pennsylvania, without giving effect to any choice of law or conflict of law provision or rule (whether of the chosen state or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the Commonwealth of Pennsylvania. Venue for any dispute relating to the Agreement shall be in the state or federal court, as applicable, having jurisdiction over claims arising in Delaware County, Pennsylvania, or such other venue as determined by LNC to best enforce its rights under this Agreement. To the extent legally possible, Grantee expressly waives any objections to LNC’s choice of venue and waives any arguments based on the inconvenience of the selected venue.

13.Incorporation of Plan Terms. This award is subject to the terms and conditions of the Plan. Such terms and conditions of the Plan are incorporated into and made a part of this Agreement by reference. In the event of any conflicts between the provisions of this Agreement and the terms of the Plan, the terms of the Plan will control. Capitalized terms used but not

6

defined in this Agreement shall have the meanings set forth in the Plan unless the context clearly requires an alternative meaning.

14.Severability. The provisions of this Agreement are severable. If any provision is held to be invalid or unenforceable, it shall not affect the validity or enforceability of any other provision.

IN WITNESS WHEREOF, LNC, by its duly authorized officer has signed this Agreement as of the effective date set out above.

LINCOLN NATIONAL CORPORATION

By:/s/ Deirdre Connelly            

Deirdre Connelly

Chair of the Compensation Committee

7

EX-10.5

Exhibit 10.5

LINCOLN NATIONAL CORPORATION

LONG-TERM INCENTIVE AWARD PROGRAM

Performance Cycle Agreement

For Senior Management Committee (other than CEO)

This Award Agreement (“Agreement”), by and between Lincoln National Corporation (“LNC”) on behalf of itself and its affiliates, and the <First Name> <Last Name> (“Grantee”), evidences the grant by LNC on <Grant Date>, of a long-term incentive performance award to Grantee, and Grantee’s acceptance of the award, in accordance with and subject to the provisions of the Lincoln National Corporation 2020 Incentive Compensation Plan effective June 11, 2020 (the “Plan”) and this Agreement. LNC and Grantee agree as follows:

1.    Form of Award. This performance award grant is for <Granted Amount>shares of LNC common stock (“Shares”). During the Performance Cycle, this award shall consist of LNC stock units but any actual award that ultimately vests will be delivered in Shares.

The number of Shares that will vest and be delivered, if any, may range from 0-<XXX>% of the aforementioned target numberof Shares plus any accumulated dividend equivalents under Section 4, below. Shares will vest and be delivered only after certification by the Compensation Committee of the LNC Board of Directors (the “Committee”) of the achievement of company performance criteria previously established and approved by the Committee for the Performance Cycle; however in no event will Shares be delivered later than March 15th of the year following the completion of the Performance Cycle.

The Committee reserves the right to adjust the target number or amount of Shares delivered at any time to the extent permissible under the Plan.

In the event an adjustment pursuant to Section 10(c) of the Plan is required, the number of Shares that may ultimately vest under this Agreement, if any, shall be adjusted in accordance with Section 10(c) of the Plan. All Shares that may ultimately vest under this Agreement, if any, after such adjustment shall be subject to the same restrictions applicable any Shares that may have vested under this Agreement before the adjustment.

2.    Full or Pro-Rata Awards upon Certain Events.

(a)    Except as provided in this Paragraph 2 and in Paragraph 3, below, if Grantee has a Separation from Service (defined in Paragraph 10, below), for any reason before the Committee certifies the achievement of company performance criteria for the Performance Cycle, the award shall be forfeited and automatically transferred back to LNC. Upon forfeiture, Grantee shall have no further rights in such award or Shares issuable pursuant to an award granted hereunder.

(b) In the case of Grantee’s Retirement (defined in Paragraph 10, below), Grantee or Grantee’s estate, if applicable, shall receive a full, non-pro-rated award as if Grantee had provided Service for the entire Performance Cycle.

1

(c)    In the case of Grantee’s death or Separation from Service on account of Total Disability (defined in Paragraph 10, below), Grantee (or Grantee's estate, if applicable) shall receive a full, non-prorated award as if Grantee had provided Service for the entire Performance Cycle.

(d) In the case of a “change in control,” within the meaning of section 409A of the Internal Revenue Code of 1986 as amended, of an LNC Subsidiary or Affiliate employing the Grantee, Grantee shall receive a pro-rated award based on the pro-ration formula described below.

(e) In the case of Grantee’s involuntary Separation from Service other than for Cause (defined in Paragraph 10, below), Grantee (or Grantee's estate, if applicable) shall receive a prorated award based on the proration formula described below, provided Grantee executes a release of claims against LNC and its affiliates (in form and substances satisfactory to LNC) or prior to the 60th day following Grantee’s Separation from Service and such release has become effective.

    The number of Shares deliverable upon the pro-rata vesting event described in Subparagraph 2(d) or (e) shall be calculated by multiplying this award by the product resulting from multiplying a fraction where the denominator is equal to the number of days during the performance cycle, and the numerator is equal to the number of days that the Grantee provided Service during the Performance Cycle, by a factor based on the company’s attainment of performance criteria during the Performance Cycle. Thereafter, the number of Shares deliverable shall be rounded up to the nearest whole Share.

Any Shares deliverable under this Paragraph 2 shall be delivered at the same time long-term incentive awards are normally paid and/or delivered after the end of the Performance Cycle.

3.    Change of Control. In connection with a Change of Control, pursuant to the definition in effect on the day immediately preceding such Change of Control, the Committee shall determine what, if any, award under this Agreement shall vest. In making such determination, the Committee shall consider the nature of such Change of Control, whether continuation of the Plan and the awards for the Performance Cycle are feasible, and whether the resulting corporate entity, if any, offers or commits to offer awards of comparable economic value; provided, however, that the Committee’s determination shall be consistent with existing LNC plans, such as the Plan and the LNC Executives’ Severance Benefit Plan.

Shares deliverable pursuant to this Paragraph 3 shall be delivered as of the earlier of (a) the time this award would normally be paid after the end of the original performance cycle established by the Committee, or (b) within 90 days after the Grantee’s involuntary Separation from Service, other than for Cause, from LNC, its affiliates or any successor entity, provided such Separation from Service occurs within two years after such Change of Control.

Notwithstanding the foregoing, a Grantee who has a voluntary Separation from Service after a Change of Control but before delivery of Shares in settlement of this award shall forfeit this award.

4.    Dividend Equivalent Units. If an award vests, Grantee shall also receive an amount equal to the dividends that would have been paid on such Shares had Grantee held such

2

Shares from the date of grant through the date the Shares become deliverable. Such dividend equivalent amount shall be delivered in Shares based on the Fair Market Value of a Share on the date of the payment of the dividend.

5.    Tax Withholding. LNC will require Grantee to remit an amount equal to any tax withholding required under federal, state or local law on the value of the Shares deliverable under this Agreement at such time as LNC is required to withhold such amounts. In accordance with procedures established by the Committee, Grantee may satisfy any required tax withholding payments in any combination of cash, certified check, or Shares (including the surrender of Shares held by the Grantee or those that would otherwise be issued in settlement of this award). Any surrendered or withheld Shares will constitute satisfaction of any required tax withholding to the extent of their Fair Market Value.

6.    Voting Rights. Grantee shall have no voting rights with respect to LNC stock units.

7.    Transferability. This award may not be transferred, sold, pledged, hypothecated, margined or otherwise encumbered by Grantee, except by will or the laws of descent and distribution.

8.    Cancellation/Rescission of Award after Vesting or Distribution/Termination for Cause.

This award and any Shares distributed in settlement of this award will be subject to potential forfeiture, recoupment or other action in accordance with the terms of this Agreement and any applicable claw back or recoupment policies implemented by the Company, as it may be amended or restated from time to time, or in accordance with any rules or regulations adopted by the Securities and Exchange Commission and the New York Stock Exchange pursuant to Section 10D of the Securities Exchange Act of 1934 or other applicable law.

(a)    If Grantee’s Service is terminated for Cause, any Shares distributed in settlement of this award during the six (6) month period prior to such termination for Cause shall be rescinded and any such Shares not yet delivered in settlement of this award shall be cancelled without further action by the Committee or its delegate.

(b)    If Grantee fails to comply with the non-competition, non-solicitation, non-disparagement or non-disclosure provisions described in Subparagraphs 9(a) through 9(d) below, before Shares are delivered in settlement of this award, in addition to the remedies provided in Subparagraph 9(e) below, this award shall be cancelled without further action by the Committee or its delegate.

(c)    If requested by LNC, at the time Shares are to be delivered pursuant to this Agreement, Grantee shall certify in a form acceptable to LNC that Grantee is in compliance with the terms and conditions described in Subparagraphs 9(a) through 9(d), below. Grantee’s failure to comply with Subparagraphs 9(a) or 9(b) at any time from the Grant Date through the applicable time periods specified in Subparagraphs 9(a) or 9(b) shall cause such Shares to be rescinded. Grantee’s failure to comply with Subparagraphs 9(c) or 9(d) at any time on or after the Grant Date shall cause such Shares to be rescinded.

3

(d)    (1) LNC must notify Grantee in writing of any such rescission: (A) in the case of Subparagraph 8(a), not later than 90 days after such termination for Cause; and (B) not later than 180 days after LNC obtains knowledge of Grantee’s failure to comply with Subparagraphs 9(a) through 9(d) below.

(2) Within ten (10) days after receiving a rescission notice from LNC: (A) Grantee must surrender to LNC the Shares acquired upon settlement of the award, or (B) if such Shares have been sold or transferred, (i) Grantee must make a payment to LNC of the proceeds from such sale or transfer, or (ii) if there are no proceeds from such transfer, Grantee must make a payment to LNC equal to the Fair Market Value of such Shares on the date of such transfer.

In all cases, Grantee shall pay to LNC the gross amount of any gain realized or payment received (not net of any withholding or other taxes paid by Grantee) as a result of the award.

9.    Covenants.

Grantee recognizes and acknowledges that during the term of employment, Grantee has had, and will continue to have, access to confidential and proprietary business information and trade secrets belonging to LNC and LNC’s customers, including, but not limited to, customer information, customer lists, pricing, products, information relating to sales, sales leads, sales performance, sales volume, LNC business and financial strategy, LNC quarterly business reviews, and LNC data, all of which are of substantial value to LNC. Grantee therefore agrees that the restrictive covenants below are reasonable and necessary to protect LNC’s trade secrets and confidential information.

(a)Non-Competition. From the Grant Date through the six (6) month period after the date Shares are distributed in settlement of this award , Grantee may not become employed by, work on behalf of, consult with, or otherwise render services that are the same or similar to the services rendered by Grantee to the business unit(s) for which Grantee provided Service or otherwise had responsibilities for within six (6) months prior to his/her Separation from Service to any other business, firm, person, partnership, corporation or other organization that competes with or provides, or is planning to provide, the same or similar products and/or services. Grantee understands and agrees that due to the nature of LNC’s nationwide business and the nationwide scope of Grantee’s employment, this restriction is nationwide in scope.

(b)Non-Solicitation of Employees and Other Service Providers. During Grantee’s employment with LNC, and for a period of twelve (12) months following the date of Grantee’s Separation from Service, for any reason, Grantee shall not directly or indirectly hire, manage, solicit, or recruit, or aid in the hiring, soliciting, or recruiting of any persons who are at the time of the hire, or were at any time within the six (6) months prior to hire, employees, agents, representatives, or consultants of LNC whom Grantee had hired, managed, supervised, or otherwise became familiar with in any capacity as a result of his/her Service.

(c)Non-Disparagement. Grantee agrees not to defame LNC or any of its affiliates, products, employees, officers, directors or services, or make or solicit any comments, statement or the like to the media or others that may be considered to be derogatory or harmful to the good name or business reputation of LNC or its affiliates, except that Grantee may testify

4

truthfully in any legal proceeding where his testimony is compelled by subpoena under oath. This provision also applies to any comments or statements which Grantee may make on the internet, including but not limited to comments, statements and/or videos placed in email, and/or on YouTube, Instagram, Facebook, Twitter or any other social media site.

(d)Non-Disclosure & Ideas Provision. Grantee shall not, without prior written authorization from LNC, disclose to anyone outside LNC, or use in other than LNC’s business, any trade secrets or confidential and/or proprietary information received from or on behalf of, developed for, or otherwise relating to the business of, LNC. Any confidentiality or non-disclosure obligations in this Agreement does not prohibit or restrict Grantee (or Grantee’s attorney) from initiating communications directly with, or responding to any inquiry from, or providing testimony before, the SEC, FINRA, any other self-regulatory organization, or any other state, local, or federal regulatory, investigative, or enforcement entity, agency, or authority. For purposes of this Agreement, a confidential disclosure to government officials or attorneys solely for purposes of reporting or investigating a suspected violation of the law (or disclosures made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal) is immune from civil and criminal liabilities under federal and state trade secret laws. Furthermore, Grantee agrees to disclose and assign to LNC all rights and interest in any invention or idea that Grantee developed or helped develop for actual or related business, research, or development work during the period of Grantee’s Service.

(e)Consent to Injunction; Attorneys’ Fees and Costs. Grantee acknowledges that any violation of the non-competition, non-solicitation, non- disparagement, or non-disclosure provisions described in Subparagraphs 9(a) through 9(d) would entail irreparable injury to the business and goodwill of LNC and would jeopardize the competitive position in the marketplace held by LNC. Therefore, Grantee also acknowledges that, in the event of any violation of Subparagraphs 9(a) through 9(d) by Grantee, the cancellation/rescission of the award alone will be inadequate to compensate LNC, and LNC will be entitled, as a matter of right and without the obligation to post a bond or other security, to an injunction issued by any court of competent jurisdiction and other equitable relief to prevent any actual, intended or likely violation of this Agreement. If LNC brings legal action for injunctive relief, LNC shall have the benefit of the full periods of the post-employment covenants set forth above. The injunction shall run from the date injunctive relief is granted but reduced by the time period after the separation of employment that Grantee was not in violation of the applicable covenant(s). In the event LNC elects to seek any remedy by court action, rendered necessary as the result of any violation or threatened violation of the Agreement by Grantee, and LNC prevails in such action, Grantee shall be responsible to pay all costs and attorneys’ fees incurred by LNC in taking such action.

Notwithstanding anything to the contrary herein, LNC may, in its discretion, waive Grantee’s compliance with Subparagraphs 9(a) through 9(d) in whole or part in any individual case. Moreover, if Grantee’s Service is terminated by LNC other than for Cause, a failure by Grantee to comply with the provisions of Subparagraph 9(a) through 9(d), above, after such termination shall not in and of itself cause rescission if the Shares were delivered in settlement of this award before Grantee’s termination.

If any term, provision or paragraph of this Paragraph 9 shall be determined by a court to be invalid or unenforceable for any reason, the term, provision or paragraph shall be construed

5

so as to be enforceable to the maximum extent compatible with the applicable laws in effect at the time; and such determination of invalidity shall not affect the remaining terms, provisions or paragraphs of this Agreement, which shall continue to be given full force and effect. If any term, provision or paragraph of this Paragraph 9 shall be determined by a court to be unenforceable because of the scope or duration thereof, the parties hereby expressly agree that the court making such determination shall have the power to reduce the scope or duration and/or restrict the geographical area of such term, provision or paragraph and/or to delete such specific words or phrases which the court shall deem necessary to permit enforcement of such term, provision or paragraph in restricted form. If any term, provision or paragraph of this Paragraph 9 is found to be in conflict with any state or local law or regulation, the applicable state or local law will control to the extent that such state or local law applies to the Grantee.

10.    Definitions. As used in this Agreement:

“Cause” means (a) a conviction of a crime that is job related or that may otherwise cause harm to the reputation of the Corporation; (b) any act or omission detrimental to the conduct of business of the Corporation; (c) inability to obtain or retain proper licenses; (d) theft, dishonesty, fraud or misrepresentation; (e) failure to cooperate or be truthful in connection with an investigation related to the Corporation; (f) violation of any rule or regulation of any regulatory agency or self-regulatory agency; or (g) violation of any policy or rule of the Corporation. Cause shall be determined in the sole discretion of the Committee.

“Corporation” means LNC or any subsidiary.

“Performance Cycle” means the three-year period that commences on the first day of the calendar year in which the grant was awarded.

“Retirement” means Grantee’s Separation from Service, other than for Cause, from LNC or any Subsidiary at age 55 or older with at least five (5) years of Service.

    “Service” means Grantee’s continuous service as a common law employee of, or as a planner with a full-time agent’s contract with, LNC or any Subsidiary. Service as a common law employee is the period of time Grantee is on the payroll of LNC or a Subsidiary but prior to the time the Grantee has had a Separation from Service. Service as a planner is the period of time Grantee’s full-time agent’s contract is in effect but prior to the time the Grantee has had a Separation from Service.

“Separation from Service” has the meaning given such term in Code section 409A and the regulations issued thereunder.

“Subsidiary” means a corporation in which LNC has ownership of at least twenty-five percent.

“Total Disability” means (as determined by the Committee) a disability that results in Grantee being unable to engage in any occupation or employment for wage or profit for which Grantee is, or becomes, reasonably qualified by training, education or experience. In addition, the disability must have lasted six (6) months and be expected to continue for at least six (6) more months or be expected to continue unto death.

6

11.    Compliance with Securities Laws. Shares shall not be issued with respect to this award unless the issuance and delivery of such Shares shall comply with all relevant provisions of state and federal laws, rules and regulations, and, in the discretion of LNC, shall be further subject to the approval of counsel for LNC with respect to that compliance.

12.Governing Law; Forum for Disputes. This Agreement shall be governed by the laws of the Commonwealth of Pennsylvania, without giving effect to any choice of law or conflict of law provision or rule (whether of the chosen state or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the Commonwealth of Pennsylvania. Venue for any dispute relating to the Agreement shall be in the state or federal court, as applicable, having jurisdiction over claims arising in Delaware County, Pennsylvania, or such other venue as determined by LNC to best enforce its rights under this Agreement. To the extent legally possible, Grantee expressly waives any objections to LNC’s choice of venue and waives any arguments based on the inconvenience of the selected venue.

13.Incorporation of Plan Terms. This award is subject to the terms and conditions of the Plan. Such terms and conditions of the Plan are incorporated into and made a part of this Agreement by reference. In the event of any conflicts between the provisions of this Agreement and the terms of the Plan, the terms of the Plan will control. Capitalized terms used but not defined in this Agreement shall have the meanings set forth in the Plan unless the context clearly requires an alternative meaning.

14.Severability. The provisions of this Agreement are severable.  If any provision is held to be invalid or unenforceable, it shall not affect the validity or enforceability of any other provision.

IN WITNESS WHEREOF, LNC, by its duly authorized officer has signed this Agreement as of the first date set forth above.

LINCOLN NATIONAL CORPORATION

By: /s/ Ellen Cooper            

Ellen Cooper

President and Chief Executive Officer

7

EX-10.6

Exhibit 10.6

LINCOLN NATIONAL CORPORATION

RESTRICTED STOCK UNIT AWARD AGREEMENT

For Senior Management Committee (other than CEO)

This Restricted Stock Unit Award Agreement (the “Agreement”) is by and between Lincoln National Corporation (“LNC”) on behalf of itself and its affiliates, and <First Name> <Last Name> (the “Grantee”), and evidences the grant on <Grant Date>(the “Grant Date”) of Restricted Stock Units (“RSUs”) to Grantee, and Grantee’s acceptance of the RSUs, in accordance with the terms and provisions of the Lincoln National Corporation 2020 Incentive Compensation Plan effective June 11, 2020 (the “Plan”) and this Agreement. LNC and Grantee agree as follows:

1.Number of Shares Granted. Grantee is awarded <Granted Amount>RSUs subject to the terms and restrictions as set forth in the Plan and in this Agreement. In the event an adjustment pursuant to Section 10(c) of the Plan is required, the number of RSUs awarded under this Agreement and/or the number of shares of LNC common stock (the “Shares”) delivered pursuant to RSUs granted under this Agreement shall be adjusted in accordance with Section 10(c) of the Plan. All RSUs after such adjustment (and/or Shares deliverable pursuant to RSUs granted under this Agreement) shall be subject to the same restrictions applicable to such RSUs (and/or Shares issuable pursuant to an RSU granted under this Agreement) before the adjustment.

2.Vesting of Restricted Stock Units. Subject to Paragraph 8, below, the RSUs shall vest upon the earliest to occur of the following dates (such date, the “Vesting Date”), provided Grantee remains in Service (defined in Paragraph 10, below) through such date:

(a)100% as ofthe third anniversary of the Grant Date; or

(b)100% as of the date on which the Grantee has a Separation from Service (defined in Paragraph 10, below) on account of Total Disability (defined in Paragraph 10, below); or

(c)100% as of the date of the Grantee’s death; or

(d)100% as of the date of the Grantee’s involuntary Separation from Service other than for Cause (defined in Paragraph 10, below), provided such Separation from Service occurs within two years after a Change of Control pursuant to the definition in effect on the day immediately preceding such Change of Control; or

1

(e)Pro-rata as ofthe date of a “change in control,” within the meaning of section 409A of the Internal Revenue Code of 1986 as amended, of an LNC Subsidiary or Affiliate employing the Grantee.

    The number of RSUs vesting pro-rata upon the events described in Subparagraph 2(e) and (g) shall be calculated by taking a fraction where the denominator is equal to the number of days during the three-year period beginning on the Grant Date and ending on the third anniversary of the Grant Date (such three-year period, the “Vesting Period”), and the numerator is equal to the number of days that the Grantee provided Service during the Vesting Period, with this award multiplied by such fraction (rounding up the nearest whole RSU).

    Except as otherwise provided in Subparagraphs 2(f) and (g) below, in the event that Grantee has a Separation from Service prior to the vesting of RSUs as set forth above, other than under the circumstances described in Subparagraphs 2(b) through (e), the RSUs shall be forfeited and automatically transferred back to LNC. Upon forfeiture, Grantee shall have no further rights in such RSUs or Shares deliverable pursuant to an RSU granted hereunder.

Special Circumstances for Retirement and Involuntary Termination Not for Cause

(f)If Grantee Retires (defined in Paragraph 10, below) prior to the Vesting Date, (i) Grantee shall be deemed, solely for purposes of this Paragraph 2, to remain in Service through the Vesting Date, and (ii) the Vesting Date shall be the date set forth in Subparagraph 2(a) or Subparagraph 2(c), whichever is earlier. In the event Grantee is rehired by LNC after Retirement but prior to the Vesting Date described in (ii) above, Grantee shall resume actual Service, and the Vesting Date shall be determined in accordance with Subparagraphs 2(a) through 2(e).

(g)If, prior to the Vesting Date, Grantee is Involuntarily Terminated not for Cause (as such terms are defined under The Severance Plan for Officers of Lincoln National Corporation), incurs a Separation from Service, and executes a Severance Agreement and General Release in form and substance satisfactory to LNC and all revocation periods applicable to such release have expired without such release having been revoked (i) Grantee shall be deemed, solely for purposes of this Paragraph 2, to remain in Service through the Vesting Date but receive a pro-rata award as described above except that the denominator is equal to the number of days during the three-year period beginning on the Grant Date and ending on the date of Separation from Service, and (ii) the Vesting Date shall be the date set forth in Subparagraph 2(a) or Subparagraph 2(c), whichever is earlier. In the event Grantee is rehired by LNC after an Involuntary Termination not for Cause but prior to the Vesting Date described in (ii) above, Grantee shall resume actual Service, and the Vesting Date shall be determined in accordance with Subparagraphs 2(a) through 2(e).    

3.Dividend Equivalent Rights. No cash dividends shall be payable with respect to the RSUs. Instead, for each RSU, Grantee shall have a dividend equivalent right (“DER”). The DER shall entitle the Grantee to additional RSUs on each date that dividends are paid on Shares while the RSU is outstanding. The number of RSUs to be credited on a dividend payment date based on each DER shall equal the number (or fraction thereof) obtained by dividing the aggregate dividend that would have been paid if the RSUs had been outstanding Shares by the

2

Fair Market Value of a Share on the date of the payment of the dividend. DERs have the same restrictions as the underlying RSUs.

4.Distribution of Shares. Except as provided below, a Share shall be distributed to Grantee (or to Grantee’s estate) as follows: (i) for every RSU (including RSUs credited based on DERs), that vested in accordance with Subparagraphs 2(a) through 2(e), on or within 60 days after the Vesting Date.

Once a Share has been issued with respect to an RSU pursuant to this Agreement and the Plan, the Grantee shall have no further rights with respect to the RSU.     

5.Tax Withholding. LNC will require Grantee to remit an amount equal to any tax withholding required by federal, state, or local law on the value of the RSUs at such time as LNC is required to withhold such amounts. In accordance with procedures established by the Committee, Grantee may satisfy any required tax withholding payments in any combination of cash, certified check, or Shares (including the surrender of Shares held by the Grantee or those that would otherwise be issued in settlement of this award). Any surrendered or withheld Shares will constitute satisfaction of any required tax withholding to the extent of their Fair Market Value.

6.Voting Rights. Grantee shall have no voting rights with respect to RSUs.

7.Transferability. Neither the RSUs granted under this Agreement, nor any interest or right therein or part thereof, shall be transferred, sold, pledged, hypothecated, margined or otherwise encumbered by the Grantee, except by will or the laws of descent and distribution.

8.Cancellation/Rescission of Award after Vesting or Distribution/Termination for Cause.

    This award and any Shares distributed in settlement of this award will be subject to potential forfeiture, recoupment or other action in accordance with the terms of this Agreement and any applicable claw back or recoupment policies implemented by the Company, as it may be amended or restated from time to time, or in accordance with any rules or regulations adopted by the Securities and Exchange Commission and the New York Stock Exchange pursuant to Section 10D of the Securities Exchange Act of 1934 or other applicable law.

(a)    If Grantee’s Service is terminated for Cause, any Shares distributed in settlement of this award during the six (6) month period prior to such termination for Cause shall be rescinded and any such Shares not yet delivered in settlement of this award shall be cancelled without further action by the Compensation Committee of the LNC Board of Directors (the “Committee”) or its delegate.

(b)    If Grantee fails to comply with the non-competition, non-solicitation, non-disparagement, or non-disclosure provisions described in Subparagraphs 9(a) through 9(d) below, before Shares are distributed in settlement of this award, in addition to the remedies

3

provided in Subparagraph 9(e) below, this award shall be cancelled without further action by the Committee or its delegate.

(c)    If requested by LNC, at the time Shares are to be distributed pursuant to this Agreement, Grantee shall certify in a form acceptable to LNC that Grantee is in compliance with the terms and conditions described in Subparagraphs 9(a) through 9(d) below. Grantee’s failure to comply with Subparagraphs 9(a) or 9(b) at any time from the Grant Date through the applicable time periods specified in Subparagraphs 9(a) or 9(b) shall cause such Shares to be rescinded. Grantee’s failure to comply with Subparagraphs 9(c) or 9(d) at any time on or after the Grant Date shall cause such Shares to be rescinded.

(d)    (1) LNC shall notify Grantee in writing of any such rescission: (A) in the case of Subparagraph 8(a), not later than 90 days after such termination for Cause; and (B) not later than 180 days after LNC obtains knowledge of Grantee’s failure to comply with Subparagraphs 9(a) through 9(d) below.

(2) Within ten (10) days after receiving a rescission notice from LNC: (A) Grantee must surrender to LNC the Shares acquired upon settlement of this award; or (B) if such Shares have been sold or transferred, (i) Grantee must make a payment to LNC of the proceeds from such sale or transfer, or (ii) if there are no proceeds from such transfer, Grantee must make a payment to LNC equal to the Fair Market Value of such Shares on the date of such transfer.

In all cases, Grantee shall pay to LNC the gross amount of any gain realized or payment received (not net of any withholding or other taxes paid by Grantee) as a result of the RSUs.

9.Covenants.

Grantee recognizes and acknowledges that during the term of employment, Grantee has had, and will continue to have, access to confidential and proprietary business information and trade secrets belonging to LNC and LNC’s customers, including, but not limited to, customer information, customer lists, pricing, products, information relating to sales, sales leads, sales performance, sales volume, LNC business and financial strategy, LNC quarterly business reviews, and LNC data, all of which are of substantial value to LNC. Grantee therefore agrees that the restrictive covenants below are reasonable and necessary to protect LNC’s trade secrets and confidential information.

(a)Non-Competition. From the Grant Date through the six (6) month period after the date Shares are distributed in settlement of the RSUs, Grantee may not become employed by, work on behalf of, consult with, or otherwise render services that are the same or similar to the services rendered by Grantee to the business unit(s) for which Grantee provided Service or otherwise had responsibilities for within six (6) months prior to his/her Separation from Service to any other business, firm, person, partnership, corporation or other organization that competes with or provides, or is planning to provide, the same or similar products and/or services. Grantee understands and agrees that due to the nature of LNC’s nationwide business and the nationwide scope of Grantee’s employment, this restriction is nationwide in scope.

4

(b)Non-Solicitation of Employees and Other Service Providers. During Grantee’s employment with LNC, and for a period of twelve (12) months following the date of Grantee’s Separation from Service, for any reason, Grantee shall not directly or indirectly hire, manage, solicit, or recruit, or aid in the hiring, soliciting, or recruiting of any persons who are at the time of hire, or were at any time within the six (6) months prior to hire, employees, agents, representatives, or consultants of LNC whom Grantee had hired, managed, supervised, or otherwise became familiar in any capacity with as a result of his/her Service.

(c)Non-Disparagement. Grantee agrees not to defame LNC or any of its affiliates, products, employees, officers, directors or services, or make or solicit any comments, statement or the like to the media or others that may be considered to be derogatory or harmful to the good name or business reputation of LNC or its affiliates, except that Grantee may testify truthfully in any legal proceeding where his testimony is compelled by subpoena under oath. This provision also applies to any comments or statements which Grantee may make on the internet, including but not limited to comments, statements and/or videos placed in email, and/or on YouTube, Instagram, Facebook, Twitter or any other social media site.

(d)Non-Disclosure & Ideas Provision. Grantee shall not, without prior written authorization from LNC, disclose to anyone outside LNC, or use in other than LNC’s business, any trade secrets or confidential and/or proprietary information received from or on behalf of, developed for, or otherwise relating to the business of, LNC. Any confidentiality or non-disclosure obligations in this Agreement does not prohibit or restrict Grantee (or Grantee’s attorney) from initiating communications directly with, or responding to any inquiry from, or providing testimony before, the SEC, FINRA, any other self-regulatory organization, or any other state, local, or federal regulatory, investigative, or enforcement entity, agency, or authority. For purposes of this Agreement, a confidential disclosure to government officials or attorneys solely for purposes of reporting or investigating a suspected violation of the law (or disclosures made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal) is immune from civil and criminal liabilities under federal and state trade secret laws. Furthermore, Grantee agrees to disclose and assign to LNC all rights and interest in any invention or idea that Grantee developed or helped develop for actual or related business, research, or development work during the period of Grantee’s Service.

(e)Consent to Injunction; Attorneys’ Fees and Costs. Grantee acknowledges that any violation of the non-competition, non-solicitation, non- disparagement, or non-disclosure provisions described in Subparagraphs 9(a) through 9(d) would entail irreparable injury to the business and goodwill of LNC and would jeopardize the competitive position in the marketplace held by LNC. Therefore, Grantee also acknowledges that, in the event of any violation of Subparagraphs 9(a) through 9(d) by Grantee, the cancellation/rescission of the award alone will be inadequate to compensate LNC, and LNC will be entitled, as a matter of right and without the obligation to post a bond or other security, to an injunction issued by any court of competent jurisdiction and other equitable relief to prevent any actual, intended or likely violation of this Agreement. If LNC brings legal action for injunctive relief, LNC shall have the benefit of the full periods of the post-employment covenants set forth above. The injunction shall run from the date injunctive relief is granted but reduced by the time period after the separation of employment that Grantee was not in violation of the applicable covenant(s). In the event LNC elects to seek any remedy by court action, rendered necessary as the result of any

5

violation or threatened violation of the Agreement by Grantee, and LNC prevails in such action, Grantee shall be responsible to pay all costs and attorneys’ fees incurred by LNC in taking such action.

Notwithstanding anything herein to the contrary, LNC may, in its discretion, waive Grantee’s compliance with Subparagraphs 9(a) through 9(d) in whole or part in any individual case. Moreover, if Grantee’s Service is terminated by LNC other than for Cause, a failure by Grantee to comply with the provisions of Subparagraph 9(a) through 9(d) above, after such termination shall not in and of itself cause rescission if the Shares were distributed in settlement of the RSUs prior to Grantee’s date of termination.

If any term, provision or paragraph of this Paragraph 9 shall be determined by a court to be invalid or unenforceable for any reason, the term, provision or paragraph shall be construed so as to be enforceable to the maximum extent compatible with the applicable laws in effect at the time; and such determination of invalidity shall not affect the remaining terms, provisions or paragraphs of this Agreement, which shall continue to be given full force and effect. If any term, provision or paragraph of this Paragraph 9 shall be determined by a court to be unenforceable because of the scope or duration thereof, the parties hereby expressly agree that the court making such determination shall have the power to reduce the scope or duration and/or restrict the geographical area of such term, provision or paragraph and/or to delete such specific words or phrases which the court shall deem necessary to permit enforcement of such term, provision or paragraph in restricted form. If any term, provision or paragraph of this Paragraph 9 is found to be in conflict with any state or local law or regulation, the applicable state or local law will control to the extent that such state or local law applies to the Grantee.

10.Definitions. As used in this Agreement:

    “Cause” means (a) a conviction of a crime that is job related or that may otherwise cause harm to the reputation of the Corporation; (b) any act or omission detrimental to the conduct of business of the Corporation; (c) inability to obtain or retain proper licenses; (d) theft, dishonesty, fraud or misrepresentation; (e) failure to cooperate or be truthful in connection with an investigation related to the Corporation; (f) violation of any rule or regulation of any regulatory agency or self-regulatory agency; or (g) violation of any policy or rule of the Corporation. . Cause shall be determined in the sole discretion of the Committee.

    “Corporation” means LNC or any subsidiary.

    “Retires” or “Retirement” means Grantee’s Separation from Service, other than for Cause, from LNC or any Subsidiary at age 55 or older with at least five (5) years of Service.

    “Service” means Grantee’s continuous service as a common law employee of, or as a planner with a full-time agent’s contract with, LNC or any Subsidiary. Service as a common law employee is the period of time Grantee is on the payroll of LNC or a Subsidiary but prior to the time the Grantee has had a Separation from Service. Service as a planner is the period of time Grantee’s full-time agent’s contract is in effect but prior to the time the Grantee has had a Separation from Service.

6

    “Separation from Service” has the meaning given such term in Code section 409A and the regulations issued thereunder.

“Subsidiary” means a corporation in which LNC has ownership of at least twenty-five percent.

“Total Disability” means (as determined by the Committee) a disability that results in Grantee being unable to engage in any occupation or employment for wage or profit for which Grantee is, or becomes, reasonably qualified by training, education or experience. In addition, the disability must have lasted six (6) months and be expected to continue for at least six (6) more months or be expected to continue unto death.

11.Compliance with Securities Laws. Shares shall not be issued with respect to RSUs unless the issuance and delivery of such Shares shall comply with all relevant provisions of state and federal laws, rules and regulations, and, in the discretion of LNC, shall be further subject to the approval of counsel for LNC with respect to that compliance.

12.Governing Law; Forum for Disputes. This Agreement shall be governed by the laws of the Commonwealth of Pennsylvania, without giving effect to any choice of law or conflict of law provision or rule (whether of the chosen state or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the Commonwealth of Pennsylvania. Venue for any dispute relating to the Agreement shall be in the state or federal court, as applicable, having jurisdiction over claims arising in Delaware County, Pennsylvania, or such other venue as determined by LNC to best enforce its rights under this Agreement. To the extent legally possible, Grantee expressly waives any objections to LNC’s choice of venue and waives any arguments based on the inconvenience of the selected venue.

13.Incorporation of Plan Terms. This award is subject to the terms and conditions of the Plan. Such terms and conditions of the Plan are incorporated into and made a part of this Agreement by reference. In the event of any conflicts between the provisions of this Agreement and the terms of the Plan, the terms of the Plan will control. Capitalized terms used but not defined in this Agreement shall have the meanings set forth in the Plan unless the context clearly requires an alternative meaning.

14.Severability.The provisions of this Agreement are severable.  If any provision is held to be invalid or unenforceable, it shall not affect the validity or enforceability of any other provision.

7

IN WITNESS WHEREOF, LNC, by its duly authorized officer has signed this Agreement as of the effective date set out above.

LINCOLN NATIONAL CORPORATION

By:/s/ Ellen Cooper            

Ellen Cooper

President and Chief Executive Officer

8

EX-31.1

Exhibit 31.1

Certification Pursuant to Section 302 of the

Sarbanes-Oxley Act of 2002

I, Ellen G. Cooper, President and Chief Executive Officer, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Lincoln National Corporation;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: May 8, 2025	/s/ Ellen G. Cooper
	Name: Ellen G. Cooper
	Title: President and Chief Executive Officer

EX-31.2

Exhibit 31.2

Certification Pursuant to Section 302 of the

Sarbanes-Oxley Act of 2002

I, Christopher Neczypor, Executive Vice President and Chief Financial Officer, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Lincoln National Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: May 8, 2025	/s/ Christopher Neczypor
	Name: Christopher Neczypor
	Title: Executive Vice President and Chief Financial Officer

EX-32.1

Exhibit 32.1

Certification Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant to Section 906

of the Sarbanes-Oxley Act of 2002

Pursuant to 18 U.S.C. § 1350, the undersigned officer of Lincoln National Corporation (the “Company”), hereby certifies that the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, (the “Report”) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: May 8, 2025	/s/ Ellen G. Cooper
	Name: Ellen G. Cooper
	Title: President and Chief Executive Officer

The foregoing certification is being furnished solely pursuant to 18 U.S.C. § 1350 and is not being filed as part of the Report or as a separate disclosure document.

A signed original of this written statement required under Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

Exhibit 32.2

Certification Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant to Section 906

of the Sarbanes-Oxley Act of 2002

Pursuant to 18 U.S.C. § 1350, the undersigned officer of Lincoln National Corporation (the “Company”), hereby certifies that the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, (the “Report”) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: May 8, 2025	/s/ Christopher Neczypor
	Name: Christopher Neczypor
	Title: Executive Vice President and Chief Financial Officer

The foregoing certification is being furnished solely pursuant to 18 U.S.C. § 1350 and is not being filed as part of the Report or as a separate disclosure document.

A signed original of this written statement required under Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Cover - shares	3 Months Ended
	Mar. 31, 2025	May 02, 2025
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2025
Document Transition Report	false
Entity File Number	1-6028
Entity Registrant Name	LINCOLN NATIONAL CORPORATION
Entity Incorporation, State or Country Code	IN
Entity Tax Identification Number	35-1140070
Entity Address, Address Line One	150 N. Radnor-Chester Road
Entity Address, Address Line Two	Suite A305
Entity Address, City or Town	Radnor
Entity Address, State or Province	PA
Entity Address, Postal Zip Code	19087
City Area Code	484
Local Phone Number	583-1400
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		170,733,897
Entity Central Index Key	0000059558
Amendment Flag	false
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31
Common Stock
Document Information [Line Items]
Title of 12(b) Security	Common Stock
Trading Symbol	LNC
Security Exchange Name	NYSE
Depositary Shares, each representing a 1/1000th interest in a share of 9.000% Non-Cumulative Preferred Stock, Series D
Document Information [Line Items]
Title of 12(b) Security	Depositary Shares, each representing a 1/1000th interest in a share of 9.000% Non-Cumulative Preferred Stock, Series D
Trading Symbol	LNC PRD
Security Exchange Name	NYSE

XML

Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2025	Dec. 31, 2024
Investments:
Fixed maturity available-for-sale securities, at fair value	$ 88,297	$ 87,111
Debt Securities, Trading	1,984	2,025
Equity Securities, FV-NI, Current	345	294
Mortgage loans on real estate, net of allowance for credit losses	21,558	21,083
Policy loans	2,529	2,476
Derivative investments	7,849	9,677
Other investments	6,653	6,588
Total investments	129,215	129,254
Cash and invested cash	4,284	5,801
Deferred acquisition costs, value of business acquired and deferred sales inducements	12,563	12,537
Reinsurance recoverables, net of allowance for credit losses	28,580	28,750
Deposit assets, net of allowance for credit losses	31,048	30,776
Market risk benefit assets	4,157	4,860
Accrued investment income	1,134	1,108
Goodwill	1,144	1,144
Other assets	8,267	8,163
Separate account assets	162,506	168,438
Total assets	382,898	390,831
Liabilities
Policyholder account balances	125,262	126,197
Future contract benefits	40,665	39,807
Funds withheld reinsurance liabilities	16,838	16,907
Market risk benefit liabilities	1,306	1,046
Deferred front-end loads	6,910	6,730
Payables for collateral on investments	8,282	10,020
Short-term debt	0	300
Long-term debt	5,868	5,856
Other liabilities	7,068	7,261
Separate account liabilities	162,506	168,438
Total liabilities	374,705	382,562
Contingencies and Commitments (See Note 13)
Stockholders’ Equity
Common stock	4,703	4,674
Retained earnings	6,810	7,645
Accumulated other comprehensive income (loss)	(4,306)	(5,036)
Total stockholders’ equity	8,193	8,269
Total liabilities and stockholders’ equity	382,898	390,831
Series C Preferred Stock
Stockholders’ Equity
Preferred stock	493	493
Series D Preferred Stock
Stockholders’ Equity
Preferred stock	$ 493	$ 493

XML

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2025	Dec. 31, 2024
Fixed maturity available-for-sale securities, at fair value
Amortized Cost	$ 97,795	$ 97,415
Allowance for Credit Losses	74	46
Mortgage loans on real estate, net of allowance for credit losses
Fair value	$ 232	$ 232
Stockholders’ Equity
Preferred stock - authorized (in shares)	10,000,000	10,000,000
Preferred stock - issued (in shares)	40,000	40,000
Preferred stock - outstanding (in shares)	40,000	40,000
Common stock - authorized (in shares)	800,000,000	800,000,000
Common stock - issued (in shares)	170,695,166	170,380,646
Common stock - outstanding (in shares)	170,695,166	170,380,646
Series C Preferred Stock
Stockholders’ Equity
Preferred stock - authorized (in shares)	20,000	20,000
Preferred stock - issued (in shares)	20,000	20,000
Preferred stock - outstanding (in shares)	20,000	20,000
Series D Preferred Stock
Stockholders’ Equity
Preferred stock - authorized (in shares)	20,000	20,000
Preferred stock - issued (in shares)	20,000	20,000
Preferred stock - outstanding (in shares)	20,000	20,000

XML

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Revenues
Insurance premiums	$ 1,676	$ 1,601
Fee income	1,365	1,324
Net investment income	1,457	1,346
Realized gain (loss)	11	(434)
Other revenues	182	279
Total revenues	4,691	4,116
Expenses
Benefits	2,068	2,003
Interest credited	890	822
Market risk benefit (gain) loss	1,293	(1,907)
Policyholder liability remeasurement (gain) loss	(59)	(12)
Commissions and other expenses	1,368	1,601
Interest and debt expense	80	81
Total expenses	5,640	2,588
Income (loss) before taxes	(949)	1,528
Federal income tax expense (benefit)	(227)	306
Net income (loss)	(722)	1,222
Other comprehensive income (loss), net of tax:
Unrealized investment gain (loss)	523	(127)
Market risk benefit non-performance risk gain (loss)	318	(464)
Policyholder liability discount rate remeasurement gain (loss)	(111)	116
Foreign currency translation adjustment	5	(1)
Funded status of employee benefit plans	(5)	1
Total other comprehensive income (loss), net of tax	730	(475)
Comprehensive income (loss)	8	747
Net Income (Loss) Available to Common Stockholders
Net income (loss)	(722)	1,222
Preferred stock dividends declared	(34)	(34)
Net income (loss) available to common stockholders	$ (756)	$ 1,188
Net Income (Loss) Per Common Share
Basic (in dollars per share)	$ (4.41)	$ 6.98
Diluted (in dollars per share)	(4.41)	6.93
Cash Dividends Declared Per Common Share (in dollars per share)	$ 0.45	$ 0.45

XML

Consolidated Statements of Stockholders' Equity - USD ($) $ in Millions	Total	Preferred Stock	Common Stock	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Balance as of beginning-of-year at Dec. 31, 2023		$ 986	$ 4,605	$ 4,778	$ (3,476)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock compensation/issued for benefit plans			19
Net income (loss)	$ 1,222			1,222
Preferred stock dividends declared				(34)
Common stock dividends declared				(79)
Other comprehensive income (loss), net of tax	(475)				(475)
Balance as of end-of-period at Mar. 31, 2024	7,546	986	4,624	5,887	(3,951)
Balance as of beginning-of-year at Dec. 31, 2024	8,269	986	4,674	7,645	(5,036)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock compensation/issued for benefit plans			29
Net income (loss)	(722)			(722)
Preferred stock dividends declared				(34)
Common stock dividends declared				(79)
Other comprehensive income (loss), net of tax	730				730
Balance as of end-of-period at Mar. 31, 2025	$ 8,193	$ 986	$ 4,703	$ 6,810	$ (4,306)

XML

Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash Flows from Operating Activities
Net income (loss)	$ (722)	$ 1,222
Adjustments to reconile net income (loss) to net cash provided by (used in) operating activities:
Realized (gain) loss	(11)	434
Market risk benefit (gain) loss	1,293	(1,907)
Sales and maturities (purchases) of trading securities, net	71	129
Change in:
Deferred acquisition costs, value of business acquired, deferred ales inducements and deferred front-end loads	156	190
Accrued investment income	(16)	(32)
Insurance liabilities and reinsurance-related balances	(216)	(1,035)
Accrued expenses	(227)	(41)
Federal income tax accruals	(227)	306
Other	(373)	(609)
Net cash provided by (used in) operating activities	(272)	(1,343)
Cash Flows from Investing Activities
Purchases of available-for-sale securities and equity securities	(3,722)	(2,360)
Sales of available-for-sale securities and equity securities	509	677
Maturities of available-for-sale securities	2,689	1,694
Purchases of alternative investments	(397)	(315)
Sales and repayments of alternative investments	213	16
Issuance of mortgage loans on real estate	(919)	(571)
Repayment and maturities of mortgage loans on real estate	502	267
Repayment (issuance) of policy loans, net	(54)	(1)
Net change in collateral on investments, certain derivatives and related settlements	(799)	2,232
Other	(68)	0
Net cash provided by (used in) investing activities	(2,046)	1,639
Cash Flows from Financing Activities
Payment of long-term debt, including current maturities	(300)	(47)
Issuance of long-term debt, net of issuance costs	0	347
Payment related to sale-leaseback transactions	(2)	(4)
Payment related to certain financing arrangements	(14)	(16)
Policyholder account balances:
Deposits	4,434	3,602
Withdrawals	(3,129)	(3,215)
Transfers from (to) separate accounts, net	(73)	(90)
Common stock issued for benefit plans	(4)	(5)
Dividends paid to preferred stockholders	(34)	(34)
Dividends paid to common stockholders	(77)	(77)
Net cash provided by (used in) financing activities	801	461
Net increase (decrease) in cash, invested cash and restricted cash	(1,517)	757
Cash, invested cash and restricted cash as of beginning-of-year	5,801	3,365
Cash, invested cash and restricted cash as of end-of-period	$ 4,284	$ 4,122

XML

Nature of Operations and Basis of Presentation

3 Months Ended

Mar. 31, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Nature of Operations and Basis of Presentation

Nature of Operations and Basis of Presentation

Nature of Operations

Lincoln National Corporation and its subsidiaries (“LNC” or the “Company,” which also may be referred to as “we,” “our” or “us”) operate multiple insurance businesses through four business segments: Annuities, Life Insurance, Group Protection and Retirement Plan Services. In addition, we include financial results for operations that are not directly related to our business segments in Other Operations. The collective group of businesses uses “Lincoln Financial” as its marketing identity. Through our business segments, we sell a wide range of wealth accumulation, wealth protection, group protection and retirement products and solutions. These products primarily include variable annuities, fixed annuities (including indexed), registered index-linked annuities (“RILA”), universal life insurance (“UL”), variable universal life insurance (“VUL”), linked-benefit UL and VUL, indexed universal life insurance (“IUL”), term life insurance, group life, disability and dental and employer-sponsored retirement plans and services. For more information on our segments and the products and solutions we provide, see Note 15.

Basis of Presentation

The accompanying unaudited consolidated financial statements are prepared in accordance with United States of America generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions for the Securities and Exchange Commission (“SEC”) Quarterly Report on Form 10-Q, including Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. The information contained in the Notes to Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended December 31, 2024 (“2024 Form 10-K”), should be read in connection with the reading of these interim unaudited consolidated financial statements.

Certain GAAP policies, which significantly affect the determination of financial condition, results of operations and cash flows, are summarized in our 2024 Form 10-K.

In the opinion of management, these statements include all normal recurring adjustments necessary for a fair presentation of the Company’s results. Interim results for the three months ended March 31, 2025, are not necessarily indicative of the results that may be expected for the full year ending December 31, 2025. All material inter-company accounts and transactions have been eliminated in consolidation.

We present disaggregated disclosures in the Notes below for long-duration insurance balances, applying the level of aggregation by business segment as follows:

Business Segment	Level of Aggregation
Annuities	Variable Annuities
	Fixed Annuities
	Payout Annuities
Life Insurance	Traditional Life
	UL and Other
Group Protection	Group Protection
Retirement Plan Services	Retirement Plan Services

The variable annuities level of aggregation includes RILA products, which are indexed variable annuities. The fixed annuities level of aggregation represents deferred fixed annuities. We have excluded amounts reported in Other Operations from our disaggregated disclosures that are attributable to the indemnity reinsurance agreements with Protective Life Insurance Company (“Protective”) and Swiss Re Life & Health America, Inc (“Swiss Re”) as these contracts are fully reinsured, run-off institutional pension business in the form of group annuity and the results of certain disability income business.

XML

New Accounting Standards

3 Months Ended

Mar. 31, 2025

Accounting Standards Update and Change in Accounting Principle [Abstract]

New Accounting Standards

New Accounting Standards

Adoption of New Accounting Standards

The following table provides a description of current period adoptions of new Accounting Standards Updates (“ASUs”).

Standard	Description	Effective Date	Effect on Financial Statements or Other Significant Matters
ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures	This ASU aims to enhance reportable segment disclosure requirements. It requires that a public entity disclose significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”), disclose and describe other segment items and report additional measures of a segment’s profit or loss if used by the CODM.	January 1, 2024 (Annual Filings) and January 1, 2025 (Quarterly Filings)	We adopted this ASU on the applicable effective dates, incorporating the required disclosures in Note 15 to the consolidated financial statements, along with retrospectively updating the applicable tabular disclosures.

Future Adoption of New Accounting Standards

The following table provides a description of future adoptions of new ASUs that may have an impact on the consolidated financial statements when adopted. ASUs not listed below were assessed and determined to be either not applicable or insignificant in presentation or amount.

Standard	Description	Effective Date	Effect on Financial Statements or Other Significant Matters
ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures	This ASU establishes new income tax disclosure requirements, as well as adjusts certain existing requirements. It specifically requires expanded and disaggregated disclosures around the tax rate reconciliation.	January 1, 2025 (Annual Filings)	We are evaluating the impact of this ASU to disclosures within the Federal Income Taxes Note to the consolidated financial statements.
ASU 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40)	This ASU requires disclosure of specified information about certain costs and expenses, including employee compensation, depreciation and intangible asset amortization.	January 1, 2027	We are evaluating the impact of this ASU to the consolidated financial statements.

XML

Investments

3 Months Ended

Mar. 31, 2025

Investments [Abstract]

Investments

Investments

Fixed Maturity AFS Securities

The amortized cost, gross unrealized gains and losses, allowance for credit losses and fair value of fixed maturity available-for-sale (“AFS”) securities (in millions) were as follows:

	As of March 31, 2025
	Amortized Cost		Gross Unrealized				Allowance for Credit Losses		Fair Value
			Gains		Losses
Fixed maturity AFS securities:
Corporate bonds	$	75,363	$	630	$	9,085	$	23	$	66,885
U.S. government bonds	567		5		34		–		538
State and municipal bonds	2,744		21		415		–		2,350
Foreign government bonds	282		13		56		–		239
RMBS	2,104		29		186		6		1,941
CMBS	1,961		6		137		–		1,830
ABS	14,515		110		340		44		14,241
Hybrid and redeemable preferred securities	259		25		10		1		273
Total fixed maturity AFS securities	$	97,795	$	839	$	10,263	$	74	$	88,297

	As of December 31, 2024
	Amortized Cost		Gross Unrealized				Allowance for Credit Losses		Fair Value
			Gains		Losses
Fixed maturity AFS securities:
Corporate bonds	$	75,556	$	563	$	9,655	$	14	$	66,450
U.S. government bonds	429		3		41		–		391
State and municipal bonds	2,798		18		445		–		2,371
Foreign government bonds	282		11		56		–		237
RMBS	2,066		24		220		7		1,863
CMBS	1,817		4		156		–		1,665
ABS	14,226		99		421		24		13,880
Hybrid and redeemable preferred securities	241		25		11		1		254
Total fixed maturity AFS securities	$	97,415	$	747	$	11,005	$	46	$	87,111

The amortized cost and fair value of fixed maturity AFS securities by contractual maturities (in millions) as of March 31, 2025, were as follows:

	Amortized Cost		Fair Value
Due in one year or less	$	4,353	$	4,332
Due after one year through five years	18,500		18,050
Due after five years through ten years	13,107		12,271
Due after ten years	43,255		35,632
Subtotal	79,215		70,285
Structured securities (RMBS, CMBS, ABS)	18,580		18,012
Total fixed maturity AFS securities	$	97,795	$	88,297

Actual maturities may differ from contractual maturities because issuers may have the right to call or pre-pay obligations.

The fair value and gross unrealized losses of fixed maturity AFS securities (dollars in millions) for which an allowance for credit losses has not been recorded, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position, were as follows:

	As of March 31, 2025
	Less Than or Equal to Twelve Months				Greater Than Twelve Months				Total
	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses (1)
Fixed maturity AFS securities:
Corporate bonds	$	23,140	$	3,798	$	29,434	$	5,287	$	52,574	$	9,085
U.S. government bonds	67		2		230		32		297		34
State and municipal bonds	940		214		766		201		1,706		415
Foreign government bonds	32		6		119		50		151		56
RMBS	660		58		786		128		1,446		186
CMBS	610		43		785		94		1,395		137
ABS	3,820		94		3,522		246		7,342		340
Hybrid and redeemable
preferred securities	24		2		92		8		116		10
Total fixed maturity AFS securities	$	29,293	$	4,217	$	35,734	$	6,046	$	65,027	$	10,263
Total number of fixed maturity AFS securities in an unrealized loss position											6,835

	As of December 31, 2024
	Less Than or Equal to Twelve Months				Greater Than Twelve Months				Total
	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses (1)
Fixed maturity AFS securities:
Corporate bonds	$	24,657	$	4,054	$	29,786	$	5,601	$	54,443	$	9,655
U.S. government bonds	86		3		224		38		310		41
State and municipal bonds	1,087		228		760		217		1,847		445
Foreign government bonds	32		5		118		51		150		56
RMBS	795		76		760		144		1,555		220
CMBS	579		50		777		106		1,356		156
ABS	2,907		118		3,827		303		6,734		421
Hybrid and redeemable
preferred securities	23		3		93		8		116		11
Total fixed maturity AFS securities	$	30,166	$	4,537	$	36,345	$	6,468	$	66,511	$	11,005
Total number of fixed maturity AFS securities in an unrealized loss position											6,985

(1) As of March 31, 2025, and December 31, 2024, we recognized $12 million and $23 million of gross unrealized losses, respectively, in other comprehensive income (loss) (“OCI”) for fixed maturity AFS securities for which an allowance for credit losses has been recorded.

The fair value, gross unrealized losses (in millions) and number of fixed maturity AFS securities where the fair value had declined and remained below amortized cost by greater than 20% were as follows:

	As of March 31, 2025
	Fair Value		Gross Unrealized Losses		Number of Securities (1)
Less than six months	$	3,053	$	900	522
Six months or greater, but less than nine months	1,600		518		324
Nine months or greater, but less than twelve months	369		187		208
Twelve months or greater	4,381		2,149		737
Total	$	9,403	$	3,754	1,791

	As of December 31, 2024
	Fair Value		Gross Unrealized Losses		Number of Securities (1)
Less than six months	$	5,405	$	1,621	799
Six months or greater, but less than nine months	371		198		216
Nine months or greater, but less than twelve months	71		28		37
Twelve months or greater	4,440		2,218		741
Total	$	10,287	$	4,065	1,793

(1) We may reflect a security in more than one aging category based on various purchase dates.

Our gross unrealized losses on fixed maturity AFS securities decreased by $742 million for the three months ended March 31, 2025. As discussed further below, we do not believe the unrealized loss position as of March 31, 2025, required an impairment recognized in earnings as: (i) we did not intend to sell these fixed maturity AFS securities; (ii) it is not more likely than not that we will be required to sell the fixed maturity AFS securities before recovery of their amortized cost basis; and (iii) the difference in the fair value compared to the amortized cost was due to factors other than credit loss. Based upon this evaluation as of March 31, 2025, management believes we have the ability to generate adequate amounts of cash from our normal operations (e.g., insurance premiums, fee income and investment income) to meet cash requirements with a prudent margin of safety without requiring the sale of our impaired securities.

As of March 31, 2025, the unrealized losses associated with our corporate bond, U.S. government bond, state and municipal bond and foreign government bond securities were attributable primarily to rising interest rates and widening credit spreads since purchase. We performed a detailed analysis of the financial performance of the underlying issuers and determined that we expected to recover the entire amortized cost of each impaired security.

Credit ratings express opinions about the credit quality of a security. Securities rated investment grade (those rated BBB- or higher by S&P Global Ratings (“S&P”) or Baa3 or higher by Moody’s Investors Service (“Moody’s”)) are generally considered by the rating agencies and market participants to be low credit risk. As of March 31, 2025, and December 31, 2024, 96% of the fair value of our corporate bond portfolio was rated investment grade. As of March 31, 2025, and December 31, 2024, the portion of our corporate bond portfolio rated below investment grade had an amortized cost of $2.8 billion and $2.9 billion, respectively, and a fair value of $2.7 billion and $2.8 billion, respectively. Based upon the analysis discussed above, we believe that as of March 31, 2025, and December 31, 2024, we would have recovered the amortized cost of each corporate bond.

As of March 31, 2025, the unrealized losses associated with our mortgage-backed securities (“MBS”) and asset-backed securities (“ABS”) were attributable primarily to rising interest rates and widening credit spreads since purchase. We assessed for credit impairment using a cash flow model that incorporates key assumptions including default rates, severities and prepayment rates. We estimated losses for a security by forecasting the underlying loans in each transaction. The forecasted loan performance was used to project cash flows to the various tranches in the structure, as applicable. Our forecasted cash flows also considered, as applicable, independent industry analyst reports and forecasts and other independent market data. Based upon our assessment of the expected credit losses of the security given the performance of the underlying collateral compared to our subordination or other credit enhancement, we expected to recover the entire amortized cost of each impaired security.

As of March 31, 2025, the unrealized losses associated with our hybrid and redeemable preferred securities were attributable primarily to wider credit spreads caused by illiquidity in the market and subordination within the capital structure, as well as credit risk of underlying issuers. For our hybrid and redeemable preferred securities, we evaluated the financial performance of the underlying issuers based upon credit performance and investment ratings and determined that we expected to recover the entire amortized cost of each impaired security.

Credit Loss Impairment on Fixed Maturity AFS Securities

We regularly review our fixed maturity AFS securities for declines in fair value that we determine to be impairment-related, including those attributable to credit risk factors that may require an allowance for credit losses. Changes in the allowance for credit losses on fixed maturity AFS securities (in millions), aggregated by investment category, were as follows:

	For the Three Months Ended March 31, 2025
	Corporate Bonds		RMBS		ABS		Hybrids		Total
Balance as of beginning-of-year	$	14	$	7	$	24	$	1	$	46
Additions from purchases of PCD debt securities (1)	–		–		–		–		–
Additions for securities for which credit losses were
not previously recognized	7		–		8		–		15
Additions (reductions) for securities for which
credit losses were previously recognized	2		(1)		12		–		13
Reductions for securities charged off	–		–		–		–		–
Balance as of end-of-period (2)	$	23	$	6	$	44	$	1	$	74

	For the Three Months Ended March 31, 2024
	Corporate Bonds		RMBS		ABS		Hybrids		Total
Balance as of beginning-of-year	$	8	$	6	$	4	$	1	$	19
Additions from purchases of PCD debt securities (1)	–		–		–		–		–
Additions for securities for which credit losses were
not previously recognized	1		–		–		–		1
Additions (reductions) for securities for which
credit losses were previously recognized	2		–		–		–		2
Reductions for disposed securities	(1)		–		–		–		(1)
Reductions for securities charged off	–		–		–		–		–
Balance as of end-of-period (2)	$	10	$	6	$	4	$	1	$	21

(1) Represents purchased credit-deteriorated (“PCD”) fixed maturity AFS securities.

(2) As of March 31, 2025 and 2024, accrued investment income on fixed maturity AFS securities totaled $911 million and $943 million, respectively, and was excluded from the estimate of credit losses.

Losses from debt instrument modifications were $5 million and zero for the three months ended March 31, 2025 and 2024, respectively.

Mortgage Loans on Real Estate

The following provides the current and past due composition of our mortgage loans on real estate (in millions):

	As of March 31, 2025						As of December 31, 2024
	Commercial		Residential		Total		Commercial		Residential		Total
Current	$	17,602	$	3,795	$	21,397	$	17,567	$	3,387	$	20,954
30 to 59 days past due	13		84		97		6		71		77
60 to 89 days past due	3		26		29		–		33		33
90 or more days past due	31		104		135		35		90		125
Allowance for credit losses	(98)		(56)		(154)		(99)		(53)		(152)
Unamortized premium (discount)	(5)		91		86		(6)		83		77
Mark-to-market gains (losses) (1)	(32)		–		(32)		(31)		–		(31)
Total carrying value	$	17,514	$	4,044	$	21,558	$	17,472	$	3,611	$	21,083

(1) Represents the mark-to-market on certain mortgage loans on real estate that support our modified coinsurance agreements, where the investment results are passed directly to the reinsurers, and for which we have elected the fair value option. As of March 31, 2025, and December 31, 2024, the amortized cost and fair value of such mortgage loans on real estate that were in nonaccrual status was $30 million and $21 million, respectively. As of March 31, 2025, and December 31, 2024, there were no such mortgage loans on real estate that were more than 90 days past due and still accruing interest. See Note 12 for additional information.

The amortized cost of mortgage loans on real estate on nonaccrual status (in millions) was as follows, excluding certain mortgage loans on real estate that support our modified coinsurance agreements, where the investment results are passed directly to the reinsurers:

	As of March 31, 2025		As of December 31, 2024
Commercial mortgage loans on real estate	$	1	$	4
Residential mortgage loans on real estate	106		92
Total	$	107	$	96

We use loan-to-value (“LTV”) and debt-service coverage ratios as credit quality indicators for our commercial mortgage loans on real estate. The amortized cost of commercial mortgage loans on real estate (dollars in millions) by year of origination and credit quality indicator was as follows:

	As of March 31, 2025
	LTV Less Than 65%		Debt-Service Coverage Ratio	LTV 65% to 75%		Debt-Service Coverage Ratio	LTV Greater Than 75%		Debt-Service Coverage Ratio	Total
Origination Year
2025	$	267	1.63	$	18	1.33	$	–	–	$	285
2024	1,551		1.73	74		1.42	1		1.69	1,626
2023	1,346		1.76	40		1.37	2		1.51	1,388
2022	1,718		2.07	87		1.52	8		1.24	1,813
2021	2,247		3.21	46		1.73	9		1.26	2,302
2020 and prior	10,103		2.48	114		1.56	13		1.13	10,230
Total	$	17,232		$	379		$	33		$	17,644

	As of December 31, 2024
	LTV Less Than 65%		Debt-Service Coverage Ratio	LTV 65% to 75%		Debt-Service Coverage Ratio	LTV Greater Than 75%		Debt-Service Coverage Ratio	Total
Origination Year
2024	$	1,548	1.73	$	83	1.41	$	–	–	$	1,631
2023	1,348		1.78	44		1.36	–		–	1,392
2022	1,724		2.11	94		1.55	4		1.30	1,822
2021	2,267		3.50	47		1.52	–		–	2,314
2020	1,167		3.33	4		1.53	–		–	1,171
2019 and prior	9,138		2.38	126		1.58	8		1.30	9,272
Total	$	17,192		$	398		$	12		$	17,602

We use loan performance status as the primary credit quality indicator for our residential mortgage loans on real estate. The amortized cost of residential mortgage loans on real estate (in millions) by year of origination and credit quality indicator was as follows:

	As of March 31, 2025
	Performing		Nonperforming		Total
Origination Year
2025	$	167	$	–	$	167
2024	2,223		29		2,252
2023	495		19		514
2022	471		31		502
2021	415		12		427
2020 and prior	223		15		238
Total	$	3,994	$	106	$	4,100

	As of December 31, 2024
	Performing		Nonperforming		Total
Origination Year
2024	$	1,895	$	14	$	1,909
2023	557		16		573
2022	492		33		525
2021	427		11		438
2020	65		4		69
2019 and prior	136		14		150
Total	$	3,572	$	92	$	3,664

Credit Losses on Mortgage Loans on Real Estate

In connection with our recognition of an allowance for credit losses for mortgage loans on real estate, we perform a quantitative analysis using a probability of default/loss given default/exposure at default approach to estimate expected credit losses in our mortgage loan portfolio as well as unfunded commitments related to commercial mortgage loans, exclusive of certain mortgage loans held at fair value.

Changes in the allowance for credit losses on mortgage loans on real estate (in millions) were as follows:

	For the Three Months Ended March 31, 2025
	Commercial		Residential		Total
Balance as of beginning-of-year	$	99	$	53	$	152
Additions (reductions) from provision for credit loss
expense (1)	(1)		3		2
Additions from purchases of PCD mortgage loans on
real estate	–		–		–
Balance as of end-of-period (2)	$	98	$	56	$	154

	For the Three Months Ended March 31, 2024
	Commercial		Residential		Total
Balance as of beginning-of-year	$	86	$	28	$	114
Additions (reductions) from provision for credit loss
expense (1)	(2)		3		1
Additions from purchases of PCD mortgage loans on
real estate	–		–		–
Balance as of end-of-period (2)	$	84	$	31	$	115

(1) We recognized $1 million of credit loss benefit (expense) related to unfunded commitments for mortgage loans on real estate for the three months ended March 31, 2025 and 2024.

(2) Accrued investment income on mortgage loans on real estate totaled $101 million and $69 million as of March 31, 2025 and 2024, respectively, and was excluded from the estimate of credit losses.

Alternative Investments 

As of March 31, 2025, and December 31, 2024, alternative investments included investments in 370 and 371 different partnerships, respectively, and represented approximately 3% of total investments.

Impairments on Fixed Maturity AFS Securities

Details underlying credit loss benefit (expense) incurred as a result of impairments that were recognized in net income (loss) and included in realized gain (loss) on fixed maturity AFS securities (in millions) were as follows:

	For the Three Months Ended March 31,
	2025		2024
Credit Loss Benefit (Expense)
Fixed maturity AFS securities:
Corporate bonds	$	(9)	$	(2)
RMBS	1		–
ABS	(20)		–
Total credit loss benefit (expense)	$	(28)	$	(2)

Payables for Collateral on Investments

The carrying value of the payables for collateral on investments included on the Consolidated Balance Sheets and the fair value of the related investments or collateral (in millions) consisted of the following:

	As of March 31, 2025				As of December 31, 2024
	Carrying Value		Fair Value		Carrying Value		Fair Value
Collateral payable for derivative investments (1)	$	5,558	$	5,558	$	7,213	$	7,213
Securities pledged under securities lending agreements (2)	167		161		157		151
Securities pledged under repurchase agreements (3)	57		59		–		–
Investments pledged for FHLBI (4)	2,500		3,480		2,650		3,657
Total payables for collateral on investments	$	8,282	$	9,258	$	10,020	$	11,021

(1) We obtain collateral based upon contractual provisions with our counterparties. These agreements take into consideration the counterparties’ credit rating as compared to ours, the fair value of the derivative investments and specified thresholds that if exceeded result in the receipt of cash that is typically invested in cash and invested cash or fixed maturity AFS securities. This also includes interest payable on collateral. See Note 5 for additional information.

(2) Our pledged securities under securities lending agreements are included in fixed maturity AFS securities on the Consolidated Balance Sheets. We generally obtain collateral in an amount equal to 102% and 105% of the fair value of the domestic and foreign securities, respectively. We value collateral daily and obtain additional collateral when deemed appropriate. The cash received in our securities lending program is typically invested in cash and invested cash or fixed maturity AFS securities.

(3) Our pledged securities under repurchase agreements are included in fixed maturity AFS securities on the Consolidated Balance Sheets. The collateral requirements are generally 80% to 95% of the fair value of the securities, and our agreements with third parties contain contractual provisions to allow for additional collateral to be obtained when necessary. The cash received in our repurchase program is typically invested in cash and invested cash or fixed maturity AFS securities.

(4) Our pledged investments for Federal Home Loan Bank (“FHLB”) of Indianapolis (“FHLBI”) are included in fixed maturity AFS securities and mortgage loans on real estate on the Consolidated Balance Sheets. The collateral requirements are generally 105% to 115% of the fair value for fixed maturity AFS securities and 155% to 175% of the fair value for mortgage loans on real estate. The cash received in these transactions is primarily invested in cash and invested cash or fixed maturity AFS securities.

Increase (decrease) in payables for collateral on investments (in millions) consisted of the following:

	For the Three Months Ended March 31,
	2025		2024
Collateral payable for derivative investments	$	(1,655)	$	1,684
Securities pledged under securities
lending agreements	10		78
Securities pledged under repurchase agreements	57		–
Investments pledged for FHLBI	(150)		250
Total increase (decrease) in payables for
collateral on investments	$	(1,738)	$	2,012

We have elected not to offset our securities lending transactions in the consolidated financial statements. The remaining contractual maturities of securities lending transactions accounted for as secured borrowings (in millions) were as follows:

	As of March 31, 2025
	Overnight  and  Continuous		Up to 30 Days		30-90 Days		Greater Than 90 Days		Total
Securities Lending
Corporate bonds	$	157	$	–	$	–	$	–	$	157
Equity securities	10		–		–		–		10
Total gross secured borrowings	$	167	$	–	$	–	$	–	$	167

	As of December 31, 2024
	Overnight  and  Continuous		Up to 30 Days		30-90 Days		Greater Than 90 Days		Total
Securities Lending
Corporate bonds	$	144	$	–	$	–	$	–	$	144
U.S. government bonds	1		–		–		–		1
Equity securities	12		–		–		–		12
Total gross secured borrowings	$	157	$	–	$	–	$	–	$	157

We accept collateral in the form of securities in connection with repurchase agreements. In instances where we are permitted to sell or re-pledge the securities received, we report the fair value of the collateral received and a related obligation to return the collateral in the consolidated financial statements. In addition, we receive securities in connection with securities borrowing agreements that we are permitted to sell or re-pledge. As of March 31, 2025, we had not received any collateral and, therefore, had not sold or repledged any

collateral under these agreements.

We also accept collateral from derivative counterparties in the form of securities that we are permitted to sell or re-pledge. As of March 31, 2025, the fair value of this collateral received that we are permitted to sell or re-pledge was $2.2 billion, and we had re-pledged $64 million of this collateral to cover our collateral requirements.

We had not pledged any fixed maturity AFS securities to derivative counterparties as of March 31, 2025.

Investment Commitments

As of March 31, 2025, our investment commitments were $4.6 billion, which included $3.5 billion of limited partnerships (“LPs”), $828 million of mortgage loans on real estate and $277 million of private placement securities.

Concentrations of Financial Instruments

As of March 31, 2025, and December 31, 2024, our most significant investments in one issuer were our investments in securities issued by the Federal National Mortgage Association with a fair value of $892 million and $851 million, respectively, or 1% of total investments, and our investments in securities issued by the Federal Home Loan Mortgage Corporation with a fair value of $604 million and $566 million, respectively, or less than 1% of total investments. These concentrations include fixed maturity AFS, trading and equity securities.

As of March 31, 2025, and December 31, 2024, our most significant investments in one industry were our investments in securities in the financial services industry with a fair value of $13.5 billion and $13.4 billion, respectively, or 10% of total investments, and our investments in securities in the consumer non-cyclical industry with a fair value of $13.0 billion and $12.9 billion, respectively, or 10% of total investments. These concentrations include fixed maturity AFS, trading and equity securities.

XML

Variable Interest Entities

3 Months Ended

Mar. 31, 2025

Variable Interest Entities [Abstract]

Variable Interest Entities

Variable Interest Entities

Consolidated VIEs

Asset information (dollars in millions) for the consolidated variable interest entities (“VIEs”) included on the Consolidated Balance Sheets was as follows:

	As of March 31, 2025					As of December 31, 2024
	Number of Instruments	Notional Amounts		Carrying Value		Number of Instruments		Notional Amounts		Carrying Value
Assets
Total return swap	1	$	504	$	–	$	1	$	522	$	–

There were no gains or losses for consolidated VIEs recognized on the Consolidated Statements of Comprehensive Income (Loss) for the three months ended March 31, 2025 and 2024.

Unconsolidated VIEs

Structured Securities

Through our investment activities, we make passive investments in structured securities issued by VIEs for which we are not the manager. These structured securities include our ABS, residential mortgage-backed securities (“RMBS”) and commercial mortgage-backed securities (“CMBS”). We have not provided financial or other support with respect to these VIEs other than our original investment. We have determined that we are not the primary beneficiary of these VIEs due to the relative size of our investment in comparison to the principal amount of the structured securities issued by the VIEs and the level of credit subordination that reduces our obligation to absorb losses or right to receive benefits. Our maximum exposure to loss on these structured securities is limited to the amortized cost for these investments. We recognize our variable interest in these VIEs at fair value on the Consolidated Balance Sheets. For information about these structured securities, see Note 3.

Limited Partnerships and Limited Liability Companies

We invest in certain LPs and limited liability companies (“LLCs”) that we have concluded are VIEs. Our exposure to loss is limited to the capital we invest in the LPs and LLCs. We do not hold any substantive kick-out or participation rights in the LPs and LLCs, and we do not receive any performance fees or decision maker fees from the LPs and LLCs. Based on our analysis of the LPs and LLCs, we are not the primary beneficiary of the VIEs as we do not have the power to direct the most significant activities of the LPs and LLCs. The carrying amounts of our investments in the LPs and LLCs are recognized in other investments on the Consolidated Balance Sheets and were $5.6 billion and $5.3 billion as of March 31, 2025, and December 31, 2024, respectively.

XML

Derivative Instruments

3 Months Ended

Mar. 31, 2025

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments

Derivative Instruments

We maintain an overall risk management strategy that incorporates the use of derivative instruments to minimize significant unplanned fluctuations in earnings that are caused by interest rate risk, foreign currency exchange risk, equity market risk, basis risk, commodity risk and credit risk. We assess these risks by continually identifying and monitoring changes in our exposures that may adversely affect expected future cash flows and by evaluating hedging opportunities.

Derivative activities are monitored by various management committees. The committees are responsible for overseeing the implementation of various hedging strategies that are developed through the analysis of financial simulation models and other internal and industry sources. The resulting hedging strategies are incorporated into our overall risk management strategies.

See Note 13 for additional disclosures related to the fair value of our derivative instruments.

Interest Rate Contracts

We use derivative instruments as part of our interest rate risk management strategy. These instruments are economic hedges unless otherwise noted and include:

Forward-Starting Interest Rate Swaps

We use forward-starting interest rate swaps to hedge the interest rate exposure within our annuity, life insurance and retirement products.

Interest Rate Cap Corridors

We use interest rate cap corridors to provide a level of protection from the effect of rising interest rates for certain annuity contracts and life insurance products. Interest rate cap corridors involve purchasing an interest rate cap at a specific cap rate and selling an interest rate cap with a higher cap rate. For each corridor, the amount of quarterly payments, if any, is determined by the rate at which the underlying index rate resets above the original capped rate. The corridor limits the benefit the purchaser can receive as the related interest rate index rises above the higher capped rate. There is no additional liability to us other than the purchase price associated with the interest rate cap corridor.

Interest Rate Futures

We use interest rate futures contracts to hedge the liability exposure on certain options in variable annuity and RILA products. These futures contracts require payment between our counterparty and us on a daily basis for changes in the futures index price.

Interest Rate Swap Agreements

We use interest rate swap agreements to hedge the liability exposure on certain options in variable annuity and RILA products.

We also use interest rate swap agreements designated and qualifying as cash flow hedges to hedge the interest rate risk of floating-rate bond coupon payments on certain variable-rate long-term debt and other variable-rate bonds held by replicating a fixed-rate bond.

Finally, we use interest rate swap agreements designated and qualifying as fair value hedges to hedge against changes in the fair value of certain fixed-rate long-term debt and fixed maturity securities due to interest rate risks.

Bond Forwards and Treasury and Reverse Treasury Locks

We use treasury locks designated and qualifying as cash flow hedges to hedge the interest rate exposure related to our issuance of fixed-rate securities or the anticipated future cash flows of floating-rate fixed maturity securities due to changes in interest rates. In addition, we use bond forwards and reverse treasury locks designated and qualifying as cash flow hedges to hedge the interest rate exposure related to the anticipated purchase of fixed-rate securities or the anticipated future cash flows of floating-rate fixed maturity securities due to changes in interest rates. These derivatives are primarily structured to hedge interest rate risk inherent in the assumptions used to price certain liabilities.

Foreign Currency Contracts

We use derivative instruments as part of our foreign currency risk management strategy. These instruments are economic hedges unless otherwise noted and include:

Currency Futures

We use currency futures to hedge foreign exchange risk associated with certain options in variable annuity products. Currency futures exchange one currency for another at a specified date in the future at a specified exchange rate.

Foreign Currency Swaps

We use foreign currency swaps to hedge foreign exchange risk of investments in fixed maturity securities denominated in foreign currencies. A foreign currency swap is a contractual agreement to exchange one currency for another at specified dates in the future at a specified exchange rate.

We also use foreign currency swaps designated and qualifying as cash flow and fair value hedges to hedge foreign exchange risk of investments in fixed maturity securities denominated in foreign currencies.

Foreign Currency Forwards

We use foreign currency forwards to hedge foreign exchange risk of investments in fixed maturity securities denominated in foreign currencies. A foreign currency forward is a contractual agreement to exchange one currency for another at specified dates in the future at a specified current exchange rate.

Equity Market Contracts

We use derivative instruments as part of our equity market risk management strategy that are economic hedges and include:

Call Options Based on the S&P 500® Index and Other Indices

We use call options to hedge the liability exposure on certain options in variable annuity, RILA, fixed indexed annuity, IUL and VUL products.

Our RILA, fixed indexed annuity and IUL contracts permit the holder to elect an interest rate return or an equity market component, where interest credited to the contracts is linked to the performance of the S&P 500 Index or other indices. Policyholders may elect to rebalance index options at renewal dates. At the end of each indexed term, which can be up to six years, we have the opportunity to re-price the indexed component by establishing participation rates, caps, spreads and specified rates, subject to contractual guarantees. We use call options that are highly correlated to the portfolio allocation decisions of our policyholders, such that we are economically hedged with respect to equity returns for the current reset period.

Consumer Price Index Swaps

We use consumer price index swaps to hedge the liability exposure on certain options in fixed annuity products. Consumer price index swaps are contracts entered into at no cost and whose payoff is the difference between the consumer price index inflation rate and the fixed-rate determined as of inception.

Equity Futures

We use equity futures contracts to hedge the liability exposure on certain options in variable annuity and RILA products. These futures contracts require payment between our counterparty and us on a daily basis for changes in the futures index price.

Put Options

We use put options to hedge the liability exposure on certain options in variable annuity, RILA and VUL products. Put options are contracts that require the buyers to pay at a specified future date the amount, if any, by which a specified equity index is less than the strike rate stated in the agreement, applied to a notional amount.

Total Return Swaps

We use total return swaps to hedge the liability exposure on certain options in variable annuity, RILA and VUL products.

In addition, we use total return swaps to hedge a portion of the liability related to our deferred compensation plans. We receive the total return on a portfolio of indexes and pay a floating-rate of interest.

Commodity Contracts

We use commodity contracts to economically hedge certain investments that are closely tied to the changes in commodity values. The commodity contract is an over-the-counter contract that combines a purchase put/sold call to lock in a commodity price within a predetermined range in exchange for a net premium.

Credit Contracts

We use derivative instruments as part of our credit risk management strategy that are economic hedges and include:

Credit Default Swaps – Buying Protection

We use credit default swaps (“CDSs”) to hedge the liability exposure on certain options in variable annuity products.

We buy CDSs to hedge against a drop in bond prices due to credit concerns of certain bond issuers. A CDS allows us to put the bond back to the counterparty at par upon a default event by the bond issuer. A default event is defined as bankruptcy, failure to pay, obligation acceleration or restructuring.

CDSs – Selling Protection

We use CDSs to hedge the liability exposure on certain options in variable annuity products.

We sell CDSs to offer credit protection to policyholders and investors. The CDSs hedge the policyholders and investors against a drop in bond prices due to credit concerns of certain bond issuers. A CDS allows the investor to put the bond back to us at par upon a default event by the bond issuer. A default event is defined as bankruptcy, failure to pay, obligation acceleration or restructuring.

Embedded Derivatives

We have embedded derivatives that include:

RILA, Fixed Indexed Annuity and IUL Contracts Embedded Derivatives

Our RILA, fixed indexed annuity and IUL contracts permit the holder to elect an interest rate return or an equity market component, where interest credited to the contracts is linked to the performance of the S&P 500® Index or other indices. Policyholders may elect to rebalance index options at renewal dates. At the end of each indexed term, which can be up to six years, we have the opportunity to re-price the indexed component by establishing participation rates, caps, spreads and specified rates, subject to contractual guarantees. We use options that are highly correlated to the portfolio allocation decisions of our policyholders, such that we are economically hedged with respect to equity returns for the current reset period.

Reinsurance-Related Embedded Derivatives

We have certain modified coinsurance and coinsurance with funds withheld reinsurance agreements with embedded derivatives related to the withheld assets of the related funds. These derivatives are considered total return swaps with contractual returns that are attributable to various assets and liabilities associated with these reinsurance agreements.

Primary Risks Managed by Derivatives

We have derivative instruments with off-balance-sheet risks whose notional or contract amounts exceed the related credit exposure. Outstanding derivative instruments with off-balance-sheet risks (in millions) were as follows:

	As of March 31, 2025						As of December 31, 2024
	Notional Amounts		Fair Value				Notional Amounts		Fair Value
			Asset		Liability				Asset		Liability
Qualifying Hedges
Cash flow hedges:
Interest rate contracts (1)	$	1,275	$	154	$	6	$	1,230	$	156	$	16
Foreign currency contracts (1)	4,805		552		44		4,738		556		44
Total cash flow hedges	6,080		706		50		5,968		712		60
Fair value hedges:
Interest rate contracts (1)	1,066		2		29		1,066		10		16
Foreign currency contracts (1)	25		–		–		25		1		–
Total fair value hedges	1,091		2		29		1,091		11		16
Non-Qualifying Hedges
Interest rate contracts (1)	81,364		40		334		75,445		63		439
Foreign currency contracts (1)	332		23		2		348		30		2
Equity market contracts (1)	168,433		10,477		3,081		191,666		13,072		3,879
Credit contracts (1)	242		–		–		57		–		–
Embedded derivatives:
Reinsurance-related (2)	–		–		138		–		–		30
RILA, fixed indexed annuity and IUL
contracts (3)	–		1,092		10,807		–		1,115		12,449
Total derivative instruments	$	257,542	$	12,340	$	14,441	$	274,575	$	15,003	$	16,875

(1) These asset and liability balances are presented on a gross basis. Amounts are reported in derivative investments and other liabilities on the Consolidated Balance Sheets after the evaluation for right of offset subject to master netting agreements.

(2) Reported in funds withheld reinsurance liabilities on the Consolidated Balance Sheets.

(3) Reported in policyholder account balances and deposit assets on the Consolidated Balance Sheets.

The maturity of the notional amounts of derivative instruments (in millions) was as follows:

	Remaining Life as of March 31, 2025
	Less Than 1 Year		1 - 5 Years		6 - 10 Years		11 - 30 Years		Over 30 Years		Total
Interest rate contracts (1)	$	12,810	$	18,418	$	23,981	$	27,898	$	598	$	83,705
Foreign currency contracts (2)	199		1,292		1,776		1,853		42		5,162
Equity market contracts	127,307		30,374		8,696		7		2,049		168,433
Credit contracts	–		172		70		–		–		242
Total derivative instruments with
notional amounts	$	140,316	$	50,256	$	34,523	$	29,758	$	2,689	$	257,542

(1) As of March 31, 2025, the latest maturity date for which we were hedging our exposure to the variability in future cash flows for these instruments was April 20, 2067.

(2) As of March 31, 2025, the latest maturity date for which we were hedging our exposure to the variability in future cash flows for these instruments was June 16, 2061.

The following amounts (in millions) were recorded on the Consolidated Balance Sheets related to cumulative basis adjustments for fair value hedges:

	Amortized Cost of the Hedged Assets (Liabilities)				Cumulative Fair Value Hedging Adjustment Included in the Amortized Cost of the Hedged Assets (Liabilities)
	As of March 31,  2025		As of  December 31, 2024		As of March 31,  2025		As of  December 31, 2024
Line Item in the Consolidated Balance Sheets in
which the Hedged Item is Included
Fixed maturity AFS securities, at fair value	$	497	$	484	$	19	$	7
Long-term debt (1)	(691)		(676)		184		199

(1) Includes $(306) million and $(310) million of unamortized adjustments from discontinued hedges as of March 31, 2025, and December 31, 2024, respectively.

The change in our unrealized gain (loss) on derivative instruments within accumulated other comprehensive income (loss) (“AOCI”) (in millions) was as follows:

	For the Three Months Ended March 31,
	2025		2024
Unrealized Gain (Loss) on Derivative Instruments
Balance as of beginning-of-year	$	638	$	375
Other comprehensive income (loss):
Unrealized holding gains (losses) arising during the period:
Cash flow hedges:
Interest rate contracts	5		89
Foreign currency contracts	168		(25)
Change in foreign currency exchange rate adjustment	(153)		101
Income tax benefit (expense)	(4)		(35)
Less:
Reclassification adjustment for gains (losses)
included in net income (loss):
Cash flow hedges:
Foreign currency contracts (1)	15		15
Interest rate contracts (2)	3		9
Foreign currency contracts (3)	3		–
Income tax benefit (expense)	(4)		(5)
Balance as of end-of-period	$	637	$	486

(1) The OCI offset is reported within net investment income on the Consolidated Statements of Comprehensive Income (Loss).

(2) The OCI offset is reported within interest and debt expense on the Consolidated Statements of Comprehensive Income (Loss).

(3) The OCI offset is reported within realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss).

The effects of qualifying and non-qualifying hedges (in millions) on the Consolidated Statements of Comprehensive Income (Loss) were as follows:

Gain (Loss) Recognized in Income For the Three Months Ended March 31,

2025

2024

Realized Gain (Loss)

Net Investment Income

Interest and Debt Expense

Realized Gain (Loss)

Net Investment Income

Interest and Debt Expense

Total Line Items in which the

Effects of Fair Value or Cash

Flow Hedges are Recorded

$

11

$

1,457

$

80

$

(434)

$

1,346

$

81

Qualifying Hedges

Gain or (loss) on fair value hedging

relationships:

Interest rate contracts:

Hedged items

–

11

(15)

–

(18)

17

Derivatives designated as hedging

instruments

–

(11)

15

–

18

(17)

Foreign currency contracts:

Hedged items

–

1

–

–

(1)

–

Derivatives designated as hedging

instruments

–

(1)

–

–

1

–

Gain or (loss) on cash flow hedging

relationships:

Interest rate contracts:

Amount of gain or (loss) reclassified

from AOCI into income

–

–

3

–

–

9

Foreign currency contracts:

Amount of gain or (loss) reclassified

from AOCI into income

3

15

–

–

15

–

Non-Qualifying Hedges

Interest rate contracts

82

–

–

(163)

–

–

Foreign currency contracts

(1)

–

–

–

–

–

Equity market contracts

(1,143)

–

–

2,134

–

–

Credit contracts

1

–

–

–

–

–

Embedded derivatives:

Reinsurance-related

(108)

–

–

197

–

–

RILA, fixed indexed annuity and IUL

contracts

1,654

–

–

(1,642)

–

–

As of March 31, 2025, $76 million of the deferred net gains (losses) on derivative instruments in AOCI were expected to be reclassified to earnings during the next 12 months. This reclassification would be due primarily to interest rate variances related to our interest rate swap agreements.

For the three months ended March 31, 2025 and 2024, there were no material reclassifications to earnings due to hedged firm commitments no longer deemed probable or due to hedged forecasted transactions that had not occurred by the end of the originally specified time period.

As of March 31, 2025, and December 31, 2024, we did not have any exposure related to CDSs for which we are the seller.

Credit Risk

We are exposed to credit losses in the event of non-performance by our counterparties on various derivative contracts and reflect assumptions regarding the credit or non-performance risk. The non-performance risk is based upon assumptions for each counterparty’s credit spread over the estimated weighted average life of the counterparty exposure, less collateral held. As of March 31, 2025, the non-performance risk adjustment was zero. The credit risk associated with such agreements is minimized by entering into agreements with financial institutions with long-standing, superior performance records. Additionally, we maintain a policy of requiring derivative contracts to be governed by an International Swaps and Derivatives Association (“ISDA”) Master Agreement. We are required to maintain minimum ratings as a matter of routine practice in negotiating ISDA agreements. Under nearly all of our ISDA agreements, our insurance subsidiaries have agreed to maintain certain financial strength ratings. A downgrade below these levels could result in termination of derivative contracts, at which time any amounts payable by us would be dependent on the market value of the underlying derivative contracts. In certain transactions, we and the counterparty have entered into a credit support annex requiring either party to post collateral when net exposures exceed pre-determined thresholds. These thresholds vary by counterparty and credit rating. The amount of such exposure is essentially the net replacement cost or market value less collateral held for such agreements with each counterparty if the net market value is in our favor. We did not have any exposure as of March 31, 2025, or December 31, 2024.

The amounts recognized (in millions) by S&P credit rating of counterparty, for which we had the right to reclaim cash collateral or were obligated to return cash collateral, were as follows:

	As of March 31, 2025				As of December 31, 2024
S&P Credit Rating of Counterparty	Collateral Posted by Counterparty		Collateral Posted to Counterparty		Collateral Posted by Counterparty		Collateral Posted to Counterparty
AA-	$	3,314	$	(12)	$	4,043	$	(21)
A+	1,741		(28)		2,460		(89)
A	32		–		47		–
A-	449		–		632		–
Total cash collateral	$	5,536	$	(40)	$	7,182	$	(110)

Balance Sheet Offsetting

Information related to the effects of offsetting on the Consolidated Balance Sheets (in millions) was as follows:

	As of March 31, 2025
	Derivative Instruments		Embedded Derivative Instruments		Total
Financial Assets
Gross amount of recognized assets	$	11,173	$	1,092	$	12,265
Gross amounts offset	(3,324)		–		(3,324)
Net amount of assets	7,849		1,092		8,941
Gross amounts not offset:
Cash collateral	(5,536)		–		(5,536)
Non-cash collateral (1)	(2,313)		–		(2,313)
Net amount	$	–	$	1,092	$	1,092
Financial Liabilities
Gross amount of recognized liabilities	$	197	$	10,945	$	11,142
Gross amounts offset	(100)		–		(100)
Net amount of liabilities	97		10,945		11,042
Gross amounts not offset:
Cash collateral	(40)		–		(40)
Non-cash collateral (2)	(57)		–		(57)
Net amount	$	–	$	10,945	$	10,945

(1) Excludes excess non-cash collateral received of $941 million, as the collateral offset is limited to the net estimated fair value of derivatives after application of netting arrangements.

(2) Excludes excess non-cash collateral pledged of $1 million, as the collateral offset is limited to the net estimated fair value of derivatives after application of netting arrangements.

	As of December 31, 2024
	Derivative Instruments		Embedded Derivative Instruments		Total
Financial Assets
Gross amount of recognized assets	$	13,483	$	1,115	$	14,598
Gross amounts offset	(3,806)		–		(3,806)
Net amount of assets	9,677		1,115		10,792
Gross amounts not offset:
Cash collateral	(7,182)		–		(7,182)
Non-cash collateral (1)	(2,495)		–		(2,495)
Net amount	$	–	$	1,115	$	1,115
Financial Liabilities
Gross amount of recognized liabilities	$	617	$	12,479	$	13,096
Gross amounts offset	(432)		–		(432)
Net amount of liabilities	185		12,479		12,664
Gross amounts not offset:
Cash collateral	(110)		–		(110)
Non-cash collateral (2)	(75)		–		(75)
Net amount	$	–	$	12,479	$	12,479

(1) Excludes excess non-cash collateral received of $817 million, as the collateral offset is limited to the net estimated fair value of derivatives after application of netting arrangements.

(2) Excludes excess non-cash collateral pledged of $39 million, as the collateral offset is limited to the net estimated fair value of derivatives after application of netting arrangements.

XML

DAC, VOBA, DSI and DFEL

3 Months Ended

Mar. 31, 2025

Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Net [Abstract]

DAC, VOBA, DSI and DFEL

DAC, VOBA, DSI and DFEL

The following table reconciles deferred acquisition costs (“DAC”), value of business acquired (“VOBA”) and deferred sales inducements (“DSI”) (in millions) to the Consolidated Balance Sheets:

	As of March 31,		As of December 31,
	2025		2024
DAC, VOBA and DSI
Variable Annuities	$	4,001	$	3,964
Fixed Annuities	416		423
Traditional Life	1,352		1,370
UL and Other	6,323		6,318
Group Protection	181		178
Retirement Plan Services	288		284
Other Operations	2		–
Total DAC, VOBA and DSI	$	12,563	$	12,537

The following table reconciles deferred front-end loads (“DFEL”) (in millions) to the Consolidated Balance Sheets:

	As of March 31,		As of December 31,
	2025		2024
DFEL
Variable Annuities	$	270	$	273
UL and Other	6,587		6,406
Other Operations (1)	53		51
Total DFEL	$	6,910	$	6,730

(1) Represents DFEL reported in Other Operations attributable to the indemnity reinsurance agreement with Protective that is excluded from the following tables. We reported $53 million and $51 million of ceded DFEL in reinsurance recoverables on the Consolidated Balance Sheets as of March 31, 2025, and December 31, 2024, respectively.

The following tables summarize the changes in DAC (in millions):

	For the Three Months Ended March 31, 2025
	Variable Annuities		Fixed Annuities		Traditional Life		UL and Other		Group Protection		Retirement Plan Services
Balance as of beginning-of-year	$	3,851	$	394	$	1,335	$	5,916	$	178	$	242
Deferrals	136		10		21		94		32		5
Amortization	(97)		(16)		(37)		(79)		(29)		(5)
Balance as of end-of-period	$	3,890	$	388	$	1,319	$	5,931	$	181	$	242

	For the Three Months Ended March 31, 2024
	Variable Annuities		Fixed Annuities		Traditional Life		UL and Other		Group Protection		Retirement Plan Services
Balance as of beginning-of-year	$	3,751	$	421	$	1,376	$	5,791	$	154	$	239
Deferrals	89		9		32		100		29		5
Amortization	(89)		(16)		(37)		(76)		(26)		(5)
Balance as of end-of-period	$	3,751	$	414	$	1,371	$	5,815	$	157	$	239

DAC amortization expense of $263 million and $249 million was recorded in commissions and other expenses on the Consolidated Statements of Comprehensive Income (Loss) for the three months ended March 31, 2025 and 2024, respectively.

The following tables summarize the changes in VOBA (in millions):

	For the Three Months Ended March 31, 2025
	Fixed Annuities		Traditional Life		UL and Other
Balance as of beginning-of-year	$	13	$	35	$	375
Amortization	(1)		(2)		(9)
Balance as of end-of-period	$	12	$	33	$	366

	For the Three Months Ended March 31, 2024
	Fixed Annuities		Traditional Life		UL and Other
Balance as of beginning-of-year	$	15	$	42	$	413
Amortization	(1)		(2)		(10)
Balance as of end-of-period	$	14	$	40	$	403

VOBA amortization expense of $12 million and $13 million was recorded in commissions and other expenses on the Consolidated Statements of Comprehensive Income (Loss) for the three months ended March 31, 2025 and 2024, respectively. No additions or write-offs were recorded for each respective period.

The following tables summarize the changes in DSI (in millions):

	For the Three Months Ended March 31, 2025
	Variable Annuities		Fixed Annuities		UL and Other		Retirement Plan Services
Balance as of beginning-of-year	$	113	$	16	$	27	$	42
Deferrals	–		–		–		4
Amortization	(2)		–		(1)		–
Balance as of end-of-period	$	111	$	16	$	26	$	46

	For the Three Months Ended March 31, 2024
	Variable Annuities		Fixed Annuities		UL and Other		Retirement Plan Services
Balance as of beginning-of-year	$	122	$	19	$	28	$	26
Deferrals	1		–		–		8
Amortization	(3)		–		–		–
Balance as of end-of-period	$	120	$	19	$	28	$	34

DSI amortization expense of $3 million was recorded in interest credited on the Consolidated Statements of Comprehensive Income (Loss) for the three months ended March 31, 2025 and 2024.

The following tables summarize the changes in DFEL (in millions):

	For the Three Months Ended March 31, 2025				For the Three Months Ended March 31, 2024
	Variable Annuities		UL and Other		Variable Annuities		UL and Other
Balance as of beginning-of-year	$	273	$	6,406	$	278	$	5,579
Deferrals	3		279		5		267
Amortization	(6)		(98)		(6)		(68)
Balance as of end-of-period	270		6,587		277		5,778
Less: Ceded DFEL	–		237		–		258
Balance as of end-of-period, net of reinsurance	$	270	$	6,350	$	277	$	5,520

DFEL amortization of $104 million and $74 million was recorded in fee income on the Consolidated Statements of Comprehensive Income (Loss) for the three months ended March 31, 2025 and 2024, respectively.

XML

Reinsurance

3 Months Ended

Mar. 31, 2025

Reinsurance Disclosures [Abstract]

Reinsurance

Reinsurance

Fortitude Re

Effective October 1, 2023, we entered into two reinsurance agreements with Fortitude Reinsurance Company Ltd. (“Fortitude Re”), an authorized Bermuda reinsurer with reciprocal jurisdiction reinsurer status in Indiana, to reinsure certain blocks of in-force UL with secondary guarantees (“ULSG”), MoneyGuard® and fixed annuity products, including group pension annuities. Fortitude Re represents our largest reinsurance exposure as of March 31, 2025, and December 31, 2024.

The first agreement was structured as a coinsurance treaty between us and Fortitude Re for the ULSG and fixed annuities blocks. As significant insurance risk was transferred for ULSG products and life-contingent annuities, amounts recoverable from Fortitude Re were $10.6 billion as of March 31, 2025, and December 31, 2024. We reported a deferred loss on the transaction of $2.6 billion as of March 31, 2025, and December 31, 2024. We amortized $23 million and $22 million of the deferred loss during the three months ended March 31, 2025 and 2024, respectively. Annuities that are not life-contingent do not contain significant insurance risk; therefore, we reported deposit assets for these contracts of $2.8 billion and $3.0 billion as of March 31, 2025, and December 31, 2024, respectively.

The second agreement was structured as coinsurance with funds withheld for the MoneyGuard block; however, as we retained significant insurance risk under the agreement, we reported deposit assets of $8.2 billion and $8.1 billion as of March 31, 2025, and December 31, 2024, respectively. In this coinsurance with funds withheld reinsurance agreement, we as the ceding company withhold, and therefore retain, the assets backing the deposit assets. We held investments with a carrying value of $9.2 billion and $9.3 billion in support of reserves associated with the Fortitude Re transaction in a funds withheld arrangement as of March 31, 2025, and December 31, 2024, respectively, which consisted of the following (in millions):

	As of March 31,		As of December 31,
	2025		2024
Fixed maturity AFS securities	$	7,549	$	7,764
Derivative investments	19		30
Other investments	1,465		1,419
Cash and invested cash	104		28
Accrued investment income	93		96
Total	$	9,230	$	9,337

XML

MRBs

3 Months Ended

Mar. 31, 2025

Insurance [Abstract]

MRBs

MRBs

The following table reconciles market risk benefits (“MRBs”) (in millions) to MRB assets and MRB liabilities on the Consolidated Balance Sheets:

	As of March 31, 2025						As of December 31, 2024
	Assets		Liabilities		Net (Assets) Liabilities		Assets		Liabilities		Net (Assets) Liabilities
Variable Annuities	$	4,041	$	1,165	$	(2,876)	$	4,737	$	933	$	(3,804)
Fixed Annuities	73		137		64		78		110		32
Retirement Plan Services	43		4		(39)		45		3		(42)
Total MRBs	$	4,157	$	1,306	$	(2,851)	$	4,860	$	1,046	$	(3,814)

The following table summarizes the balances of and changes in net MRB (assets) liabilities (in millions):

	As of or For the Three Months Ended March 31, 2025						As of or For the Three Months Ended March 31, 2024
	Variable Annuities		Fixed Annuities		Retirement Plan Services		Variable Annuities		Fixed Annuities		Retirement Plan Services
Balance as of beginning-of-year	$	(3,804)	$	32	$	(42)	$	(2,180)	$	32	$	(30)
Less: Effect of cumulative changes in
non-performance risk	(153)		(33)		–		(1,299)		(58)		(4)
Balance as of beginning-of-year, before the effect
of changes in non-performance risk	(3,651)		65		(42)		(881)		90		(26)
Issuances	5		–		–		3		–		–
Attributed fees collected	373		8		1		380		9		2
Benefit payments	(6)		–		–		(11)		–		–
Effect of changes in interest rates	396		39		1		(1,081)		(17)		(6)
Effect of changes in equity markets	456		2		2		(1,343)		(11)		(4)
Effect of changes in equity index volatility	31		–		–		4		(2)		–
In-force updates and other changes in MRBs (1)	59		(2)		1		51		1		1
Balance as of end-of-period, before the effect of
changes in non-performance risk	(2,337)		112		(37)		(2,878)		70		(33)
Effect of cumulative changes in
non-performance risk	(539)		(48)		(2)		(726)		(43)		(2)
Balance as of end-of-period	(2,876)		64		(39)		(3,604)		27		(35)
Less: Ceded MRB assets (liabilities)	(312)		–		–		(358)		–		–
Balance as of end-of-period, net of reinsurance	$	(2,564)	$	64	$	(39)	$	(3,246)	$	27	$	(35)
Weighted-average age of policyholders (years)	73		70		63		72		69		63
Net amount at risk (2)	$	2,518	$	255	$	4	$	2,056	$	210	$	3

(1)     Consists primarily of changes in MRB assets and liabilities related to differences between separate account fund performance and modeled indices and other changes such as actual to expected policyholder behavior.

(2)     Net amount at risk (“NAR”) is the current guaranteed minimum benefit in excess of the current account balance as of the balance sheet date. For guaranteed living benefits (“GLBs”), the guaranteed minimum benefit is calculated based on the present value of GLB payments. Our variable annuity products may offer more than one type of guaranteed benefit rider to a policyholder. In instances where more than one guaranteed benefit feature exists in a contract, the guaranteed benefit rider that provides the highest NAR is used in the calculation.

See “MRBs” in Note 12 for details related to our fair value judgments, assumptions, inputs and valuation methodology.

XML

Separate Accounts

3 Months Ended

Mar. 31, 2025

Separate Accounts Disclosure [Abstract]

Separate Accounts

Separate Accounts

The following table presents the fair value of separate account assets (in millions) reported on the Consolidated Balance Sheets by major investment category:

	As of March 31,		As of December 31,
	2025		2024
Mutual funds and collective investment trusts	$	161,823	$	167,759
Exchange-traded funds	249		336
Fixed maturity AFS securities	168		161
Cash and invested cash	77		12
Other investments	189		170
Total separate account assets	$	162,506	$	168,438

The following table reconciles separate account liabilities (in millions) to the Consolidated Balance Sheets:

	As of March 31,		As of December 31,
	2025		2024
Variable Annuities	$	113,635	$	117,998
UL and Other	28,106		28,841
Retirement Plan Services	20,708		21,541
Other Operations (1)	57		58
Total separate account liabilities	$	162,506	$	168,438

(1) Represents separate account liabilities reported in Other Operations primarily attributable to the indemnity reinsurance agreements with Protective ($47 million and $49 million as of March 31, 2025, and December 31, 2024, respectively) that are excluded from the following tables.

The following table summarizes the balances of and changes in separate account liabilities (in millions):

	As of or For the Three Months Ended March 31, 2025						As of or For the Three Months Ended March 31, 2024
	Variable Annuities		UL and Other		Retirement Plan Services		Variable Annuities		UL and Other		Retirement Plan Services
Balance as of beginning-of-year	$	117,998	$	28,841	$	21,541	$	113,356	$	25,150	$	19,699
Gross deposits	1,557		353		627		904		358		570
Withdrawals	(3,915)		(204)		(902)		(3,208)		(103)		(732)
Policyholder assessments	(656)		(246)		(46)		(648)		(246)		(44)
Change in market performance	(1,798)		(624)		(478)		7,503		1,885		1,475
Net transfers from (to) general account	449		(14)		(34)		269		(37)		18
Balance as of end-of-period	$	113,635	$	28,106	$	20,708	$	118,176	$	27,007	$	20,986
Cash surrender value	$	112,239	$	23,577	$	20,695	$	116,771	$	24,606	$	20,971

XML

Policyholder Account Balances

3 Months Ended

Mar. 31, 2025

Policyholder Account Balance [Abstract]

Policyholder Account Balance

Policyholder Account Balances

The following table reconciles policyholder account balances (in millions) to the Consolidated Balance Sheets:

	As of March 31,		As of December 31,
	2025		2024
Variable Annuities	$	34,370	$	35,267
Fixed Annuities	26,039		25,963
UL and Other	36,220		36,599
Retirement Plan Services	23,479		23,619
Other (1)	5,154		4,749
Total policyholder account balances	$	125,262	$	126,197

(1) Represents policyholder account balances reported primarily in Other Operations attributable to the indemnity reinsurance agreements with Protective ($4.3 billion and $4.4 billion as of March 31, 2025, and December 31, 2024, respectively) and funding agreements, that are excluded from the following tables. See “Funding Agreements” below for more information.

The following table summarizes the balances and changes in policyholder account balances (in millions):

	As of or For the Three Months Ended March 31, 2025
	Variable Annuities		Fixed Annuities		UL and Other		Retirement Plan Services
Balance as of beginning-of-year	$	35,267	$	25,963	$	36,599	$	23,619
Gross deposits	1,369		873		865		811
Withdrawals	(612)		(947)		(445)		(1,330)
Policyholder assessments	–		(15)		(1,104)		(4)
Net transfers from (to) separate account	(287)		–		14		211
Interest credited	199		210		356		172
Change in fair value of embedded derivative
instruments and other	(1,566)		(45)		(65)		–
Balance as of end-of-period	$	34,370	$	26,039	$	36,220	$	23,479
Weighted-average crediting rate	2.3%		3.2%		3.9%		2.9%
Net amount at risk (1) (2)	$	2,518	$	255	$	299,107	$	4
Cash surrender value	33,108		24,935		32,645		23,443

	As of or For the Three Months Ended March 31, 2024
	Variable Annuities			Fixed Annuities			UL and Other			Retirement Plan Services
Balance as of beginning-of-year	$	29,141		$	25,355		$	37,180		$	23,784
Gross deposits	973			973			850			790
Withdrawals	(224)			(1,410)			(364)			(1,203)
Policyholder assessments	–			(17)			(1,124)			(3)
Net transfers from (to) separate account	(178)			–			38			50
Interest credited	158			183			365			168
Change in fair value of embedded derivative
instruments and other	1,538			78			61			–
Balance as of end-of-period	$	31,408		$	25,162		$	37,006		$	23,586
Weighted-average crediting rate	2.1		%	2.9		%	3.9		%	2.8		%
Net amount at risk (1) (2)	$	2,056		$	210		$	300,740		$	3
Cash surrender value	30,228			24,139			33,314			23,560

(1) NAR is the current guaranteed minimum benefit in excess of the current account balance as of the balance sheet date. For GLBs, the guaranteed minimum benefit is calculated based on the present value of GLB payments. Our variable annuity products may offer more than one type of guaranteed benefit rider to a policyholder. In instances where more than one guaranteed benefit rider exists in a contract, the guaranteed benefit rider that provides the highest NAR is used in the calculation.

(2) Calculation is based on total account balances and includes both policyholder account balances and separate account balances.

Funding Agreements

FABN Program

The Lincoln National Life Insurance Company (“LNL”) established a $5.0 billion funding agreement-backed notes (“FABN”) program in 2024 pursuant to which LNL may issue unsecured funding agreements to an unaffiliated and unconsolidated special purpose statutory trust (the “Trust”) that will then issue medium-term notes for which payment of interest and principal is secured by such funding agreement. Funding agreements issued to the Trust are reported in policyholder account balances on the Consolidated Balance Sheets, and the associated interest is reported within interest credited on the Consolidated Statements of Comprehensive Income (Loss). We had funding agreements issued under the program of $500 million as of March 31, 2025, compared to none as of December 31, 2024.

The following table presents policyholder account balances (in millions) by range of guaranteed minimum crediting rates and the related range of difference, in basis points, between the interest being credited to policyholders and the respective guaranteed contract minimums:

	As of March 31, 2025
	At Guaranteed Minimum		1-50 Basis Points Above		51-100 Basis Points Above		101-150 Basis Points Above		Greater Than 150 Basis Points Above		Total
Range of Guaranteed
Minimum Crediting Rate
Variable Annuities
Up to 1.00%	$	9	$	–	$	–	$	–	$	–	$	9
1.01% - 2.00%	3		–		–		–		7		10
2.01% - 3.00%	495		–		–		–		–		495
3.01% - 4.00%	1,197		–		–		–		–		1,197
4.01% and above	7		–		–		–		–		7
Other (1)	–		–		–		–		–		32,652
Total	$	1,711	$	–	$	–	$	–	$	7	$	34,370
Fixed Annuities
Up to 1.00%	$	201	$	855	$	459	$	229	$	2,266	$	4,010
1.01% - 2.00%	223		202		146		161		5,908		6,640
2.01% - 3.00%	1,499		33		1		2		38		1,573
3.01% - 4.00%	930		–		–		–		–		930
4.01% and above	166		–		–		–		–		166
Other (1)	–		–		–		–		–		12,720
Total	$	3,019	$	1,090	$	606	$	392	$	8,212	$	26,039
UL and Other
Up to 1.00%	$	261	$	–	$	231	$	31	$	453	$	976
1.01% - 2.00%	541		–		–		–		2,976		3,517
2.01% - 3.00%	6,483		9		152		–		–		6,644
3.01% - 4.00%	14,972		–		1		–		–		14,973
4.01% and above	3,525		–		–		–		–		3,525
Other (1)	–		–		–		–		–		6,585
Total	$	25,782	$	9	$	384	$	31	$	3,429	$	36,220
Retirement Plan Services
Up to 1.00%	$	573	$	312	$	725	$	3,498	$	5,766	$	10,874
1.01% - 2.00%	477		996		1,847		451		662		4,433
2.01% - 3.00%	1,680		542		48		18		1		2,289
3.01% - 4.00%	4,194		107		8		11		–		4,320
4.01% and above	1,426		137		–		–		–		1,563
Total	$	8,350	$	2,094	$	2,628	$	3,978	$	6,429	$	23,479

	As of March 31, 2024
	At Guaranteed Minimum		1-50 Basis Points Above		51-100 Basis Points Above		101-150 Basis Points Above		Greater Than 150 Basis Points Above		Total
Range of Guaranteed
Minimum Crediting Rate
Variable Annuities
Up to 1.00%	$	–	$	–	$	–	$	–	$	–	$	–
1.01% - 2.00%	5		–		–		–		6		11
2.01% - 3.00%	560		–		–		–		–		560
3.01% - 4.00%	1,319		–		–		–		–		1,319
4.01% and above	9		–		–		–		–		9
Other (1)	–		–		–		–		–		29,509
Total	$	1,893	$	–	$	–	$	–	$	6	$	31,408
Fixed Annuities
Up to 1.00%	$	679	$	605	$	560	$	493	$	2,466	$	4,803
1.01% - 2.00%	360		99		285		500		3,231		4,475
2.01% - 3.00%	1,749		39		5		1		25		1,819
3.01% - 4.00%	916		–		–		–		–		916
4.01% and above	177		–		–		–		–		177
Other (1)	–		–		–		–		–		12,972
Total	$	3,881	$	743	$	850	$	994	$	5,722	$	25,162
UL and Other
Up to 1.00%	$	264	$	–	$	219	$	119	$	30	$	632
1.01% - 2.00%	548		–		–		–		3,208		3,756
2.01% - 3.00%	6,848		10		149		–		–		7,007
3.01% - 4.00%	15,596		–		1		–		–		15,597
4.01% and above	3,722		–		–		–		–		3,722
Other (1)	–		–		–		–		–		6,292
Total	$	26,978	$	10	$	369	$	119	$	3,238	$	37,006
Retirement Plan Services
Up to 1.00%	$	437	$	500	$	740	$	3,706	$	4,320	$	9,703
1.01% - 2.00%	527		1,660		1,413		1,345		14		4,959
2.01% - 3.00%	2,342		21		63		17		1		2,444
3.01% - 4.00%	4,842		31		3		3		–		4,879
4.01% and above	1,458		143		–		–		–		1,601
Total	$	9,606	$	2,355	$	2,219	$	5,071	$	4,335	$	23,586

(1) Consists of indexed account balances that include the fair value of embedded derivative instruments, non-life contingent payout annuity account balances, short-term dollar cost averaging annuities business and policy loans.

XML

Future Contract Benefits

3 Months Ended

Mar. 31, 2025

Liability for Future Policy Benefits and Unpaid Claims and Claims Adjustment Expense [Abstract]

Future Contract Benefits

Future Contract Benefits

The following table reconciles future contract benefits (in millions) to the Consolidated Balance Sheets:

	As of March 31,		As of December 31,
	2025		2024
Payout Annuities (1)	$	2,033	$	2,009
Traditional Life (1)	3,821		3,774
Group Protection (2)	5,712		5,628
UL and Other (3)	16,702		16,062
Other Operations (4)	9,062		9,070
Other (5)	3,335		3,264
Total future contract benefits	$	40,665	$	39,807

(1) See “Liability for Future Policy Benefits” below for further information.

(2) See “Liability for Future Claims” below for further information.

(3) See “Additional Liabilities for Other Insurance Benefits” below for further information.

(4) Represents future contract benefits reported in Other Operations primarily attributable to the indemnity reinsurance agreements with Protective ($5.4 billion as of March 31, 2025, and December 31, 2024) and Swiss Re ($1.8 billion as of March 31, 2025, and December 31, 2024) that are excluded from the following tables.

(5) Represents other miscellaneous reserves that are not representative of long-duration contracts and are excluded from the following tables.

Liability for Future Policy Benefits

The following table summarizes the balances of and changes in the present values of expected net premiums and liability for future policy benefits (“LFPB”) (in millions, except years):

	As of or For the Three Months Ended March 31, 2025				As of or For the Three Months Ended March 31, 2024
	Payout Annuities		Traditional Life		Payout Annuities		Traditional Life
Present Value of Expected Net Premiums
Balance as of beginning-of-year	$	–	$	5,873	$	–	$	6,200
Less: Effect of cumulative changes in discount
rate assumptions	–		(275)		–		(148)
Beginning balance at original discount rate	–		6,148		–		6,348
Effect of actual variances from expected experience	–		(48)		–		2
Adjusted balance as of beginning-of-year	–		6,100		–		6,350
Issuances	–		64		–		108
Interest accrual	–		62		–		63
Net premiums collected	–		(192)		–		(202)
Flooring impact of LFPB	–		(5)		–		3
Ending balance at original discount rate	–		6,029		–		6,322
Effect of cumulative changes in discount
rate assumptions	–		(196)		–		(254)
Balance as of end-of-period	$	–	$	5,833	$	–	$	6,068
Present Value of Expected LFPB
Balance as of beginning-of-year	$	2,009	$	9,647	$	2,085	$	10,041
Less: Effect of cumulative changes in discount
rate assumptions	(251)		(438)		(187)		(189)
Beginning balance at original discount rate (1)	2,260		10,085		2,272		10,230
Effect of actual variances from expected experience	(1)		(55)		1		7
Adjusted balance as of beginning-of-year	2,259		10,030		2,273		10,237
Issuances	22		64		15		108
Interest accrual	22		99		22		100
Benefit payments	(49)		(234)		(49)		(206)
Ending balance at original discount rate (1)	2,254		9,959		2,261		10,239
Effect of cumulative changes in discount
rate assumptions	(221)		(305)		(227)		(378)
Balance as of end-of-period	$	2,033	$	9,654	$	2,034	$	9,861
Net balance as of end-of-period	$	2,033	$	3,821	$	2,034	$	3,793
Less: Reinsurance recoverables	1,478		360		1,562		421
Net balance as of end-of-period, net of reinsurance	$	555	$	3,461	$	472	$	3,372
Weighted-average duration of future policyholder
benefit liability (years)	9		9		9		9

(1) Includes deferred profit liability within Payout Annuities of $65 million and $60 million as of March 31, 2025 and 2024, respectively.

For the three months ended March 31, 2025 and 2024, Payout Annuities and Traditional Life did not have any significantly different actual experience compared to expected.

The following table summarizes the discounted and undiscounted expected future gross premiums and expected future benefit payments (in millions):

	As of March 31, 2025				As of March 31, 2024
	Undiscounted		Discounted		Undiscounted		Discounted
Payout Annuities
Expected future gross premiums	$	–	$	–	$	–	$	–
Expected future benefit payments	3,408		2,033		3,438		2,034
Traditional Life
Expected future gross premiums	13,807		9,447		13,896		9,570
Expected future benefit payments	14,129		9,654		14,582		9,861

The following table summarizes the gross premiums and interest accretion (in millions) recognized in insurance premiums and benefits, respectively, on the Consolidated Statements of Comprehensive Income (Loss):

	For the Three Months Ended March 31,
	2025		2024
Payout Annuities
Gross premiums	$	23	$	21
Interest accretion	22		22
Traditional Life
Gross premiums	314		314
Interest accretion	37		37

The following table summarizes the weighted-average interest rates:

	For the Three Months Ended March 31,
	2025		2024
Payout Annuities
Interest accretion rate	4.0	%	3.9	%
Current discount rate	5.2	%	5.2	%
Traditional Life
Interest accretion rate	5.0	%	5.0	%
Current discount rate	4.9	%	5.0	%

Liability for Future Claims

The following table summarizes the balances of and changes in liability for future claims (in millions, except years):

	Group Protection
	As of or For the Three Months Ended March 31,
	2025		2024
Balance as of beginning-of-year	$	5,628	$	5,689
Less: Effect of cumulative changes in discount
rate assumptions	(550)		(490)
Beginning balance at original discount rate	6,178		6,179
Effect of actual variances from expected experience	(72)		(67)
Adjusted beginning-of-year balance	6,106		6,112
New incidence	402		408
Interest	50		48
Benefit payments	(371)		(382)
Ending balance at original discount rate	6,187		6,186
Effect of cumulative changes in discount
rate assumptions	(475)		(546)
Balance as of end-of-period	5,712		5,640
Less: Reinsurance recoverables	121		123
Balance as of end-of-period, net of reinsurance	$	5,591	$	5,517
Weighted-average duration of liability for future
claims (years)	5		5

For the three months ended March 31, 2025, we experienced more favorable reported incidence and claim terminations than assumed.

For the three months ended March 31, 2024, we experienced more favorable claim terminations than assumed.

The following table summarizes the discounted and undiscounted expected future benefit payments (in millions):

	As of March 31, 2025				As of March 31, 2024
	Undiscounted		Discounted		Undiscounted		Discounted
Group Protection
Expected future benefit payments	$	7,413	$	5,712	$	7,296	$	5,640

The following table summarizes the gross premiums and interest accretion (in millions) recognized in insurance premiums and benefits, respectively, on the Consolidated Statements of Comprehensive Income (Loss):

	For the Three Months Ended March 31,
	2025		2024
Group Protection
Gross premiums	$	933	$	896
Interest accretion	50		48

The following table summarizes the weighted-average interest rates:

	For the Three Months Ended March 31,
	2025		2024
Group Protection
Interest accretion rate	3.4	%	3.2	%
Current discount rate	4.9	%	5.0	%

Additional Liabilities for Other Insurance Benefits

The following table summarizes the balances of and changes in additional liabilities for other insurance benefits (in millions, except years):

	UL and Other
	As of or For the Three Months Ended March 31,
	2025		2024
Balance as of beginning-of-year	$	16,062	$	15,000
Less: Effect of cumulative changes in shadow
balance in AOCI	(2,673)		(2,222)
Balance as of beginning-of-year, excluding
shadow balance in AOCI	18,735		17,222
Effect of actual variances from expected experience	23		106
Adjusted beginning-of-year balance	18,758		17,328
Interest accrual	228		209
Net assessments collected	293		303
Benefit payments	(200)		(313)
Balance as of end-of-period, excluding shadow
balance in AOCI	19,079		17,527
Effect of cumulative changes in shadow
balance in AOCI	(2,377)		(3,083)
Balance as of end-of-period	16,702		14,444
Less: Reinsurance recoverables	5,316		4,776
Balance as of end-of-period, net of reinsurance	$	11,386	$	9,668
Weighted-average duration of additional liabilities
for other insurance benefits (years)	16		17

For the three months ended March 31, 2025, we did not have any significantly different actual experience compared to expected.

For the three months ended March 31, 2024, we had unfavorable actual mortality experience compared to expected on reinsured and retained business.

The following table summarizes the gross assessments and interest accretion (in millions) recognized in insurance premiums and benefits, respectively, on the Consolidated Statements of Comprehensive Income (Loss):

	For the Three Months Ended March 31,
	2025		2024
UL and Other
Gross assessments	$	700	$	766
Interest accretion	228		209

The following table summarizes the weighted-average interest rates:

	For the Three Months Ended March 31,
	2025		2024
UL and Other
Interest accretion rate	5.4	%	5.3	%

XML

Fair Value of Financial Instruments

3 Months Ended

Mar. 31, 2025

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

Fair Value of Financial Instruments

Financial Instruments Carried at Fair Value

The following summarizes our financial instruments carried at fair value (in millions) on a recurring basis by the fair value hierarchy levels:

	As of March 31, 2025
	Quoted
	Prices
	in Active
	Markets for		Significant		Significant
	Identical		Observable		Unobservable		Total
	Assets		Inputs		Inputs		Fair
	(Level 1)		(Level 2)		(Level 3)		Value
Assets
Investments:
Fixed maturity AFS securities:
Corporate bonds	$	–	$	63,911	$	2,974	$	66,885
U.S. government bonds	518		20		–		538
State and municipal bonds	–		2,350		–		2,350
Foreign government bonds	–		239		–		239
RMBS	–		1,922		19		1,941
CMBS	–		1,800		30		1,830
ABS	–		11,610		2,631		14,241
Hybrid and redeemable preferred securities	47		145		81		273
Trading securities	–		1,697		287		1,984
Equity securities	–		310		35		345
Mortgage loans on real estate	–		–		232		232
Derivative investments (1)	–		11,238		10		11,248
Other investments – short-term investments	–		468		15		483
MRB assets	–		–		4,157		4,157
Other assets:
Ceded MRBs	–		–		2		2
Indexed annuity ceded embedded derivatives	–		–		1,092		1,092
Separate account assets	373		162,133		–		162,506
Total assets	$	938	$	257,843	$	11,565	$	270,346
Liabilities
Policyholder account balances – RILA, fixed annuity
and IUL contracts	$	–	$	–	$	(10,807)	$	(10,807)
Funds withheld reinsurance liabilities – reinsurance-related
embedded derivatives	–		185		(323)		(138)
MRB liabilities	–		–		(1,306)		(1,306)
Other liabilities:
Ceded MRBs	–		–		(314)		(314)
Derivative liabilities (1)	–		(3,377)		(119)		(3,496)
Total liabilities	$	–	$	(3,192)	$	(12,869)	$	(16,061)

	As of December 31, 2024
	Quoted
	Prices
	in Active
	Markets for		Significant		Significant
	Identical		Observable		Unobservable		Total
	Assets		Inputs		Inputs		Fair
	(Level 1)		(Level 2)		(Level 3)		Value
Assets
Investments:
Fixed maturity AFS securities:
Corporate bonds	$	–	$	63,585	$	2,865	$	66,450
U.S. government bonds	371		20		–		391
State and municipal bonds	–		2,371		–		2,371
Foreign government bonds	–		237		–		237
RMBS	–		1,851		12		1,863
CMBS	–		1,657		8		1,665
ABS	–		11,781		2,099		13,880
Hybrid and redeemable preferred securities	48		133		73		254
Trading securities	–		1,760		265		2,025
Equity securities	–		260		34		294
Mortgage loans on real estate	–		–		232		232
Derivative investments (1)	–		13,884		3		13,887
Other investments – short-term investments	–		369		23		392
MRB assets	–		–		4,860		4,860
Other assets:
Ceded MRBs	–		–		2		2
Indexed annuity ceded embedded derivatives	–		–		1,115		1,115
Separate account assets	391		168,047		–		168,438
Total assets	$	810	$	265,955	$	11,591	$	278,356
Liabilities
Policyholder account balances – RILA, fixed annuity
and IUL contracts	$	–	$	–	$	(12,449)	$	(12,449)
Funds withheld reinsurance liabilities – reinsurance-related
embedded derivatives	–		204		(234)		(30)
MRB liabilities	–		–		(1,046)		(1,046)
Other liabilities:
Ceded MRBs	–		–		(381)		(381)
Derivative liabilities (1)	–		(4,256)		(139)		(4,395)
Total liabilities	$	–	$	(4,052)	$	(14,249)	$	(18,301)

(1) Derivative investment assets and liabilities are presented within the fair value hierarchy on a gross basis by derivative type and not on a master netting basis by counterparty.

The following summarizes changes to our financial instruments carried at fair value (in millions) and classified within Level 3 of the fair value hierarchy. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology. The summary schedule excludes changes to MRB assets and MRB liabilities as these balances are rolled forward in Note 8.

	For the Three Months Ended March 31, 2025
					Gains		Issuances,		Transfers
			Items		(Losses)		Sales,		Into or
			Included		in		Maturities,		Out
	Beginning		in		OCI		Settlements,		of		Ending
	Fair		Net		and		Calls,		Level 3,		Fair
	Value		Income		Other (1)		Net		Net		Value
Assets
Investments: (2)
Fixed maturity AFS securities:
Corporate bonds	$	2,865	$	(13)	$	1	$	99	$	22	$	2,974
RMBS	12		–		–		7		–		19
CMBS	8		–		–		22		–		30
ABS	2,099		(21)		18		478		57		2,631
Hybrid and redeemable preferred
securities	73		–		–		18		(10)		81
Trading securities	265		1		–		4		17		287
Equity securities	34		(6)		–		7		–		35
Mortgage loans on real estate	232		(1)		2		(1)		–		232
Other investments	23		–		–		(8)		–		15
Other assets:
Ceded MRBs (3)	2		–		–		–		–		2
Indexed annuity ceded embedded
derivatives (4)	1,115		(24)		–		1		–		1,092
Liabilities
Policyholder account balances –
RILA, fixed annuity and
IUL contracts (4)	(12,449)		1,676		–		(34)		–		(10,807)
Funds withheld reinsurance
liabilities – reinsurance-related
embedded derivatives (4)	(234)		(89)		–		–		–		(323)
Other liabilities:
Ceded MRBs (3)	(381)		67		–		–		–		(314)
Derivative liabilities	(136)		27		–		–		–		(109)
Total, net	$	(6,472)	$	1,617	$	21	$	593	$	86	$	(4,155)

	For the Three Months Ended March 31, 2024
					Gains		Issuances,		Transfers
			Items		(Losses)		Sales,		Into or
			Included		in		Maturities,		Out
	Beginning		in		OCI		Settlements,		of		Ending
	Fair		Net		and		Calls,		Level 3,		Fair
	Value		Income		Other (1)		Net		Net		Value
Assets
Investments: (2)
Fixed maturity AFS securities:
Corporate bonds	$	2,497	$	2	$	(10)	$	22	$	(22)	$	2,489
State and municipal bonds	5		–		–		–		(5)		–
RMBS	13		–		(1)		–		–		12
CMBS	8		–		–		–		–		8
ABS	1,484		–		(1)		201		8		1,692
Hybrid and redeemable preferred
securities	48		–		3		–		–		51
Trading securities	284		–		–		(13)		–		271
Equity securities	42		(3)		–		–		–		39
Mortgage loans on real estate	288		–		1		–		–		289
Derivative investments	36		12		–		4		(51)		1
Other assets:
Ceded MRBs (3)	2		–		–		–		–		2
Indexed annuity ceded embedded
derivatives (4)	940		33		–		–		–		973
Liabilities
Policyholder account balances –
RILA, fixed annuity and
IUL contracts (4)	(9,077)		(1,677)		–		(142)		–		(10,896)
Funds withheld reinsurance
liabilities – reinsurance-related
embedded derivatives (4)	(789)		206		–		–		–		(583)
Other liabilities – ceded MRBs (3)	(239)		(121)		–		–		–		(360)
Total, net	$	(4,458)	$	(1,548)	$	(8)	$	72	$	(70)	$	(6,012)

(1) The changes in fair value of the interest rate swaps are offset by an adjustment to derivative investments (see Note 5).

(2) Amortization and accretion of premiums and discounts are included in net investment income on the Consolidated Statements of Comprehensive Income (Loss). Gains (losses) from sales, maturities, settlements and calls and credit loss expense are included in realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss).

(3) Gains (losses) from the changes in fair value are included in market risk benefit gain (loss) on the Consolidated Statements of Comprehensive Income (Loss).

(4) Gains (losses) from the changes in fair value are included in realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss).

The following provides the components of the items included in issuances, sales, maturities, settlements and calls, net, (in millions) as reported above:

	For the Three Months Ended March 31, 2025
	Issuances		Sales		Maturities		Settlements		Calls		Total
Investments:
Fixed maturity AFS securities:
Corporate bonds	$	246	$	(45)	$	–	$	(102)	$	–	$	99
RMBS	7		–		–		–		–		7
CMBS	22		–		–		–		–		22
ABS	594		–		(10)		(90)		(16)		478
Hybrid and redeemable preferred
securities	20		(2)		–		–		–		18
Trading securities	50		(42)		–		(4)		–		4
Equity securities	8		(1)		–		–		–		7
Mortgage loans on real estate	–		(1)		–		–		–		(1)
Other investments	2		–		(10)		–		–		(8)
Other assets – indexed annuity ceded
embedded derivatives	27		–		–		(26)		–		1
Policyholder account balances –
RILA, fixed annuity and
IUL contracts	(234)		–		–		200		–		(34)
Total, net	$	742	$	(91)	$	(20)	$	(22)	$	(16)	$	593

	For the Three Months Ended March 31, 2024
	Issuances		Sales		Maturities		Settlements		Calls		Total
Investments:
Fixed maturity AFS securities:
Corporate bonds	$	277	$	(141)	$	(2)	$	(111)	$	(1)	$	22
ABS	264		–		–		(63)		–		201
Trading securities	–		(2)		–		(11)		–		(13)
Mortgage loans on real estate	1		(1)		–		–		–		–
Derivative investments	7		–		(3)		–		–		4
Other assets – indexed annuity ceded
embedded derivatives	26		–		–		(26)		–		–
Policyholder account balances –
RILA, fixed annuity and
IUL contracts	(249)		–		–		107		–		(142)
Total, net	$	326	$	(144)	$	(5)	$	(104)	$	(1)	$	72

The following summarizes changes in unrealized gains (losses) included in net income related to financial instruments carried at fair value classified within Level 3 that we still held (in millions):

	For the Three Months Ended March 31,
	2025		2024
Investments:
Trading securities (1)	$	(3)	$	–
Equity securities (1)	(6)		(3)
Mortgage loans on real estate (1)	(1)		–
Derivative investments (1)	12		16
MRBs (2)	(1,299)		1,896
Funds withheld reinsurance liabilities –
reinsurance-related embedded derivatives (1)	(89)		206
Embedded derivatives – indexed annuity
and IUL contracts (1)	169		241
Total, net	$	(1,217)	$	2,356

(1) Included in realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss).

(2) Included in market risk benefit gain (loss) on the Consolidated Statements of Comprehensive Income (Loss).

The following summarizes changes in unrealized gains (losses) included in OCI, net of tax, related to financial instruments carried at fair value classified within Level 3 that we still held (in millions):

	For the Three Months Ended March 31,
	2025		2024
Investments:
Fixed maturity AFS securities:
Corporate bonds	$	(7)	$	(11)
ABS	16		(1)
Hybrid and redeemable preferred
securities	–		2
Mortgage loans on real estate	2		1
Total, net	$	11	$	(9)

The following provides the components of the transfers into and out of Level 3 (in millions) as reported above:

	For the Three Months Ended March 31, 2025						For the Three Months Ended March 31, 2024
	Transfers		Transfers				Transfers		Transfers
	Into		Out of				Into		Out of
	Level 3		Level 3		Total		Level 3		Level 3		Total
Investments:
Fixed maturity AFS securities:
Corporate bonds	$	22	$	–	$	22	$	22	$	(44)	$	(22)
State and municipal bonds	–		–		–		–		(5)		(5)
ABS	57		–		57		31		(23)		8
Hybrid and redeemable preferred
securities	–		(10)		(10)		–		–		–
Trading securities	17		–		17		–		–		–
Derivative investments	–		–		–		–		(51)		(51)
Total, net	$	96	$	(10)	$	86	$	53	$	(123)	$	(70)

Transfers into and out of Level 3 are generally the result of observable market information on financial instruments no longer being available or becoming available to our pricing vendors. For the three months ended March 31, 2025 and 2024, transfers in and out of Level 3 were attributable primarily to the financial instruments’ observable market information no longer being available or becoming available.

The following summarizes the fair value (in millions), valuation techniques and significant unobservable inputs of the Level 3 fair value measurements as of March 31, 2025:

										Weighted
										Average
	Fair		Valuation	Significant	Assumption or					Input
	Value		Technique	Unobservable Inputs	Input Ranges					Range (1)
Assets
Investments:
Fixed maturity AFS
securities:
Corporate bonds	$	190	Discounted cash flow	Liquidity/duration adjustment (2)	0.0	%	–	4.3	%	1.9	%
ABS	10		Discounted cash flow	Liquidity/duration adjustment (2)	1.4	%	–	1.4	%	1.4	%
CMBS	8		Discounted cash flow	Liquidity/duration adjustment (2)	2.0	%	—	2.0	%	2.0	%
Hybrid and redeemable
preferred securities	39		Discounted cash flow	Liquidity/duration adjustment (2)	1.2	%	–	2.1	%	1.8	%
Equity securities	5		Discounted cash flow	Liquidity/duration adjustment (2)	4.5	%	–	4.5	%	4.5	%
MRB assets	4,157		Discounted cash flow	Lapse (3)	1.0	%	—	30.0	%	(10)
				Utilization of GLB withdrawals (4)	85.0	%	—	100.0	%	92.0	%
				Claims utilization factor (5)	60.0	%	—	100.0	%	(10)
				Premiums utilization factor (5)	80.0	%	—	115.0	%	(10)
				Non-performance risk (6)	0.3	%	—	2.2	%	1.8	%
				Mortality (7)				(9)		(10)
				Volatility (8)	1.0	%	—	29.0	%	14.3	%
Other assets:
Ceded MRBs (11)	2
Indexed annuity
ceded embedded
derivatives	1,092		Discounted cash flow	Lapse (3)	0.0	%	–	9.0	%	(10)
				Mortality (7)				(9)		(10)
Liabilities
Policyholder account
balances – indexed annuity
contracts embedded
derivatives	$	(10,860)	Discounted cash flow	Lapse (3)	0.0	%	–	9.0	%	(10)
				Mortality (7)				(9)		(10)
MRB liabilities	(1,306)		Discounted cash flow	Lapse (3)	1.0	%	—	30.0	%	(10)
				Utilization of GLB withdrawals (4)	85.0	%	—	100.0	%	92.0	%
				Claims utilization factor (5)	60.0	%	—	100.0	%	(10)
				Premiums utilization factor (5)	80.0	%	—	115.0	%	(10)
				Non-performance risk (6)	0.3	%	—	2.2	%	1.8	%
				Mortality (7)				(9)		(10)
				Volatility (8)	1.0	%	—	29.0	%	14.3	%
Other liabilities – ceded
MRBs (11)	(314)

The following summarizes the fair value (in millions), valuation techniques and significant unobservable inputs of the Level 3 fair value measurements as of December 31, 2024:

										Weighted
										Average
	Fair		Valuation	Significant	Assumption or					Input
	Value		Technique	Unobservable Inputs	Input Ranges					Range (1)
Assets
Investments:
Fixed maturity AFS
securities:
Corporate bonds	$	187	Discounted cash flow	Liquidity/duration adjustment (2)	0.0	%	–	3.1	%	1.7	%
ABS	10		Discounted cash flow	Liquidity/duration adjustment (2)	1.3	%	–	1.3	%	1.3	%
CMBS	8		Discounted cash flow	Liquidity/duration adjustment (2)	1.9	%	–	1.9	%	1.9	%
Hybrid and redeemable
preferred securities	19		Discounted cash flow	Liquidity/duration adjustment (2)	1.4	%	–	1.9	%	1.8	%
Equity securities	5		Discounted cash flow	Liquidity/duration adjustment (2)	4.5	%	–	4.5	%	4.5	%
MRB assets	4,860		Discounted cash flow	Lapse (3)	1.0	%	—	30.0	%	(10)
				Utilization of GLB withdrawals (4)	85.0	%	–	100.0	%	92.0	%
				Claims utilization factor (5)	60.0	%	–	100.0	%	(10)
				Premiums utilization factor (5)	80.0	%	–	115.0	%	(10)
				Non-performance risk (6)	0.3	%	–	2.0	%	1.6	%
				Mortality (7)				(9)		(10)
				Volatility (8)	1.0	%	–	29.0	%	14.5	%
Other assets:
Ceded MRBs (11)	2
Indexed annuity
ceded embedded
derivatives	1,115		Discounted cash flow	Lapse (3)	0.0	%	—	9.0	%	(10)
				Mortality (7)				(9)		(10)
Liabilities
Policyholder account
balances – indexed annuity
contracts embedded
derivatives	$	(12,402)	Discounted cash flow	Lapse (3)	0.0	%	–	9.0	%	(10)
				Mortality (7)				(9)		(10)
MRB liabilities	(1,046)		Discounted cash flow	Lapse (3)	1.0	%	–	30.0	%	(10)
				Utilization of GLB withdrawals (4)	85.0	%	–	100.0	%	92.0	%
				Claims utilization factor (5)	60.0	%	–	100.0	%	(10)
				Premiums utilization factor (5)	80.0	%	–	115.0	%	(10)
				Non-performance risk (6)	0.3	%	—	2.0	%	1.6	%
				Mortality (7)				(9)		(10)
				Volatility (8)	1.0	%	–	29.0	%	14.5	%
Other liabilities – ceded
MRBs (11)	(381)

(1) Unobservable inputs were weighted by the relative fair value of the instruments, unless otherwise noted.

(2) The liquidity/duration adjustment input represents an estimated market participant composite of adjustments attributable to liquidity premiums, expected durations, structures and credit quality that would be applied to the market observable information of an investment.

(3) The lapse input represents the estimated probability of a contract surrendering during a year, and thereby forgoing any future benefits. The range for indexed annuity contracts represents the lapses during the surrender charge period.

(4) The utilization of GLB withdrawals input represents the estimated percentage of policyholders that utilize the GLB withdrawal riders.

(5) The utilization factors are applied to the present value of claims or premiums, as appropriate, in the MRB calculation to estimate the impact of inefficient GLB withdrawal behavior, including taking less than or more than the maximum GLB withdrawal.

(6) The non-performance risk input represents the estimated additional credit spread that market participants would apply to the market observable discount rate when pricing a contract. The non-performance risk input was weighted by the absolute value of the sensitivity of the reserve to the non-performance risk assumption.

(7) The mortality input represents the estimated probability of when an individual belonging to a particular group, categorized according to age or some other factor such as gender, will die.

(8) The volatility input represents overall volatilities assumed for the underlying variable annuity funds, which include a mixture of equity and fixed-income assets. Volatility assumptions vary by fund due to the benchmarking of different indices. The volatility input was weighted by the relative account balance assigned to each index.

(9) The mortality is based on a combination of company and industry experience, adjusted for improvement factors.

(10) A weighted average input range is not a meaningful measurement for lapse, utilization factors or mortality.

(11) The fair value inputs for ceded MRBs are consistent with those used to value MRB assets and liabilities.

From the table above, we have excluded Level 3 fair value measurements obtained from independent, third-party pricing sources. We do not develop the significant inputs used to measure the fair value of these assets and liabilities, and the information regarding the significant inputs is not readily available to us. Independent broker-quoted fair values are non-binding quotes developed by market makers or broker-dealers obtained from third-party sources recognized as market participants. The fair value of a broker-quoted asset or liability is based solely on the receipt of an updated quote from a single market maker or a broker-dealer recognized as a market participant as we do not adjust broker quotes when used as the fair value measurement for an asset or liability. Significant increases or decreases in any of the quotes received from a third-party broker-dealer may result in a significantly higher or lower fair value measurement.

The embedded derivative liability associated with Fortitude Re was excluded from the above table. As discussed in Note 7, this embedded derivative liability was created through a coinsurance with funds withheld reinsurance agreement where the investments supporting the reinsurance agreement were withheld by and continue to be reported on the Consolidated Balance Sheets. This reinsurance-related embedded derivative is valued as a total return swap with reference to the fair value of the investments held by us. Accordingly, the unobservable inputs utilized in the valuation of the reinsurance-related embedded derivative are a component of the investments supporting the reinsurance agreement that are reported on the Consolidated Balance Sheets.

Changes in any of the significant inputs presented in the table above would have resulted in a significant change in the fair value measurement of the asset or liability as follows:

•Investments – An increase in the liquidity/duration adjustment input would have resulted in a decrease in the fair value measurement.

•Indexed annuity contracts embedded derivatives – For direct embedded derivatives, an increase in the lapse or mortality inputs would have resulted in a decrease in the fair value measurement.

•MRBs – Assuming our MRBs are in a liability position: an increase in our lapse, non-performance risk or mortality inputs would have resulted in a decrease in the fair value measurement, except for policies with guaranteed death benefit (“GDB”) riders only, in which case an increase in mortality inputs would have resulted in an increase in the fair value measurement.

For each category discussed above, the unobservable inputs are not inter-related; therefore, a directional change in one input would not have affected the other inputs.

As part of our ongoing valuation process, we assess the reasonableness of our valuation techniques or models and make adjustments as necessary.

Fair Value Option

Mortgage loans on real estate, net of allowance for credit losses, as reported on the Consolidated Balance Sheets, includes mortgage loans on real estate for which the fair value option was elected. The fair value option allows us to elect fair value as an alternative measurement for mortgage loans not otherwise reported at fair value. We have made these elections for certain mortgage loans associated with modified coinsurance agreements to help mitigate the inconsistency in earnings that would otherwise result from the use of embedded derivatives included with these loans. Changes in fair value are reflected in realized gain (loss) on the Consolidated Statement of Comprehensive Income (Loss). Changes in fair value due to instrument-specific credit risk are estimated using changes in credit spreads and quality ratings for the period reported. Mortgage loans on real estate for which the fair value option was elected are valued using third-party pricing services. We have procedures in place to review the valuations each quarter to ensure they are reasonable, including utilizing a separate third party to reperform the valuation for a selection of mortgage loans on an annual basis. Due to lack of observable inputs, mortgage loans electing the fair value option are classified as Level 3 within the fair value hierarchy.

The fair value and aggregate contractual principal for mortgage loans on real estate where the fair value option was elected (in millions) were as follows:

	As of March 31,		As of December 31,
	2025		2024
Fair value	$	232	$	232
Aggregate contractual principal	263		263

For information on current and past due composition and accruing status for loans where we have elected the fair value option, see Note 3.

Financial Instruments Not Carried at Fair Value

The following summarizes the fair value by the fair value hierarchy levels and the carrying amount of our financial instruments not carried at fair value (in millions):

	As of March 31, 2025
	Quoted
	Prices
	in Active
	Markets for		Significant		Significant
	Identical		Observable		Unobservable		Total
	Assets		Inputs		Inputs		Fair		Carrying
	(Level 1)		(Level 2)		(Level 3)		Value		Amount
Assets
Investments:
Mortgage loans on real estate	$	–	$	20,373	$	–	$	20,373	$	21,326
Other investments	–		513		5,657		6,170		6,170
Policy loans	–		2,529		–		2,529		2,529
Cash and invested cash	–		4,284		–		4,284		4,284
Liabilities
Policyholder account balances – certain investment
contracts and other liabilities	$	–	$	–	$	(30,876)	$	(30,876)	$	(41,005)
Policyholder account balances – funding agreements	–		(508)		–		(508)		(500)
Long-term debt	–		(5,356)		–		(5,356)		(5,868)
Funds withheld reinsurance-related liabilities – excluding
embedded derivatives	–		–		(16,700)		(16,700)		(16,700)

	As of December 31, 2024
	Quoted
	Prices
	in Active
	Markets for		Significant		Significant
	Identical		Observable		Unobservable		Total
	Assets		Inputs		Inputs		Fair		Carrying
	(Level 1)		(Level 2)		(Level 3)		Value		Amount
Assets
Investments:
Mortgage loans on real estate	$	–	$	19,647	$	–	$	19,647	$	21,083
Other investments	–		1,119		5,469		6,588		6,588
Policy loans	–		2,476		–		2,476		2,476
Cash and invested cash	–		5,801		–		5,801		5,801
Liabilities
Policyholder account balances – certain investment
contracts and other liabilities	$	–	$	–	$	(30,505)	$	(30,505)	$	(40,394)
Short-term debt	–		(299)		–		(299)		(300)
Long-term debt	–		(5,304)		–		(5,304)		(5,856)
Funds withheld reinsurance-related liabilities – excluding
embedded derivatives	–		–		(16,877)		(16,877)		(16,877)

The following discussion outlines the methodologies and assumptions used to determine the fair value of our financial instruments not carried at fair value on the Consolidated Balance Sheets. Considerable judgment is required to develop these assumptions used to measure fair value. Accordingly, the estimates shown above are not necessarily indicative of the amounts that would be realized in a one-time, current market exchange of all of our financial instruments.

Mortgage Loans on Real Estate

The fair value of mortgage loans on real estate, excluding mortgage loans accounted for using the fair value option, is established using a discounted cash flow method based on credit rating, maturity and future income. The ratings for mortgages in good standing are based on property type, location, market conditions, occupancy, debt-service coverage, LTV, quality of tenancy, borrower and payment record. The fair value for impaired mortgage loans is based on the present value of expected future cash flows discounted at the loan’s effective interest rate, the loan’s market price or the fair value of the collateral if the loan is collateral dependent. The inputs used to measure the fair value of our mortgage loans on real estate, excluding mortgage loans accounted for using the fair value option, are classified as Level 2 within the fair value hierarchy.

Other Investments

The carrying value of our assets classified as other investments, excluding short-term investments, approximates fair value. Other investments includes primarily LPs and other privately held investments that are accounted for using the equity method of accounting and the carrying value is based on our proportional share of the net assets of the LPs. Other investments also includes FHLB stock carried at cost and periodically evaluated for impairment based on ultimate recovery of par value. The inputs used to measure the fair value of our LPs, other privately held investments and FHLB stock are classified as Level 3 within the fair value hierarchy. The remaining assets in other investments include cash collateral receivables and securities that are not LPs or other privately held investments. The inputs used to measure the fair value of these assets are classified as Level 2 within the fair value hierarchy.

Policy Loans

The carrying value for policy loans are the unpaid principal balances. Policy loans are fully collateralized by the cash surrender value of underlying insurance policies. As a result, the carrying value of the policy loans approximates the fair value. The inputs used to measure the fair value of these assets are classified as Level 2 within the fair value hierarchy.

Cash and Invested Cash

Cash and invested cash is carried at cost. The inputs used to measure its fair value are classified as Level 2 within the fair value hierarchy.

Policyholder Account Balances – Certain Investment Contracts and Other Liabilities

Policyholder account balances and other liabilities include account balances of certain investment contracts that exclude significant mortality or morbidity risk. The fair value of the account balances of certain investment contracts is based on a discounted cash flow model as of the balance sheet date. The inputs used to measure the fair value of these policyholder account balances are classified as Level 3 within the fair value hierarchy.

Policyholder Account Balances – Funding Agreements

The fair value of funding agreements is based on quoted market prices and is measured using inputs that are classified as Level 2 within the fair value hierarchy. For more information on funding agreements, see Note 10.

Short-Term and Long-Term Debt

The fair value of short-term and long-term debt is based on quoted market prices. The inputs used to measure the fair value of our short-term and long-term debt are classified as Level 2 within the fair value hierarchy.

Funds Withheld Reinsurance Liabilities

Funds withheld reinsurance liabilities includes our obligation to pay reinsurers under coinsurance with funds withheld and modified coinsurance arrangements where the Company is the cedant. This liability includes embedded derivatives, which are total return swaps with contractual returns that are attributable to the Company’s reinsurance agreements. The embedded derivatives are carried at fair value and thus excluded from the preceding table. The inputs used to measure the remaining balance are classified as Level 3 within the fair value hierarchy.

XML

Contingencies and Commitments

3 Months Ended

Mar. 31, 2025

Commitments and Contingencies Disclosure [Abstract]

Contingencies and Commitments

Contingencies and Commitments

Contingencies

Regulatory and Litigation Matters

Regulatory bodies, such as state insurance departments, the SEC, the Financial Industry Regulatory Authority, tax authorities and other regulatory bodies regularly make inquiries and conduct examinations, investigations or audits concerning our compliance with, among other things, insurance laws, securities laws, tax laws, laws governing the activities of broker-dealers and registered investment advisers and unclaimed property laws. Tax-related matters can include disputes with taxing authorities, ongoing audits, evaluation of filing positions and any potential assessments related thereto.

LNC is involved in various pending or threatened legal or regulatory proceedings, including purported class actions, arising from the conduct of business both in the ordinary course and otherwise. In some of the matters, very large and/or indeterminate amounts, including punitive and treble damages, are sought. Modern pleading practice in the U.S. permits considerable variation in the assertion of monetary damages or other relief. Jurisdictions may permit claimants not to specify the monetary damages sought or may permit claimants to state only that the amount sought is sufficient to invoke the jurisdiction of the trial court. In addition, jurisdictions may permit plaintiffs to allege monetary damages in amounts well exceeding verdicts obtained in the jurisdiction for similar matters. This variability in pleadings, together with the actual experiences of LNC in litigating or resolving through settlement numerous claims over an extended period of time, demonstrates to management that the monetary relief which may be specified in a lawsuit or claim bears little relevance to its merits or disposition value.

Due to the unpredictable nature of litigation, the outcome of a litigation matter and the amount or range of potential loss at particular points in time is normally difficult to ascertain. Uncertainties can include how fact finders will evaluate documentary evidence and the credibility and effectiveness of witness testimony, and how trial and appellate courts will apply the law in the context of the pleadings or evidence presented, whether by motion practice, or at trial or on appeal. Disposition valuations are also subject to the uncertainty of how opposing parties and their counsel will themselves view the relevant evidence and applicable law.

We establish liabilities for litigation and regulatory loss contingencies when information related to the loss contingencies shows both that it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. It is possible that some matters could require us to pay damages or make other expenditures or establish accruals in amounts that could not be estimated as of March 31, 2025.

For some matters, the Company is able to estimate a reasonably possible range of loss. For such matters in which a loss is probable, an accrual has been made. For such matters where a loss is believed to be reasonably possible, but not probable, no accrual has been made. Accordingly, the estimate contained in this paragraph reflects two types of matters. For some matters included within this estimate, an accrual has been made, but there is a reasonable possibility that an exposure exists in excess of the amount accrued. In these cases, the estimate reflects the reasonably possible range of loss in excess of the accrued amount. For other matters included within this estimation, no accrual has been made because a loss, while potentially estimable, is believed to be reasonably possible but not probable. In these cases, the estimate reflects the reasonably possible loss or range of loss. As of March 31, 2025, we estimate the aggregate range of reasonably possible losses, including amounts in excess of amounts accrued for these matters as of such date, to be up to approximately $150 million, after-tax. Any estimate is not an indication of expected loss, if any, or of the Company’s maximum possible loss exposure on such matters.

For other matters, we are not currently able to estimate the reasonably possible loss or range of loss. We are often unable to estimate the possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from other parties and investigation of factual allegations, rulings by the court on motions or appeals, analysis by experts and the progress of settlement negotiations. On a quarterly and annual basis, we review relevant information with respect to litigation contingencies and update our accruals, disclosures and estimates of reasonably possible losses or ranges of loss based on such reviews.

Among other matters, we are presently engaged in litigation, including relating to cost of insurance rates (“Cost of Insurance and Other Litigation”), as described below. No accrual has been made for some of these matters. Although a loss is believed to be reasonably possible for these matters, for some of these matters, we are not able to estimate a reasonably possible amount or range of potential liability. An adverse outcome in one or more of these matters may have a material impact on the consolidated financial statements, but, based on information currently known, management does not believe those cases are likely to have such an impact.

Cost of Insurance and Other Litigation

Cost of Insurance Litigation

Glover v. Connecticut General Life Insurance Company and The Lincoln National Life Insurance Company, filed in the U.S. District Court for the District of Connecticut, No. 3:16-cv-00827, is a putative class action that was served on LNL on June 8, 2016. Plaintiff is the owner of a universal life insurance policy who alleges that LNL charged more for non-guaranteed cost of insurance than permitted by the policy. Plaintiff seeks to represent all universal life and variable universal life policyholders who owned policies containing non-guaranteed cost of insurance provisions that are similar to those of plaintiff’s policy and seeks damages on behalf of all such policyholders. On January 11, 2019, the court dismissed plaintiff’s complaint in its entirety. In response, plaintiff filed a motion for leave to amend the complaint, which, on September 25, 2023, the court granted in part and denied in part. Plaintiff filed an amended complaint on October 10, 2023. On March 7, 2024, the parties entered into a provisional settlement agreement that encompasses policies that are at issue in this case, which also includes all policies at issue in the lawsuits captioned Iwanski v. First Penn-Pacific Life Insurance Company, TVPX ARS INC., as Securities Intermediary for Consolidated Wealth Management, LTD. v. The Lincoln National Life Insurance Company and Vida Longevity Fund, LP v. Lincoln Life & Annuity Company of New York, each of which are described below. The Glover plaintiffs’ motion for preliminary approval of the provisional settlement was filed on March 8, 2024, and on September 4, 2024, the court granted preliminary approval of the provisional settlement. On December 16, 2024, the court heard oral argument on the issue of whether to grant final approval of the provisional settlement. The provisional settlement, which is still subject to final approval of the court, consists of a $147.5 million pre-tax cash payment for Glover class members (inclusive of all policyholders in Iwanski, TVPX ARS INC. and Vida). As of March 31, 2025, the total provisional settlement amount of $147.5 million, pre-tax, remains accrued.

Iwanski v. First Penn-Pacific Life Insurance Company (“FPP”), No. 2:18-cv-01573, filed in the U.S. District Court for the Eastern District of Pennsylvania is a putative class action that was filed on April 13, 2018. Plaintiff alleges that defendant FPP breached the terms of his life insurance policy by deducting non-guaranteed cost of insurance charges in excess of what is permitted by the policies. Plaintiff seeks to represent all owners of universal life insurance policies issued by FPP containing non-guaranteed cost of insurance provisions that are similar to those of Plaintiff’s policy and seeks damages on their behalf. Breach of contract is the only cause of action asserted. On March 7, 2024, the parties in Glover v. Connecticut General Life Insurance Company and The Lincoln National Life Insurance Company (discussed above) entered into a provisional settlement agreement that encompasses all policies at issue in this case, as the Glover case is inclusive of all policies in this case, as well as in the lawsuits captioned TVPX ARS INC., as Securities Intermediary for Consolidated Wealth Management, LTD. v. The Lincoln National Life Insurance Company and Vida Longevity Fund, LP v. Lincoln Life & Annuity Company of New York (both discussed below). The Glover plaintiffs’ motion for preliminary approval of the provisional settlement was filed on March 8, 2024, and on September 4, 2024, the court granted preliminary approval of the provisional settlement. On December 16, 2024, the court heard oral argument on the issue of whether to grant final approval of the provisional settlement. The provisional settlement, which is still subject to final approval of the court, consists of a $147.5 million pre-tax cash payment for Glover class members (inclusive of all policyholders in Iwanski, TVPX ARS INC. and Vida). A motion has been filed to stay the proceedings in this matter pending the completion of the settlement approval process in Glover.

TVPX ARS INC., as Securities Intermediary for Consolidated Wealth Management, LTD. v. The Lincoln National Life Insurance Company, filed in the U.S. District Court for the Eastern District of Pennsylvania, No. 2:18-cv-02989, is a putative class action that was filed on July 17, 2018. Plaintiff alleges that LNL charged more for non-guaranteed cost of insurance than permitted by the policy. Plaintiff seeks to represent all universal life and variable universal life policyholders who own policies issued by LNL or its predecessors containing non-guaranteed cost of insurance provisions that are similar to those of Plaintiff’s policy and seeks damages on behalf of all such policyholders. On March 7, 2024, the parties in Glover v. Connecticut General Life Insurance Company and The Lincoln National Life Insurance Company (discussed above) entered into a provisional settlement agreement that encompasses all policies at issue in this case, as the Glover case is inclusive of all policies in this case, as well as in the lawsuits captioned Iwanski v. First Penn-Pacific Life Insurance Company (discussed above) and Vida Longevity Fund, LP v. Lincoln Life & Annuity Company of New York (discussed below). The Glover plaintiffs’ motion for preliminary approval of the provisional settlement was filed on March 8, 2024, and on September 4, 2024, the court granted preliminary approval of the provisional settlement. On December 16, 2024, the court heard oral argument on the issue of whether to grant final approval of the provisional settlement. The provisional settlement, which is still subject to final approval of the court, consists of a $147.5 million pre-tax cash payment for Glover class members (inclusive of all policyholders in Iwanski, TVPX ARS INC. and Vida). A motion has been filed to stay the proceedings in this matter pending the completion of the settlement approval process in Glover.

Vida Longevity Fund, LP v. Lincoln Life & Annuity Company of New York, pending in the U.S. District Court for the Southern District of New York, No. 1:19-cv-06004, is a putative class action that was filed on June 27, 2019. Plaintiff alleges that Lincoln Life & Annuity Company of New York (“LLANY”) charged more for non-guaranteed cost of insurance than was permitted by the policies. On March 31, 2022, the court issued an order granting plaintiff’s motion for class certification and certified a class of all current or former owners of six universal life insurance products issued by LLANY that were assessed a cost of insurance charge any time on or after June 27, 2013. Plaintiff seeks damages on behalf of the class. On April 19, 2023, LLANY filed a motion for summary judgment. On March 7, 2024, the parties in Glover v. Connecticut General Life Insurance Company and The Lincoln National Life Insurance Company (discussed above) entered into a provisional settlement agreement that encompasses all policies at issue in this case, as the Glover case is inclusive of all policies in this case, as well as in the lawsuits captioned Iwanski v. First Penn-Pacific Life Insurance Company and TVPX ARS INC., as Securities Intermediary for Consolidated Wealth Management, LTD. v. The Lincoln National Life Insurance Company (both discussed above). The Glover plaintiffs’ motion for preliminary approval of the provisional settlement was filed on March 8, 2024, and on September 4, 2024, the court granted preliminary approval of the provisional settlement. On December 16, 2024, the court heard oral argument on the issue of whether to grant final approval of the provisional settlement. The provisional settlement, which is still subject to final approval of the court, consists of a $147.5 million pre-tax cash payment for Glover class members (inclusive of all policyholders in Iwanski, TVPX ARS INC. and Vida). On March 29, 2024, the court issued its summary judgment decision, granting LLANY’s motion in part and denying it in part, and entering summary judgment against twenty-two policyholders that the court determined were not economically harmed. On June 25, 2024, the court granted LLANY’s April 12, 2024, motion to stay proceedings in this matter pending the completion of the approval process in Glover.

Angus v. The Lincoln National Life Insurance Company, pending in the U.S. District Court for the Eastern District of Pennsylvania, No. 2:22-cv-01878, is a putative class action filed on May 13, 2022. Plaintiff alleges that defendant LNL breached the terms of her life insurance policy by deducting non-guaranteed cost of insurance charges in excess of what is permitted by the policies. Plaintiff seeks to represent all owners of universal life insurance policies issued or insured by LNL or its predecessors containing non-guaranteed cost of insurance provisions that are similar to those of plaintiff’s policy and seeks damages on their behalf. Breach of contract is the only cause of action asserted. On August 26, 2022, LNL filed a motion to dismiss. We are vigorously defending this matter.

EFG Bank AG, Cayman Branch, et al. v. The Lincoln National Life Insurance Company, No. 17-cv-02592-GJP (E.D. Pa.), filed on February 1, 2017; Conestoga Trust, et al, v. Lincoln National Corp., et al., No. 18-cv-02379-GJP (E.D. Pa.), filed on June 6, 2018; Brighton Trustees, LLC, et al. v. The Lincoln National Life Insurance Company, No. 2:23-cv-2251-GJP (E.D. Pa.), filed on April 20, 2023 (and transferred to the U.S. District Court for the Eastern District of Pennsylvania on June 12, 2023); and Ryan K. Crayne, on behalf of and as trustee for Carlton Peak Trust v. The Lincoln National Life Insurance Company, No. 2:24-cv-00053-GJP, filed on November 17, 2023 (and transferred to the U.S. District Court for the Eastern District of Pennsylvania on January 4, 2024) are consolidated civil actions pending in the Eastern District of Pennsylvania. In each case other than Crayne, plaintiffs purport to own universal life insurance policies or interests in universal life insurance policies originally issued by Jefferson-Pilot (now LNL). In Crayne, plaintiffs purport to own litigation claims concerning universal life policies originally issued by Jefferson-Pilot (now LNL). Among other things, plaintiffs in each case allege that LNL (or, in Conestoga, LNL and LNC) breached the terms of policyholders’ contracts when it increased non-guaranteed cost of insurance rates beginning in 2016 (or, in Brighton Trustees, in 2016 and 2017). We are vigorously defending these consolidated matters.

Wells Fargo Bank, N.A, solely in its capacity as securities intermediary v. The Lincoln National Life Insurance Company, pending in the U.S. District Court for the Eastern District of Pennsylvania, No. 25-cv-00152-GJP (E.D. Pa.), is a civil action initially filed on December 4, 2024, in the U.S. District Court for the Northern District of Indiana. On January 9, 2025, this case was transferred to the Eastern District of Pennsylvania. Plaintiff, purporting to act solely in its capacity as securities intermediary for the beneficial owner of universal life insurance policies originally issued by Jefferson-Pilot (now LNL), alleges, among other things, that LNL breached the terms of Plaintiff’s contracts when it increased non-guaranteed cost of insurance rates beginning in 2016 and 2017. We are vigorously defending this matter.

Other Litigation

Henry Morgan et al. v. Lincoln National Corporation d/b/a Lincoln Financial Group, et al, filed in the District Court of the 14th Judicial District of Dallas County, Texas, No. DC-23-02492, is a putative class action that was filed on February 22, 2023. Plaintiffs Henry Morgan, Susan Smith, Charles Smith, Laura Seale, Terri Cogburn, Laura Baesel, Kathleen Walton, Terry Warner, and Toni Hale (“Plaintiffs”) allege on behalf of a putative class that Lincoln National Corporation d/b/a Lincoln Financial Group, LNL and LLANY (together, “Lincoln”), FMR, LLC, and Fidelity Product Services, LLC (“Fidelity”) created and marketed misleading and deceptive insurance products with attributes of investment products. The putative class comprises all individuals and entities who purchased Lincoln OptiBlend products that allocated account monies to the 1-Year Fidelity AIM Dividend Participation Account, between January 1, 2020, to December 31, 2022. Plaintiffs assert the following claims individually and on behalf of the class, (1) violations of the Texas Deceptive Trade Practices Act against Lincoln; (2) common-law fraud against Lincoln; (3) negligent misrepresentation against Lincoln and Fidelity; and (4) aiding and abetting fraud against Fidelity. Plaintiffs allege they suffered damages from “a missed investment return of approximately 5-6%” and mitigation damages. They seek actual, consequential and punitive damages, as well as pre-judgment and post-judgment interest, attorney’s fees and litigation costs. On March 31, 2023, the Lincoln defendants filed a notice of removal removing the action from the 14th Judicial District of Dallas County, Texas, to the United States District Court for the Northern District of Texas, Dallas Division. On May 8, 2023, the Lincoln defendants and the Fidelity defendants filed motions to dismiss, which remain pending. We are vigorously defending this matter.

Donald C. Meade v. Lincoln National Corporation, Ellen Cooper, Dennis Glass, and Randal Freitag (“Defendants”), No. 2:24-cv-01704, pending in the U.S. District Court for the Eastern District of Pennsylvania, is a putative class action that was filed on April 23, 2024. On June 24, 2024, Local 295 IBT Employer Group Pension Trust Fund (“Local 295”) filed a motion for appointment as lead plaintiff. On October 23, 2024, the court granted this motion. Local 295 seeks to represent persons and entities that purchased or otherwise acquired Lincoln National Corporation common stock between December 8, 2021, and November 2, 2022, inclusive (the “Class Period”). On December 23, 2024, plaintiff filed an amended complaint. Plaintiff alleges claims under Section 10(b) and Section 20(a) of the Securities Exchange Act of 1934, and under SEC Rule 10b-5. Plaintiff alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts that plaintiff alleges Defendants knew, or recklessly disregarded, at the time the statements were made, about the Company’s business, operations and prospects with respect to its Guaranteed Universal Life policies and their lapse rates. The action seeks unspecified compensatory damages and reasonable costs and expenses incurred in this action, including counsel fees and expert fees, together with equitable/injunctive relief or such other relief as the court may deem just and proper. On February 21, 2025, Defendants filed a motion to dismiss. We are vigorously defending this matter.

In Re Lincoln National Corporation Stockholder Derivative Litigation, No. 2:24-cv-02713, is the matter name for the following two civil actions that were consolidated for all purposes on September 26, 2024, by the U.S. District Court for the Eastern District of Pennsylvania: Lawrence Hollin, derivatively on behalf of Nominal Defendant Lincoln National Corporation v. Ellen G. Cooper, Dennis R. Glass, Randal J. Freitag, Deirdre P Connelly, William H. Cunningham, Reginald E. Davis, Eric G. Johnson, Gary C. Kelly, M. Leanne Lachman, Dale LeFebvre, Janet Liang, Michael F. Mee, Lynn M. Utter and Patrick S. Pittard (“Individual Defendants”) and Lincoln National Corporation (“Nominal Defendant”), No. 2:24-cv-02713 (E.D. Pa.), filed on June 20, 2024; and Robert R. Wiersum, derivatively on behalf of Lincoln National Corporation v. Ellen G. Cooper, Dennis R. Glass, Randal J. Freitag, Deirdre P Connelly, William H. Cunningham, Reginald E. Davis, Eric G. Johnson, Gary C. Kelly, M. Leanne Lachman, Dale LeFebvre, Janet Liang, Michael F. Mee, Lynn M. Utter and Patrick S. Pittard (“Individual Defendants”) and Lincoln National Corporation (“Nominal Defendant”), No. 2:24-cv-03251 (E.D. Pa.), filed on July 23, 2024. By the same September 26, 2024, order, the court directed, among other things, that all proceedings and deadlines in this consolidated case be stayed until 30 days after resolution of all motions to dismiss (including the exhaustion of all related appeals) in the Meade matter discussed above. Plaintiffs bring this complaint for, inter alia, alleged breaches of fiduciary duties between November 4, 2020, at latest, through the date of filing and allege violations of the federal securities laws caused by the issuance of allegedly materially false and misleading statements issued, or caused to be issued, by the Individual Defendants in the Company’s SEC filings and other public statements. Plaintiffs allege that the Company thereby suffered loss, injury and damage. Among other relief, plaintiffs seek, in favor of the Company, damages sustained by the Company, punitive damages and attorney’s fees, an accounting for all damages to the Company and an unspecified order directing the Company to improve existing corporate governance and internal procedures. The Individual Defendants are vigorously defending these consolidated matters.

In Re Lincoln National Corporation Shareholder Derivative Litigation, No. CV-2024-0011319, is the matter name for the following two civil actions that were consolidated for all purposes on February 28, 2025, by the Court of Common Pleas of Delaware County, Pennsylvania: Anthony Morgan, derivatively on behalf of Nominal Defendant Lincoln National Corporation v. Ellen G. Cooper, Deirdre P. Connelly, William H. Cunningham, Reginald Davis, Eric C. [G.] Johnson, Gary C. Kelly, M. Leanne Lachman, Dale LeFebvre, Janet Liang, Lynn M. Utter, Dennis Glass and Randal Freitag (“Individual Defendants”) and Lincoln National Corporation (“Nominal Defendant”), No. CV-2024-011319 (Court of Common Pleas of Delaware County, Pennsylvania) filed on December 31, 2024; and Harry Rosenthal, derivatively on behalf of Nominal Defendant Lincoln National Corporation v. Ellen G. Cooper, Deirdre P Connelly, William H. Cunningham, Reginald Davis, Eric C. [G.] Johnson, Gary C. Kelly, M. Leanne Lachman, Dale LeFebvre, Janet Liang, Lynn M. Utter, Dennis Glass and Randal Freitag (“Individual Defendants”) and Lincoln National Corporation (“Nominal Defendant”), No. CV-2025-00146 (Court of Common Pleas of Delaware County, Pennsylvania) filed on January 3, 2025. By the same February 28, 2025, order, the court directed, among other things, that all proceedings and deadlines in this consolidated case be stayed until 30 days after resolution of all motions to dismiss (including the exhaustion of all related appeals) in the Meade matter discussed above. Plaintiffs bring this verified stockholder derivative complaint purportedly on behalf of Nominal Defendant

Lincoln National Corporation against the Individual Defendants, inter alia, for alleged breaches of fiduciary duties for allegedly failing to comply with federal securities laws, by the issuance of allegedly materially false and misleading statements in the Company’s SEC filings and other public statements. Plaintiffs allege claims against the Individual Defendants for breach of fiduciary duties and for unjust enrichment. Plaintiffs allege, inter alia, that the Individual Defendants failed to disclose to investors: (i) that the Company was experiencing a decline in its VUL business; (ii) that, as a result, the goodwill associated with the life insurance business was overstated; (iii) that, as a result, the Company’s policy lapse assumptions were outdated; (iv) that, as a result, the Company’s reserves were overstated; (v) that, as a result, the Company’s reported financial results and financial statements were misstated; and (vi) that, as a result, the Individual Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. Plaintiffs allege that the Company thereby suffered loss, injury and damage. Among other relief, the action seeks specifically, in favor of the Company: damages sustained by the Company; a direction by the court for the Company to take all necessary actions to reform and improve its corporate governance and internal procedures to comply with all applicable laws and to protect the Company and its shareholders; restitution from the Individual Defendants, and each of them, and an order for the disgorgement of all profits, benefits and other compensation obtained by the Individual Defendants; the costs and disbursements of the action, including reasonable attorneys’ fees, accountants’ and experts’ fees, costs and expenses; and such other and further relief as the court deems just and proper. The Individual Defendants are vigorously defending this matter.

Kelly Grink v. Virtua Health and Lincoln National Corporation et al., No. 1:24-cv-09919, is a putative class action filed on October 18, 2024, in the U.S. District Court for the District of New Jersey. On March 7, 2025, Plaintiffs filed an amended complaint which, inter alia, added an additional named plaintiff (Steven Molnar) and additional named defendants, including Lincoln Retirement Services Company, LLC, and [The] Lincoln National Life Insurance Company. Plaintiffs Kelly Grink, Diane Trump and Steven Molnar are participants in Virtua Health’s defined contribution plans. Plaintiffs seek to represent all current and former participants or beneficiaries of Virtua’s 401(k) savings plan and 403(b) retirement program (together, the “Plans”) who invested in the Plans’ fixed annuity option in the six years prior to the filing of this lawsuit. Lincoln offers a fixed annuity investment option to plan participants through its group annuity contract with the Plans. Lincoln also provides recordkeeping and administration services to the Plans. Plaintiffs allege that the Virtua defendants acted in breach of their fiduciary duty including by maintaining the Plans’ investment in the Lincoln stable value fund when other investment providers are alleged to have provided superior alternatives at substantially lower cost. Plaintiffs allege that the Lincoln defendants were at all relevant times fiduciaries to the Plans and were parties in interest to a prohibited transaction under ERISA. The action seeks relief against the Lincoln defendants including the disgorgement of any profits they received as a result of the alleged breaches of fiduciary duty, together with plaintiffs’ attorney’s fees and costs, prejudgment and post-judgment interest and such other equitable or remedial relief as the court deems appropriate. On April 4, 2025, the Lincoln defendants filed a motion to dismiss. We are vigorously defending this matter.

Tax Assessment Proceeding

Lincoln National Life Insurance Company v. Township of Radnor, pending in the Court of Common Pleas of Delaware County, Pennsylvania Civil Division, No. 2022-001894, is a de novo appeal filed by LNL on March 21, 2022, regarding a September 30, 2021, Notice of Tax Assessment issued by the Township of Radnor to LNL for additional business privilege tax (“BPT”) for the years 2014-2019/2020 estimate. The assessment was based on an audit undertaken by a third-party auditor and consultant to the Township of Radnor, following a periodic business review of LNL undertaken by the same individual in 2018. The assessment is comprised of taxes, interest and penalties for the period in question. LNL filed a motion for summary judgment that was denied by the court. The trial of this matter was held in the fourth quarter of 2024. The court’s ruling remains pending. We are vigorously defending this matter.

Reinsurance Disputes

Certain reinsurers have in the past sought, and may in the future seek, rate increases on certain yearly renewable term agreements. We may initiate legal proceedings, as necessary, under these agreements in order to protect our contractual rights. Additionally, reinsurers have in the past initiated, and may in the future initiate, legal proceedings against us.

State Guaranty Fund Assessments

State guaranty associations levy assessments on insurance companies doing business within their jurisdictions to cover policyholder losses from insolvent or impaired insurance companies. Mandatory assessments may be partially recovered through a reduction in future premium taxes in some states. We accrue the cost of future guaranty fund assessments based on estimates of insurance company insolvencies provided by the National Organization of Life & Health Insurance Guaranty Associations and the amount of premiums written in each state. We reported the undiscounted expected state guaranty fund assessment liability within other liabilities on the Consolidated Balance Sheets of $63 million as of March 31, 2025, and December 31, 2024. The actual amount of assessments levied against us in connection with insurance company insolvencies may vary from this estimate. Future guaranty fund assessments are expected to be paid based on anticipated funding periods for each guaranty association obligation. In addition, we reported the related receivable for expected future state premium tax recoveries within other assets on the Consolidated Balance Sheets of $100 million and $99 million as of March 31, 2025, and December 31, 2024, respectively. Premium tax recoveries are expected to be realized based on regulations set forth by the various state taxing authorities. The balance sheet position as of March 31, 2025, and December 31, 2024, nets to recoveries of $37 million and $36 million, respectively.

XML

Shares and Stockholders’ Equity

3 Months Ended

Mar. 31, 2025

Stockholders' Equity Note [Abstract]

Shares and Stockholders' Equity

Shares and Stockholders’ Equity

Preferred Shares

Preferred stock authorized, issued and outstanding (number of shares) was as follows:

	As of March 31, 2025			As of December 31, 2024
	Shares Authorized	Shares Issued	Shares Outstanding	Shares Authorized	Shares Issued	Shares Outstanding
9.250% Fixed Rate Reset Non-Cumulative
Preferred Stock, Series C	20,000	20,000	20,000	20,000	20,000	20,000
9.000% Non-Cumulative Preferred Stock,   Series D	20,000	20,000	20,000	20,000	20,000	20,000
Not designated	9,960,000	–	–	9,960,000	–	–
Total preferred shares	10,000,000	40,000	40,000	10,000,000	40,000	40,000

The per share and aggregate dividends declared for preferred stock by series (in millions except per share data) was as follows:

	For the Three Months Ended March 31,
	2025				2024
	Dividend		Aggregate		Dividend		Aggregate
Series	Per Share		Dividend		Per Share		Dividend
Series C	$	1,156.25	$	23	$	1,156.25	$	23
Series D	562.50		11		562.50		11
Total	$	1,718.75	$	34	$	1,718.75	$	34

Common Shares

The changes in our common stock (number of shares) were as follows:

	For the Three Months Ended March 31,
	2025	2024
Common Stock
Balance as of beginning-of-year	170,380,646	169,666,137
Stock compensation/issued for benefit   plans	314,520	350,750
Balance as of end-of-period	170,695,166	170,016,887

Our common stock is without par value.

Earnings Per Share

The calculation of earnings per share (“EPS”) was as follows (in millions except per share data):

	For the Three Months Ended March 31,
	2025		2024
Net income (loss) available to common stockholders – basic	$	(756)	$	1,188
Deferred units of LNC stock in our
deferred compensation plans (1)	–		3
Net income (loss) available to common
stockholders – diluted	$	(756)	$	1,191
Weighted-average shares, as used in basic calculation	171,321,440		170,049,994
Incremental common shares from assumed exercise or
issuance of stock-based incentive compensation awards	2,765,580		1,096,272
Average deferred compensation shares (1)	–		688,480
Weighted-average shares, as used in diluted calculation (2)	174,087,020		171,834,746
Net income (loss) per share:
Basic	$	(4.41)	$	6.98
Diluted	(4.41)		6.93

(1)    We have participants in our deferred compensation plans who selected LNC stock as the measure for the investment return attributable to all or a portion of their deferral amounts. This obligation is settled in either cash or LNC stock pursuant to the applicable plan document. We exclude deferred units of LNC stock that are antidilutive from our diluted EPS calculation.

(2)     Due to reporting a net loss for the three months ended March 31, 2025, basic shares were used in the diluted EPS calculation for this period as the use of diluted shares would have resulted in a lower loss per share.

In the event the average market price of LNC common stock exceeds the issue price of stock options and the options have a dilutive effect to our EPS, such options will be shown in the table above.

AOCI

The following summarizes the components and changes in AOCI (in millions):

	For the Three Months Ended March 31,
	2025		2024
Unrealized Gain (Loss) on Fixed Maturity AFS Securities and Certain
Other Investments
Balance as of beginning-of-year	$	(6,239)	$	(5,188)
Unrealized holding gains (losses)	744		(1,140)
Change in foreign currency exchange rate adjustment	156		(103)
Change in future contract benefits and policyholder account balances,
net of reinsurance	(326)		891
Income tax benefit (expense)	(121)		71
Less:
Reclassification adjustment for gains (losses) included in net income (loss)	(90)		(55)
Income tax benefit (expense)	19		12
Balance as of end-of-period	$	(5,715)	$	(5,426)
Unrealized Gain (Loss) on Derivative Instruments
Balance as of beginning-of-year	$	638	$	375
Unrealized holding gains (losses)	173		64
Change in foreign currency exchange rate adjustment	(153)		101
Income tax benefit (expense)	(4)		(35)
Less:
Reclassification adjustment for gains (losses) included in net income (loss)	21		24
Income tax benefit (expense)	(4)		(5)
Balance as of end-of-period	$	637	$	486
Market Risk Benefit Non-Performance Risk Gain (Loss)
Balance as of beginning-of-year	$	146	$	1,070
OCI before reclassification	403		(590)
Income tax benefit (expense)	(85)		126
Balance as of end-of-period	$	464	$	606
Policyholder Liability Discount Rate Remeasurement Gain (Loss)
Balance as of beginning-of-year	$	744	$	587
OCI before reclassification	(141)		147
Income tax benefit (expense)	30		(31)
Balance as of end-of-period	$	633	$	703
Foreign Currency Translation Adjustment
Balance as of beginning-of-year	$	(29)	$	(26)
OCI before reclassification	5		(1)
Balance as of end-of-period	$	(24)	$	(27)
Funded Status of Employee Benefit Plans
Balance as of beginning-of-year	$	(296)	$	(294)
OCI before reclassification	(5)		1
Balance as of end-of-period	$	(301)	$	(293)

The following summarizes the reclassifications out of AOCI (in millions) and the associated line item on the Consolidated Statements of Comprehensive Income (Loss):

	For the Three Months Ended March 31,
	2025		2024
Unrealized Gain (Loss) on Fixed Maturity AFS
Securities and Certain Other Investments
Reclassification	$	(118)	$	(54)	Realized gain (loss)
Associated change in future contract benefits	28		(1)		Benefits
Reclassification before income tax benefit (expense)	(90)		(55)		Income (loss) before taxes
Income tax benefit (expense)	19		12		Federal income tax expense (benefit)
Reclassification, net of income tax	$	(71)	$	(43)	Net income (loss)
Unrealized Gain (Loss) on Derivative Instruments
Interest rate contracts	$	3	$	9	Interest and debt expense
Foreign currency contracts	15		15		Net investment income
Foreign currency contracts	3		–		Realized gain (loss)
Reclassification before income tax benefit (expense)	21		24		Income (loss) before taxes
Income tax benefit (expense)	(4)		(5)		Federal income tax expense (benefit)
Reclassification, net of income tax	$	17	$	19	Net income (loss)

XML

Segment Information

3 Months Ended

Mar. 31, 2025

Segment Reporting [Abstract]

Segment Information

Segment Information

We provide products and services and report results through our Annuities, Life Insurance, Group Protection and Retirement Plan Services business segments. The accounting policies of the business segments and Other Operations are the same as those described in

Note 1 in our 2024 Form 10-K. We also have Other Operations, which includes the financial data for operations that are not directly related to the business segments. Our business segments and Other Operations reflect the manner by which our CODM views and manages the business. Our CODM is the Chief Executive Officer. A discussion of these segments and Other Operations is found in Note 19 in our 2024 Form 10-K.

Income (loss) from operations is the internal measure used by our CODM that explains the results of our ongoing operations in a manner that allows for a better understanding of the underlying trends by excluding items that are unpredictable and not necessarily indicative of current operating fundamentals or future performance, and, in many instances, decisions regarding these adjustments do not necessarily relate to the operations of the individual business segments. Income (loss) from operations is used by our CODM to evaluate financial performance, to assess the budgeting and forecasting process and to determine future resource allocation. In the third quarter of 2024, we revised our definition of income (loss) from operations to exclude the impact of certain additional items that are not indicative of the ongoing operations of the business and may obscure trends in the underlying performance of the Company. The presentation of prior period income (loss) from operations was recast for such third quarter 2024 revisions to conform to the current period presentation.

Income (loss) from operations is GAAP net income excluding the following items, as applicable:

•Items related to annuity product features, which include changes in MRBs, including gains and losses and benefit payments, changes in the fair value of the derivative instruments we hold to hedge GLB and GDB riders, net of fee income allocated to support the cost of hedging them, and changes in the fair value of the embedded derivative liabilities of our indexed annuity contracts and the associated index options we hold to hedge them, including collateral expense associated with the hedge program (collectively, “net annuity product features”);

•Items related to life insurance product features, which include changes in the fair value of derivatives we hold as part of VUL hedging, changes in reserves resulting from benefit ratio unlocking associated with the impact of capital markets, and changes in the fair value of the embedded derivative liabilities of our IUL contracts and the associated index options we hold to hedge them (collectively, “net life insurance product features”);

•Credit loss-related adjustments on fixed maturity AFS securities, mortgage loans on real estate and reinsurance-related assets (“credit loss-related adjustments”);

•Changes in the fair value of equity securities, certain derivatives, certain other investments and realized gains (losses) on sales, disposals and impairments of financial assets (collectively, “investment gains (losses)”);

•Changes in the fair value of reinsurance-related embedded derivatives, trading securities and mortgage loans on real estate electing the fair value option (“changes in the fair value of reinsurance-related embedded derivatives, trading securities and certain mortgage loans”);

•Income (loss) from the initial adoption of new accounting standards, accounting policy changes and new regulations, including changes in tax law;

•Income (loss) from reserve changes, net of related amortization, on business sold through reinsurance;

•Losses from the impairment of intangible assets and gains (losses) on other non-financial assets;

•Income (loss) from discontinued operations;

•Other items, which include the following: certain legal and regulatory accruals; severance expense related to initiatives that realign the workforce; transaction and integration costs related to mergers and acquisitions including the acquisition or divestiture, through reinsurance or other means, of businesses or blocks of business; mark-to-market adjustment related to the LNC stock component of our deferred compensation plans (“deferred compensation mark-to-market adjustment”); gains (losses) on modification or early extinguishment of debt; and impacts from settlement or curtailment of defined benefit obligations; and

•Income tax benefit (expense) related to the above pre-tax items, including the effect of tax adjustments such as changes to deferred tax valuation allowances.

We use our prevailing corporate federal income tax rate of 21% and an estimated state income tax rate, where applicable, net of the impacts related to dividends-received deduction and foreign tax credits and any other permanent differences for events recognized differently in the consolidated financial statements and federal income tax returns.

We do not report total assets by segment because this is not a metric used by the CODM to allocate resources or evaluate segment performance.

The tables below reconcile our internal measure of performance to the GAAP measure presented in the Consolidated Statements of Comprehensive Income (Loss) (in millions):

	For the Three Months Ended March 31, 2025
	Annuities		Life Insurance		Group Protection		Retirement Plan Services		Other Operations		Total
Operating Revenues (1)	$	1,198	$	1,587	$	1,521	$	327	$	52	$	4,685
Operating Expenses (2)
Benefits and policyholder liability
remeasurement (gain) loss	28		1,002		994		–		4		2,028
Interest credited	419		287		–		170		14		890
Commissions	298		99		133		27		–		557
General and administrative expenses	125		131		222		84		68		630
Interest and debt expense	–		–		–		–		80		80
Other (3)	(12)		100		44		8		(2)		138
Total operating expenses	858		1,619		1,393		289		164		4,323
Total federal income tax expense (benefit)	50		(16)		27		4		(17)		48
Total income (loss) from operations	290		(16)		101		34		(95)		314
Reconciliation of total income (loss) from
operations to net income (loss):
Net annuity product features, pre-tax											(1,092)
Net life insurance product features, pre-tax											42
Credit loss-related adjustments, pre-tax											(28)
Investment gains (losses), pre-tax											(103)
Changes in the fair value of
reinsurance-related embedded
derivatives, trading securities and
certain mortgage loans, pre-tax (4)											(90)
Other items, pre-tax (5) (6) (7)											(35)
Income tax benefit (expense) related to
the above pre-tax items											270
Total net income (loss)											$	(722)

(1)    See table below for reconciliation of total operating revenues to the GAAP measure presented in the Consolidated Statements of Comprehensive Income (Loss).

(2)    The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM. Inter-segment expenses are included within the amounts shown.

(3)    Other operating expenses include: Annuities: DAC and VOBA capitalization and amortization; taxes, licenses and fees; expenses associated with reserve financing and letters of credit (“LOCs”) and amortization of deferred loss on business sold through reinsurance. Life Insurance: DAC and VOBA capitalization and amortization; taxes, licenses and fees; expenses associated with reserve financing and LOCs; amortization of deferred loss on business sold through reinsurance and other intangible amortization. Group Protection: Taxes, licenses and fees; DAC capitalization and amortization; other intangible amortization and expenses associated with LOCs. Retirement Plan Services: Taxes, licenses and fees; DAC capitalization and amortization and expenses associated with LOCs. Other Operations: DAC capitalization and amortization; taxes, licenses and fees and reimbursements to Other Operations from the Life Insurance segment for the use of proceeds from certain issuances of senior notes that were used as long-term structured solutions, net of expenses incurred by Other Operations for its access to a financing facility and issuance of LOCs.

(4)    Includes primarily changes in the fair value of the embedded derivative related to the fourth quarter 2023 reinsurance transaction. For more information, see Note 7.

(5)    Includes severance expense related to initiatives to realign the workforce of $(6) million.

(6)    Includes transaction and integration costs related to mergers, acquisitions and divestitures of $(20) million.

(7)    Includes deferred compensation mark-to-market adjustment of $(9) million.

	For the Three Months Ended March 31, 2024
	Annuities		Life Insurance		Group Protection		Retirement Plan Services		Other Operations		Total
Operating Revenues (1)	$	1,269	$	1,541	$	1,425	$	322	$	27	$	4,584
Operating Expenses (2)
Benefits and policyholder liability
remeasurement (gain) loss	27		987		963		–		7		1,984
Interest credited	354		294		1		166		7		822
Commissions	254		113		109		23		–		499
General and administrative expenses	120		143		208		86		57		613
Interest and debt expense	–		–		–		–		81		81
Other (3)	197		54		43		6		(6)		295
Total operating expenses	952		1,591		1,324		281		146		4,294
Total federal income tax expense (benefit)	58		(15)		21		5		(23)		46
Total income (loss) from operations	259		(35)		80		36		(96)		244
Reconciliation of total income (loss) from
operations to net income (loss) (4):
Net annuity product features, pre-tax											1,450
Net life insurance product features, pre-tax											(130)
Credit loss-related adjustments, pre-tax											(1)
Investment gains (losses), pre-tax											(81)
Changes in the fair value of
reinsurance-related embedded
derivatives, trading securities and
certain mortgage loans, pre-tax (5)											194
Other items, pre-tax (6) (7) (8) (9)											(186)
Income tax benefit (expense) related to
the above pre-tax items											(268)
Total net income (loss)											$	1,222

(1)    See table below for reconciliation of total operating revenues to the GAAP measure presented in the Consolidated Statements of Comprehensive Income (Loss).

(2)    The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM. Inter-segment expenses are included within the amounts shown.

(3)    Other operating expenses include: Annuities: Broker-dealer expenses; DAC and VOBA capitalization and amortization; taxes, licenses and fees and expenses associated with reserve financing and LOCs. Life Insurance: DAC and VOBA capitalization and amortization; taxes, licenses and fees; expenses associated with reserve financing and LOCs and other intangible amortization. Group Protection: Taxes, licenses and fees; DAC capitalization and amortization; other intangible amortization and expenses associated with LOCs. Retirement Plan Services: DAC capitalization and amortization; taxes, licenses and fees and expenses associated with LOCs. Other Operations: Taxes, licenses and fees and reimbursements to Other Operations from the Life Insurance segment for the use of proceeds from certain issuances of senior notes that were used as long-term structured solutions, net of expenses incurred by Other Operations for its access to a financing facility and issuance of LOCs.

(4)    The prior period presentation was recast to conform to the revised definition of income (loss) from operations.

(5)    Includes primarily changes in the fair value of the embedded derivative related to the fourth quarter 2023 reinsurance transaction. For more information, see Note 7.

(6)    Includes $(114) million primarily related to the settlement of cost of insurance litigation in the first quarter of 2024.

(7)    Includes severance expense related to initiatives to realign the workforce of $(49) million.

(8)    Includes transaction and integration costs related to mergers, acquisitions and divestitures of $(10) million.

(9)    Includes deferred compensation mark-to-market adjustment of $(13) million.

The tables below reconcile our total operating revenues to the GAAP measure presented in the Consolidated Statements of Comprehensive Income (Loss) (in millions):

	For the Three Months Ended March 31, 2025
	Annuities		Life Insurance		Group Protection		Retirement Plan Services		Other Operations		Total
Operating revenues	$	1,198	$	1,587	$	1,521	$	327	$	52	$	4,685
Revenue adjustments from annuity and life
insurance product features	209		18		–		–		–		227
Credit loss-related adjustments	(17)		1		(2)		(2)		(8)		(28)
Investment gains (losses)	(6)		(109)		–		(2)		14		(103)
Changes in the fair value of reinsurance-
related embedded derivatives, trading
securities and certain mortgage loans	10		(89)		–		–		(11)		(90)
Total revenues	$	1,394	$	1,408	$	1,519	$	323	$	47	$	4,691

	For the Three Months Ended March 31, 2024
	Annuities		Life Insurance		Group Protection		Retirement Plan Services		Other Operations		Total
Operating revenues	$	1,269	$	1,541	$	1,425	$	322	$	27	$	4,584
Revenue adjustments from annuity and life
insurance product features	(446)		(134)		–		–		–		(580)
Credit loss-related adjustments	(4)		5		–		–		(2)		(1)
Investment gains (losses)	19		(29)		–		(5)		(66)		(81)
Changes in the fair value of reinsurance-
related embedded derivatives, trading
securities and certain mortgage loans	(3)		205		–		–		(8)		194
Total revenues	$	835	$	1,588	$	1,425	$	317	$	(49)	$	4,116

Other business segment and Other Operations information (in millions) was as follows:

	For the Three Months Ended March 31,
	2025		2024
Net Investment Income
Annuities	$	452	$	379
Life Insurance	624		622
Group Protection	89		85
Retirement Plan Services	251		244
Other Operations	41		16
Total net investment income	$	1,457	$	1,346

XML

Realized Gain (Loss)

3 Months Ended

Mar. 31, 2025

Realized Gain (Loss) [Abstract]

Realized Gain (Loss)

Realized Gain (Loss)

Realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss) includes realized gains and losses from the sale of investments, write-downs for impairments of investments and changes in the allowance for credit losses for financial assets, changes in fair value for mortgage loans on real estate accounted for under the fair value option, changes in fair value of equity securities, VUL derivative and embedded derivative gains and losses, gains and losses on the sale of subsidiaries and businesses and net gains and losses on reinsurance-related embedded derivatives and trading securities. Realized gains and losses on the sale of investments are determined using the specific identification method. Realized gain (loss) is also net of allocations of investment gains and losses to certain policyholders, certain funds withheld on reinsurance arrangements and certain modified coinsurance arrangements for which we have a contractual obligation. Details underlying realized gain (loss) (in millions) were as follows:

	For the Three Months Ended March 31,
	2025		2024
Fixed maturity AFS securities:
Gross gains	$	4	$	7
Gross losses	(122)		(61)
Credit loss benefit (expense) (1)	(28)		(2)
Realized gain (loss) on equity securities (2)	(5)		11
Credit loss benefit (expense) on mortgage loans on real estate (1)	(1)		–
Credit loss benefit (expense) on reinsurance-related assets	1		1
Realized gain (loss) on the mark-to-market on certain
instruments (3)(4)	(55)		12
Indexed product derivative results (5)	(69)		145
Derivative results (6)	287		(548)
Other realized gain (loss)	(1)		1
Total realized gain (loss)	$	11	$	(434)

(1) Includes changes in the allowance for credit losses as well as direct write-downs to amortized cost as a result of negative credit events.

(2) Includes mark-to-market adjustments on equity securities still held of $(5) million and $11 million for the three months ended March 31, 2025 and 2024, respectively.

(3) Represents changes in the fair values of derivatives we hold as part of VUL hedging, reinsurance-related embedded derivatives and trading securities.

(4) Includes gains and losses from fair value changes on mortgage loans on real estate accounted for under the fair value option of $(1) million and less than $1 million for the three months ended March 31, 2025 and 2024, respectively.

(5) Represents the change in fair value of the index options that we hold and the change in the fair value of the embedded derivative liabilities of our indexed annuity and IUL contracts, and the associated index options to hedge policyholder index allocations applicable to future reset periods for our indexed annuity products.

(6) Includes the change in the fair value of the derivative instruments we own to support capital needs associated with our GLB and GDB riders net of fee income allocated to support the cost of purchasing the hedging instruments.

XML

Federal Income Taxes

3 Months Ended

Mar. 31, 2025

Income Tax Disclosure [Abstract]

Federal Income Taxes

Federal Income Taxes

The effective tax rate is the ratio of tax expense (benefit) over pre-tax income (loss). The effective tax rate was 24% and 20% for the three months ended March 31, 2025 and 2024, respectively. The effective tax rate on pre-tax income is typically lower than the prevailing corporate federal income tax rate of 21% due to benefits from preferential tax items including the separate account dividends-received deduction and tax credits.

For the three months ended March 31, 2025, the effective tax rate differed from the prevailing corporate federal income tax rate due primarily to a tax benefit at 21% from pre-tax losses in addition to the effects of preferential tax items.

For the three months ended March 31, 2024, the effective tax rate differed from the prevailing corporate federal income tax rate due primarily to the effects of preferential tax items.

XML

Subsequent Events

3 Months Ended

Mar. 31, 2025

Subsequent Events [Abstract]

Subsequent Events

Subsequent Event

On April 9, 2025, we announced our entry into a stock purchase agreement (the “Purchase Agreement”) with Bain Capital Prairie, LLC (the “Buyer”), a newly formed subsidiary of Bain Capital, pursuant to which we will sell shares (the “Shares”) representing approximately 9.9% of our outstanding Common Stock (“Common Stock) on a post-issuance basis, to the Buyer for aggregate consideration of approximately $825 million in cash (the “Transaction”). The closing of the Transaction is subject to the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and the satisfaction of customary closing conditions.

The Purchase Agreement provides for, among other things, certain limitations on the Buyer’s and certain of its affiliates’ ability to transfer Common Stock, purchase additional Common Stock, and take certain other actions with respect to the Company and its Common Stock, and an agreement that the Buyer and certain of its affiliates will, subject to certain limitations, vote Common Stock they beneficially own in favor of the matters recommended for approval by the Company’s board of directors (the “Board”). The Purchase Agreement also grants the Buyer the right to designate one observer to be present in a nonvoting capacity at all meetings of the Board and, following the first anniversary of the closing of the Transaction, the right to replace such observer with a voting member of the Board, in each case subject to the Buyer’s satisfaction of certain conditions and approval of the Board.

XML

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Pay vs Performance Disclosure
Net income (loss)	$ (722)	$ 1,222

XML

Insider Trading Arrangements	3 Months Ended
	Mar. 31, 2025
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

XML

Nature of Operations and Basis of Presentation (Policies)

3 Months Ended

Mar. 31, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

Basis of Presentation

The accompanying unaudited consolidated financial statements are prepared in accordance with United States of America generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions for the Securities and Exchange Commission (“SEC”) Quarterly Report on Form 10-Q, including Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. The information contained in the Notes to Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended December 31, 2024 (“2024 Form 10-K”), should be read in connection with the reading of these interim unaudited consolidated financial statements.

Principles of Consolidation

In the opinion of management, these statements include all normal recurring adjustments necessary for a fair presentation of the Company’s results. Interim results for the three months ended March 31, 2025, are not necessarily indicative of the results that may be expected for the full year ending December 31, 2025. All material inter-company accounts and transactions have been eliminated in consolidation.

Segment Reporting

We present disaggregated disclosures in the Notes below for long-duration insurance balances, applying the level of aggregation by business segment as follows:

Business Segment	Level of Aggregation
Annuities	Variable Annuities
	Fixed Annuities
	Payout Annuities
Life Insurance	Traditional Life
	UL and Other
Group Protection	Group Protection
Retirement Plan Services	Retirement Plan Services

The variable annuities level of aggregation includes RILA products, which are indexed variable annuities. The fixed annuities level of aggregation represents deferred fixed annuities. We have excluded amounts reported in Other Operations from our disaggregated disclosures that are attributable to the indemnity reinsurance agreements with Protective Life Insurance Company (“Protective”) and Swiss Re Life & Health America, Inc (“Swiss Re”) as these contracts are fully reinsured, run-off institutional pension business in the form of group annuity and the results of certain disability income business.

New Accounting Standards

Adoption of New Accounting Standards

The following table provides a description of current period adoptions of new Accounting Standards Updates (“ASUs”).

Standard	Description	Effective Date	Effect on Financial Statements or Other Significant Matters
ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures	This ASU aims to enhance reportable segment disclosure requirements. It requires that a public entity disclose significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”), disclose and describe other segment items and report additional measures of a segment’s profit or loss if used by the CODM.	January 1, 2024 (Annual Filings) and January 1, 2025 (Quarterly Filings)	We adopted this ASU on the applicable effective dates, incorporating the required disclosures in Note 15 to the consolidated financial statements, along with retrospectively updating the applicable tabular disclosures.

Future Adoption of New Accounting Standards

The following table provides a description of future adoptions of new ASUs that may have an impact on the consolidated financial statements when adopted. ASUs not listed below were assessed and determined to be either not applicable or insignificant in presentation or amount.

Standard	Description	Effective Date	Effect on Financial Statements or Other Significant Matters
ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures	This ASU establishes new income tax disclosure requirements, as well as adjusts certain existing requirements. It specifically requires expanded and disaggregated disclosures around the tax rate reconciliation.	January 1, 2025 (Annual Filings)	We are evaluating the impact of this ASU to disclosures within the Federal Income Taxes Note to the consolidated financial statements.
ASU 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40)	This ASU requires disclosure of specified information about certain costs and expenses, including employee compensation, depreciation and intangible asset amortization.	January 1, 2027	We are evaluating the impact of this ASU to the consolidated financial statements.

XML

Nature of Operations and Basis of Presentation (Tables)

3 Months Ended

Mar. 31, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Segment Information

We present disaggregated disclosures in the Notes below for long-duration insurance balances, applying the level of aggregation by business segment as follows:

Business Segment	Level of Aggregation
Annuities	Variable Annuities
	Fixed Annuities
	Payout Annuities
Life Insurance	Traditional Life
	UL and Other
Group Protection	Group Protection
Retirement Plan Services	Retirement Plan Services

Other business segment and Other Operations information (in millions) was as follows:

	For the Three Months Ended March 31,
	2025		2024
Net Investment Income
Annuities	$	452	$	379
Life Insurance	624		622
Group Protection	89		85
Retirement Plan Services	251		244
Other Operations	41		16
Total net investment income	$	1,457	$	1,346

XML

New Accounting Standards (Tables)

3 Months Ended

Mar. 31, 2025

Accounting Standards Update and Change in Accounting Principle [Abstract]

New Accounting Standards

The following table provides a description of current period adoptions of new Accounting Standards Updates (“ASUs”).

Standard	Description	Effective Date	Effect on Financial Statements or Other Significant Matters
ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures	This ASU aims to enhance reportable segment disclosure requirements. It requires that a public entity disclose significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”), disclose and describe other segment items and report additional measures of a segment’s profit or loss if used by the CODM.	January 1, 2024 (Annual Filings) and January 1, 2025 (Quarterly Filings)	We adopted this ASU on the applicable effective dates, incorporating the required disclosures in Note 15 to the consolidated financial statements, along with retrospectively updating the applicable tabular disclosures.

Future Adoption of New Accounting Standards

The following table provides a description of future adoptions of new ASUs that may have an impact on the consolidated financial statements when adopted. ASUs not listed below were assessed and determined to be either not applicable or insignificant in presentation or amount.

Standard	Description	Effective Date	Effect on Financial Statements or Other Significant Matters
ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures	This ASU establishes new income tax disclosure requirements, as well as adjusts certain existing requirements. It specifically requires expanded and disaggregated disclosures around the tax rate reconciliation.	January 1, 2025 (Annual Filings)	We are evaluating the impact of this ASU to disclosures within the Federal Income Taxes Note to the consolidated financial statements.
ASU 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40)	This ASU requires disclosure of specified information about certain costs and expenses, including employee compensation, depreciation and intangible asset amortization.	January 1, 2027	We are evaluating the impact of this ASU to the consolidated financial statements.

XML

Investments (Tables)

3 Months Ended

Mar. 31, 2025

Investments [Abstract]

Schedule of Available-for-Sale Securities Reconciliation

The amortized cost, gross unrealized gains and losses, allowance for credit losses and fair value of fixed maturity available-for-sale (“AFS”) securities (in millions) were as follows:

	As of March 31, 2025
	Amortized Cost		Gross Unrealized				Allowance for Credit Losses		Fair Value
			Gains		Losses
Fixed maturity AFS securities:
Corporate bonds	$	75,363	$	630	$	9,085	$	23	$	66,885
U.S. government bonds	567		5		34		–		538
State and municipal bonds	2,744		21		415		–		2,350
Foreign government bonds	282		13		56		–		239
RMBS	2,104		29		186		6		1,941
CMBS	1,961		6		137		–		1,830
ABS	14,515		110		340		44		14,241
Hybrid and redeemable preferred securities	259		25		10		1		273
Total fixed maturity AFS securities	$	97,795	$	839	$	10,263	$	74	$	88,297

	As of December 31, 2024
	Amortized Cost		Gross Unrealized				Allowance for Credit Losses		Fair Value
			Gains		Losses
Fixed maturity AFS securities:
Corporate bonds	$	75,556	$	563	$	9,655	$	14	$	66,450
U.S. government bonds	429		3		41		–		391
State and municipal bonds	2,798		18		445		–		2,371
Foreign government bonds	282		11		56		–		237
RMBS	2,066		24		220		7		1,863
CMBS	1,817		4		156		–		1,665
ABS	14,226		99		421		24		13,880
Hybrid and redeemable preferred securities	241		25		11		1		254
Total fixed maturity AFS securities	$	97,415	$	747	$	11,005	$	46	$	87,111

Investments Classified by Contractual Maturity Date

The amortized cost and fair value of fixed maturity AFS securities by contractual maturities (in millions) as of March 31, 2025, were as follows:

	Amortized Cost		Fair Value
Due in one year or less	$	4,353	$	4,332
Due after one year through five years	18,500		18,050
Due after five years through ten years	13,107		12,271
Due after ten years	43,255		35,632
Subtotal	79,215		70,285
Structured securities (RMBS, CMBS, ABS)	18,580		18,012
Total fixed maturity AFS securities	$	97,795	$	88,297

Schedule of Available-for-Sale Securities Unrealized Loss Position

The fair value and gross unrealized losses of fixed maturity AFS securities (dollars in millions) for which an allowance for credit losses has not been recorded, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position, were as follows:

	As of March 31, 2025
	Less Than or Equal to Twelve Months				Greater Than Twelve Months				Total
	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses (1)
Fixed maturity AFS securities:
Corporate bonds	$	23,140	$	3,798	$	29,434	$	5,287	$	52,574	$	9,085
U.S. government bonds	67		2		230		32		297		34
State and municipal bonds	940		214		766		201		1,706		415
Foreign government bonds	32		6		119		50		151		56
RMBS	660		58		786		128		1,446		186
CMBS	610		43		785		94		1,395		137
ABS	3,820		94		3,522		246		7,342		340
Hybrid and redeemable
preferred securities	24		2		92		8		116		10
Total fixed maturity AFS securities	$	29,293	$	4,217	$	35,734	$	6,046	$	65,027	$	10,263
Total number of fixed maturity AFS securities in an unrealized loss position											6,835

	As of December 31, 2024
	Less Than or Equal to Twelve Months				Greater Than Twelve Months				Total
	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses (1)
Fixed maturity AFS securities:
Corporate bonds	$	24,657	$	4,054	$	29,786	$	5,601	$	54,443	$	9,655
U.S. government bonds	86		3		224		38		310		41
State and municipal bonds	1,087		228		760		217		1,847		445
Foreign government bonds	32		5		118		51		150		56
RMBS	795		76		760		144		1,555		220
CMBS	579		50		777		106		1,356		156
ABS	2,907		118		3,827		303		6,734		421
Hybrid and redeemable
preferred securities	23		3		93		8		116		11
Total fixed maturity AFS securities	$	30,166	$	4,537	$	36,345	$	6,468	$	66,511	$	11,005
Total number of fixed maturity AFS securities in an unrealized loss position											6,985

(1) As of March 31, 2025, and December 31, 2024, we recognized $12 million and $23 million of gross unrealized losses, respectively, in other comprehensive income (loss) (“OCI”) for fixed maturity AFS securities for which an allowance for credit losses has been recorded.

The fair value, gross unrealized losses (in millions) and number of fixed maturity AFS securities where the fair value had declined and remained below amortized cost by greater than 20% were as follows:

	As of March 31, 2025
	Fair Value		Gross Unrealized Losses		Number of Securities (1)
Less than six months	$	3,053	$	900	522
Six months or greater, but less than nine months	1,600		518		324
Nine months or greater, but less than twelve months	369		187		208
Twelve months or greater	4,381		2,149		737
Total	$	9,403	$	3,754	1,791

	As of December 31, 2024
	Fair Value		Gross Unrealized Losses		Number of Securities (1)
Less than six months	$	5,405	$	1,621	799
Six months or greater, but less than nine months	371		198		216
Nine months or greater, but less than twelve months	71		28		37
Twelve months or greater	4,440		2,218		741
Total	$	10,287	$	4,065	1,793

(1) We may reflect a security in more than one aging category based on various purchase dates.

Debt Securities, Available-for-Sale

Changes in the allowance for credit losses on fixed maturity AFS securities (in millions), aggregated by investment category, were as follows:

	For the Three Months Ended March 31, 2025
	Corporate Bonds		RMBS		ABS		Hybrids		Total
Balance as of beginning-of-year	$	14	$	7	$	24	$	1	$	46
Additions from purchases of PCD debt securities (1)	–		–		–		–		–
Additions for securities for which credit losses were
not previously recognized	7		–		8		–		15
Additions (reductions) for securities for which
credit losses were previously recognized	2		(1)		12		–		13
Reductions for securities charged off	–		–		–		–		–
Balance as of end-of-period (2)	$	23	$	6	$	44	$	1	$	74

	For the Three Months Ended March 31, 2024
	Corporate Bonds		RMBS		ABS		Hybrids		Total
Balance as of beginning-of-year	$	8	$	6	$	4	$	1	$	19
Additions from purchases of PCD debt securities (1)	–		–		–		–		–
Additions for securities for which credit losses were
not previously recognized	1		–		–		–		1
Additions (reductions) for securities for which
credit losses were previously recognized	2		–		–		–		2
Reductions for disposed securities	(1)		–		–		–		(1)
Reductions for securities charged off	–		–		–		–		–
Balance as of end-of-period (2)	$	10	$	6	$	4	$	1	$	21

(1) Represents purchased credit-deteriorated (“PCD”) fixed maturity AFS securities.

(2) As of March 31, 2025 and 2024, accrued investment income on fixed maturity AFS securities totaled $911 million and $943 million, respectively, and was excluded from the estimate of credit losses.

Composition of Current and Past Due Mortgage Loans on Real Estate

The following provides the current and past due composition of our mortgage loans on real estate (in millions):

	As of March 31, 2025						As of December 31, 2024
	Commercial		Residential		Total		Commercial		Residential		Total
Current	$	17,602	$	3,795	$	21,397	$	17,567	$	3,387	$	20,954
30 to 59 days past due	13		84		97		6		71		77
60 to 89 days past due	3		26		29		–		33		33
90 or more days past due	31		104		135		35		90		125
Allowance for credit losses	(98)		(56)		(154)		(99)		(53)		(152)
Unamortized premium (discount)	(5)		91		86		(6)		83		77
Mark-to-market gains (losses) (1)	(32)		–		(32)		(31)		–		(31)
Total carrying value	$	17,514	$	4,044	$	21,558	$	17,472	$	3,611	$	21,083

(1) Represents the mark-to-market on certain mortgage loans on real estate that support our modified coinsurance agreements, where the investment results are passed directly to the reinsurers, and for which we have elected the fair value option. As of March 31, 2025, and December 31, 2024, the amortized cost and fair value of such mortgage loans on real estate that were in nonaccrual status was $30 million and $21 million, respectively. As of March 31, 2025, and December 31, 2024, there were no such mortgage loans on real estate that were more than 90 days past due and still accruing interest. See Note 12 for additional information.

Amortized Cost of Mortgage Loans on Real Estate on Nonaccrual Status

The amortized cost of mortgage loans on real estate on nonaccrual status (in millions) was as follows, excluding certain mortgage loans on real estate that support our modified coinsurance agreements, where the investment results are passed directly to the reinsurers:

	As of March 31, 2025		As of December 31, 2024
Commercial mortgage loans on real estate	$	1	$	4
Residential mortgage loans on real estate	106		92
Total	$	107	$	96

Financing Receivable Credit Quality Indicators

The amortized cost of commercial mortgage loans on real estate (dollars in millions) by year of origination and credit quality indicator was as follows:

	As of March 31, 2025
	LTV Less Than 65%		Debt-Service Coverage Ratio	LTV 65% to 75%		Debt-Service Coverage Ratio	LTV Greater Than 75%		Debt-Service Coverage Ratio	Total
Origination Year
2025	$	267	1.63	$	18	1.33	$	–	–	$	285
2024	1,551		1.73	74		1.42	1		1.69	1,626
2023	1,346		1.76	40		1.37	2		1.51	1,388
2022	1,718		2.07	87		1.52	8		1.24	1,813
2021	2,247		3.21	46		1.73	9		1.26	2,302
2020 and prior	10,103		2.48	114		1.56	13		1.13	10,230
Total	$	17,232		$	379		$	33		$	17,644

	As of December 31, 2024
	LTV Less Than 65%		Debt-Service Coverage Ratio	LTV 65% to 75%		Debt-Service Coverage Ratio	LTV Greater Than 75%		Debt-Service Coverage Ratio	Total
Origination Year
2024	$	1,548	1.73	$	83	1.41	$	–	–	$	1,631
2023	1,348		1.78	44		1.36	–		–	1,392
2022	1,724		2.11	94		1.55	4		1.30	1,822
2021	2,267		3.50	47		1.52	–		–	2,314
2020	1,167		3.33	4		1.53	–		–	1,171
2019 and prior	9,138		2.38	126		1.58	8		1.30	9,272
Total	$	17,192		$	398		$	12		$	17,602

The amortized cost of residential mortgage loans on real estate (in millions) by year of origination and credit quality indicator was as follows:

	As of March 31, 2025
	Performing		Nonperforming		Total
Origination Year
2025	$	167	$	–	$	167
2024	2,223		29		2,252
2023	495		19		514
2022	471		31		502
2021	415		12		427
2020 and prior	223		15		238
Total	$	3,994	$	106	$	4,100

	As of December 31, 2024
	Performing		Nonperforming		Total
Origination Year
2024	$	1,895	$	14	$	1,909
2023	557		16		573
2022	492		33		525
2021	427		11		438
2020	65		4		69
2019 and prior	136		14		150
Total	$	3,572	$	92	$	3,664

Changes in Allowance for Credit Losses on Mortgage Loans on Real Estate

Changes in the allowance for credit losses on mortgage loans on real estate (in millions) were as follows:

	For the Three Months Ended March 31, 2025
	Commercial		Residential		Total
Balance as of beginning-of-year	$	99	$	53	$	152
Additions (reductions) from provision for credit loss
expense (1)	(1)		3		2
Additions from purchases of PCD mortgage loans on
real estate	–		–		–
Balance as of end-of-period (2)	$	98	$	56	$	154

	For the Three Months Ended March 31, 2024
	Commercial		Residential		Total
Balance as of beginning-of-year	$	86	$	28	$	114
Additions (reductions) from provision for credit loss
expense (1)	(2)		3		1
Additions from purchases of PCD mortgage loans on
real estate	–		–		–
Balance as of end-of-period (2)	$	84	$	31	$	115

(1) We recognized $1 million of credit loss benefit (expense) related to unfunded commitments for mortgage loans on real estate for the three months ended March 31, 2025 and 2024.

(2) Accrued investment income on mortgage loans on real estate totaled $101 million and $69 million as of March 31, 2025 and 2024, respectively, and was excluded from the estimate of credit losses.

Credit Loss Expense Incurred

Details underlying credit loss benefit (expense) incurred as a result of impairments that were recognized in net income (loss) and included in realized gain (loss) on fixed maturity AFS securities (in millions) were as follows:

	For the Three Months Ended March 31,
	2025		2024
Credit Loss Benefit (Expense)
Fixed maturity AFS securities:
Corporate bonds	$	(9)	$	(2)
RMBS	1		–
ABS	(20)		–
Total credit loss benefit (expense)	$	(28)	$	(2)

Payables for Collateral on Investments

The carrying value of the payables for collateral on investments included on the Consolidated Balance Sheets and the fair value of the related investments or collateral (in millions) consisted of the following:

	As of March 31, 2025				As of December 31, 2024
	Carrying Value		Fair Value		Carrying Value		Fair Value
Collateral payable for derivative investments (1)	$	5,558	$	5,558	$	7,213	$	7,213
Securities pledged under securities lending agreements (2)	167		161		157		151
Securities pledged under repurchase agreements (3)	57		59		–		–
Investments pledged for FHLBI (4)	2,500		3,480		2,650		3,657
Total payables for collateral on investments	$	8,282	$	9,258	$	10,020	$	11,021

(1) We obtain collateral based upon contractual provisions with our counterparties. These agreements take into consideration the counterparties’ credit rating as compared to ours, the fair value of the derivative investments and specified thresholds that if exceeded result in the receipt of cash that is typically invested in cash and invested cash or fixed maturity AFS securities. This also includes interest payable on collateral. See Note 5 for additional information.

(2) Our pledged securities under securities lending agreements are included in fixed maturity AFS securities on the Consolidated Balance Sheets. We generally obtain collateral in an amount equal to 102% and 105% of the fair value of the domestic and foreign securities, respectively. We value collateral daily and obtain additional collateral when deemed appropriate. The cash received in our securities lending program is typically invested in cash and invested cash or fixed maturity AFS securities.

(3) Our pledged securities under repurchase agreements are included in fixed maturity AFS securities on the Consolidated Balance Sheets. The collateral requirements are generally 80% to 95% of the fair value of the securities, and our agreements with third parties contain contractual provisions to allow for additional collateral to be obtained when necessary. The cash received in our repurchase program is typically invested in cash and invested cash or fixed maturity AFS securities.

(4) Our pledged investments for Federal Home Loan Bank (“FHLB”) of Indianapolis (“FHLBI”) are included in fixed maturity AFS securities and mortgage loans on real estate on the Consolidated Balance Sheets. The collateral requirements are generally 105% to 115% of the fair value for fixed maturity AFS securities and 155% to 175% of the fair value for mortgage loans on real estate. The cash received in these transactions is primarily invested in cash and invested cash or fixed maturity AFS securities.

Schedule of Increase (Decrease) in Payables for Collateral on Investments

Increase (decrease) in payables for collateral on investments (in millions) consisted of the following:

	For the Three Months Ended March 31,
	2025		2024
Collateral payable for derivative investments	$	(1,655)	$	1,684
Securities pledged under securities
lending agreements	10		78
Securities pledged under repurchase agreements	57		–
Investments pledged for FHLBI	(150)		250
Total increase (decrease) in payables for
collateral on investments	$	(1,738)	$	2,012

Schedule of Securities Pledged by Contractual Maturity

The remaining contractual maturities of securities lending transactions accounted for as secured borrowings (in millions) were as follows:

	As of March 31, 2025
	Overnight  and  Continuous		Up to 30 Days		30-90 Days		Greater Than 90 Days		Total
Securities Lending
Corporate bonds	$	157	$	–	$	–	$	–	$	157
Equity securities	10		–		–		–		10
Total gross secured borrowings	$	167	$	–	$	–	$	–	$	167

	As of December 31, 2024
	Overnight  and  Continuous		Up to 30 Days		30-90 Days		Greater Than 90 Days		Total
Securities Lending
Corporate bonds	$	144	$	–	$	–	$	–	$	144
U.S. government bonds	1		–		–		–		1
Equity securities	12		–		–		–		12
Total gross secured borrowings	$	157	$	–	$	–	$	–	$	157

XML

Variable Interest Entities (Tables)

3 Months Ended

Mar. 31, 2025

Variable Interest Entities [Abstract]

Schedule of Variable Interest Entities

Asset information (dollars in millions) for the consolidated variable interest entities (“VIEs”) included on the Consolidated Balance Sheets was as follows:

	As of March 31, 2025					As of December 31, 2024
	Number of Instruments	Notional Amounts		Carrying Value		Number of Instruments		Notional Amounts		Carrying Value
Assets
Total return swap	1	$	504	$	–	$	1	$	522	$	–

XML

Derivative Instruments (Tables)

3 Months Ended

Mar. 31, 2025

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value

Outstanding derivative instruments with off-balance-sheet risks (in millions) were as follows:

	As of March 31, 2025						As of December 31, 2024
	Notional Amounts		Fair Value				Notional Amounts		Fair Value
			Asset		Liability				Asset		Liability
Qualifying Hedges
Cash flow hedges:
Interest rate contracts (1)	$	1,275	$	154	$	6	$	1,230	$	156	$	16
Foreign currency contracts (1)	4,805		552		44		4,738		556		44
Total cash flow hedges	6,080		706		50		5,968		712		60
Fair value hedges:
Interest rate contracts (1)	1,066		2		29		1,066		10		16
Foreign currency contracts (1)	25		–		–		25		1		–
Total fair value hedges	1,091		2		29		1,091		11		16
Non-Qualifying Hedges
Interest rate contracts (1)	81,364		40		334		75,445		63		439
Foreign currency contracts (1)	332		23		2		348		30		2
Equity market contracts (1)	168,433		10,477		3,081		191,666		13,072		3,879
Credit contracts (1)	242		–		–		57		–		–
Embedded derivatives:
Reinsurance-related (2)	–		–		138		–		–		30
RILA, fixed indexed annuity and IUL
contracts (3)	–		1,092		10,807		–		1,115		12,449
Total derivative instruments	$	257,542	$	12,340	$	14,441	$	274,575	$	15,003	$	16,875

(1) These asset and liability balances are presented on a gross basis. Amounts are reported in derivative investments and other liabilities on the Consolidated Balance Sheets after the evaluation for right of offset subject to master netting agreements.

(2) Reported in funds withheld reinsurance liabilities on the Consolidated Balance Sheets.

(3) Reported in policyholder account balances and deposit assets on the Consolidated Balance Sheets.

Schedule of Derivative Instruments

The maturity of the notional amounts of derivative instruments (in millions) was as follows:

	Remaining Life as of March 31, 2025
	Less Than 1 Year		1 - 5 Years		6 - 10 Years		11 - 30 Years		Over 30 Years		Total
Interest rate contracts (1)	$	12,810	$	18,418	$	23,981	$	27,898	$	598	$	83,705
Foreign currency contracts (2)	199		1,292		1,776		1,853		42		5,162
Equity market contracts	127,307		30,374		8,696		7		2,049		168,433
Credit contracts	–		172		70		–		–		242
Total derivative instruments with
notional amounts	$	140,316	$	50,256	$	34,523	$	29,758	$	2,689	$	257,542

(1) As of March 31, 2025, the latest maturity date for which we were hedging our exposure to the variability in future cash flows for these instruments was April 20, 2067.

(2) As of March 31, 2025, the latest maturity date for which we were hedging our exposure to the variability in future cash flows for these instruments was June 16, 2061.

Cumulative Basis Adjustments for Fair Value Hedges

The following amounts (in millions) were recorded on the Consolidated Balance Sheets related to cumulative basis adjustments for fair value hedges:

	Amortized Cost of the Hedged Assets (Liabilities)				Cumulative Fair Value Hedging Adjustment Included in the Amortized Cost of the Hedged Assets (Liabilities)
	As of March 31,  2025		As of  December 31, 2024		As of March 31,  2025		As of  December 31, 2024
Line Item in the Consolidated Balance Sheets in
which the Hedged Item is Included
Fixed maturity AFS securities, at fair value	$	497	$	484	$	19	$	7
Long-term debt (1)	(691)		(676)		184		199

(1) Includes $(306) million and $(310) million of unamortized adjustments from discontinued hedges as of March 31, 2025, and December 31, 2024, respectively.

Change in Our Unrealized Gain on Derivative Instruments in AOCI

The change in our unrealized gain (loss) on derivative instruments within accumulated other comprehensive income (loss) (“AOCI”) (in millions) was as follows:

	For the Three Months Ended March 31,
	2025		2024
Unrealized Gain (Loss) on Derivative Instruments
Balance as of beginning-of-year	$	638	$	375
Other comprehensive income (loss):
Unrealized holding gains (losses) arising during the period:
Cash flow hedges:
Interest rate contracts	5		89
Foreign currency contracts	168		(25)
Change in foreign currency exchange rate adjustment	(153)		101
Income tax benefit (expense)	(4)		(35)
Less:
Reclassification adjustment for gains (losses)
included in net income (loss):
Cash flow hedges:
Foreign currency contracts (1)	15		15
Interest rate contracts (2)	3		9
Foreign currency contracts (3)	3		–
Income tax benefit (expense)	(4)		(5)
Balance as of end-of-period	$	637	$	486

(1) The OCI offset is reported within net investment income on the Consolidated Statements of Comprehensive Income (Loss).

(2) The OCI offset is reported within interest and debt expense on the Consolidated Statements of Comprehensive Income (Loss).

(3) The OCI offset is reported within realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss).

Effects of Qualifying and Non-Qualifying Hedges

The effects of qualifying and non-qualifying hedges (in millions) on the Consolidated Statements of Comprehensive Income (Loss) were as follows:

Gain (Loss) Recognized in Income For the Three Months Ended March 31,

2025

2024

Realized Gain (Loss)

Net Investment Income

Interest and Debt Expense

Realized Gain (Loss)

Net Investment Income

Interest and Debt Expense

Total Line Items in which the

Effects of Fair Value or Cash

Flow Hedges are Recorded

$

11

$

1,457

$

80

$

(434)

$

1,346

$

81

Qualifying Hedges

Gain or (loss) on fair value hedging

relationships:

Interest rate contracts:

Hedged items

–

11

(15)

–

(18)

17

Derivatives designated as hedging

instruments

–

(11)

15

–

18

(17)

Foreign currency contracts:

Hedged items

–

1

–

–

(1)

–

Derivatives designated as hedging

instruments

–

(1)

–

–

1

–

Gain or (loss) on cash flow hedging

relationships:

Interest rate contracts:

Amount of gain or (loss) reclassified

from AOCI into income

–

–

3

–

–

9

Foreign currency contracts:

Amount of gain or (loss) reclassified

from AOCI into income

3

15

–

–

15

–

Non-Qualifying Hedges

Interest rate contracts

82

–

–

(163)

–

–

Foreign currency contracts

(1)

–

–

–

–

–

Equity market contracts

(1,143)

–

–

2,134

–

–

Credit contracts

1

–

–

–

–

–

Embedded derivatives:

Reinsurance-related

(108)

–

–

197

–

–

RILA, fixed indexed annuity and IUL

contracts

1,654

–

–

(1,642)

–

–

Schedule of Collateral Amounts With Rights to Reclaim or Obligation to Return Cash

The amounts recognized (in millions) by S&P credit rating of counterparty, for which we had the right to reclaim cash collateral or were obligated to return cash collateral, were as follows:

	As of March 31, 2025				As of December 31, 2024
S&P Credit Rating of Counterparty	Collateral Posted by Counterparty		Collateral Posted to Counterparty		Collateral Posted by Counterparty		Collateral Posted to Counterparty
AA-	$	3,314	$	(12)	$	4,043	$	(21)
A+	1,741		(28)		2,460		(89)
A	32		–		47		–
A-	449		–		632		–
Total cash collateral	$	5,536	$	(40)	$	7,182	$	(110)

Schedule of Offsetting Assets

Information related to the effects of offsetting on the Consolidated Balance Sheets (in millions) was as follows:

	As of March 31, 2025
	Derivative Instruments		Embedded Derivative Instruments		Total
Financial Assets
Gross amount of recognized assets	$	11,173	$	1,092	$	12,265
Gross amounts offset	(3,324)		–		(3,324)
Net amount of assets	7,849		1,092		8,941
Gross amounts not offset:
Cash collateral	(5,536)		–		(5,536)
Non-cash collateral (1)	(2,313)		–		(2,313)
Net amount	$	–	$	1,092	$	1,092
Financial Liabilities
Gross amount of recognized liabilities	$	197	$	10,945	$	11,142
Gross amounts offset	(100)		–		(100)
Net amount of liabilities	97		10,945		11,042
Gross amounts not offset:
Cash collateral	(40)		–		(40)
Non-cash collateral (2)	(57)		–		(57)
Net amount	$	–	$	10,945	$	10,945

(1) Excludes excess non-cash collateral received of $941 million, as the collateral offset is limited to the net estimated fair value of derivatives after application of netting arrangements.

(2) Excludes excess non-cash collateral pledged of $1 million, as the collateral offset is limited to the net estimated fair value of derivatives after application of netting arrangements.

	As of December 31, 2024
	Derivative Instruments		Embedded Derivative Instruments		Total
Financial Assets
Gross amount of recognized assets	$	13,483	$	1,115	$	14,598
Gross amounts offset	(3,806)		–		(3,806)
Net amount of assets	9,677		1,115		10,792
Gross amounts not offset:
Cash collateral	(7,182)		–		(7,182)
Non-cash collateral (1)	(2,495)		–		(2,495)
Net amount	$	–	$	1,115	$	1,115
Financial Liabilities
Gross amount of recognized liabilities	$	617	$	12,479	$	13,096
Gross amounts offset	(432)		–		(432)
Net amount of liabilities	185		12,479		12,664
Gross amounts not offset:
Cash collateral	(110)		–		(110)
Non-cash collateral (2)	(75)		–		(75)
Net amount	$	–	$	12,479	$	12,479

(1) Excludes excess non-cash collateral received of $817 million, as the collateral offset is limited to the net estimated fair value of derivatives after application of netting arrangements.

(2) Excludes excess non-cash collateral pledged of $39 million, as the collateral offset is limited to the net estimated fair value of derivatives after application of netting arrangements.

Schedule of Offsetting Liabilities

Information related to the effects of offsetting on the Consolidated Balance Sheets (in millions) was as follows:

	As of March 31, 2025
	Derivative Instruments		Embedded Derivative Instruments		Total
Financial Assets
Gross amount of recognized assets	$	11,173	$	1,092	$	12,265
Gross amounts offset	(3,324)		–		(3,324)
Net amount of assets	7,849		1,092		8,941
Gross amounts not offset:
Cash collateral	(5,536)		–		(5,536)
Non-cash collateral (1)	(2,313)		–		(2,313)
Net amount	$	–	$	1,092	$	1,092
Financial Liabilities
Gross amount of recognized liabilities	$	197	$	10,945	$	11,142
Gross amounts offset	(100)		–		(100)
Net amount of liabilities	97		10,945		11,042
Gross amounts not offset:
Cash collateral	(40)		–		(40)
Non-cash collateral (2)	(57)		–		(57)
Net amount	$	–	$	10,945	$	10,945

(1) Excludes excess non-cash collateral received of $941 million, as the collateral offset is limited to the net estimated fair value of derivatives after application of netting arrangements.

(2) Excludes excess non-cash collateral pledged of $1 million, as the collateral offset is limited to the net estimated fair value of derivatives after application of netting arrangements.

	As of December 31, 2024
	Derivative Instruments		Embedded Derivative Instruments		Total
Financial Assets
Gross amount of recognized assets	$	13,483	$	1,115	$	14,598
Gross amounts offset	(3,806)		–		(3,806)
Net amount of assets	9,677		1,115		10,792
Gross amounts not offset:
Cash collateral	(7,182)		–		(7,182)
Non-cash collateral (1)	(2,495)		–		(2,495)
Net amount	$	–	$	1,115	$	1,115
Financial Liabilities
Gross amount of recognized liabilities	$	617	$	12,479	$	13,096
Gross amounts offset	(432)		–		(432)
Net amount of liabilities	185		12,479		12,664
Gross amounts not offset:
Cash collateral	(110)		–		(110)
Non-cash collateral (2)	(75)		–		(75)
Net amount	$	–	$	12,479	$	12,479

(1) Excludes excess non-cash collateral received of $817 million, as the collateral offset is limited to the net estimated fair value of derivatives after application of netting arrangements.

(2) Excludes excess non-cash collateral pledged of $39 million, as the collateral offset is limited to the net estimated fair value of derivatives after application of netting arrangements.

XML

DAC, VOBA, DSI and DFEL (Tables)

3 Months Ended

Mar. 31, 2025

Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Net [Abstract]

Reconciliation of DAC, VOBA and DSI

The following table reconciles deferred acquisition costs (“DAC”), value of business acquired (“VOBA”) and deferred sales inducements (“DSI”) (in millions) to the Consolidated Balance Sheets:

	As of March 31,		As of December 31,
	2025		2024
DAC, VOBA and DSI
Variable Annuities	$	4,001	$	3,964
Fixed Annuities	416		423
Traditional Life	1,352		1,370
UL and Other	6,323		6,318
Group Protection	181		178
Retirement Plan Services	288		284
Other Operations	2		–
Total DAC, VOBA and DSI	$	12,563	$	12,537

Reconciliation of DFEL

The following table reconciles deferred front-end loads (“DFEL”) (in millions) to the Consolidated Balance Sheets:

	As of March 31,		As of December 31,
	2025		2024
DFEL
Variable Annuities	$	270	$	273
UL and Other	6,587		6,406
Other Operations (1)	53		51
Total DFEL	$	6,910	$	6,730

(1) Represents DFEL reported in Other Operations attributable to the indemnity reinsurance agreement with Protective that is excluded from the following tables. We reported $53 million and $51 million of ceded DFEL in reinsurance recoverables on the Consolidated Balance Sheets as of March 31, 2025, and December 31, 2024, respectively.

DAC

The following tables summarize the changes in DAC (in millions):

	For the Three Months Ended March 31, 2025
	Variable Annuities		Fixed Annuities		Traditional Life		UL and Other		Group Protection		Retirement Plan Services
Balance as of beginning-of-year	$	3,851	$	394	$	1,335	$	5,916	$	178	$	242
Deferrals	136		10		21		94		32		5
Amortization	(97)		(16)		(37)		(79)		(29)		(5)
Balance as of end-of-period	$	3,890	$	388	$	1,319	$	5,931	$	181	$	242

	For the Three Months Ended March 31, 2024
	Variable Annuities		Fixed Annuities		Traditional Life		UL and Other		Group Protection		Retirement Plan Services
Balance as of beginning-of-year	$	3,751	$	421	$	1,376	$	5,791	$	154	$	239
Deferrals	89		9		32		100		29		5
Amortization	(89)		(16)		(37)		(76)		(26)		(5)
Balance as of end-of-period	$	3,751	$	414	$	1,371	$	5,815	$	157	$	239

VOBA

The following tables summarize the changes in VOBA (in millions):

	For the Three Months Ended March 31, 2025
	Fixed Annuities		Traditional Life		UL and Other
Balance as of beginning-of-year	$	13	$	35	$	375
Amortization	(1)		(2)		(9)
Balance as of end-of-period	$	12	$	33	$	366

	For the Three Months Ended March 31, 2024
	Fixed Annuities		Traditional Life		UL and Other
Balance as of beginning-of-year	$	15	$	42	$	413
Amortization	(1)		(2)		(10)
Balance as of end-of-period	$	14	$	40	$	403

DSI

The following tables summarize the changes in DSI (in millions):

	For the Three Months Ended March 31, 2025
	Variable Annuities		Fixed Annuities		UL and Other		Retirement Plan Services
Balance as of beginning-of-year	$	113	$	16	$	27	$	42
Deferrals	–		–		–		4
Amortization	(2)		–		(1)		–
Balance as of end-of-period	$	111	$	16	$	26	$	46

	For the Three Months Ended March 31, 2024
	Variable Annuities		Fixed Annuities		UL and Other		Retirement Plan Services
Balance as of beginning-of-year	$	122	$	19	$	28	$	26
Deferrals	1		–		–		8
Amortization	(3)		–		–		–
Balance as of end-of-period	$	120	$	19	$	28	$	34

DFEL

The following tables summarize the changes in DFEL (in millions):

	For the Three Months Ended March 31, 2025				For the Three Months Ended March 31, 2024
	Variable Annuities		UL and Other		Variable Annuities		UL and Other
Balance as of beginning-of-year	$	273	$	6,406	$	278	$	5,579
Deferrals	3		279		5		267
Amortization	(6)		(98)		(6)		(68)
Balance as of end-of-period	270		6,587		277		5,778
Less: Ceded DFEL	–		237		–		258
Balance as of end-of-period, net of reinsurance	$	270	$	6,350	$	277	$	5,520

XML

Reinsurance (Tables)

3 Months Ended

Mar. 31, 2025

Reinsurance Disclosures [Abstract]

Schedule of Assets in Support of Reserves

We held investments with a carrying value of $9.2 billion and $9.3 billion in support of reserves associated with the Fortitude Re transaction in a funds withheld arrangement as of March 31, 2025, and December 31, 2024, respectively, which consisted of the following (in millions):

	As of March 31,		As of December 31,
	2025		2024
Fixed maturity AFS securities	$	7,549	$	7,764
Derivative investments	19		30
Other investments	1,465		1,419
Cash and invested cash	104		28
Accrued investment income	93		96
Total	$	9,230	$	9,337

XML

MRBs (Tables)

3 Months Ended

Mar. 31, 2025

Insurance [Abstract]

Reconciles of MRBs Assets and Liabilities

The following table reconciles market risk benefits (“MRBs”) (in millions) to MRB assets and MRB liabilities on the Consolidated Balance Sheets:

	As of March 31, 2025						As of December 31, 2024
	Assets		Liabilities		Net (Assets) Liabilities		Assets		Liabilities		Net (Assets) Liabilities
Variable Annuities	$	4,041	$	1,165	$	(2,876)	$	4,737	$	933	$	(3,804)
Fixed Annuities	73		137		64		78		110		32
Retirement Plan Services	43		4		(39)		45		3		(42)
Total MRBs	$	4,157	$	1,306	$	(2,851)	$	4,860	$	1,046	$	(3,814)

Summary of Balances of Changes in Net MRB (Assets) Liabilities

The following table summarizes the balances of and changes in net MRB (assets) liabilities (in millions):

	As of or For the Three Months Ended March 31, 2025						As of or For the Three Months Ended March 31, 2024
	Variable Annuities		Fixed Annuities		Retirement Plan Services		Variable Annuities		Fixed Annuities		Retirement Plan Services
Balance as of beginning-of-year	$	(3,804)	$	32	$	(42)	$	(2,180)	$	32	$	(30)
Less: Effect of cumulative changes in
non-performance risk	(153)		(33)		–		(1,299)		(58)		(4)
Balance as of beginning-of-year, before the effect
of changes in non-performance risk	(3,651)		65		(42)		(881)		90		(26)
Issuances	5		–		–		3		–		–
Attributed fees collected	373		8		1		380		9		2
Benefit payments	(6)		–		–		(11)		–		–
Effect of changes in interest rates	396		39		1		(1,081)		(17)		(6)
Effect of changes in equity markets	456		2		2		(1,343)		(11)		(4)
Effect of changes in equity index volatility	31		–		–		4		(2)		–
In-force updates and other changes in MRBs (1)	59		(2)		1		51		1		1
Balance as of end-of-period, before the effect of
changes in non-performance risk	(2,337)		112		(37)		(2,878)		70		(33)
Effect of cumulative changes in
non-performance risk	(539)		(48)		(2)		(726)		(43)		(2)
Balance as of end-of-period	(2,876)		64		(39)		(3,604)		27		(35)
Less: Ceded MRB assets (liabilities)	(312)		–		–		(358)		–		–
Balance as of end-of-period, net of reinsurance	$	(2,564)	$	64	$	(39)	$	(3,246)	$	27	$	(35)
Weighted-average age of policyholders (years)	73		70		63		72		69		63
Net amount at risk (2)	$	2,518	$	255	$	4	$	2,056	$	210	$	3

(1)     Consists primarily of changes in MRB assets and liabilities related to differences between separate account fund performance and modeled indices and other changes such as actual to expected policyholder behavior.

(2)     Net amount at risk (“NAR”) is the current guaranteed minimum benefit in excess of the current account balance as of the balance sheet date. For guaranteed living benefits (“GLBs”), the guaranteed minimum benefit is calculated based on the present value of GLB payments. Our variable annuity products may offer more than one type of guaranteed benefit rider to a policyholder. In instances where more than one guaranteed benefit feature exists in a contract, the guaranteed benefit rider that provides the highest NAR is used in the calculation.

XML

Separate Accounts (Tables)

3 Months Ended

Mar. 31, 2025

Separate Accounts Disclosure [Abstract]

Schedule of Fair Value of Separate Account Assets

The following table presents the fair value of separate account assets (in millions) reported on the Consolidated Balance Sheets by major investment category:

	As of March 31,		As of December 31,
	2025		2024
Mutual funds and collective investment trusts	$	161,823	$	167,759
Exchange-traded funds	249		336
Fixed maturity AFS securities	168		161
Cash and invested cash	77		12
Other investments	189		170
Total separate account assets	$	162,506	$	168,438

Schedule of Reconciliation of Separate Account Liabilities

The following table reconciles separate account liabilities (in millions) to the Consolidated Balance Sheets:

	As of March 31,		As of December 31,
	2025		2024
Variable Annuities	$	113,635	$	117,998
UL and Other	28,106		28,841
Retirement Plan Services	20,708		21,541
Other Operations (1)	57		58
Total separate account liabilities	$	162,506	$	168,438

(1) Represents separate account liabilities reported in Other Operations primarily attributable to the indemnity reinsurance agreements with Protective ($47 million and $49 million as of March 31, 2025, and December 31, 2024, respectively) that are excluded from the following tables.

Summary of Balances and changes in Separate Account Liabilities

The following table summarizes the balances of and changes in separate account liabilities (in millions):

	As of or For the Three Months Ended March 31, 2025						As of or For the Three Months Ended March 31, 2024
	Variable Annuities		UL and Other		Retirement Plan Services		Variable Annuities		UL and Other		Retirement Plan Services
Balance as of beginning-of-year	$	117,998	$	28,841	$	21,541	$	113,356	$	25,150	$	19,699
Gross deposits	1,557		353		627		904		358		570
Withdrawals	(3,915)		(204)		(902)		(3,208)		(103)		(732)
Policyholder assessments	(656)		(246)		(46)		(648)		(246)		(44)
Change in market performance	(1,798)		(624)		(478)		7,503		1,885		1,475
Net transfers from (to) general account	449		(14)		(34)		269		(37)		18
Balance as of end-of-period	$	113,635	$	28,106	$	20,708	$	118,176	$	27,007	$	20,986
Cash surrender value	$	112,239	$	23,577	$	20,695	$	116,771	$	24,606	$	20,971

XML

Policyholder Account Balances (Tables)

3 Months Ended

Mar. 31, 2025

Policyholder Account Balance [Abstract]

Schedule of Policyholder Account Balances

The following table reconciles policyholder account balances (in millions) to the Consolidated Balance Sheets:

	As of March 31,		As of December 31,
	2025		2024
Variable Annuities	$	34,370	$	35,267
Fixed Annuities	26,039		25,963
UL and Other	36,220		36,599
Retirement Plan Services	23,479		23,619
Other (1)	5,154		4,749
Total policyholder account balances	$	125,262	$	126,197

(1) Represents policyholder account balances reported primarily in Other Operations attributable to the indemnity reinsurance agreements with Protective ($4.3 billion and $4.4 billion as of March 31, 2025, and December 31, 2024, respectively) and funding agreements, that are excluded from the following tables. See “Funding Agreements” below for more information.

Summary of Balances and Changes in Policyholder Account Balances

The following table summarizes the balances and changes in policyholder account balances (in millions):

	As of or For the Three Months Ended March 31, 2025
	Variable Annuities		Fixed Annuities		UL and Other		Retirement Plan Services
Balance as of beginning-of-year	$	35,267	$	25,963	$	36,599	$	23,619
Gross deposits	1,369		873		865		811
Withdrawals	(612)		(947)		(445)		(1,330)
Policyholder assessments	–		(15)		(1,104)		(4)
Net transfers from (to) separate account	(287)		–		14		211
Interest credited	199		210		356		172
Change in fair value of embedded derivative
instruments and other	(1,566)		(45)		(65)		–
Balance as of end-of-period	$	34,370	$	26,039	$	36,220	$	23,479
Weighted-average crediting rate	2.3%		3.2%		3.9%		2.9%
Net amount at risk (1) (2)	$	2,518	$	255	$	299,107	$	4
Cash surrender value	33,108		24,935		32,645		23,443

	As of or For the Three Months Ended March 31, 2024
	Variable Annuities			Fixed Annuities			UL and Other			Retirement Plan Services
Balance as of beginning-of-year	$	29,141		$	25,355		$	37,180		$	23,784
Gross deposits	973			973			850			790
Withdrawals	(224)			(1,410)			(364)			(1,203)
Policyholder assessments	–			(17)			(1,124)			(3)
Net transfers from (to) separate account	(178)			–			38			50
Interest credited	158			183			365			168
Change in fair value of embedded derivative
instruments and other	1,538			78			61			–
Balance as of end-of-period	$	31,408		$	25,162		$	37,006		$	23,586
Weighted-average crediting rate	2.1		%	2.9		%	3.9		%	2.8		%
Net amount at risk (1) (2)	$	2,056		$	210		$	300,740		$	3
Cash surrender value	30,228			24,139			33,314			23,560

(1) NAR is the current guaranteed minimum benefit in excess of the current account balance as of the balance sheet date. For GLBs, the guaranteed minimum benefit is calculated based on the present value of GLB payments. Our variable annuity products may offer more than one type of guaranteed benefit rider to a policyholder. In instances where more than one guaranteed benefit rider exists in a contract, the guaranteed benefit rider that provides the highest NAR is used in the calculation.

(2) Calculation is based on total account balances and includes both policyholder account balances and separate account balances.

Summary of Policyholder Account Balances by Range

The following table presents policyholder account balances (in millions) by range of guaranteed minimum crediting rates and the related range of difference, in basis points, between the interest being credited to policyholders and the respective guaranteed contract minimums:

	As of March 31, 2025
	At Guaranteed Minimum		1-50 Basis Points Above		51-100 Basis Points Above		101-150 Basis Points Above		Greater Than 150 Basis Points Above		Total
Range of Guaranteed
Minimum Crediting Rate
Variable Annuities
Up to 1.00%	$	9	$	–	$	–	$	–	$	–	$	9
1.01% - 2.00%	3		–		–		–		7		10
2.01% - 3.00%	495		–		–		–		–		495
3.01% - 4.00%	1,197		–		–		–		–		1,197
4.01% and above	7		–		–		–		–		7
Other (1)	–		–		–		–		–		32,652
Total	$	1,711	$	–	$	–	$	–	$	7	$	34,370
Fixed Annuities
Up to 1.00%	$	201	$	855	$	459	$	229	$	2,266	$	4,010
1.01% - 2.00%	223		202		146		161		5,908		6,640
2.01% - 3.00%	1,499		33		1		2		38		1,573
3.01% - 4.00%	930		–		–		–		–		930
4.01% and above	166		–		–		–		–		166
Other (1)	–		–		–		–		–		12,720
Total	$	3,019	$	1,090	$	606	$	392	$	8,212	$	26,039
UL and Other
Up to 1.00%	$	261	$	–	$	231	$	31	$	453	$	976
1.01% - 2.00%	541		–		–		–		2,976		3,517
2.01% - 3.00%	6,483		9		152		–		–		6,644
3.01% - 4.00%	14,972		–		1		–		–		14,973
4.01% and above	3,525		–		–		–		–		3,525
Other (1)	–		–		–		–		–		6,585
Total	$	25,782	$	9	$	384	$	31	$	3,429	$	36,220
Retirement Plan Services
Up to 1.00%	$	573	$	312	$	725	$	3,498	$	5,766	$	10,874
1.01% - 2.00%	477		996		1,847		451		662		4,433
2.01% - 3.00%	1,680		542		48		18		1		2,289
3.01% - 4.00%	4,194		107		8		11		–		4,320
4.01% and above	1,426		137		–		–		–		1,563
Total	$	8,350	$	2,094	$	2,628	$	3,978	$	6,429	$	23,479

	As of March 31, 2024
	At Guaranteed Minimum		1-50 Basis Points Above		51-100 Basis Points Above		101-150 Basis Points Above		Greater Than 150 Basis Points Above		Total
Range of Guaranteed
Minimum Crediting Rate
Variable Annuities
Up to 1.00%	$	–	$	–	$	–	$	–	$	–	$	–
1.01% - 2.00%	5		–		–		–		6		11
2.01% - 3.00%	560		–		–		–		–		560
3.01% - 4.00%	1,319		–		–		–		–		1,319
4.01% and above	9		–		–		–		–		9
Other (1)	–		–		–		–		–		29,509
Total	$	1,893	$	–	$	–	$	–	$	6	$	31,408
Fixed Annuities
Up to 1.00%	$	679	$	605	$	560	$	493	$	2,466	$	4,803
1.01% - 2.00%	360		99		285		500		3,231		4,475
2.01% - 3.00%	1,749		39		5		1		25		1,819
3.01% - 4.00%	916		–		–		–		–		916
4.01% and above	177		–		–		–		–		177
Other (1)	–		–		–		–		–		12,972
Total	$	3,881	$	743	$	850	$	994	$	5,722	$	25,162
UL and Other
Up to 1.00%	$	264	$	–	$	219	$	119	$	30	$	632
1.01% - 2.00%	548		–		–		–		3,208		3,756
2.01% - 3.00%	6,848		10		149		–		–		7,007
3.01% - 4.00%	15,596		–		1		–		–		15,597
4.01% and above	3,722		–		–		–		–		3,722
Other (1)	–		–		–		–		–		6,292
Total	$	26,978	$	10	$	369	$	119	$	3,238	$	37,006
Retirement Plan Services
Up to 1.00%	$	437	$	500	$	740	$	3,706	$	4,320	$	9,703
1.01% - 2.00%	527		1,660		1,413		1,345		14		4,959
2.01% - 3.00%	2,342		21		63		17		1		2,444
3.01% - 4.00%	4,842		31		3		3		–		4,879
4.01% and above	1,458		143		–		–		–		1,601
Total	$	9,606	$	2,355	$	2,219	$	5,071	$	4,335	$	23,586

(1) Consists of indexed account balances that include the fair value of embedded derivative instruments, non-life contingent payout annuity account balances, short-term dollar cost averaging annuities business and policy loans.

XML

Future Contract Benefits (Tables)

3 Months Ended

Mar. 31, 2025

Liability for Future Policy Benefits and Unpaid Claims and Claims Adjustment Expense [Abstract]

Summary of Reconciliation of Future Contract Benefits

The following table reconciles future contract benefits (in millions) to the Consolidated Balance Sheets:

	As of March 31,		As of December 31,
	2025		2024
Payout Annuities (1)	$	2,033	$	2,009
Traditional Life (1)	3,821		3,774
Group Protection (2)	5,712		5,628
UL and Other (3)	16,702		16,062
Other Operations (4)	9,062		9,070
Other (5)	3,335		3,264
Total future contract benefits	$	40,665	$	39,807

(1) See “Liability for Future Policy Benefits” below for further information.

(2) See “Liability for Future Claims” below for further information.

(3) See “Additional Liabilities for Other Insurance Benefits” below for further information.

(4) Represents future contract benefits reported in Other Operations primarily attributable to the indemnity reinsurance agreements with Protective ($5.4 billion as of March 31, 2025, and December 31, 2024) and Swiss Re ($1.8 billion as of March 31, 2025, and December 31, 2024) that are excluded from the following tables.

(5) Represents other miscellaneous reserves that are not representative of long-duration contracts and are excluded from the following tables.

Liability for Future Policy Benefit, Activity

The following table summarizes the balances of and changes in the present values of expected net premiums and liability for future policy benefits (“LFPB”) (in millions, except years):

	As of or For the Three Months Ended March 31, 2025				As of or For the Three Months Ended March 31, 2024
	Payout Annuities		Traditional Life		Payout Annuities		Traditional Life
Present Value of Expected Net Premiums
Balance as of beginning-of-year	$	–	$	5,873	$	–	$	6,200
Less: Effect of cumulative changes in discount
rate assumptions	–		(275)		–		(148)
Beginning balance at original discount rate	–		6,148		–		6,348
Effect of actual variances from expected experience	–		(48)		–		2
Adjusted balance as of beginning-of-year	–		6,100		–		6,350
Issuances	–		64		–		108
Interest accrual	–		62		–		63
Net premiums collected	–		(192)		–		(202)
Flooring impact of LFPB	–		(5)		–		3
Ending balance at original discount rate	–		6,029		–		6,322
Effect of cumulative changes in discount
rate assumptions	–		(196)		–		(254)
Balance as of end-of-period	$	–	$	5,833	$	–	$	6,068
Present Value of Expected LFPB
Balance as of beginning-of-year	$	2,009	$	9,647	$	2,085	$	10,041
Less: Effect of cumulative changes in discount
rate assumptions	(251)		(438)		(187)		(189)
Beginning balance at original discount rate (1)	2,260		10,085		2,272		10,230
Effect of actual variances from expected experience	(1)		(55)		1		7
Adjusted balance as of beginning-of-year	2,259		10,030		2,273		10,237
Issuances	22		64		15		108
Interest accrual	22		99		22		100
Benefit payments	(49)		(234)		(49)		(206)
Ending balance at original discount rate (1)	2,254		9,959		2,261		10,239
Effect of cumulative changes in discount
rate assumptions	(221)		(305)		(227)		(378)
Balance as of end-of-period	$	2,033	$	9,654	$	2,034	$	9,861
Net balance as of end-of-period	$	2,033	$	3,821	$	2,034	$	3,793
Less: Reinsurance recoverables	1,478		360		1,562		421
Net balance as of end-of-period, net of reinsurance	$	555	$	3,461	$	472	$	3,372
Weighted-average duration of future policyholder
benefit liability (years)	9		9		9		9

(1) Includes deferred profit liability within Payout Annuities of $65 million and $60 million as of March 31, 2025 and 2024, respectively.

The following table summarizes the balances of and changes in liability for future claims (in millions, except years):

	Group Protection
	As of or For the Three Months Ended March 31,
	2025		2024
Balance as of beginning-of-year	$	5,628	$	5,689
Less: Effect of cumulative changes in discount
rate assumptions	(550)		(490)
Beginning balance at original discount rate	6,178		6,179
Effect of actual variances from expected experience	(72)		(67)
Adjusted beginning-of-year balance	6,106		6,112
New incidence	402		408
Interest	50		48
Benefit payments	(371)		(382)
Ending balance at original discount rate	6,187		6,186
Effect of cumulative changes in discount
rate assumptions	(475)		(546)
Balance as of end-of-period	5,712		5,640
Less: Reinsurance recoverables	121		123
Balance as of end-of-period, net of reinsurance	$	5,591	$	5,517
Weighted-average duration of liability for future
claims (years)	5		5

The following table summarizes the balances of and changes in additional liabilities for other insurance benefits (in millions, except years):

	UL and Other
	As of or For the Three Months Ended March 31,
	2025		2024
Balance as of beginning-of-year	$	16,062	$	15,000
Less: Effect of cumulative changes in shadow
balance in AOCI	(2,673)		(2,222)
Balance as of beginning-of-year, excluding
shadow balance in AOCI	18,735		17,222
Effect of actual variances from expected experience	23		106
Adjusted beginning-of-year balance	18,758		17,328
Interest accrual	228		209
Net assessments collected	293		303
Benefit payments	(200)		(313)
Balance as of end-of-period, excluding shadow
balance in AOCI	19,079		17,527
Effect of cumulative changes in shadow
balance in AOCI	(2,377)		(3,083)
Balance as of end-of-period	16,702		14,444
Less: Reinsurance recoverables	5,316		4,776
Balance as of end-of-period, net of reinsurance	$	11,386	$	9,668
Weighted-average duration of additional liabilities
for other insurance benefits (years)	16		17

Summary of Discounted and Undiscounted Expected Future Gross premiums and Expected Future Benefit Payments

The following table summarizes the discounted and undiscounted expected future gross premiums and expected future benefit payments (in millions):

	As of March 31, 2025				As of March 31, 2024
	Undiscounted		Discounted		Undiscounted		Discounted
Payout Annuities
Expected future gross premiums	$	–	$	–	$	–	$	–
Expected future benefit payments	3,408		2,033		3,438		2,034
Traditional Life
Expected future gross premiums	13,807		9,447		13,896		9,570
Expected future benefit payments	14,129		9,654		14,582		9,861

The following table summarizes the discounted and undiscounted expected future benefit payments (in millions):

	As of March 31, 2025				As of March 31, 2024
	Undiscounted		Discounted		Undiscounted		Discounted
Group Protection
Expected future benefit payments	$	7,413	$	5,712	$	7,296	$	5,640

Summary of Gross Premiums and Interest Accretion

The following table summarizes the gross premiums and interest accretion (in millions) recognized in insurance premiums and benefits, respectively, on the Consolidated Statements of Comprehensive Income (Loss):

	For the Three Months Ended March 31,
	2025		2024
Payout Annuities
Gross premiums	$	23	$	21
Interest accretion	22		22
Traditional Life
Gross premiums	314		314
Interest accretion	37		37

The following table summarizes the gross premiums and interest accretion (in millions) recognized in insurance premiums and benefits, respectively, on the Consolidated Statements of Comprehensive Income (Loss):

	For the Three Months Ended March 31,
	2025		2024
Group Protection
Gross premiums	$	933	$	896
Interest accretion	50		48

The following table summarizes the gross assessments and interest accretion (in millions) recognized in insurance premiums and benefits, respectively, on the Consolidated Statements of Comprehensive Income (Loss):

	For the Three Months Ended March 31,
	2025		2024
UL and Other
Gross assessments	$	700	$	766
Interest accretion	228		209

Summary of Weighted-Average Interest Rates

The following table summarizes the weighted-average interest rates:

	For the Three Months Ended March 31,
	2025		2024
Payout Annuities
Interest accretion rate	4.0	%	3.9	%
Current discount rate	5.2	%	5.2	%
Traditional Life
Interest accretion rate	5.0	%	5.0	%
Current discount rate	4.9	%	5.0	%

The following table summarizes the weighted-average interest rates:

	For the Three Months Ended March 31,
	2025		2024
Group Protection
Interest accretion rate	3.4	%	3.2	%
Current discount rate	4.9	%	5.0	%

The following table summarizes the weighted-average interest rates:

	For the Three Months Ended March 31,
	2025		2024
UL and Other
Interest accretion rate	5.4	%	5.3	%

XML

Fair Value of Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2025

Fair Value Disclosures [Abstract]

Fair Value of Assets and Liabilities on a Recurring Basis

The following summarizes our financial instruments carried at fair value (in millions) on a recurring basis by the fair value hierarchy levels:

	As of March 31, 2025
	Quoted
	Prices
	in Active
	Markets for		Significant		Significant
	Identical		Observable		Unobservable		Total
	Assets		Inputs		Inputs		Fair
	(Level 1)		(Level 2)		(Level 3)		Value
Assets
Investments:
Fixed maturity AFS securities:
Corporate bonds	$	–	$	63,911	$	2,974	$	66,885
U.S. government bonds	518		20		–		538
State and municipal bonds	–		2,350		–		2,350
Foreign government bonds	–		239		–		239
RMBS	–		1,922		19		1,941
CMBS	–		1,800		30		1,830
ABS	–		11,610		2,631		14,241
Hybrid and redeemable preferred securities	47		145		81		273
Trading securities	–		1,697		287		1,984
Equity securities	–		310		35		345
Mortgage loans on real estate	–		–		232		232
Derivative investments (1)	–		11,238		10		11,248
Other investments – short-term investments	–		468		15		483
MRB assets	–		–		4,157		4,157
Other assets:
Ceded MRBs	–		–		2		2
Indexed annuity ceded embedded derivatives	–		–		1,092		1,092
Separate account assets	373		162,133		–		162,506
Total assets	$	938	$	257,843	$	11,565	$	270,346
Liabilities
Policyholder account balances – RILA, fixed annuity
and IUL contracts	$	–	$	–	$	(10,807)	$	(10,807)
Funds withheld reinsurance liabilities – reinsurance-related
embedded derivatives	–		185		(323)		(138)
MRB liabilities	–		–		(1,306)		(1,306)
Other liabilities:
Ceded MRBs	–		–		(314)		(314)
Derivative liabilities (1)	–		(3,377)		(119)		(3,496)
Total liabilities	$	–	$	(3,192)	$	(12,869)	$	(16,061)

	As of December 31, 2024
	Quoted
	Prices
	in Active
	Markets for		Significant		Significant
	Identical		Observable		Unobservable		Total
	Assets		Inputs		Inputs		Fair
	(Level 1)		(Level 2)		(Level 3)		Value
Assets
Investments:
Fixed maturity AFS securities:
Corporate bonds	$	–	$	63,585	$	2,865	$	66,450
U.S. government bonds	371		20		–		391
State and municipal bonds	–		2,371		–		2,371
Foreign government bonds	–		237		–		237
RMBS	–		1,851		12		1,863
CMBS	–		1,657		8		1,665
ABS	–		11,781		2,099		13,880
Hybrid and redeemable preferred securities	48		133		73		254
Trading securities	–		1,760		265		2,025
Equity securities	–		260		34		294
Mortgage loans on real estate	–		–		232		232
Derivative investments (1)	–		13,884		3		13,887
Other investments – short-term investments	–		369		23		392
MRB assets	–		–		4,860		4,860
Other assets:
Ceded MRBs	–		–		2		2
Indexed annuity ceded embedded derivatives	–		–		1,115		1,115
Separate account assets	391		168,047		–		168,438
Total assets	$	810	$	265,955	$	11,591	$	278,356
Liabilities
Policyholder account balances – RILA, fixed annuity
and IUL contracts	$	–	$	–	$	(12,449)	$	(12,449)
Funds withheld reinsurance liabilities – reinsurance-related
embedded derivatives	–		204		(234)		(30)
MRB liabilities	–		–		(1,046)		(1,046)
Other liabilities:
Ceded MRBs	–		–		(381)		(381)
Derivative liabilities (1)	–		(4,256)		(139)		(4,395)
Total liabilities	$	–	$	(4,052)	$	(14,249)	$	(18,301)

(1) Derivative investment assets and liabilities are presented within the fair value hierarchy on a gross basis by derivative type and not on a master netting basis by counterparty.

The following summarizes the fair value by the fair value hierarchy levels and the carrying amount of our financial instruments not carried at fair value (in millions):

	As of March 31, 2025
	Quoted
	Prices
	in Active
	Markets for		Significant		Significant
	Identical		Observable		Unobservable		Total
	Assets		Inputs		Inputs		Fair		Carrying
	(Level 1)		(Level 2)		(Level 3)		Value		Amount
Assets
Investments:
Mortgage loans on real estate	$	–	$	20,373	$	–	$	20,373	$	21,326
Other investments	–		513		5,657		6,170		6,170
Policy loans	–		2,529		–		2,529		2,529
Cash and invested cash	–		4,284		–		4,284		4,284
Liabilities
Policyholder account balances – certain investment
contracts and other liabilities	$	–	$	–	$	(30,876)	$	(30,876)	$	(41,005)
Policyholder account balances – funding agreements	–		(508)		–		(508)		(500)
Long-term debt	–		(5,356)		–		(5,356)		(5,868)
Funds withheld reinsurance-related liabilities – excluding
embedded derivatives	–		–		(16,700)		(16,700)		(16,700)

	As of December 31, 2024
	Quoted
	Prices
	in Active
	Markets for		Significant		Significant
	Identical		Observable		Unobservable		Total
	Assets		Inputs		Inputs		Fair		Carrying
	(Level 1)		(Level 2)		(Level 3)		Value		Amount
Assets
Investments:
Mortgage loans on real estate	$	–	$	19,647	$	–	$	19,647	$	21,083
Other investments	–		1,119		5,469		6,588		6,588
Policy loans	–		2,476		–		2,476		2,476
Cash and invested cash	–		5,801		–		5,801		5,801
Liabilities
Policyholder account balances – certain investment
contracts and other liabilities	$	–	$	–	$	(30,505)	$	(30,505)	$	(40,394)
Short-term debt	–		(299)		–		(299)		(300)
Long-term debt	–		(5,304)		–		(5,304)		(5,856)
Funds withheld reinsurance-related liabilities – excluding
embedded derivatives	–		–		(16,877)		(16,877)		(16,877)

Fair Value Measured on a Recurring Basis Reconciliation

The following summarizes changes to our financial instruments carried at fair value (in millions) and classified within Level 3 of the fair value hierarchy. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology. The summary schedule excludes changes to MRB assets and MRB liabilities as these balances are rolled forward in Note 8.

	For the Three Months Ended March 31, 2025
					Gains		Issuances,		Transfers
			Items		(Losses)		Sales,		Into or
			Included		in		Maturities,		Out
	Beginning		in		OCI		Settlements,		of		Ending
	Fair		Net		and		Calls,		Level 3,		Fair
	Value		Income		Other (1)		Net		Net		Value
Assets
Investments: (2)
Fixed maturity AFS securities:
Corporate bonds	$	2,865	$	(13)	$	1	$	99	$	22	$	2,974
RMBS	12		–		–		7		–		19
CMBS	8		–		–		22		–		30
ABS	2,099		(21)		18		478		57		2,631
Hybrid and redeemable preferred
securities	73		–		–		18		(10)		81
Trading securities	265		1		–		4		17		287
Equity securities	34		(6)		–		7		–		35
Mortgage loans on real estate	232		(1)		2		(1)		–		232
Other investments	23		–		–		(8)		–		15
Other assets:
Ceded MRBs (3)	2		–		–		–		–		2
Indexed annuity ceded embedded
derivatives (4)	1,115		(24)		–		1		–		1,092
Liabilities
Policyholder account balances –
RILA, fixed annuity and
IUL contracts (4)	(12,449)		1,676		–		(34)		–		(10,807)
Funds withheld reinsurance
liabilities – reinsurance-related
embedded derivatives (4)	(234)		(89)		–		–		–		(323)
Other liabilities:
Ceded MRBs (3)	(381)		67		–		–		–		(314)
Derivative liabilities	(136)		27		–		–		–		(109)
Total, net	$	(6,472)	$	1,617	$	21	$	593	$	86	$	(4,155)

	For the Three Months Ended March 31, 2024
					Gains		Issuances,		Transfers
			Items		(Losses)		Sales,		Into or
			Included		in		Maturities,		Out
	Beginning		in		OCI		Settlements,		of		Ending
	Fair		Net		and		Calls,		Level 3,		Fair
	Value		Income		Other (1)		Net		Net		Value
Assets
Investments: (2)
Fixed maturity AFS securities:
Corporate bonds	$	2,497	$	2	$	(10)	$	22	$	(22)	$	2,489
State and municipal bonds	5		–		–		–		(5)		–
RMBS	13		–		(1)		–		–		12
CMBS	8		–		–		–		–		8
ABS	1,484		–		(1)		201		8		1,692
Hybrid and redeemable preferred
securities	48		–		3		–		–		51
Trading securities	284		–		–		(13)		–		271
Equity securities	42		(3)		–		–		–		39
Mortgage loans on real estate	288		–		1		–		–		289
Derivative investments	36		12		–		4		(51)		1
Other assets:
Ceded MRBs (3)	2		–		–		–		–		2
Indexed annuity ceded embedded
derivatives (4)	940		33		–		–		–		973
Liabilities
Policyholder account balances –
RILA, fixed annuity and
IUL contracts (4)	(9,077)		(1,677)		–		(142)		–		(10,896)
Funds withheld reinsurance
liabilities – reinsurance-related
embedded derivatives (4)	(789)		206		–		–		–		(583)
Other liabilities – ceded MRBs (3)	(239)		(121)		–		–		–		(360)
Total, net	$	(4,458)	$	(1,548)	$	(8)	$	72	$	(70)	$	(6,012)

(1) The changes in fair value of the interest rate swaps are offset by an adjustment to derivative investments (see Note 5).

(2) Amortization and accretion of premiums and discounts are included in net investment income on the Consolidated Statements of Comprehensive Income (Loss). Gains (losses) from sales, maturities, settlements and calls and credit loss expense are included in realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss).

(3) Gains (losses) from the changes in fair value are included in market risk benefit gain (loss) on the Consolidated Statements of Comprehensive Income (Loss).

(4) Gains (losses) from the changes in fair value are included in realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss).

Schedule of Investment Holdings Movements

The following provides the components of the items included in issuances, sales, maturities, settlements and calls, net, (in millions) as reported above:

	For the Three Months Ended March 31, 2025
	Issuances		Sales		Maturities		Settlements		Calls		Total
Investments:
Fixed maturity AFS securities:
Corporate bonds	$	246	$	(45)	$	–	$	(102)	$	–	$	99
RMBS	7		–		–		–		–		7
CMBS	22		–		–		–		–		22
ABS	594		–		(10)		(90)		(16)		478
Hybrid and redeemable preferred
securities	20		(2)		–		–		–		18
Trading securities	50		(42)		–		(4)		–		4
Equity securities	8		(1)		–		–		–		7
Mortgage loans on real estate	–		(1)		–		–		–		(1)
Other investments	2		–		(10)		–		–		(8)
Other assets – indexed annuity ceded
embedded derivatives	27		–		–		(26)		–		1
Policyholder account balances –
RILA, fixed annuity and
IUL contracts	(234)		–		–		200		–		(34)
Total, net	$	742	$	(91)	$	(20)	$	(22)	$	(16)	$	593

	For the Three Months Ended March 31, 2024
	Issuances		Sales		Maturities		Settlements		Calls		Total
Investments:
Fixed maturity AFS securities:
Corporate bonds	$	277	$	(141)	$	(2)	$	(111)	$	(1)	$	22
ABS	264		–		–		(63)		–		201
Trading securities	–		(2)		–		(11)		–		(13)
Mortgage loans on real estate	1		(1)		–		–		–		–
Derivative investments	7		–		(3)		–		–		4
Other assets – indexed annuity ceded
embedded derivatives	26		–		–		(26)		–		–
Policyholder account balances –
RILA, fixed annuity and
IUL contracts	(249)		–		–		107		–		(142)
Total, net	$	326	$	(144)	$	(5)	$	(104)	$	(1)	$	72

Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings

The following summarizes changes in unrealized gains (losses) included in net income related to financial instruments carried at fair value classified within Level 3 that we still held (in millions):

	For the Three Months Ended March 31,
	2025		2024
Investments:
Trading securities (1)	$	(3)	$	–
Equity securities (1)	(6)		(3)
Mortgage loans on real estate (1)	(1)		–
Derivative investments (1)	12		16
MRBs (2)	(1,299)		1,896
Funds withheld reinsurance liabilities –
reinsurance-related embedded derivatives (1)	(89)		206
Embedded derivatives – indexed annuity
and IUL contracts (1)	169		241
Total, net	$	(1,217)	$	2,356

(1) Included in realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss).

(2) Included in market risk benefit gain (loss) on the Consolidated Statements of Comprehensive Income (Loss).

Changes in Unrealized Gains (Losses) Included in OCI

The following summarizes changes in unrealized gains (losses) included in OCI, net of tax, related to financial instruments carried at fair value classified within Level 3 that we still held (in millions):

	For the Three Months Ended March 31,
	2025		2024
Investments:
Fixed maturity AFS securities:
Corporate bonds	$	(7)	$	(11)
ABS	16		(1)
Hybrid and redeemable preferred
securities	–		2
Mortgage loans on real estate	2		1
Total, net	$	11	$	(9)

Components of the Transfers In and Out of Level 3

The following provides the components of the transfers into and out of Level 3 (in millions) as reported above:

	For the Three Months Ended March 31, 2025						For the Three Months Ended March 31, 2024
	Transfers		Transfers				Transfers		Transfers
	Into		Out of				Into		Out of
	Level 3		Level 3		Total		Level 3		Level 3		Total
Investments:
Fixed maturity AFS securities:
Corporate bonds	$	22	$	–	$	22	$	22	$	(44)	$	(22)
State and municipal bonds	–		–		–		–		(5)		(5)
ABS	57		–		57		31		(23)		8
Hybrid and redeemable preferred
securities	–		(10)		(10)		–		–		–
Trading securities	17		–		17		–		–		–
Derivative investments	–		–		–		–		(51)		(51)
Total, net	$	96	$	(10)	$	86	$	53	$	(123)	$	(70)

Fair Value Inputs Quantitative Information

The following summarizes the fair value (in millions), valuation techniques and significant unobservable inputs of the Level 3 fair value measurements as of March 31, 2025:

										Weighted
										Average
	Fair		Valuation	Significant	Assumption or					Input
	Value		Technique	Unobservable Inputs	Input Ranges					Range (1)
Assets
Investments:
Fixed maturity AFS
securities:
Corporate bonds	$	190	Discounted cash flow	Liquidity/duration adjustment (2)	0.0	%	–	4.3	%	1.9	%
ABS	10		Discounted cash flow	Liquidity/duration adjustment (2)	1.4	%	–	1.4	%	1.4	%
CMBS	8		Discounted cash flow	Liquidity/duration adjustment (2)	2.0	%	—	2.0	%	2.0	%
Hybrid and redeemable
preferred securities	39		Discounted cash flow	Liquidity/duration adjustment (2)	1.2	%	–	2.1	%	1.8	%
Equity securities	5		Discounted cash flow	Liquidity/duration adjustment (2)	4.5	%	–	4.5	%	4.5	%
MRB assets	4,157		Discounted cash flow	Lapse (3)	1.0	%	—	30.0	%	(10)
				Utilization of GLB withdrawals (4)	85.0	%	—	100.0	%	92.0	%
				Claims utilization factor (5)	60.0	%	—	100.0	%	(10)
				Premiums utilization factor (5)	80.0	%	—	115.0	%	(10)
				Non-performance risk (6)	0.3	%	—	2.2	%	1.8	%
				Mortality (7)				(9)		(10)
				Volatility (8)	1.0	%	—	29.0	%	14.3	%
Other assets:
Ceded MRBs (11)	2
Indexed annuity
ceded embedded
derivatives	1,092		Discounted cash flow	Lapse (3)	0.0	%	–	9.0	%	(10)
				Mortality (7)				(9)		(10)
Liabilities
Policyholder account
balances – indexed annuity
contracts embedded
derivatives	$	(10,860)	Discounted cash flow	Lapse (3)	0.0	%	–	9.0	%	(10)
				Mortality (7)				(9)		(10)
MRB liabilities	(1,306)		Discounted cash flow	Lapse (3)	1.0	%	—	30.0	%	(10)
				Utilization of GLB withdrawals (4)	85.0	%	—	100.0	%	92.0	%
				Claims utilization factor (5)	60.0	%	—	100.0	%	(10)
				Premiums utilization factor (5)	80.0	%	—	115.0	%	(10)
				Non-performance risk (6)	0.3	%	—	2.2	%	1.8	%
				Mortality (7)				(9)		(10)
				Volatility (8)	1.0	%	—	29.0	%	14.3	%
Other liabilities – ceded
MRBs (11)	(314)

The following summarizes the fair value (in millions), valuation techniques and significant unobservable inputs of the Level 3 fair value measurements as of December 31, 2024:

										Weighted
										Average
	Fair		Valuation	Significant	Assumption or					Input
	Value		Technique	Unobservable Inputs	Input Ranges					Range (1)
Assets
Investments:
Fixed maturity AFS
securities:
Corporate bonds	$	187	Discounted cash flow	Liquidity/duration adjustment (2)	0.0	%	–	3.1	%	1.7	%
ABS	10		Discounted cash flow	Liquidity/duration adjustment (2)	1.3	%	–	1.3	%	1.3	%
CMBS	8		Discounted cash flow	Liquidity/duration adjustment (2)	1.9	%	–	1.9	%	1.9	%
Hybrid and redeemable
preferred securities	19		Discounted cash flow	Liquidity/duration adjustment (2)	1.4	%	–	1.9	%	1.8	%
Equity securities	5		Discounted cash flow	Liquidity/duration adjustment (2)	4.5	%	–	4.5	%	4.5	%
MRB assets	4,860		Discounted cash flow	Lapse (3)	1.0	%	—	30.0	%	(10)
				Utilization of GLB withdrawals (4)	85.0	%	–	100.0	%	92.0	%
				Claims utilization factor (5)	60.0	%	–	100.0	%	(10)
				Premiums utilization factor (5)	80.0	%	–	115.0	%	(10)
				Non-performance risk (6)	0.3	%	–	2.0	%	1.6	%
				Mortality (7)				(9)		(10)
				Volatility (8)	1.0	%	–	29.0	%	14.5	%
Other assets:
Ceded MRBs (11)	2
Indexed annuity
ceded embedded
derivatives	1,115		Discounted cash flow	Lapse (3)	0.0	%	—	9.0	%	(10)
				Mortality (7)				(9)		(10)
Liabilities
Policyholder account
balances – indexed annuity
contracts embedded
derivatives	$	(12,402)	Discounted cash flow	Lapse (3)	0.0	%	–	9.0	%	(10)
				Mortality (7)				(9)		(10)
MRB liabilities	(1,046)		Discounted cash flow	Lapse (3)	1.0	%	–	30.0	%	(10)
				Utilization of GLB withdrawals (4)	85.0	%	–	100.0	%	92.0	%
				Claims utilization factor (5)	60.0	%	–	100.0	%	(10)
				Premiums utilization factor (5)	80.0	%	–	115.0	%	(10)
				Non-performance risk (6)	0.3	%	—	2.0	%	1.6	%
				Mortality (7)				(9)		(10)
				Volatility (8)	1.0	%	–	29.0	%	14.5	%
Other liabilities – ceded
MRBs (11)	(381)

(1) Unobservable inputs were weighted by the relative fair value of the instruments, unless otherwise noted.

(2) The liquidity/duration adjustment input represents an estimated market participant composite of adjustments attributable to liquidity premiums, expected durations, structures and credit quality that would be applied to the market observable information of an investment.

(3) The lapse input represents the estimated probability of a contract surrendering during a year, and thereby forgoing any future benefits. The range for indexed annuity contracts represents the lapses during the surrender charge period.

(4) The utilization of GLB withdrawals input represents the estimated percentage of policyholders that utilize the GLB withdrawal riders.

(5) The utilization factors are applied to the present value of claims or premiums, as appropriate, in the MRB calculation to estimate the impact of inefficient GLB withdrawal behavior, including taking less than or more than the maximum GLB withdrawal.

(6) The non-performance risk input represents the estimated additional credit spread that market participants would apply to the market observable discount rate when pricing a contract. The non-performance risk input was weighted by the absolute value of the sensitivity of the reserve to the non-performance risk assumption.

(7) The mortality input represents the estimated probability of when an individual belonging to a particular group, categorized according to age or some other factor such as gender, will die.

(8) The volatility input represents overall volatilities assumed for the underlying variable annuity funds, which include a mixture of equity and fixed-income assets. Volatility assumptions vary by fund due to the benchmarking of different indices. The volatility input was weighted by the relative account balance assigned to each index.

(9) The mortality is based on a combination of company and industry experience, adjusted for improvement factors.

(10) A weighted average input range is not a meaningful measurement for lapse, utilization factors or mortality.

(11) The fair value inputs for ceded MRBs are consistent with those used to value MRB assets and liabilities.

Fair Value Option

The fair value and aggregate contractual principal for mortgage loans on real estate where the fair value option was elected (in millions) were as follows:

	As of March 31,		As of December 31,
	2025		2024
Fair value	$	232	$	232
Aggregate contractual principal	263		263

XML

Shares and Stockholders’ Equity (Tables)

3 Months Ended

Mar. 31, 2025

Stockholders' Equity Note [Abstract]

Schedule of Changes in Preferred

Preferred stock authorized, issued and outstanding (number of shares) was as follows:

	As of March 31, 2025			As of December 31, 2024
	Shares Authorized	Shares Issued	Shares Outstanding	Shares Authorized	Shares Issued	Shares Outstanding
9.250% Fixed Rate Reset Non-Cumulative
Preferred Stock, Series C	20,000	20,000	20,000	20,000	20,000	20,000
9.000% Non-Cumulative Preferred Stock,   Series D	20,000	20,000	20,000	20,000	20,000	20,000
Not designated	9,960,000	–	–	9,960,000	–	–
Total preferred shares	10,000,000	40,000	40,000	10,000,000	40,000	40,000

The per share and aggregate dividends declared for preferred stock by series (in millions except per share data) was as follows:

	For the Three Months Ended March 31,
	2025				2024
	Dividend		Aggregate		Dividend		Aggregate
Series	Per Share		Dividend		Per Share		Dividend
Series C	$	1,156.25	$	23	$	1,156.25	$	23
Series D	562.50		11		562.50		11
Total	$	1,718.75	$	34	$	1,718.75	$	34

Schedule of Common Stock Outstanding Roll Forward

The changes in our common stock (number of shares) were as follows:

	For the Three Months Ended March 31,
	2025	2024
Common Stock
Balance as of beginning-of-year	170,380,646	169,666,137
Stock compensation/issued for benefit   plans	314,520	350,750
Balance as of end-of-period	170,695,166	170,016,887

Reconciliation of the Denominator Calculations of Basic and Diluted Earnings per Share

The calculation of earnings per share (“EPS”) was as follows (in millions except per share data):

	For the Three Months Ended March 31,
	2025		2024
Net income (loss) available to common stockholders – basic	$	(756)	$	1,188
Deferred units of LNC stock in our
deferred compensation plans (1)	–		3
Net income (loss) available to common
stockholders – diluted	$	(756)	$	1,191
Weighted-average shares, as used in basic calculation	171,321,440		170,049,994
Incremental common shares from assumed exercise or
issuance of stock-based incentive compensation awards	2,765,580		1,096,272
Average deferred compensation shares (1)	–		688,480
Weighted-average shares, as used in diluted calculation (2)	174,087,020		171,834,746
Net income (loss) per share:
Basic	$	(4.41)	$	6.98
Diluted	(4.41)		6.93

(1)    We have participants in our deferred compensation plans who selected LNC stock as the measure for the investment return attributable to all or a portion of their deferral amounts. This obligation is settled in either cash or LNC stock pursuant to the applicable plan document. We exclude deferred units of LNC stock that are antidilutive from our diluted EPS calculation.

(2)     Due to reporting a net loss for the three months ended March 31, 2025, basic shares were used in the diluted EPS calculation for this period as the use of diluted shares would have resulted in a lower loss per share.

Components and Changes in AOCI

The following summarizes the components and changes in AOCI (in millions):

	For the Three Months Ended March 31,
	2025		2024
Unrealized Gain (Loss) on Fixed Maturity AFS Securities and Certain
Other Investments
Balance as of beginning-of-year	$	(6,239)	$	(5,188)
Unrealized holding gains (losses)	744		(1,140)
Change in foreign currency exchange rate adjustment	156		(103)
Change in future contract benefits and policyholder account balances,
net of reinsurance	(326)		891
Income tax benefit (expense)	(121)		71
Less:
Reclassification adjustment for gains (losses) included in net income (loss)	(90)		(55)
Income tax benefit (expense)	19		12
Balance as of end-of-period	$	(5,715)	$	(5,426)
Unrealized Gain (Loss) on Derivative Instruments
Balance as of beginning-of-year	$	638	$	375
Unrealized holding gains (losses)	173		64
Change in foreign currency exchange rate adjustment	(153)		101
Income tax benefit (expense)	(4)		(35)
Less:
Reclassification adjustment for gains (losses) included in net income (loss)	21		24
Income tax benefit (expense)	(4)		(5)
Balance as of end-of-period	$	637	$	486
Market Risk Benefit Non-Performance Risk Gain (Loss)
Balance as of beginning-of-year	$	146	$	1,070
OCI before reclassification	403		(590)
Income tax benefit (expense)	(85)		126
Balance as of end-of-period	$	464	$	606
Policyholder Liability Discount Rate Remeasurement Gain (Loss)
Balance as of beginning-of-year	$	744	$	587
OCI before reclassification	(141)		147
Income tax benefit (expense)	30		(31)
Balance as of end-of-period	$	633	$	703
Foreign Currency Translation Adjustment
Balance as of beginning-of-year	$	(29)	$	(26)
OCI before reclassification	5		(1)
Balance as of end-of-period	$	(24)	$	(27)
Funded Status of Employee Benefit Plans
Balance as of beginning-of-year	$	(296)	$	(294)
OCI before reclassification	(5)		1
Balance as of end-of-period	$	(301)	$	(293)

Schedule of Reclassifications Out of AOCI

The following summarizes the reclassifications out of AOCI (in millions) and the associated line item on the Consolidated Statements of Comprehensive Income (Loss):

	For the Three Months Ended March 31,
	2025		2024
Unrealized Gain (Loss) on Fixed Maturity AFS
Securities and Certain Other Investments
Reclassification	$	(118)	$	(54)	Realized gain (loss)
Associated change in future contract benefits	28		(1)		Benefits
Reclassification before income tax benefit (expense)	(90)		(55)		Income (loss) before taxes
Income tax benefit (expense)	19		12		Federal income tax expense (benefit)
Reclassification, net of income tax	$	(71)	$	(43)	Net income (loss)
Unrealized Gain (Loss) on Derivative Instruments
Interest rate contracts	$	3	$	9	Interest and debt expense
Foreign currency contracts	15		15		Net investment income
Foreign currency contracts	3		–		Realized gain (loss)
Reclassification before income tax benefit (expense)	21		24		Income (loss) before taxes
Income tax benefit (expense)	(4)		(5)		Federal income tax expense (benefit)
Reclassification, net of income tax	$	17	$	19	Net income (loss)

XML

Segment Information (Tables)

3 Months Ended

Mar. 31, 2025

Segment Reporting [Abstract]

Reconciliation of Income (Loss) from Operations by Segment to Consolidated Net Income (Loss)

The tables below reconcile our internal measure of performance to the GAAP measure presented in the Consolidated Statements of Comprehensive Income (Loss) (in millions):

	For the Three Months Ended March 31, 2025
	Annuities		Life Insurance		Group Protection		Retirement Plan Services		Other Operations		Total
Operating Revenues (1)	$	1,198	$	1,587	$	1,521	$	327	$	52	$	4,685
Operating Expenses (2)
Benefits and policyholder liability
remeasurement (gain) loss	28		1,002		994		–		4		2,028
Interest credited	419		287		–		170		14		890
Commissions	298		99		133		27		–		557
General and administrative expenses	125		131		222		84		68		630
Interest and debt expense	–		–		–		–		80		80
Other (3)	(12)		100		44		8		(2)		138
Total operating expenses	858		1,619		1,393		289		164		4,323
Total federal income tax expense (benefit)	50		(16)		27		4		(17)		48
Total income (loss) from operations	290		(16)		101		34		(95)		314
Reconciliation of total income (loss) from
operations to net income (loss):
Net annuity product features, pre-tax											(1,092)
Net life insurance product features, pre-tax											42
Credit loss-related adjustments, pre-tax											(28)
Investment gains (losses), pre-tax											(103)
Changes in the fair value of
reinsurance-related embedded
derivatives, trading securities and
certain mortgage loans, pre-tax (4)											(90)
Other items, pre-tax (5) (6) (7)											(35)
Income tax benefit (expense) related to
the above pre-tax items											270
Total net income (loss)											$	(722)

(1)    See table below for reconciliation of total operating revenues to the GAAP measure presented in the Consolidated Statements of Comprehensive Income (Loss).

(2)    The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM. Inter-segment expenses are included within the amounts shown.

(3)    Other operating expenses include: Annuities: DAC and VOBA capitalization and amortization; taxes, licenses and fees; expenses associated with reserve financing and letters of credit (“LOCs”) and amortization of deferred loss on business sold through reinsurance. Life Insurance: DAC and VOBA capitalization and amortization; taxes, licenses and fees; expenses associated with reserve financing and LOCs; amortization of deferred loss on business sold through reinsurance and other intangible amortization. Group Protection: Taxes, licenses and fees; DAC capitalization and amortization; other intangible amortization and expenses associated with LOCs. Retirement Plan Services: Taxes, licenses and fees; DAC capitalization and amortization and expenses associated with LOCs. Other Operations: DAC capitalization and amortization; taxes, licenses and fees and reimbursements to Other Operations from the Life Insurance segment for the use of proceeds from certain issuances of senior notes that were used as long-term structured solutions, net of expenses incurred by Other Operations for its access to a financing facility and issuance of LOCs.

(4)    Includes primarily changes in the fair value of the embedded derivative related to the fourth quarter 2023 reinsurance transaction. For more information, see Note 7.

(5)    Includes severance expense related to initiatives to realign the workforce of $(6) million.

(6)    Includes transaction and integration costs related to mergers, acquisitions and divestitures of $(20) million.

(7)    Includes deferred compensation mark-to-market adjustment of $(9) million.

	For the Three Months Ended March 31, 2024
	Annuities		Life Insurance		Group Protection		Retirement Plan Services		Other Operations		Total
Operating Revenues (1)	$	1,269	$	1,541	$	1,425	$	322	$	27	$	4,584
Operating Expenses (2)
Benefits and policyholder liability
remeasurement (gain) loss	27		987		963		–		7		1,984
Interest credited	354		294		1		166		7		822
Commissions	254		113		109		23		–		499
General and administrative expenses	120		143		208		86		57		613
Interest and debt expense	–		–		–		–		81		81
Other (3)	197		54		43		6		(6)		295
Total operating expenses	952		1,591		1,324		281		146		4,294
Total federal income tax expense (benefit)	58		(15)		21		5		(23)		46
Total income (loss) from operations	259		(35)		80		36		(96)		244
Reconciliation of total income (loss) from
operations to net income (loss) (4):
Net annuity product features, pre-tax											1,450
Net life insurance product features, pre-tax											(130)
Credit loss-related adjustments, pre-tax											(1)
Investment gains (losses), pre-tax											(81)
Changes in the fair value of
reinsurance-related embedded
derivatives, trading securities and
certain mortgage loans, pre-tax (5)											194
Other items, pre-tax (6) (7) (8) (9)											(186)
Income tax benefit (expense) related to
the above pre-tax items											(268)
Total net income (loss)											$	1,222

(1)    See table below for reconciliation of total operating revenues to the GAAP measure presented in the Consolidated Statements of Comprehensive Income (Loss).

(2)    The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM. Inter-segment expenses are included within the amounts shown.

(3)    Other operating expenses include: Annuities: Broker-dealer expenses; DAC and VOBA capitalization and amortization; taxes, licenses and fees and expenses associated with reserve financing and LOCs. Life Insurance: DAC and VOBA capitalization and amortization; taxes, licenses and fees; expenses associated with reserve financing and LOCs and other intangible amortization. Group Protection: Taxes, licenses and fees; DAC capitalization and amortization; other intangible amortization and expenses associated with LOCs. Retirement Plan Services: DAC capitalization and amortization; taxes, licenses and fees and expenses associated with LOCs. Other Operations: Taxes, licenses and fees and reimbursements to Other Operations from the Life Insurance segment for the use of proceeds from certain issuances of senior notes that were used as long-term structured solutions, net of expenses incurred by Other Operations for its access to a financing facility and issuance of LOCs.

(4)    The prior period presentation was recast to conform to the revised definition of income (loss) from operations.

(5)    Includes primarily changes in the fair value of the embedded derivative related to the fourth quarter 2023 reinsurance transaction. For more information, see Note 7.

(6)    Includes $(114) million primarily related to the settlement of cost of insurance litigation in the first quarter of 2024.

(7)    Includes severance expense related to initiatives to realign the workforce of $(49) million.

(8)    Includes transaction and integration costs related to mergers, acquisitions and divestitures of $(10) million.

(9)    Includes deferred compensation mark-to-market adjustment of $(13) million.

Reconciliation of Revenue from Segments to Consolidated

The tables below reconcile our total operating revenues to the GAAP measure presented in the Consolidated Statements of Comprehensive Income (Loss) (in millions):

	For the Three Months Ended March 31, 2025
	Annuities		Life Insurance		Group Protection		Retirement Plan Services		Other Operations		Total
Operating revenues	$	1,198	$	1,587	$	1,521	$	327	$	52	$	4,685
Revenue adjustments from annuity and life
insurance product features	209		18		–		–		–		227
Credit loss-related adjustments	(17)		1		(2)		(2)		(8)		(28)
Investment gains (losses)	(6)		(109)		–		(2)		14		(103)
Changes in the fair value of reinsurance-
related embedded derivatives, trading
securities and certain mortgage loans	10		(89)		–		–		(11)		(90)
Total revenues	$	1,394	$	1,408	$	1,519	$	323	$	47	$	4,691

	For the Three Months Ended March 31, 2024
	Annuities		Life Insurance		Group Protection		Retirement Plan Services		Other Operations		Total
Operating revenues	$	1,269	$	1,541	$	1,425	$	322	$	27	$	4,584
Revenue adjustments from annuity and life
insurance product features	(446)		(134)		–		–		–		(580)
Credit loss-related adjustments	(4)		5		–		–		(2)		(1)
Investment gains (losses)	19		(29)		–		(5)		(66)		(81)
Changes in the fair value of reinsurance-
related embedded derivatives, trading
securities and certain mortgage loans	(3)		205		–		–		(8)		194
Total revenues	$	835	$	1,588	$	1,425	$	317	$	(49)	$	4,116

Schedule of Segment Information

We present disaggregated disclosures in the Notes below for long-duration insurance balances, applying the level of aggregation by business segment as follows:

Business Segment	Level of Aggregation
Annuities	Variable Annuities
	Fixed Annuities
	Payout Annuities
Life Insurance	Traditional Life
	UL and Other
Group Protection	Group Protection
Retirement Plan Services	Retirement Plan Services

Other business segment and Other Operations information (in millions) was as follows:

	For the Three Months Ended March 31,
	2025		2024
Net Investment Income
Annuities	$	452	$	379
Life Insurance	624		622
Group Protection	89		85
Retirement Plan Services	251		244
Other Operations	41		16
Total net investment income	$	1,457	$	1,346

XML

Realized Gain (Loss) (Tables)

3 Months Ended

Mar. 31, 2025

Realized Gain (Loss) [Abstract]

Schedule of Realized Gain (Loss)

Details underlying realized gain (loss) (in millions) were as follows:

	For the Three Months Ended March 31,
	2025		2024
Fixed maturity AFS securities:
Gross gains	$	4	$	7
Gross losses	(122)		(61)
Credit loss benefit (expense) (1)	(28)		(2)
Realized gain (loss) on equity securities (2)	(5)		11
Credit loss benefit (expense) on mortgage loans on real estate (1)	(1)		–
Credit loss benefit (expense) on reinsurance-related assets	1		1
Realized gain (loss) on the mark-to-market on certain
instruments (3)(4)	(55)		12
Indexed product derivative results (5)	(69)		145
Derivative results (6)	287		(548)
Other realized gain (loss)	(1)		1
Total realized gain (loss)	$	11	$	(434)

(1) Includes changes in the allowance for credit losses as well as direct write-downs to amortized cost as a result of negative credit events.

(2) Includes mark-to-market adjustments on equity securities still held of $(5) million and $11 million for the three months ended March 31, 2025 and 2024, respectively.

(3) Represents changes in the fair values of derivatives we hold as part of VUL hedging, reinsurance-related embedded derivatives and trading securities.

(4) Includes gains and losses from fair value changes on mortgage loans on real estate accounted for under the fair value option of $(1) million and less than $1 million for the three months ended March 31, 2025 and 2024, respectively.

(5) Represents the change in fair value of the index options that we hold and the change in the fair value of the embedded derivative liabilities of our indexed annuity and IUL contracts, and the associated index options to hedge policyholder index allocations applicable to future reset periods for our indexed annuity products.

(6) Includes the change in the fair value of the derivative instruments we own to support capital needs associated with our GLB and GDB riders net of fee income allocated to support the cost of purchasing the hedging instruments.

XML

Nature of Operations and Basis of Presentation (Details)	3 Months Ended
	Mar. 31, 2025 segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of operating segments	4

XML

Investments - Reconciliation of Available-for-Sale Securities from Cost Basis to Fair Value (Details) - USD ($) $ in Millions	Mar. 31, 2025	Dec. 31, 2024	Mar. 31, 2024	Dec. 31, 2023
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	$ 97,795	$ 97,415
Gross Unrealized Gains	839	747
Gross Unrealized Losses	10,263	11,005
Allowance for Credit Losses	74	46	$ 21	$ 19
Fair Value	88,297	87,111
Corporate bonds
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	75,363	75,556
Gross Unrealized Gains	630	563
Gross Unrealized Losses	9,085	9,655
Allowance for Credit Losses	23	14	10	8
Fair Value	66,885	66,450
U.S. government bonds
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	567	429
Gross Unrealized Gains	5	3
Gross Unrealized Losses	34	41
Allowance for Credit Losses	0	0
Fair Value	538	391
State and municipal bonds
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	2,744	2,798
Gross Unrealized Gains	21	18
Gross Unrealized Losses	415	445
Allowance for Credit Losses	0	0
Fair Value	2,350	2,371
Foreign government bonds
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	282	282
Gross Unrealized Gains	13	11
Gross Unrealized Losses	56	56
Allowance for Credit Losses	0	0
Fair Value	239	237
RMBS
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	2,104	2,066
Gross Unrealized Gains	29	24
Gross Unrealized Losses	186	220
Allowance for Credit Losses	6	7	6	6
Fair Value	1,941	1,863
CMBS
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	1,961	1,817
Gross Unrealized Gains	6	4
Gross Unrealized Losses	137	156
Allowance for Credit Losses	0	0
Fair Value	1,830	1,665
ABS
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	14,515	14,226
Gross Unrealized Gains	110	99
Gross Unrealized Losses	340	421
Allowance for Credit Losses	44	24	$ 4	$ 4
Fair Value	14,241	13,880
Hybrid and redeemable preferred securities
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	259	241
Gross Unrealized Gains	25	25
Gross Unrealized Losses	10	11
Allowance for Credit Losses	1	1
Fair Value	$ 273	$ 254

XML

Investments - Available-for-Sale Securities by Contractual Maturities (Details) - USD ($) $ in Millions	Mar. 31, 2025	Dec. 31, 2024
Amortized Cost
Amortized Cost	$ 97,795	$ 97,415
Fair Value
Total fixed maturity AFS securities	88,297	$ 87,111
Fixed maturity AFS securities other than structured securities
Amortized Cost
Due in one year or less	4,353
Due after one year through five years	18,500
Due after five years through ten years	13,107
Due after ten years	43,255
Amortized Cost	79,215
Fair Value
Due in one year or less	4,332
Due after one year through five years	18,050
Due after five years through ten years	12,271
Due after ten years	35,632
Total fixed maturity AFS securities	70,285
Structured securities (RMBS, CMBS, ABS)
Amortized Cost
Amortized Cost	18,580
Fair Value
Total fixed maturity AFS securities	$ 18,012

XML

Investments - Fair Value and Gross Unrealized Losses in a Continuous Unrealized Loss Position (Details) $ in Millions	3 Months Ended	12 Months Ended
	Mar. 31, 2025 USD ($) security	Dec. 31, 2024 USD ($) security
Fair Value
Less Than or Equal to Twelve Months	$ 29,293	$ 30,166
Greater Than Twelve Months	35,734	36,345
Total	65,027	66,511
Gross Unrealized Losses
Less Than or Equal to Twelve Months	4,217	4,537
Greater Than Twelve Months	6,046	6,468
Total	$ 10,263	$ 11,005
Total number of fixed maturity AFS securities in an unrealized loss position | security	6,835	6,985,000,000
Unrealized holding gains (losses) arising during the period	$ (12)	$ (23)
Corporate bonds
Fair Value
Less Than or Equal to Twelve Months	23,140	24,657
Greater Than Twelve Months	29,434	29,786
Total	52,574	54,443
Gross Unrealized Losses
Less Than or Equal to Twelve Months	3,798	4,054
Greater Than Twelve Months	5,287	5,601
Total	9,085	9,655
U.S. government bonds
Fair Value
Less Than or Equal to Twelve Months	67	86
Greater Than Twelve Months	230	224
Total	297	310
Gross Unrealized Losses
Less Than or Equal to Twelve Months	2	3
Greater Than Twelve Months	32	38
Total	34	41
State and municipal bonds
Fair Value
Less Than or Equal to Twelve Months	940	1,087
Greater Than Twelve Months	766	760
Total	1,706	1,847
Gross Unrealized Losses
Less Than or Equal to Twelve Months	214	228
Greater Than Twelve Months	201	217
Total	415	445
Foreign government bonds
Fair Value
Less Than or Equal to Twelve Months	32	32
Greater Than Twelve Months	119	118
Total	151	150
Gross Unrealized Losses
Less Than or Equal to Twelve Months	6	5
Greater Than Twelve Months	50	51
Total	56	56
RMBS
Fair Value
Less Than or Equal to Twelve Months	660	795
Greater Than Twelve Months	786	760
Total	1,446	1,555
Gross Unrealized Losses
Less Than or Equal to Twelve Months	58	76
Greater Than Twelve Months	128	144
Total	186	220
CMBS
Fair Value
Less Than or Equal to Twelve Months	610	579
Greater Than Twelve Months	785	777
Total	1,395	1,356
Gross Unrealized Losses
Less Than or Equal to Twelve Months	43	50
Greater Than Twelve Months	94	106
Total	137	156
ABS
Fair Value
Less Than or Equal to Twelve Months	3,820	2,907
Greater Than Twelve Months	3,522	3,827
Total	7,342	6,734
Gross Unrealized Losses
Less Than or Equal to Twelve Months	94	118
Greater Than Twelve Months	246	303
Total	340	421
Hybrid and redeemable preferred securities
Fair Value
Less Than or Equal to Twelve Months	24	23
Greater Than Twelve Months	92	93
Total	116	116
Gross Unrealized Losses
Less Than or Equal to Twelve Months	2	3
Greater Than Twelve Months	8	8
Total	$ 10	$ 11

XML

Investments - Schedule of Available-for-Sale Securities Whose Value is Below Amortized Cost (Details) $ in Millions	Mar. 31, 2025 USD ($) security	Dec. 31, 2024 USD ($) security
Fair Value
Nine months or greater, but less than twelve months	$ 29,293	$ 30,166
Twelve months or greater	35,734	36,345
Total	65,027	66,511
Gross Unrealized Losses
Nine months or greater, but less than twelve months	4,217	4,537
Twelve months or greater	6,046	6,468
Total	$ 10,263	$ 11,005
Number of Securities
Total | security	6,835	6,985,000,000
Fair Value Decline, Greater Than 20%
Fair Value
Less than six months	$ 3,053	$ 5,405
Six months or greater, but less than nine months	1,600	371
Nine months or greater, but less than twelve months	369	71
Twelve months or greater	4,381	4,440
Total	9,403	10,287
Gross Unrealized Losses
Less than six months	900	1,621
Six months or greater, but less than nine months	518	198
Nine months or greater, but less than twelve months	187	28
Twelve months or greater	2,149	2,218
Total	$ 3,754	$ 4,065
Number of Securities
Less than six months | security	522	799,000,000
Six months or greater, but less than nine months | security	324	216,000,000
Nine months or greater, but less than twelve months | security	208	37,000,000
Twelve months or greater | security	737	741,000,000
Total | security	1,791	1,793,000,000

XML

Investments - Narrative (Details) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2025 USD ($) investment	Mar. 31, 2024 USD ($)	Dec. 31, 2024 USD ($) investment
Investments [Line Items]
Decrease in gross AFS securities unrealized losses	$ 742
Percentage of fair value rated as investment grade	96.00%		96.00%
Losses from loan modifications	$ 5	$ 0
Number of partnerships in alternative investment portfolio | investment	370		371
Alternative investments as a percentage of overall invested assets	3.00%		3.00%
Investment commitments	$ 4,600
Investment commitments for limited partnerships	3,500
Investment commitments for mortgage loans on real estate	828
Investment commitments for private placements	277
Derivative Counterparties
Investments [Line Items]
Fair value of collateral received that we are permitted to sell or re-pledge	2,200
Fair value of securities received as collateral that have been resold or repledged	64
Corporate bonds
Investments [Line Items]
Amortized cost of portfolio rated below investment grade	2,800		$ 2,900
Fair value of portfolio rated below investment grade	2,700		2,800
Fannie Mae | MBS
Investments [Line Items]
Fair value, concentration of risk, investments	$ 892		$ 851
Fannie Mae | Investments | Lender Concentration Risk | MBS
Investments [Line Items]
Concentration risk	1.00%		1.00%
Federal Home Loan Mortgage Corporation | MBS
Investments [Line Items]
Fair value, concentration of risk, investments	$ 604		$ 566
Federal Home Loan Mortgage Corporation | Investments | Lender Concentration Risk | MBS
Investments [Line Items]
Concentration risk	1.00%		1.00%
Financial Service | Securities Investment
Investments [Line Items]
Fair value, concentration of risk, investments	$ 13,500		$ 13,400
Financial Service | Investments | Lender Concentration Risk | Securities Investment
Investments [Line Items]
Concentration risk	10.00%		10.00%
Consumer Non-Cyclical Industry | Securities Investment
Investments [Line Items]
Fair value, concentration of risk, investments	$ 13,000		$ 12,900
Consumer Non-Cyclical Industry | Investments | Lender Concentration Risk | Securities Investment
Investments [Line Items]
Concentration risk			10.00%

XML

Investments - Changes in Allowance for Credit Losses on AFS (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward]
Balance as of beginning-of-period	$ 46	$ 19
Additions from purchases of PCD debt securities	0	0
Additions for securities for which credit losses were not previously recognized	15	1
Additions (reductions) for securities for which credit losses were previously recognized	13	2
Reductions for disposed securities		(1)
Reductions for securities charged off	0	0
Balance as of end-of-period	74	21
Accrued interest receivable on fixed maturity AFS securities	911	943
Corporate bonds
Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward]
Balance as of beginning-of-period	14	8
Additions from purchases of PCD debt securities	0	0
Additions for securities for which credit losses were not previously recognized	7	1
Additions (reductions) for securities for which credit losses were previously recognized	2	2
Reductions for disposed securities		(1)
Reductions for securities charged off	0	0
Balance as of end-of-period	23	10
RMBS
Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward]
Balance as of beginning-of-period	7	6
Additions from purchases of PCD debt securities	0	0
Additions for securities for which credit losses were not previously recognized	0	0
Additions (reductions) for securities for which credit losses were previously recognized	(1)	0
Reductions for disposed securities		0
Reductions for securities charged off	0	0
Balance as of end-of-period	6	6
ABS
Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward]
Balance as of beginning-of-period	24	4
Additions from purchases of PCD debt securities	0	0
Additions for securities for which credit losses were not previously recognized	8	0
Additions (reductions) for securities for which credit losses were previously recognized	12	0
Reductions for disposed securities		0
Reductions for securities charged off	0	0
Balance as of end-of-period	44	4
Hybrids
Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward]
Balance as of beginning-of-period	1	1
Additions from purchases of PCD debt securities	0	0
Additions for securities for which credit losses were not previously recognized	0	0
Additions (reductions) for securities for which credit losses were previously recognized	0	0
Reductions for disposed securities		0
Reductions for securities charged off	0	0
Balance as of end-of-period	$ 1	$ 1

XML

Investments - Composition of Current and Past Due Mortgage Loans on Real Estate (Details) - USD ($)	Mar. 31, 2025	Dec. 31, 2024
Loans and Leases Receivable Disclosure [Line Items]
Allowance for credit losses	$ (154,000,000)	$ (152,000,000)
Unamortized premium (discount)	86,000,000	77,000,000
Mark-to-market gains (losses)	(32,000,000)	(31,000,000)
Total carrying value	21,558,000,000	21,083,000,000
Loans with fair value option in non-accrual, amortized cost	30,000,000	30,000,000
Loans with fair value option in non-accrual	21,000,000	21,000,000
Loans with fair value option, 90 days past due and still accruing	0	0
Current
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans on real estate, gross	21,397,000,000	20,954,000,000
30 to 59 days past due
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans on real estate, gross	97,000,000	77,000,000
60 to 89 days past due
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans on real estate, gross	29,000,000	33,000,000
90 or more days past due
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans on real estate, gross	135,000,000	125,000,000
Commercial
Loans and Leases Receivable Disclosure [Line Items]
Allowance for credit losses	(98,000,000)	(99,000,000)
Unamortized premium (discount)	(5,000,000)	(6,000,000)
Mark-to-market gains (losses)	(32,000,000)	(31,000,000)
Total carrying value	17,514,000,000	17,472,000,000
Commercial | Current
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans on real estate, gross	17,602,000,000	17,567,000,000
Commercial | 30 to 59 days past due
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans on real estate, gross	13,000,000	6,000,000
Commercial | 60 to 89 days past due
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans on real estate, gross	3,000,000	0
Commercial | 90 or more days past due
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans on real estate, gross	31,000,000	35,000,000
Residential mortgage loans on real estate
Loans and Leases Receivable Disclosure [Line Items]
Allowance for credit losses	(56,000,000)	(53,000,000)
Unamortized premium (discount)	91,000,000	83,000,000
Mark-to-market gains (losses)	0	0
Total carrying value	4,044,000,000	3,611,000,000
Residential mortgage loans on real estate | Current
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans on real estate, gross	3,795,000,000	3,387,000,000
Residential mortgage loans on real estate | 30 to 59 days past due
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans on real estate, gross	84,000,000	71,000,000
Residential mortgage loans on real estate | 60 to 89 days past due
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans on real estate, gross	26,000,000	33,000,000
Residential mortgage loans on real estate | 90 or more days past due
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans on real estate, gross	$ 104,000,000	$ 90,000,000

XML

Investments - Amortized Cost of Mortgage Loans on Real Estate on Nonaccrual Status (Details) - USD ($) $ in Millions	Mar. 31, 2025	Dec. 31, 2024
Financing Receivable, Nonaccrual [Line Items]
Financing Receivable, Nonaccrual	$ 107	$ 96
Commercial mortgage loans on real estate
Financing Receivable, Nonaccrual [Line Items]
Financing Receivable, Nonaccrual	1	4
Residential mortgage loans on real estate
Financing Receivable, Nonaccrual [Line Items]
Financing Receivable, Nonaccrual	$ 106	$ 92

XML

Investments - Commercial Mortgage Loans by Year of Origination (Details) - Commercial $ in Millions	Mar. 31, 2025 USD ($)	Dec. 31, 2024 USD ($)
Origination Year
Year one	$ 285	$ 1,631
Year two	1,626	1,392
Year three	1,388	1,822
Year four	1,813	2,314
Year five	2,302	1,171
Year six and prior	10,230	9,272
Total	17,644	17,602
LTV Less Than 65%
Origination Year
Year one	267	1,548
Year two	1,551	1,348
Year three	1,346	1,724
Year four	1,718	2,267
Year five	2,247	1,167
Year six and prior	10,103	9,138
Total	$ 17,232	$ 17,192
Debt-Service Coverage Ratio
Year one	1.63	1.73
Year two	1.73	1.78
Year three	1.76	2.11
Year four	2.07	3.50
Year five	3.21	3.33
Year six and prior	2.48	2.38
LTV 65% to 75%
Origination Year
Year one	$ 18	$ 83
Year two	74	44
Year three	40	94
Year four	87	47
Year five	46	4
Year six and prior	114	126
Total	$ 379	$ 398
Debt-Service Coverage Ratio
Year one	1.33	1.41
Year two	1.42	1.36
Year three	1.37	1.55
Year four	1.52	1.52
Year five	1.73	1.53
Year six and prior	1.56	1.58
LTV Greater Than 75%
Origination Year
Year one	$ 0	$ 0
Year two	1	0
Year three	2	4
Year four	8	0
Year five	9	0
Year six and prior	13	8
Total	$ 33	$ 12
Debt-Service Coverage Ratio
Year one	0	0
Year two	1.69	0
Year three	1.51	1.30
Year four	1.24	0
Year five	1.26	0
Year six and prior	1.13	1.30

XML

Investments - Residential Mortgage Loans by Year of Origination (Details) - Residential - USD ($) $ in Millions	Mar. 31, 2025	Dec. 31, 2024
Financing Receivable, Credit Quality Indicator [Line Items]
Year one	$ 167	$ 1,909
Year two	2,252	573
Year three	514	525
Year four	502	438
Year five	427	69
Year six and prior	238	150
Total	4,100	3,664
Performing
Financing Receivable, Credit Quality Indicator [Line Items]
Year one	167	1,895
Year two	2,223	557
Year three	495	492
Year four	471	427
Year five	415	65
Year six and prior	223	136
Total	3,994	3,572
Nonperforming
Financing Receivable, Credit Quality Indicator [Line Items]
Year one	0	14
Year two	29	16
Year three	19	33
Year four	31	11
Year five	12	4
Year six and prior	15	14
Total	$ 106	$ 92

XML

Investments - Changes in Allowance for Credit Losses on Mortgage Loans on Real Estate (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Balance as of beginning-of-year	$ 152
Additions (reductions) from provision for credit loss expense	1	$ 0
Balance as of end-of-year	154
Accrued interest receivable excluded from credit losses	101	69
Mortgage loans on real estate
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Balance as of beginning-of-year	152	114
Additions (reductions) from provision for credit loss expense	2	1
Additions from purchases of PCD mortgage loans on real estate	0	0
Balance as of end-of-year	154	115
Credit loss expense (reversal)	(1)	(1)
Commercial
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Balance as of beginning-of-year	99
Balance as of end-of-year	98
Commercial | Mortgage loans on real estate
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Balance as of beginning-of-year	99	86
Additions (reductions) from provision for credit loss expense	(1)	(2)
Additions from purchases of PCD mortgage loans on real estate	0	0
Balance as of end-of-year	98	84
Residential
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Balance as of beginning-of-year	53
Balance as of end-of-year	56
Residential | Mortgage loans on real estate
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Balance as of beginning-of-year	53	28
Additions (reductions) from provision for credit loss expense	3	3
Additions from purchases of PCD mortgage loans on real estate	0	0
Balance as of end-of-year	$ 56	$ 31

XML

Investments - Credit Loss Expense Incurred (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Debt Securities, Available-for-Sale, Allowance for Credit Loss [Line Items]
Total credit loss benefit (expense)	$ (15)	$ (1)
Realized Gain (Loss)
Debt Securities, Available-for-Sale, Allowance for Credit Loss [Line Items]
Total credit loss benefit (expense)	(28)	(2)
Corporate bonds
Debt Securities, Available-for-Sale, Allowance for Credit Loss [Line Items]
Total credit loss benefit (expense)	(7)	(1)
Corporate bonds | Realized Gain (Loss)
Debt Securities, Available-for-Sale, Allowance for Credit Loss [Line Items]
Total credit loss benefit (expense)	(9)	(2)
RMBS
Debt Securities, Available-for-Sale, Allowance for Credit Loss [Line Items]
Total credit loss benefit (expense)	0	0
RMBS | Realized Gain (Loss)
Debt Securities, Available-for-Sale, Allowance for Credit Loss [Line Items]
Total credit loss benefit (expense)	1	0
ABS
Debt Securities, Available-for-Sale, Allowance for Credit Loss [Line Items]
Total credit loss benefit (expense)	(8)	0
ABS | Realized Gain (Loss)
Debt Securities, Available-for-Sale, Allowance for Credit Loss [Line Items]
Total credit loss benefit (expense)	$ (20)	$ 0

XML

Investments - Payables for Collateral on Investments (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Dec. 31, 2024
Carrying Value
Collateral payable for derivative investments	$ 5,558	$ 7,213
Securities pledged under securities lending agreements	167	157
Securities pledged under repurchase agreements	57	0
Investments pledged for FHLBI	2,500	2,650
Total payables for collateral on investments	8,282	10,020
Fair Value
Collateral payable for derivative investments	5,558	7,213
Securities pledged under securities lending agreements	161	151
Securities pledged under repurchase agreements	59	0
Investments pledged for Federal Home Loan Bank of Indianapolis('FHLBI')	3,480	3,657
Total payables for collateral on investments	$ 9,258	$ 11,021
Percentage of the fair value of domestic securities obtained as collateral under securities lending agreements.	102.00%
Percentage of the fair value of foreign securities obtained as collateral under securities lending agreements.	105.00%
Minimum
Fair Value
Percentage of the fair value of securities obtained as collateral under reverse repurchase agreements	80.00%
Percentage of the fair value of FHLBI securities obtained as collateral under securities pledged for FHLBI for AFS Securities	105.00%
Percentage of the fair value of FHLBI securities obtained as collateral under securities pledged for FHLBI for mortgage loan	155.00%
Maximum
Fair Value
Percentage of the fair value of securities obtained as collateral under reverse repurchase agreements	95.00%
Percentage of the fair value of FHLBI securities obtained as collateral under securities pledged for FHLBI for AFS Securities	115.00%
Percentage of the fair value of FHLBI securities obtained as collateral under securities pledged for FHLBI for mortgage loan	175.00%

XML

Investments - Schedule of Increase (Decrease) in Payables for Collateral on Investments (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Investments [Abstract]
Collateral payable for derivative investments	$ (1,655)	$ 1,684
Securities pledged under securities lending agreements	10	78
Securities pledged under repurchase agreements	57	0
Investments pledged for FHLBI	(150)	250
Total increase (decrease) in payables for collateral on investments	$ (1,738)	$ 2,012

XML

Investments - Schedule of Securities Pledged by Contractual Maturity (Details) - USD ($) $ in Millions	Mar. 31, 2025	Dec. 31, 2024
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities pledged under securities lending agreements	$ 167	$ 157
Total gross secured borrowings	167	157
Corporate bonds
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities pledged under securities lending agreements	157	144
U.S. government bonds
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities pledged under securities lending agreements		1
Equity securities
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities pledged under securities lending agreements	10	12
Overnight and Continuous
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Total gross secured borrowings	167	157
Overnight and Continuous | Corporate bonds
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities pledged under securities lending agreements	157	144
Overnight and Continuous | U.S. government bonds
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities pledged under securities lending agreements		1
Overnight and Continuous | Equity securities
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities pledged under securities lending agreements	10	12
Up to 30 Days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Total gross secured borrowings	0	0
Up to 30 Days | Corporate bonds
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities pledged under securities lending agreements	0	0
Up to 30 Days | U.S. government bonds
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities pledged under securities lending agreements		0
Up to 30 Days | Equity securities
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities pledged under securities lending agreements	0	0
30-90 Days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Total gross secured borrowings	0	0
30-90 Days | Corporate bonds
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities pledged under securities lending agreements	0	0
30-90 Days | U.S. government bonds
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities pledged under securities lending agreements		0
30-90 Days | Equity securities
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities pledged under securities lending agreements	0	0
Greater Than 90 Days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Total gross secured borrowings	0	0
Greater Than 90 Days | Corporate bonds
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities pledged under securities lending agreements	0	0
Greater Than 90 Days | U.S. government bonds
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities pledged under securities lending agreements		0
Greater Than 90 Days | Equity securities
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities pledged under securities lending agreements	$ 0	$ 0

XML

Variable Interest Entities - Consolidated Variable Interest Entity Asset and Liability Information (Details) $ in Millions	Mar. 31, 2025 USD ($) instrument	Dec. 31, 2024 USD ($) instrument
Disclosure of Variable Interest Entities Assets and Liabilities [Line Items]
Carrying Value	$ 7,849	$ 9,677
Variable Interest Entity, Primary Beneficiary
Disclosure of Variable Interest Entities Assets and Liabilities [Line Items]
Number of Instruments | instrument	1	1,000,000
Notional Amounts	$ 504	$ 522
Carrying Value	$ 0	$ 0

XML

Variable Interest Entities - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024	Dec. 31, 2024
Variable Interest Entity [Line Items]
Other comprehensive income (loss), net of tax	$ 730	$ (475)
Other investments	6,653		$ 6,588
Variable Interest Entity, Primary Beneficiary
Variable Interest Entity [Line Items]
Other comprehensive income (loss), net of tax	0	$ 0
Variable Interest Entity, Not Primary Beneficiary
Variable Interest Entity [Line Items]
Other investments	$ 5,600		$ 5,300

XML

Derivative Instruments - Outstanding Derivative Instruments With Off-Balance-Sheet Risks (Details) - USD ($) $ in Millions	Mar. 31, 2025	Dec. 31, 2024
Outstanding derivative instruments with off-balance-sheet risks
Notional Amounts	$ 257,542	$ 274,575
Gross amount of recognized assets	12,340	15,003
Gross amount of recognized liabilities	14,441	16,875
Interest rate contracts
Outstanding derivative instruments with off-balance-sheet risks
Notional Amounts	83,705
Foreign currency contracts
Outstanding derivative instruments with off-balance-sheet risks
Notional Amounts	5,162
Equity market contracts
Outstanding derivative instruments with off-balance-sheet risks
Notional Amounts	168,433
Credit contracts
Outstanding derivative instruments with off-balance-sheet risks
Notional Amounts	242
Qualifying Hedges | Cash flow hedges
Outstanding derivative instruments with off-balance-sheet risks
Notional Amounts	6,080	5,968
Gross amount of recognized assets	706	712
Gross amount of recognized liabilities	50	60
Qualifying Hedges | Cash flow hedges | Interest rate contracts
Outstanding derivative instruments with off-balance-sheet risks
Notional Amounts	1,275	1,230
Gross amount of recognized assets	154	156
Gross amount of recognized liabilities	6	16
Qualifying Hedges | Cash flow hedges | Foreign currency contracts
Outstanding derivative instruments with off-balance-sheet risks
Notional Amounts	4,805	4,738
Gross amount of recognized assets	552	556
Gross amount of recognized liabilities	44	44
Qualifying Hedges | Fair value hedges
Outstanding derivative instruments with off-balance-sheet risks
Notional Amounts	1,091	1,091
Gross amount of recognized assets	2	11
Gross amount of recognized liabilities	29	16
Qualifying Hedges | Fair value hedges | Interest rate contracts
Outstanding derivative instruments with off-balance-sheet risks
Notional Amounts	1,066	1,066
Gross amount of recognized assets	2	10
Gross amount of recognized liabilities	29	16
Qualifying Hedges | Fair value hedges | Foreign currency contracts
Outstanding derivative instruments with off-balance-sheet risks
Notional Amounts	25	25
Gross amount of recognized assets	0	1
Gross amount of recognized liabilities	0	0
Non-Qualifying Hedges | Interest rate contracts
Outstanding derivative instruments with off-balance-sheet risks
Notional Amounts	81,364	75,445
Gross amount of recognized assets	40	63
Gross amount of recognized liabilities	334	439
Non-Qualifying Hedges | Foreign currency contracts
Outstanding derivative instruments with off-balance-sheet risks
Notional Amounts	332	348
Gross amount of recognized assets	23	30
Gross amount of recognized liabilities	2	2
Non-Qualifying Hedges | Equity market contracts
Outstanding derivative instruments with off-balance-sheet risks
Notional Amounts	168,433	191,666
Gross amount of recognized assets	10,477	13,072
Gross amount of recognized liabilities	3,081	3,879
Non-Qualifying Hedges | Credit contracts
Outstanding derivative instruments with off-balance-sheet risks
Notional Amounts	242	57
Gross amount of recognized assets	0	0
Gross amount of recognized liabilities	0	0
Non-Qualifying Hedges | Reinsurance-related
Outstanding derivative instruments with off-balance-sheet risks
Notional Amounts	0	0
Gross amount of recognized assets	0	0
Gross amount of recognized liabilities	138	30
Non-Qualifying Hedges | RILA, fixed indexed annuity and IUL contracts
Outstanding derivative instruments with off-balance-sheet risks
Notional Amounts	0	0
Gross amount of recognized assets	1,092	1,115
Gross amount of recognized liabilities	$ 10,807	$ 12,449

XML

Derivative Instruments - Maturity of the Notional Amounts of Derivative Financial Instruments (Details) - USD ($) $ in Millions	Mar. 31, 2025	Dec. 31, 2024
Maturity of the notional amounts of derivative financial instruments
Less Than 1 Year	$ 140,316
1 - 5 Years	50,256
6 - 10 Years	34,523
11 - 30 Years	29,758
Over 30 Years	2,689
Total	257,542	$ 274,575
Interest rate contracts
Maturity of the notional amounts of derivative financial instruments
Less Than 1 Year	12,810
1 - 5 Years	18,418
6 - 10 Years	23,981
11 - 30 Years	27,898
Over 30 Years	598
Total	83,705
Foreign currency contracts
Maturity of the notional amounts of derivative financial instruments
Less Than 1 Year	199
1 - 5 Years	1,292
6 - 10 Years	1,776
11 - 30 Years	1,853
Over 30 Years	42
Total	5,162
Equity market contracts
Maturity of the notional amounts of derivative financial instruments
Less Than 1 Year	127,307
1 - 5 Years	30,374
6 - 10 Years	8,696
11 - 30 Years	7
Over 30 Years	2,049
Total	168,433
Credit contracts
Maturity of the notional amounts of derivative financial instruments
Less Than 1 Year	0
1 - 5 Years	172
6 - 10 Years	70
11 - 30 Years	0
Over 30 Years	0
Total	$ 242

XML

Derivative Instruments - Cumulative Basis Adjustments for Fair Value Hedges (Details) - USD ($) $ in Millions	Mar. 31, 2025	Dec. 31, 2024
Derivatives, Fair Value [Line Items]
Amortized cost of the hedged assets	$ 497	$ 484
Amortized cost of the hedged liabilities	(691)	(676)
Cumulative fair value hedging adjustment included in the amortized cost of the hedged assets	19	7
Cumulative fair value hedging adjustment included in the amortized cost of the hedged assets (liabilities)	184	199
Discontinued Hedges
Derivatives, Fair Value [Line Items]
Cumulative fair value hedging adjustment included in the amortized cost of the hedged assets (liabilities)	$ (306)	$ (310)

XML

Derivative Instruments - Change in Our Unrealized Gain on Derivative Instruments in AOCI (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Change in our unrealized gain on derivative instruments in accumulated OCI
Balance as of beginning-of-year	$ 8,269
Balance as of end-of-period	8,193	$ 7,546
Unrealized Gain (Loss) on Derivative Instruments
Change in our unrealized gain on derivative instruments in accumulated OCI
Balance as of beginning-of-year	638	375
Income tax benefit (expense)	(4)	(35)
Reclassification adjustment for gains (losses) included in net income (loss)	21	24
Income tax benefit (expense)	(4)	(5)
Balance as of end-of-period	637	486
Unrealized Gain (Loss) on Derivative Instruments | Interest rate contracts | Interest and Debt Expense
Change in our unrealized gain on derivative instruments in accumulated OCI
Reclassification adjustment for gains (losses) included in net income (loss)	3	9
Unrealized Gain (Loss) on Derivative Instruments | Foreign currency contracts | Net Investment Income
Change in our unrealized gain on derivative instruments in accumulated OCI
Reclassification adjustment for gains (losses) included in net income (loss)	15	15
Unrealized Gain (Loss) on Derivative Instruments | Foreign currency contracts | Realized Gain (Loss)
Change in our unrealized gain on derivative instruments in accumulated OCI
Reclassification adjustment for gains (losses) included in net income (loss)	3	0
Unrealized holding gains (losses) arising during the period - cash flow hedges
Change in our unrealized gain on derivative instruments in accumulated OCI
Changes arising during the year	173	64
Unrealized holding gains (losses) arising during the period - cash flow hedges | Interest rate contracts
Change in our unrealized gain on derivative instruments in accumulated OCI
Changes arising during the year	5	89
Unrealized holding gains (losses) arising during the period - cash flow hedges | Foreign currency contracts
Change in our unrealized gain on derivative instruments in accumulated OCI
Changes arising during the year	168	(25)
Change in foreign currency exchange rate adjustment
Change in our unrealized gain on derivative instruments in accumulated OCI
Changes arising during the year	$ (153)	$ 101

XML

Derivative Instruments - Effects of Qualifying and Non-Qualifying Hedges (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Derivative Instruments, Gain (Loss) [Line Items]
Realized gain (loss)	$ 11	$ (434)
Net investment income	1,457	1,346
Interest and debt expense	80	81
Qualifying Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Realized gain (loss)	11	(434)
Net investment income	1,457	1,346
Interest and debt expense	80	81
Realized Gain (Loss) | Qualifying Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Interest rate contracts, amount of gain or (loss) reclassified from AOCI into income	0	0
Foreign currency contracts, amount of gain or (loss) reclassified from AOCI into income	3	0
Realized Gain (Loss) | Interest rate contracts | Non-Qualifying Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Non-Qualifying Hedges	82	(163)
Realized Gain (Loss) | Foreign currency contracts | Non-Qualifying Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Non-Qualifying Hedges	(1)	0
Realized Gain (Loss) | Equity market contracts | Non-Qualifying Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Non-Qualifying Hedges	(1,143)	2,134
Realized Gain (Loss) | Credit contracts | Non-Qualifying Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Non-Qualifying Hedges	1	0
Realized Gain (Loss) | Reinsurance-related | Non-Qualifying Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Non-Qualifying Hedges	(108)	197
Realized Gain (Loss) | RILA, fixed indexed annuity and IUL contracts | Non-Qualifying Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Non-Qualifying Hedges	1,654	(1,642)
Net Investment Income | Qualifying Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Interest rate contracts, amount of gain or (loss) reclassified from AOCI into income	0	0
Foreign currency contracts, amount of gain or (loss) reclassified from AOCI into income	15	15
Net Investment Income | Interest rate contracts | Qualifying Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Hedged items	11	(18)
Derivatives designated as hedging instruments	(11)	18
Net Investment Income | Interest rate contracts | Non-Qualifying Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Non-Qualifying Hedges	0	0
Net Investment Income | Foreign currency contracts | Qualifying Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Hedged items	1	(1)
Derivatives designated as hedging instruments	(1)	1
Net Investment Income | Foreign currency contracts | Non-Qualifying Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Non-Qualifying Hedges	0	0
Net Investment Income | Equity market contracts | Non-Qualifying Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Non-Qualifying Hedges	0	0
Net Investment Income | Credit contracts | Non-Qualifying Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Non-Qualifying Hedges	0	0
Net Investment Income | Reinsurance-related | Non-Qualifying Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Non-Qualifying Hedges	0	0
Net Investment Income | RILA, fixed indexed annuity and IUL contracts | Non-Qualifying Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Non-Qualifying Hedges	0	0
Interest and Debt Expense | Qualifying Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Interest rate contracts, amount of gain or (loss) reclassified from AOCI into income	3	9
Foreign currency contracts, amount of gain or (loss) reclassified from AOCI into income	0	0
Interest and Debt Expense | Interest rate contracts | Qualifying Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Hedged items	(15)	17
Derivatives designated as hedging instruments	15	(17)
Interest and Debt Expense | Interest rate contracts | Non-Qualifying Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Non-Qualifying Hedges	0	0
Interest and Debt Expense | Foreign currency contracts | Qualifying Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Hedged items	0	0
Derivatives designated as hedging instruments	0	0
Interest and Debt Expense | Foreign currency contracts | Non-Qualifying Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Non-Qualifying Hedges	0	0
Interest and Debt Expense | Equity market contracts | Non-Qualifying Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Non-Qualifying Hedges	0	0
Interest and Debt Expense | Credit contracts | Non-Qualifying Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Non-Qualifying Hedges	0	0
Interest and Debt Expense | Reinsurance-related | Non-Qualifying Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Non-Qualifying Hedges	0	0
Interest and Debt Expense | RILA, fixed indexed annuity and IUL contracts | Non-Qualifying Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Non-Qualifying Hedges	$ 0	$ 0

XML

Derivative Instruments - Narrative (Details) $ in Millions	3 Months Ended
	Mar. 31, 2025 USD ($)
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Cash flow hedge gain (loss) to be reclassified within 12 months	$ 76

XML

Derivative Instruments - Schedule of Collateral Amounts With Rights to Reclaim or Obligation to Return Cash (Details) - USD ($) $ in Millions	Mar. 31, 2025	Dec. 31, 2024
Credit Derivatives [Line Items]
Collateral Posted by Counterparty	$ 5,536	$ 7,182
Collateral Posted to Counterparty	(40)	(110)
AA-
Credit Derivatives [Line Items]
Collateral Posted by Counterparty	3,314	4,043
Collateral Posted to Counterparty	(12)	(21)
A+
Credit Derivatives [Line Items]
Collateral Posted by Counterparty	1,741	2,460
Collateral Posted to Counterparty	(28)	(89)
A
Credit Derivatives [Line Items]
Collateral Posted by Counterparty	32	47
Collateral Posted to Counterparty	0	0
A-
Credit Derivatives [Line Items]
Collateral Posted by Counterparty	449	632
Collateral Posted to Counterparty	$ 0	$ 0

XML

Derivative Instruments - Schedule of Offsetting Assets and Liabilities (Details) - USD ($) $ in Millions	Mar. 31, 2025	Dec. 31, 2024
Financial Assets
Gross amount of recognized assets	$ 12,265	$ 14,598
Gross amounts offset	(3,324)	(3,806)
Net amount of assets	8,941	10,792
Cash collateral	(5,536)	(7,182)
Non-cash collateral	(2,313)	(2,495)
Net amount	1,092	1,115
Financial Liabilities
Gross amount of recognized liabilities	11,142	13,096
Gross amounts offset	(100)	(432)
Net amount of liabilities	11,042	12,664
Cash collateral	(40)	(110)
Non-cash collateral	(57)	(75)
Net amount	10,945	12,479
Excess non-cash collateral received	941	817
Excess non-cash collateral pledged	1	39
Derivative Instruments
Financial Assets
Gross amount of recognized assets	11,173	13,483
Gross amounts offset	(3,324)	(3,806)
Net amount of assets	7,849	9,677
Cash collateral	(5,536)	(7,182)
Non-cash collateral	(2,313)	(2,495)
Net amount	0	0
Financial Liabilities
Gross amount of recognized liabilities	197	617
Gross amounts offset	(100)	(432)
Net amount of liabilities	97	185
Cash collateral	(40)	(110)
Non-cash collateral	(57)	(75)
Net amount	0	0
Embedded Derivative Instruments
Financial Assets
Gross amount of recognized assets	1,092	1,115
Gross amounts offset	0	0
Net amount of assets	1,092	1,115
Cash collateral	0	0
Non-cash collateral	0	0
Net amount	1,092	1,115
Financial Liabilities
Gross amount of recognized liabilities	10,945	12,479
Gross amounts offset	0	0
Net amount of liabilities	10,945	12,479
Cash collateral	0	0
Non-cash collateral	0	0
Net amount	$ 10,945	$ 12,479

XML

DAC, VOBA, DSI, and DFEL - Reconciliation of DAC, VOBA and DSI (Details) - USD ($) $ in Millions	Mar. 31, 2025	Dec. 31, 2024
Deferred Policy Acquisition Cost [Line Items]
Deferred acquisition costs, value of business acquired and deferred sales inducements	$ 12,563	$ 12,537
Other Operations
Deferred Policy Acquisition Cost [Line Items]
Deferred acquisition costs, value of business acquired and deferred sales inducements	2	0
Traditional Life
Deferred Policy Acquisition Cost [Line Items]
Deferred acquisition costs, value of business acquired and deferred sales inducements	1,352	1,370
UL and Other
Deferred Policy Acquisition Cost [Line Items]
Deferred acquisition costs, value of business acquired and deferred sales inducements	6,323	6,318
Group Protection
Deferred Policy Acquisition Cost [Line Items]
Deferred acquisition costs, value of business acquired and deferred sales inducements	181	178
Retirement Plan Services
Deferred Policy Acquisition Cost [Line Items]
Deferred acquisition costs, value of business acquired and deferred sales inducements	288	284
Variable Annuities
Deferred Policy Acquisition Cost [Line Items]
Deferred acquisition costs, value of business acquired and deferred sales inducements	4,001	3,964
Fixed Annuities
Deferred Policy Acquisition Cost [Line Items]
Deferred acquisition costs, value of business acquired and deferred sales inducements	$ 416	$ 423

XML

DAC, VOBA, DSI, and DFEL - Reconciliation of DEFL (Details) - USD ($) $ in Millions	Mar. 31, 2025	Dec. 31, 2024	Mar. 31, 2024	Dec. 31, 2023
Deferred Policy Acquisition Cost [Line Items]
Deferred front-end loads	$ 6,910	$ 6,730
Other Operations
Deferred Policy Acquisition Cost [Line Items]
Deferred front-end loads	53	51
Ceded deferred front end loads	53	51
UL and Other
Deferred Policy Acquisition Cost [Line Items]
Deferred front-end loads	6,587	6,406	$ 5,778	$ 5,579
Ceded deferred front end loads	237		258
Variable Annuities
Deferred Policy Acquisition Cost [Line Items]
Deferred front-end loads	270	$ 273	277	$ 278
Ceded deferred front end loads	$ 0		$ 0

XML

DAC, VOBA, DSI, and DFEL - DAC (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Amortization	$ (263)	$ (249)
Traditional Life
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Balance as of beginning-of-year	1,335	1,376
Deferrals	21	32
Amortization	(37)	(37)
Balance as of end-of-period	1,319	1,371
UL and Other
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Balance as of beginning-of-year	5,916	5,791
Deferrals	94	100
Amortization	(79)	(76)
Balance as of end-of-period	5,931	5,815
Group Protection
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Balance as of beginning-of-year	178	154
Deferrals	32	29
Amortization	(29)	(26)
Balance as of end-of-period	181	157
Retirement Plan Services
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Balance as of beginning-of-year	242	239
Deferrals	5	5
Amortization	(5)	(5)
Balance as of end-of-period	242	239
Variable Annuities
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Balance as of beginning-of-year	3,851	3,751
Deferrals	136	89
Amortization	(97)	(89)
Balance as of end-of-period	3,890	3,751
Fixed Annuities
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Balance as of beginning-of-year	394	421
Deferrals	10	9
Amortization	(16)	(16)
Balance as of end-of-period	$ 388	$ 414

XML

DAC, VOBA, DSI and DFEL - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Net [Abstract]
Deferred policy acquisition costs, amortization expense	$ 263	$ 249
Value of future insurance profits, amortization expense	12	13
Deferred sales inducements, amortization expense	3	3
Deferred front end loads, amortization expense	$ 104	$ 74

XML

DAC, VOBA, DSI, and DFEL - VOBA (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Movement in Present Value of Future Insurance Profits [Roll Forward]
Amortization	$ (12)	$ (13)
Traditional Life
Movement in Present Value of Future Insurance Profits [Roll Forward]
Balance as of beginning-of-year	35	42
Amortization	(2)	(2)
Balance as of end-of-period	33	40
UL and Other
Movement in Present Value of Future Insurance Profits [Roll Forward]
Balance as of beginning-of-year	375	413
Amortization	(9)	(10)
Balance as of end-of-period	366	403
Fixed Annuities
Movement in Present Value of Future Insurance Profits [Roll Forward]
Balance as of beginning-of-year	13	15
Amortization	(1)	(1)
Balance as of end-of-period	$ 12	$ 14

XML

DAC, VOBA, DSI, and DFEL - DSI (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Movement in Deferred Sales Inducements [Roll Forward]
Amortization	$ (3)	$ (3)
UL and Other
Movement in Deferred Sales Inducements [Roll Forward]
Balance as of beginning-of-year	27	28
Deferrals	0	0
Amortization	(1)	0
Balance as of end-of-period	26	28
Retirement Plan Services
Movement in Deferred Sales Inducements [Roll Forward]
Balance as of beginning-of-year	42	26
Deferrals	4	8
Amortization	0	0
Balance as of end-of-period	46	34
Variable Annuities
Movement in Deferred Sales Inducements [Roll Forward]
Balance as of beginning-of-year	113	122
Deferrals	0	1
Amortization	(2)	(3)
Balance as of end-of-period	111	120
Fixed Annuities
Movement in Deferred Sales Inducements [Roll Forward]
Balance as of beginning-of-year	16	19
Deferrals	0	0
Amortization	0	0
Balance as of end-of-period	$ 16	$ 19

XML

DAC, VOBA, DSI, and DFEL - DFEL (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Changes in DFEL [Roll Forward]
Balance as of beginning-of-year	$ 6,730
Amortization	(104)	$ (74)
Balance as of end-of-period	6,910
UL and Other
Changes in DFEL [Roll Forward]
Balance as of beginning-of-year	6,406	5,579
Deferrals	279	267
Amortization	(98)	(68)
Balance as of end-of-period	6,587	5,778
Less: Ceded DFEL	237	258
Balance as of end-of-period, net of reinsurance	6,350	5,520
Variable Annuities
Changes in DFEL [Roll Forward]
Balance as of beginning-of-year	273	278
Deferrals	3	5
Amortization	(6)	(6)
Balance as of end-of-period	270	277
Less: Ceded DFEL	0	0
Balance as of end-of-period, net of reinsurance	$ 270	$ 277

XML

Reinsurance - Narrative (Details) $ in Millions	Mar. 31, 2025 USD ($)	Dec. 31, 2024 USD ($)	Oct. 01, 2023 agreement
Ceded Credit Risk [Line Items]
Number of reinsurance recoverable agreements | agreement			2
Investments	$ 129,215	$ 129,254
Fortitude Re
Ceded Credit Risk [Line Items]
Deposits assets	8,200	8,100
Investments	9,200	9,300
Fixed Annuities | Fortitude Re
Ceded Credit Risk [Line Items]
Reinsurance recoverables	10,600	10,600
Reinsurance recoverables on unpaid losses	2,600	2,600
Reinsurance recoverable for unpaid claims and claims adjustments	23	22
Deposits assets	$ 2,800	$ 3,000

XML

Reinsurance - Schedule of Assets in Support of Reserves (Details) - USD ($) $ in Millions	Mar. 31, 2025	Dec. 31, 2024	Mar. 31, 2024	Dec. 31, 2023
Ceded Credit Risk [Line Items]
Fixed maturity AFS securities	$ 88,297	$ 87,111
Derivative investments	7,849	9,677
Other investments	6,653	6,588
Cash and invested cash	4,284	5,801	$ 4,122	$ 3,365
Accrued investment income	1,134	1,108
Fortitude Re
Ceded Credit Risk [Line Items]
Fixed maturity AFS securities	7,549	7,764
Derivative investments	19	30
Other investments	1,465	1,419
Cash and invested cash	104	28
Accrued investment income	93	96
Total	$ 9,230	$ 9,337

XML

MRBs - Reconciles of MRBs Assets and Liabilities (Details) - USD ($) $ in Millions	Mar. 31, 2025	Dec. 31, 2024	Mar. 31, 2024	Dec. 31, 2023
Market Risk Benefit [Line Items]
Assets	$ 4,157	$ 4,860
Liabilities	1,306	1,046
Net (Assets) Liabilities	(2,851)	(3,814)
Variable Annuities
Market Risk Benefit [Line Items]
Assets	4,041	4,737
Liabilities	1,165	933
Net (Assets) Liabilities	(2,876)	(3,804)	$ (3,604)	$ (2,180)
Fixed Annuities
Market Risk Benefit [Line Items]
Assets	73	78
Liabilities	137	110
Net (Assets) Liabilities	64	32	27	32
Retirement Plan Services
Market Risk Benefit [Line Items]
Assets	43	45
Liabilities	4	3
Net (Assets) Liabilities	$ (39)	$ (42)	$ (35)	$ (30)

XML

MRBs - Summary of Balances of Changes in Net MRB (Assets) Liabilities (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Market Risk Benefit [Roll Forward]
Balance as of beginning-of-year	$ (3,814)
Balance as of end-of-period	(2,851)
Variable Annuities
Market Risk Benefit [Roll Forward]
Balance as of beginning-of-year	(3,804)	$ (2,180)
Balance as of beginning-of-period, before the effect of changes in non-performance risk	(3,651)	(881)
Issuances	5	3
Attributed fees collected	373	380
Benefit payments	(6)	(11)
Effect of changes in interest rates	396	(1,081)
Effect of changes in equity markets	456	(1,343)
Effect of changes in equity index volatility	31	4
In-force updates and other changes in MRBs	59	51
Balance as of end-of-year, before the effect of changes in non-performance risk	(2,337)	(2,878)
Effect of cumulative changes in non-performance risk	(539)	(726)
Balance as of end-of-period	(2,876)	(3,604)
Less: Ceded MRB assets (liabilities)	(312)	(358)
Balance as of end-of-period, net of reinsurance	$ (2,564)	$ (3,246)
Weighted-average age of policyholders (years)	73 years	72 years
Net amount at risk	$ 2,518	$ 2,056
Variable Annuities | Cumulative Effect, Period of Adoption, Adjustment
Market Risk Benefit [Roll Forward]
Balance as of beginning-of-year	(153)	(1,299)
Fixed Annuities
Market Risk Benefit [Roll Forward]
Balance as of beginning-of-year	32	32
Balance as of beginning-of-period, before the effect of changes in non-performance risk	65	90
Issuances	0	0
Attributed fees collected	8	9
Benefit payments	0	0
Effect of changes in interest rates	39	(17)
Effect of changes in equity markets	2	(11)
Effect of changes in equity index volatility	0	(2)
In-force updates and other changes in MRBs	(2)	1
Balance as of end-of-year, before the effect of changes in non-performance risk	112	70
Effect of cumulative changes in non-performance risk	(48)	(43)
Balance as of end-of-period	64	27
Less: Ceded MRB assets (liabilities)	0	0
Balance as of end-of-period, net of reinsurance	$ 64	$ 27
Weighted-average age of policyholders (years)	70 years	69 years
Net amount at risk	$ 255	$ 210
Fixed Annuities | Cumulative Effect, Period of Adoption, Adjustment
Market Risk Benefit [Roll Forward]
Balance as of beginning-of-year	(33)	(58)
Retirement Plan Services
Market Risk Benefit [Roll Forward]
Balance as of beginning-of-year	(42)	(30)
Balance as of beginning-of-period, before the effect of changes in non-performance risk	(42)	(26)
Issuances	0	0
Attributed fees collected	1	2
Benefit payments	0	0
Effect of changes in interest rates	1	(6)
Effect of changes in equity markets	2	(4)
Effect of changes in equity index volatility	0	0
In-force updates and other changes in MRBs	1	1
Balance as of end-of-year, before the effect of changes in non-performance risk	(37)	(33)
Effect of cumulative changes in non-performance risk	(2)	(2)
Balance as of end-of-period	(39)	(35)
Less: Ceded MRB assets (liabilities)	0	0
Balance as of end-of-period, net of reinsurance	$ (39)	$ (35)
Weighted-average age of policyholders (years)	63 years	63 years
Net amount at risk	$ 4	$ 3
Retirement Plan Services | Cumulative Effect, Period of Adoption, Adjustment
Market Risk Benefit [Roll Forward]
Balance as of beginning-of-year	$ 0	$ (4)

XML

Separate Accounts - Schedule of Fair Value of Separate Account Assets (Details) - USD ($) $ in Millions	Mar. 31, 2025	Dec. 31, 2024
Fair Value, Separate Account Investment [Line Items]
Separate account assets	$ 162,506	$ 168,438
Mutual funds and collective investment trusts
Fair Value, Separate Account Investment [Line Items]
Separate account assets	161,823	167,759
Exchange-traded funds
Fair Value, Separate Account Investment [Line Items]
Separate account assets	249	336
Fixed maturity AFS securities
Fair Value, Separate Account Investment [Line Items]
Separate account assets	168	161
Cash and invested cash
Fair Value, Separate Account Investment [Line Items]
Separate account assets	77	12
Other investments
Fair Value, Separate Account Investment [Line Items]
Separate account assets	$ 189	$ 170

XML

Separate Accounts - Summary of Balances and Changes in Separate Account Liabilities (Details) - USD ($) $ in Millions	Mar. 31, 2025	Dec. 31, 2024	Mar. 31, 2024	Dec. 31, 2023
Fair Value, Separate Account Investment [Line Items]
Separate account liabilities	$ 162,506	$ 168,438
Reinsurance Agreement | Protective
Fair Value, Separate Account Investment [Line Items]
Separate account liabilities	47	49
Variable Annuities
Fair Value, Separate Account Investment [Line Items]
Separate account liabilities	113,635	117,998	$ 118,176	$ 113,356
UL and Other
Fair Value, Separate Account Investment [Line Items]
Separate account liabilities	28,106	28,841	27,007	25,150
Retirement Plan Services
Fair Value, Separate Account Investment [Line Items]
Separate account liabilities	20,708	21,541	$ 20,986	$ 19,699
Other
Fair Value, Separate Account Investment [Line Items]
Separate account liabilities	$ 57	$ 58

XML

Separate Accounts - Schedule of Reconciliation of Separate Account Liabilities (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Separate Account, Liability [Roll Forward]
Balance as of beginning-of-year	$ 168,438
Balance as of end-of-period	162,506
Variable Annuities
Separate Account, Liability [Roll Forward]
Balance as of beginning-of-year	117,998	$ 113,356
Gross deposits	1,557	904
Withdrawals	(3,915)	(3,208)
Policyholder assessments	(656)	(648)
Change in market performance	(1,798)	7,503
Net transfers from (to) general account	449	269
Balance as of end-of-period	113,635	118,176
Cash surrender value	112,239	116,771
UL and Other
Separate Account, Liability [Roll Forward]
Balance as of beginning-of-year	28,841	25,150
Gross deposits	353	358
Withdrawals	(204)	(103)
Policyholder assessments	(246)	(246)
Change in market performance	(624)	1,885
Net transfers from (to) general account	(14)	(37)
Balance as of end-of-period	28,106	27,007
Cash surrender value	23,577	24,606
Retirement Plan Services
Separate Account, Liability [Roll Forward]
Balance as of beginning-of-year	21,541	19,699
Gross deposits	627	570
Withdrawals	(902)	(732)
Policyholder assessments	(46)	(44)
Change in market performance	(478)	1,475
Net transfers from (to) general account	(34)	18
Balance as of end-of-period	20,708	20,986
Cash surrender value	$ 20,695	$ 20,971

XML

Policyholder Account Balances - Schedule of Policyholder Account Balances (Details) - USD ($) $ in Millions	Mar. 31, 2025	Dec. 31, 2024	Mar. 31, 2024	Dec. 31, 2023
Policyholder Account Balance [Line Items]
Policyholder account balances	$ 125,262	$ 126,197
Variable Annuities
Policyholder Account Balance [Line Items]
Policyholder account balances	34,370	35,267	$ 31,408	$ 29,141
Fixed Annuities
Policyholder Account Balance [Line Items]
Policyholder account balances	26,039	25,963	25,162	25,355
UL and Other
Policyholder Account Balance [Line Items]
Policyholder account balances	36,220	36,599	37,006	37,180
Retirement Plan Services
Policyholder Account Balance [Line Items]
Policyholder account balances	23,479	23,619	$ 23,586	$ 23,784
Other
Policyholder Account Balance [Line Items]
Policyholder account balances	5,154	4,749
Other | Reinsurance Agreement
Policyholder Account Balance [Line Items]
Policyholder account balances	$ 4,300	$ 4,400

XML

Policyholder Account Balances - Summary of Balances and Changes in Policyholder Account Balances (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Policyholder Account Balance [Roll Forward]
Balance as of beginning-of-year	$ 126,197
Interest credited	890	$ 822
Balance as of end-of-period	125,262
Variable Annuities
Policyholder Account Balance [Roll Forward]
Balance as of beginning-of-year	35,267	29,141
Gross deposits	1,369	973
Withdrawals	(612)	(224)
Policyholder assessments	0	0
Net transfers from (to) separate account	(287)	(178)
Interest credited	199	158
Change in fair value of embedded derivative instrument and other	(1,566)	1,538
Balance as of end-of-period	$ 34,370	$ 31,408
Weighted-average crediting rate	2.30%	2.10%
Net amount at risk	$ 2,518	$ 2,056
Cash surrender value	33,108	30,228
Fixed Annuities
Policyholder Account Balance [Roll Forward]
Balance as of beginning-of-year	25,963	25,355
Gross deposits	873	973
Withdrawals	(947)	(1,410)
Policyholder assessments	(15)	(17)
Net transfers from (to) separate account	0	0
Interest credited	210	183
Change in fair value of embedded derivative instrument and other	(45)	78
Balance as of end-of-period	$ 26,039	$ 25,162
Weighted-average crediting rate	3.20%	2.90%
Net amount at risk	$ 255	$ 210
Cash surrender value	24,935	24,139
UL and Other
Policyholder Account Balance [Roll Forward]
Balance as of beginning-of-year	36,599	37,180
Gross deposits	865	850
Withdrawals	(445)	(364)
Policyholder assessments	(1,104)	(1,124)
Net transfers from (to) separate account	14	38
Interest credited	356	365
Change in fair value of embedded derivative instrument and other	(65)	61
Balance as of end-of-period	$ 36,220	$ 37,006
Weighted-average crediting rate	3.90%	3.90%
Net amount at risk	$ 299,107	$ 300,740
Cash surrender value	32,645	33,314
Retirement Plan Services
Policyholder Account Balance [Roll Forward]
Balance as of beginning-of-year	23,619	23,784
Gross deposits	811	790
Withdrawals	(1,330)	(1,203)
Policyholder assessments	(4)	(3)
Net transfers from (to) separate account	211	50
Interest credited	172	168
Change in fair value of embedded derivative instrument and other	0	0
Balance as of end-of-period	$ 23,479	$ 23,586
Weighted-average crediting rate	2.90%	2.80%
Net amount at risk	$ 4	$ 3
Cash surrender value	$ 23,443	$ 23,560

XML

Policyholder Account Balances - Narrative (Details) - USD ($)	Mar. 31, 2025	Dec. 31, 2024
Policyholder Account Balance [Line Items]
Long-term debt	$ 5,868,000,000	$ 5,856,000,000
FABN | Sustainable Financing | The Lincoln National Life Insurance Company
Policyholder Account Balance [Line Items]
Debt instrument, face amount	5,000,000,000
Long-term debt	$ 500,000,000	$ 0

XML

Policyholder Account Balances - Summary of Policyholder Account Balances by Ranges (Details) - USD ($) $ in Millions	Mar. 31, 2025	Dec. 31, 2024	Mar. 31, 2024	Dec. 31, 2023
Policyholder Account Balance [Line Items]
Policyholder account balances	$ 125,262	$ 126,197
Variable Annuities
Policyholder Account Balance [Line Items]
Policyholder account balances	34,370	35,267	$ 31,408	$ 29,141
Variable Annuities | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Policyholder account balances	1,711		1,893
Variable Annuities | 1-50 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Variable Annuities | 51-100 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Variable Annuities | 101-150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Variable Annuities | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	$ 7		$ 6
Variable Annuities | Up to 1.00%
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	1.00%		1.00%
Policyholder account balances	$ 9		$ 0
Variable Annuities | Up to 1.00% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Policyholder account balances	9		0
Variable Annuities | Up to 1.00% | 1-50 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Variable Annuities | Up to 1.00% | 51-100 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Variable Annuities | Up to 1.00% | 101-150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Variable Annuities | Up to 1.00% | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Variable Annuities | 1.01% - 2.00%
Policyholder Account Balance [Line Items]
Policyholder account balances	10		11
Variable Annuities | 1.01% - 2.00% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Policyholder account balances	3		5
Variable Annuities | 1.01% - 2.00% | 1-50 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Variable Annuities | 1.01% - 2.00% | 51-100 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Variable Annuities | 1.01% - 2.00% | 101-150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Variable Annuities | 1.01% - 2.00% | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	7		6
Variable Annuities | 2.01% - 3.00%
Policyholder Account Balance [Line Items]
Policyholder account balances	495		560
Variable Annuities | 2.01% - 3.00% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Policyholder account balances	495		560
Variable Annuities | 2.01% - 3.00% | 1-50 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Variable Annuities | 2.01% - 3.00% | 51-100 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Variable Annuities | 2.01% - 3.00% | 101-150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Variable Annuities | 2.01% - 3.00% | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Variable Annuities | 3.01% - 4.00%
Policyholder Account Balance [Line Items]
Policyholder account balances	1,197		1,319
Variable Annuities | 3.01% - 4.00% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Policyholder account balances	1,197		1,319
Variable Annuities | 3.01% - 4.00% | 1-50 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Variable Annuities | 3.01% - 4.00% | 51-100 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Variable Annuities | 3.01% - 4.00% | 101-150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Variable Annuities | 3.01% - 4.00% | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	$ 0		$ 0
Variable Annuities | 4.01% and above
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	4.01%		4.01%
Policyholder account balances	$ 7		$ 9
Variable Annuities | 4.01% and above | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Policyholder account balances	7		9
Variable Annuities | 4.01% and above | 1-50 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Variable Annuities | 4.01% and above | 51-100 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Variable Annuities | 4.01% and above | 101-150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Variable Annuities | 4.01% and above | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Variable Annuities | Other
Policyholder Account Balance [Line Items]
Policyholder account balances	32,652		29,509
Variable Annuities | Other | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Variable Annuities | Other | 1-50 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Variable Annuities | Other | 51-100 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Variable Annuities | Other | 101-150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Variable Annuities | Other | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	$ 0		$ 0
Variable Annuities | Minimum | 1.01% - 2.00%
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	1.01%		1.01%
Variable Annuities | Minimum | 2.01% - 3.00%
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	2.01%		2.01%
Variable Annuities | Minimum | 3.01% - 4.00%
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	3.01%		3.01%
Variable Annuities | Maximum | 1.01% - 2.00%
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	2.00%		2.00%
Variable Annuities | Maximum | 2.01% - 3.00%
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	3.00%		3.00%
Variable Annuities | Maximum | 3.01% - 4.00%
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	4.00%		4.00%
Fixed Annuities
Policyholder Account Balance [Line Items]
Policyholder account balances	$ 26,039	25,963	$ 25,162	25,355
Fixed Annuities | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Policyholder account balances	3,019		3,881
Fixed Annuities | 1-50 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	1,090		743
Fixed Annuities | 51-100 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	606		850
Fixed Annuities | 101-150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	392		994
Fixed Annuities | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	$ 8,212		$ 5,722
Fixed Annuities | Up to 1.00%
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	1.00%		1.00%
Policyholder account balances	$ 4,010		$ 4,803
Fixed Annuities | Up to 1.00% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Policyholder account balances	201		679
Fixed Annuities | Up to 1.00% | 1-50 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	855		605
Fixed Annuities | Up to 1.00% | 51-100 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	459		560
Fixed Annuities | Up to 1.00% | 101-150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	229		493
Fixed Annuities | Up to 1.00% | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	2,266		2,466
Fixed Annuities | 1.01% - 2.00%
Policyholder Account Balance [Line Items]
Policyholder account balances	6,640		4,475
Fixed Annuities | 1.01% - 2.00% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Policyholder account balances	223		360
Fixed Annuities | 1.01% - 2.00% | 1-50 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	202		99
Fixed Annuities | 1.01% - 2.00% | 51-100 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	146		285
Fixed Annuities | 1.01% - 2.00% | 101-150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	161		500
Fixed Annuities | 1.01% - 2.00% | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	5,908		3,231
Fixed Annuities | 2.01% - 3.00%
Policyholder Account Balance [Line Items]
Policyholder account balances	1,573		1,819
Fixed Annuities | 2.01% - 3.00% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Policyholder account balances	1,499		1,749
Fixed Annuities | 2.01% - 3.00% | 1-50 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	33		39
Fixed Annuities | 2.01% - 3.00% | 51-100 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	1		5
Fixed Annuities | 2.01% - 3.00% | 101-150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	2		1
Fixed Annuities | 2.01% - 3.00% | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	38		25
Fixed Annuities | 3.01% - 4.00%
Policyholder Account Balance [Line Items]
Policyholder account balances	930		916
Fixed Annuities | 3.01% - 4.00% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Policyholder account balances	930		916
Fixed Annuities | 3.01% - 4.00% | 1-50 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Fixed Annuities | 3.01% - 4.00% | 51-100 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Fixed Annuities | 3.01% - 4.00% | 101-150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Fixed Annuities | 3.01% - 4.00% | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	$ 0		$ 0
Fixed Annuities | 4.01% and above
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	4.01%		4.01%
Policyholder account balances	$ 166		$ 177
Fixed Annuities | 4.01% and above | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Policyholder account balances	166		177
Fixed Annuities | 4.01% and above | 1-50 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Fixed Annuities | 4.01% and above | 51-100 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Fixed Annuities | 4.01% and above | 101-150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Fixed Annuities | 4.01% and above | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Fixed Annuities | Other
Policyholder Account Balance [Line Items]
Policyholder account balances	12,720		12,972
Fixed Annuities | Other | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Fixed Annuities | Other | 1-50 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Fixed Annuities | Other | 51-100 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Fixed Annuities | Other | 101-150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Fixed Annuities | Other | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	$ 0		$ 0
Fixed Annuities | Minimum | 1.01% - 2.00%
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	1.01%		1.01%
Fixed Annuities | Minimum | 2.01% - 3.00%
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	2.01%		2.01%
Fixed Annuities | Minimum | 3.01% - 4.00%
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	3.01%		3.01%
Fixed Annuities | Maximum | 1.01% - 2.00%
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	2.00%		2.00%
Fixed Annuities | Maximum | 2.01% - 3.00%
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	3.00%		3.00%
Fixed Annuities | Maximum | 3.01% - 4.00%
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	4.00%		4.00%
UL and Other
Policyholder Account Balance [Line Items]
Policyholder account balances	$ 36,220	36,599	$ 37,006	37,180
UL and Other | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Policyholder account balances	25,782		26,978
UL and Other | 1-50 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	9		10
UL and Other | 51-100 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	384		369
UL and Other | 101-150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	31		119
UL and Other | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	$ 3,429		$ 3,238
UL and Other | Up to 1.00%
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	1.00%		1.00%
Policyholder account balances	$ 976		$ 632
UL and Other | Up to 1.00% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Policyholder account balances	261		264
UL and Other | Up to 1.00% | 1-50 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
UL and Other | Up to 1.00% | 51-100 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	231		219
UL and Other | Up to 1.00% | 101-150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	31		119
UL and Other | Up to 1.00% | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	453		30
UL and Other | 1.01% - 2.00%
Policyholder Account Balance [Line Items]
Policyholder account balances	3,517		3,756
UL and Other | 1.01% - 2.00% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Policyholder account balances	541		548
UL and Other | 1.01% - 2.00% | 1-50 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
UL and Other | 1.01% - 2.00% | 51-100 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
UL and Other | 1.01% - 2.00% | 101-150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
UL and Other | 1.01% - 2.00% | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	2,976		3,208
UL and Other | 2.01% - 3.00%
Policyholder Account Balance [Line Items]
Policyholder account balances	6,644		7,007
UL and Other | 2.01% - 3.00% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Policyholder account balances	6,483		6,848
UL and Other | 2.01% - 3.00% | 1-50 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	9		10
UL and Other | 2.01% - 3.00% | 51-100 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	152		149
UL and Other | 2.01% - 3.00% | 101-150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
UL and Other | 2.01% - 3.00% | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
UL and Other | 3.01% - 4.00%
Policyholder Account Balance [Line Items]
Policyholder account balances	14,973		15,597
UL and Other | 3.01% - 4.00% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Policyholder account balances	14,972		15,596
UL and Other | 3.01% - 4.00% | 1-50 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
UL and Other | 3.01% - 4.00% | 51-100 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	1		1
UL and Other | 3.01% - 4.00% | 101-150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
UL and Other | 3.01% - 4.00% | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	$ 0		$ 0
UL and Other | 4.01% and above
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	4.01%		4.01%
Policyholder account balances	$ 3,525		$ 3,722
UL and Other | 4.01% and above | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Policyholder account balances	3,525		3,722
UL and Other | 4.01% and above | 1-50 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
UL and Other | 4.01% and above | 51-100 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
UL and Other | 4.01% and above | 101-150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
UL and Other | 4.01% and above | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
UL and Other | Other
Policyholder Account Balance [Line Items]
Policyholder account balances	6,585		6,292
UL and Other | Other | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
UL and Other | Other | 1-50 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
UL and Other | Other | 51-100 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
UL and Other | Other | 101-150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
UL and Other | Other | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	$ 0		$ 0
UL and Other | Minimum | 1.01% - 2.00%
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	1.01%		1.01%
UL and Other | Minimum | 2.01% - 3.00%
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	2.01%		2.01%
UL and Other | Minimum | 3.01% - 4.00%
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	3.01%		3.01%
UL and Other | Maximum | 1.01% - 2.00%
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	2.00%		2.00%
UL and Other | Maximum | 2.01% - 3.00%
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	3.00%		3.00%
UL and Other | Maximum | 3.01% - 4.00%
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	4.00%		4.00%
Retirement Plan Services
Policyholder Account Balance [Line Items]
Policyholder account balances	$ 23,479	$ 23,619	$ 23,586	$ 23,784
Retirement Plan Services | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Policyholder account balances	8,350		9,606
Retirement Plan Services | 1-50 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	2,094		2,355
Retirement Plan Services | 51-100 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	2,628		2,219
Retirement Plan Services | 101-150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	3,978		5,071
Retirement Plan Services | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	$ 6,429		$ 4,335
Retirement Plan Services | Up to 1.00%
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	1.00%		1.00%
Policyholder account balances	$ 10,874		$ 9,703
Retirement Plan Services | Up to 1.00% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Policyholder account balances	573		437
Retirement Plan Services | Up to 1.00% | 1-50 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	312		500
Retirement Plan Services | Up to 1.00% | 51-100 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	725		740
Retirement Plan Services | Up to 1.00% | 101-150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	3,498		3,706
Retirement Plan Services | Up to 1.00% | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	5,766		4,320
Retirement Plan Services | 1.01% - 2.00%
Policyholder Account Balance [Line Items]
Policyholder account balances	4,433		4,959
Retirement Plan Services | 1.01% - 2.00% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Policyholder account balances	477		527
Retirement Plan Services | 1.01% - 2.00% | 1-50 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	996		1,660
Retirement Plan Services | 1.01% - 2.00% | 51-100 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	1,847		1,413
Retirement Plan Services | 1.01% - 2.00% | 101-150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	451		1,345
Retirement Plan Services | 1.01% - 2.00% | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	662		14
Retirement Plan Services | 2.01% - 3.00%
Policyholder Account Balance [Line Items]
Policyholder account balances	2,289		2,444
Retirement Plan Services | 2.01% - 3.00% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Policyholder account balances	1,680		2,342
Retirement Plan Services | 2.01% - 3.00% | 1-50 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	542		21
Retirement Plan Services | 2.01% - 3.00% | 51-100 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	48		63
Retirement Plan Services | 2.01% - 3.00% | 101-150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	18		17
Retirement Plan Services | 2.01% - 3.00% | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	1		1
Retirement Plan Services | 3.01% - 4.00%
Policyholder Account Balance [Line Items]
Policyholder account balances	4,320		4,879
Retirement Plan Services | 3.01% - 4.00% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Policyholder account balances	4,194		4,842
Retirement Plan Services | 3.01% - 4.00% | 1-50 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	107		31
Retirement Plan Services | 3.01% - 4.00% | 51-100 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	8		3
Retirement Plan Services | 3.01% - 4.00% | 101-150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	11		3
Retirement Plan Services | 3.01% - 4.00% | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	$ 0		$ 0
Retirement Plan Services | 4.01% and above
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	4.01%		4.01%
Policyholder account balances	$ 1,563		$ 1,601
Retirement Plan Services | 4.01% and above | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Policyholder account balances	1,426		1,458
Retirement Plan Services | 4.01% and above | 1-50 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	137		143
Retirement Plan Services | 4.01% and above | 51-100 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Retirement Plan Services | 4.01% and above | 101-150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	0		0
Retirement Plan Services | 4.01% and above | Greater Than 150 Basis Points Above
Policyholder Account Balance [Line Items]
Policyholder account balances	$ 0		$ 0
Retirement Plan Services | Minimum | 1.01% - 2.00%
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	1.01%		1.01%
Retirement Plan Services | Minimum | 2.01% - 3.00%
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	2.01%		2.01%
Retirement Plan Services | Minimum | 3.01% - 4.00%
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	3.01%		3.01%
Retirement Plan Services | Maximum | 1.01% - 2.00%
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	2.00%		2.00%
Retirement Plan Services | Maximum | 2.01% - 3.00%
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	3.00%		3.00%
Retirement Plan Services | Maximum | 3.01% - 4.00%
Policyholder Account Balance [Line Items]
Range of guaranteed minimum crediting rate	4.00%		4.00%

XML

Future Contract Benefit - Summary of Reconciliation of Future Contract Benefits (Details) - USD ($) $ in Millions	Mar. 31, 2025	Dec. 31, 2024	Mar. 31, 2024
Liability for Future Policy Benefit, Activity [Line Items]
Future contract benefits	$ 40,665	$ 39,807
Other
Liability for Future Policy Benefit, Activity [Line Items]
Future contract benefits	3,335	3,264
Payout Annuities
Liability for Future Policy Benefit, Activity [Line Items]
Future contract benefits	2,033	2,009	$ 2,034
Traditional Life
Liability for Future Policy Benefit, Activity [Line Items]
Future contract benefits	3,821	3,774	$ 3,793
Group Protection
Liability for Future Policy Benefit, Activity [Line Items]
Future contract benefits	5,712	5,628
UL and Other
Liability for Future Policy Benefit, Activity [Line Items]
Future contract benefits	16,702	16,062
Other Operations [Member]
Liability for Future Policy Benefit, Activity [Line Items]
Future contract benefits	9,062	9,070
Protective | Other Operations [Member]
Liability for Future Policy Benefit, Activity [Line Items]
Future contract benefits	5,400	5,400
Swiss Re | Other Operations [Member]
Liability for Future Policy Benefit, Activity [Line Items]
Future contract benefits	$ 1,800	$ 1,800

XML

Future Contract Benefits - Summary of Changes in Present Values of Expected Net Premiums and LFPB (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024	Dec. 31, 2024	Dec. 31, 2023
Present Value of Expected LFPB
Net balance as of end-of-period	$ 40,665		$ 39,807
Payout Annuities
Present Value of Expected Net Premiums
Balance as of beginning-of-year	0	$ 0
Beginning balance at original discount rate	0	0
Effect of actual variances from expected experience			0	$ 0
Adjusted balance as of beginning-of-year	0	0
Issuances	0	0
Interest accrual	0	0
Net premiums collected	0	0
Flooring impact of LFPB	0	0
Ending balance at original discount rate	0	0
Effect of cumulative changes in discount rate assumptions	0	0
Balance as of end-of-period	0	0
Present Value of Expected LFPB
Balance as of beginning-of-year	2,009	2,085
Beginning balance at original discount rate	2,260	2,272
Effect of actual variances from expected experience			(1)	1
Adjusted balance as of beginning-of-year			2,259	2,273
Issuances	22	15
Interest accrual	22	22
Benefit payments	(49)	(49)
Ending balance at original discount rate	2,254	2,261
Effect of cumulative changes in discount rate assumptions	(221)	(227)
Balance as of end-of-period	2,033	2,034
Net balance as of end-of-period	2,033	2,034	2,009
Less: Reinsurance recoverables	1,478	1,562
Net balance as of end-of-period, net of reinsurance	$ 555	$ 472
Weighted-average duration of future policyholder benefit liability	9 years	9 years
Deferred profit liability	$ 65	$ 60
Payout Annuities | Cumulative Effect, Period of Adoption, Adjustment
Present Value of Expected Net Premiums
Balance as of beginning-of-year	0	0
Present Value of Expected LFPB
Balance as of beginning-of-year	(251)	(187)
Traditional Life
Present Value of Expected Net Premiums
Balance as of beginning-of-year	5,873	6,200
Beginning balance at original discount rate	6,148	6,348
Effect of actual variances from expected experience			(48)	2
Adjusted balance as of beginning-of-year	6,100	6,350
Issuances	64	108
Interest accrual	62	63
Net premiums collected	(192)	(202)
Flooring impact of LFPB	(5)	3
Ending balance at original discount rate	6,029	6,322
Effect of cumulative changes in discount rate assumptions	(196)	(254)
Balance as of end-of-period	5,833	6,068
Present Value of Expected LFPB
Balance as of beginning-of-year	9,647	10,041
Beginning balance at original discount rate	10,085	10,230
Effect of actual variances from expected experience			(55)	7
Adjusted balance as of beginning-of-year			10,030	$ 10,237
Issuances	64	108
Interest accrual	99	100
Benefit payments	(234)	(206)
Ending balance at original discount rate	9,959	10,239
Effect of cumulative changes in discount rate assumptions	(305)	(378)
Balance as of end-of-period	9,654	9,861
Net balance as of end-of-period	3,821	3,793	$ 3,774
Less: Reinsurance recoverables	360	421
Net balance as of end-of-period, net of reinsurance	$ 3,461	$ 3,372
Weighted-average duration of future policyholder benefit liability	9 years	9 years
Traditional Life | Cumulative Effect, Period of Adoption, Adjustment
Present Value of Expected Net Premiums
Balance as of beginning-of-year	$ (275)	$ (148)
Present Value of Expected LFPB
Balance as of beginning-of-year	$ (438)	$ (189)

XML

Future Contract Benefits - Summary of Discounted and Undiscounted Expected Future Gross Premiums and Expected Future Benefit Payments (Details) - USD ($) $ in Millions	Mar. 31, 2025	Mar. 31, 2024
Payout Annuities
Undiscounted
Expected future gross premiums	$ 0	$ 0
Expected future benefit payments	3,408	3,438
Discounted
Expected future gross premiums	0	0
Expected future benefit payments	2,033	2,034
Traditional Life
Undiscounted
Expected future gross premiums	13,807	13,896
Expected future benefit payments	14,129	14,582
Discounted
Expected future gross premiums	9,447	9,570
Expected future benefit payments	$ 9,654	$ 9,861

XML

Future Contract Benefit - Summary of Gross Premiums and Interest Accretion (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Payout Annuities
Liability for Future Policy Benefit, Activity [Line Items]
Gross premiums	$ 23	$ 21
Interest accretion	22	22
Traditional Life
Liability for Future Policy Benefit, Activity [Line Items]
Gross premiums	314	314
Interest accretion	$ 37	$ 37

XML

Future Contract Benefit - Summary of Weighted-Average Interest Rates (Details)	Mar. 31, 2025	Mar. 31, 2024
Payout Annuities
Liability for Future Policy Benefit, Activity [Line Items]
Interest accretion rate	4.00%	3.90%
Current discount rate	5.20%	5.20%
Traditional Life
Liability for Future Policy Benefit, Activity [Line Items]
Interest accretion rate	5.00%	5.00%
Current discount rate	4.90%	5.00%

XML

Future Contract Benefits - Summary of Changes in Present Values of LFPB (Group Protection) (Details) - Group Protection - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024	Dec. 31, 2024	Dec. 31, 2023
Present Value of Expected LFPB
Balance as of beginning-of-year	$ 5,628	$ 5,689
Effect of cumulative changes in discount rate assumptions			$ (550)	$ (490)
Beginning balance at original discount rate	6,178	6,179
Effect of actual variances from expected experience			$ (72)	$ (67)
Adjusted balance as of beginning-of-year	6,106	6,112
Issuances	402	408
Interest accrual	50	48
Benefit payments	(371)	(382)
Ending balance at original discount rate	6,187	6,186
Effect of cumulative changes in discount rate assumptions	(475)	(546)
Balance as of end-of-period	5,712	5,640
Less: Reinsurance recoverables	121	123
Net balance as of end-of-period, net of reinsurance	$ 5,591	$ 5,517
Weighted-average duration of future policyholder benefit liability	5 years	5 years

XML

Future Contract Benefits - Summary of Discounted and Undiscounted Expected Future Benefit Payments (Group Protection) (Details) - Group Protection - USD ($) $ in Millions	Mar. 31, 2025	Mar. 31, 2024
Undiscounted
Expected future benefit payments	$ 7,413	$ 7,296
Discounted
Expected future benefit payments	$ 5,712	$ 5,640

XML

Future Contract Benefit - Summary of Gross Premiums and Interest Accretion (Group Protection) (Details) - Group Protection - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Liability for Future Policy Benefit, Activity [Line Items]
Gross premiums	$ 933	$ 896
Interest accretion	$ 50	$ 48

XML

Future Contract Benefit - Summary of Weighted-Average Interest Rates (Group Protection) (Details) - Group Protection	Mar. 31, 2025	Mar. 31, 2024
Liability for Future Policy Benefit, Activity [Line Items]
Interest accretion rate	3.40%	3.20%
Current discount rate	4.90%	5.00%

XML

Future Contract Benefits - Summary of Changes in Present Values of LFPB (UL and Other) (Details) - UL and Other - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024	Dec. 31, 2024	Dec. 31, 2023
Present Value of Expected LFPB
Balance as of beginning-of-year	$ 16,062	$ 15,000
Effect of cumulative changes in shadow balance in AOCI	(2,377)	(3,083)	$ (2,673)	$ (2,222)
Balance as of beginning-of-year, excluding shadow balance in AOCI	18,735	17,222
Effect of actual variances from expected experience			$ 23	$ 106
Adjusted balance as of beginning-of-year	18,758	17,328
Interest accrual	228	209
Net assessments collected	293	303
Benefit payments	(200)	(313)
Balance as of end-of-year, excluding shadow balance in AOCI	19,079	17,527
Balance as of end-of-period	16,702	14,444
Less: Reinsurance recoverables	5,316	4,776
Net balance as of end-of-period, net of reinsurance	$ 11,386	$ 9,668
Weighted-average duration of future policyholder benefit liability	16 years	17 years

XML

Future Contract Benefit - Summary of Gross Premiums and Interest Accretion (UL and Other) (Details) - UL and Other - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Liability for Future Policy Benefit, Activity [Line Items]
Gross assessments	$ 700	$ 766
Interest accretion	$ 228	$ 209

XML

Future Contract Benefit - Summary of Weighted-Average Interest Rates (UL and Other) (Details)	Mar. 31, 2025	Mar. 31, 2024
UL and Other
Liability for Future Policy Benefit, Activity [Line Items]
Interest accretion rate	5.40%	5.30%

XML

Fair Value of Financial Instruments - Fair Value of Assets and Liabilities on a Recurring Basis (Details) - USD ($) $ in Millions	Mar. 31, 2025	Dec. 31, 2024
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	$ 270,346	$ 278,356
Liabilities	(16,061)	(18,301)
Corporate bonds
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	66,885	66,450
U.S. government bonds
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	538	391
State and municipal bonds
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	2,350	2,371
Foreign government bonds
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	239	237
RMBS
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	1,941	1,863
CMBS
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	1,830	1,665
ABS
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	14,241	13,880
Hybrid and redeemable preferred securities
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	273	254
Trading securities
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	1,984	2,025
Equity securities
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	345	294
Mortgage loans on real estate
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	232	232
Derivative investments
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	11,248	13,887
Other investments – short-term investments
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	483	392
MRB assets
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	4,157	4,860
Ceded MRBs
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	2	2
Liabilities	(314)	(381)
Indexed annuity ceded embedded derivatives
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	1,092	1,115
Separate account assets
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	162,506	168,438
RILA, fixed indexed annuity and IUL contracts
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Liabilities	(10,807)	(12,449)
Reinsurance-related embedded derivatives
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Liabilities	(138)	(30)
MRB liabilities
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Liabilities	(1,306)	(1,046)
Derivative liabilities
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Liabilities	(3,496)	(4,395)
Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	938	810
Liabilities	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Corporate bonds
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. government bonds
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	518	371
Quoted Prices in Active Markets for Identical Assets (Level 1) | State and municipal bonds
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Foreign government bonds
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | RMBS
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | CMBS
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | ABS
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Hybrid and redeemable preferred securities
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	47	48
Quoted Prices in Active Markets for Identical Assets (Level 1) | Trading securities
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Equity securities
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Mortgage loans on real estate
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Derivative investments
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Other investments – short-term investments
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | MRB assets
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Ceded MRBs
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	0	0
Liabilities	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Indexed annuity ceded embedded derivatives
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Separate account assets
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	373	391
Quoted Prices in Active Markets for Identical Assets (Level 1) | RILA, fixed indexed annuity and IUL contracts
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Liabilities	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Reinsurance-related embedded derivatives
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Liabilities	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | MRB liabilities
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Liabilities	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Derivative liabilities
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Liabilities	0	0
Significant Observable Inputs (Level 2)
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	257,843	265,955
Liabilities	(3,192)	(4,052)
Significant Observable Inputs (Level 2) | Corporate bonds
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	63,911	63,585
Significant Observable Inputs (Level 2) | U.S. government bonds
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	20	20
Significant Observable Inputs (Level 2) | State and municipal bonds
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	2,350	2,371
Significant Observable Inputs (Level 2) | Foreign government bonds
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	239	237
Significant Observable Inputs (Level 2) | RMBS
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	1,922	1,851
Significant Observable Inputs (Level 2) | CMBS
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	1,800	1,657
Significant Observable Inputs (Level 2) | ABS
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	11,610	11,781
Significant Observable Inputs (Level 2) | Hybrid and redeemable preferred securities
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	145	133
Significant Observable Inputs (Level 2) | Trading securities
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	1,697	1,760
Significant Observable Inputs (Level 2) | Equity securities
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	310	260
Significant Observable Inputs (Level 2) | Mortgage loans on real estate
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	0	0
Significant Observable Inputs (Level 2) | Derivative investments
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	11,238	13,884
Significant Observable Inputs (Level 2) | Other investments – short-term investments
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	468	369
Significant Observable Inputs (Level 2) | MRB assets
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	0	0
Significant Observable Inputs (Level 2) | Ceded MRBs
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	0	0
Liabilities	0	0
Significant Observable Inputs (Level 2) | Indexed annuity ceded embedded derivatives
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	0	0
Significant Observable Inputs (Level 2) | Separate account assets
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	162,133	168,047
Significant Observable Inputs (Level 2) | RILA, fixed indexed annuity and IUL contracts
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Liabilities	0	0
Significant Observable Inputs (Level 2) | Reinsurance-related embedded derivatives
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Liabilities	185	204
Significant Observable Inputs (Level 2) | MRB liabilities
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Liabilities	0	0
Significant Observable Inputs (Level 2) | Derivative liabilities
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Liabilities	(3,377)	(4,256)
Significant Unobservable Inputs (Level 3)
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	11,565	11,591
Liabilities	(12,869)	(14,249)
Significant Unobservable Inputs (Level 3) | Corporate bonds
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	2,974	2,865
Significant Unobservable Inputs (Level 3) | U.S. government bonds
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	0	0
Significant Unobservable Inputs (Level 3) | State and municipal bonds
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	0	0
Significant Unobservable Inputs (Level 3) | Foreign government bonds
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	0	0
Significant Unobservable Inputs (Level 3) | RMBS
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	19	12
Significant Unobservable Inputs (Level 3) | CMBS
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	30	8
Significant Unobservable Inputs (Level 3) | ABS
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	2,631	2,099
Significant Unobservable Inputs (Level 3) | Hybrid and redeemable preferred securities
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	81	73
Significant Unobservable Inputs (Level 3) | Trading securities
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	287	265
Significant Unobservable Inputs (Level 3) | Equity securities
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	35	34
Significant Unobservable Inputs (Level 3) | Mortgage loans on real estate
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	232	232
Significant Unobservable Inputs (Level 3) | Derivative investments
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	10	3
Significant Unobservable Inputs (Level 3) | Other investments – short-term investments
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	15	23
Significant Unobservable Inputs (Level 3) | MRB assets
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	4,157	4,860
Significant Unobservable Inputs (Level 3) | Ceded MRBs
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	2	2
Liabilities	(314)	(381)
Significant Unobservable Inputs (Level 3) | Indexed annuity ceded embedded derivatives
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	1,092	1,115
Significant Unobservable Inputs (Level 3) | Separate account assets
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Assets	0	0
Significant Unobservable Inputs (Level 3) | RILA, fixed indexed annuity and IUL contracts
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Liabilities	(10,807)	(12,449)
Significant Unobservable Inputs (Level 3) | Reinsurance-related embedded derivatives
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Liabilities	(323)	(234)
Significant Unobservable Inputs (Level 3) | MRB liabilities
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Liabilities	(1,306)	(1,046)
Significant Unobservable Inputs (Level 3) | Derivative liabilities
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Liabilities	$ (119)	$ (139)

XML

Fair Value of Financial Instruments - Fair Value Measured on a Recurring Basis Reconciliation (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]
Beginning Fair Value	$ (6,472)	$ (4,458)
Items Included in Net Income	1,617	(1,548)
Gains (Losses) in OCI and Other	21	(8)
Issuances, Sales, Maturities, Settlements, Calls, Net	593	72
Transfers Into or Out of Level 3, Net	86	(70)
Ending Fair Value	(4,155)	(6,012)
Corporate bonds | Fixed maturity AFS securities, at fair value
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]
Beginning Fair Value	2,865	2,497
Items Included in Net Income	(13)	2
Gains (Losses) in OCI and Other	1	(10)
Issuances, Sales, Maturities, Settlements, Calls, Net	99	22
Transfers Into or Out of Level 3, Net	22	(22)
Ending Fair Value	2,974	2,489
State and municipal bonds | Fixed maturity AFS securities, at fair value
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]
Beginning Fair Value		5
Items Included in Net Income		0
Gains (Losses) in OCI and Other		0
Issuances, Sales, Maturities, Settlements, Calls, Net		0
Transfers Into or Out of Level 3, Net		(5)
Ending Fair Value		0
RMBS | Fixed maturity AFS securities, at fair value
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]
Beginning Fair Value	12	13
Items Included in Net Income	0	0
Gains (Losses) in OCI and Other	0	(1)
Issuances, Sales, Maturities, Settlements, Calls, Net	7	0
Transfers Into or Out of Level 3, Net	0	0
Ending Fair Value	19	12
CMBS | Fixed maturity AFS securities, at fair value
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]
Beginning Fair Value	8	8
Items Included in Net Income	0	0
Gains (Losses) in OCI and Other	0	0
Issuances, Sales, Maturities, Settlements, Calls, Net	22	0
Transfers Into or Out of Level 3, Net	0	0
Ending Fair Value	30	8
ABS | Fixed maturity AFS securities, at fair value
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]
Beginning Fair Value	2,099	1,484
Items Included in Net Income	(21)	0
Gains (Losses) in OCI and Other	18	(1)
Issuances, Sales, Maturities, Settlements, Calls, Net	478	201
Transfers Into or Out of Level 3, Net	57	8
Ending Fair Value	2,631	1,692
Hybrid and redeemable preferred securities | Fixed maturity AFS securities, at fair value
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]
Beginning Fair Value	73	48
Items Included in Net Income	0	0
Gains (Losses) in OCI and Other	0	3
Issuances, Sales, Maturities, Settlements, Calls, Net	18	0
Transfers Into or Out of Level 3, Net	(10)	0
Ending Fair Value	81	51
Trading securities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]
Beginning Fair Value	265	284
Items Included in Net Income	1	0
Gains (Losses) in OCI and Other	0	0
Issuances, Sales, Maturities, Settlements, Calls, Net	4	(13)
Transfers Into or Out of Level 3, Net	17	0
Ending Fair Value	287	271
Equity securities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]
Beginning Fair Value	34	42
Items Included in Net Income	(6)	(3)
Gains (Losses) in OCI and Other	0	0
Issuances, Sales, Maturities, Settlements, Calls, Net	7	0
Transfers Into or Out of Level 3, Net	0	0
Ending Fair Value	35	39
Mortgage loans on real estate
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]
Beginning Fair Value	232	288
Items Included in Net Income	(1)	0
Gains (Losses) in OCI and Other	2	1
Issuances, Sales, Maturities, Settlements, Calls, Net	(1)	0
Transfers Into or Out of Level 3, Net	0	0
Ending Fair Value	232	289
Other investments
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]
Beginning Fair Value	23
Items Included in Net Income	0
Gains (Losses) in OCI and Other	0
Issuances, Sales, Maturities, Settlements, Calls, Net	(8)
Transfers Into or Out of Level 3, Net	0
Ending Fair Value	15
Derivative investments
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]
Beginning Fair Value		36
Items Included in Net Income		12
Gains (Losses) in OCI and Other		0
Issuances, Sales, Maturities, Settlements, Calls, Net		4
Transfers Into or Out of Level 3, Net		(51)
Ending Fair Value		1
Ceded MRBs | Other Assets
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]
Beginning Fair Value	2	2
Items Included in Net Income	0	0
Gains (Losses) in OCI and Other	0	0
Issuances, Sales, Maturities, Settlements, Calls, Net	0	0
Transfers Into or Out of Level 3, Net	0	0
Ending Fair Value	2	2
Ceded MRBs | Other Liabilities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]
Beginning Fair Value	(381)	(239)
Items Included in Net Income	67	(121)
Gains (Losses) in OCI and Other	0	0
Issuances, Sales, Maturities, Settlements, Calls, Net	0	0
Transfers Into or Out of Level 3, Net	0	0
Ending Fair Value	(314)	(360)
Indexed annuity ceded embedded derivatives | Other Assets
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]
Beginning Fair Value	1,115	940
Items Included in Net Income	(24)	33
Gains (Losses) in OCI and Other	0	0
Issuances, Sales, Maturities, Settlements, Calls, Net	1	0
Transfers Into or Out of Level 3, Net	0	0
Ending Fair Value	1,092	973
RILA, fixed indexed annuity and IUL contracts | Policyholder Account Balances
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]
Beginning Fair Value	(12,449)	(9,077)
Items Included in Net Income	1,676	(1,677)
Gains (Losses) in OCI and Other	0	0
Issuances, Sales, Maturities, Settlements, Calls, Net	(34)	(142)
Transfers Into or Out of Level 3, Net	0	0
Ending Fair Value	(10,807)	(10,896)
Reinsurance-related embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]
Beginning Fair Value	(234)	(789)
Items Included in Net Income	(89)	206
Gains (Losses) in OCI and Other	0	0
Issuances, Sales, Maturities, Settlements, Calls, Net	0	0
Transfers Into or Out of Level 3, Net	0	0
Ending Fair Value	(323)	$ (583)
Derivative liabilities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]
Beginning Fair Value	(136)
Items Included in Net Income	27
Gains (Losses) in OCI and Other	0
Issuances, Sales, Maturities, Settlements, Calls, Net	0
Transfers Into or Out of Level 3, Net	0
Ending Fair Value	$ (109)

XML

Fair Value of Financial Instruments - Schedule of Investment Holdings Movements (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Fair Value Investments Entities That Calculate Net Asset Value Per Share Unobservable Input Investment Holdings Movements [Abstract]
Issuances	$ 742	$ 326
Sales	(91)	(144)
Maturities	(20)	(5)
Settlements	(22)	(104)
Calls	(16)	(1)
Total	593	72
Corporate bonds | Fixed maturity AFS securities, at fair value
Fair Value Investments Entities That Calculate Net Asset Value Per Share Unobservable Input Investment Holdings Movements [Abstract]
Issuances	246	277
Sales	(45)	(141)
Maturities	0	(2)
Settlements	(102)	(111)
Calls	0	(1)
Total	99	22
RMBS | Fixed maturity AFS securities, at fair value
Fair Value Investments Entities That Calculate Net Asset Value Per Share Unobservable Input Investment Holdings Movements [Abstract]
Issuances	7
Sales	0
Maturities	0
Settlements	0
Calls	0
Total	7	0
CMBS | Fixed maturity AFS securities, at fair value
Fair Value Investments Entities That Calculate Net Asset Value Per Share Unobservable Input Investment Holdings Movements [Abstract]
Issuances	22
Sales	0
Maturities	0
Settlements	0
Calls	0
Total	22	0
ABS | Fixed maturity AFS securities, at fair value
Fair Value Investments Entities That Calculate Net Asset Value Per Share Unobservable Input Investment Holdings Movements [Abstract]
Issuances	594	264
Sales	0	0
Maturities	(10)	0
Settlements	(90)	(63)
Calls	(16)	0
Total	478	201
Hybrid and redeemable preferred securities | Fixed maturity AFS securities, at fair value
Fair Value Investments Entities That Calculate Net Asset Value Per Share Unobservable Input Investment Holdings Movements [Abstract]
Issuances	20
Sales	(2)
Maturities	0
Settlements	0
Calls	0
Total	18	0
Trading securities
Fair Value Investments Entities That Calculate Net Asset Value Per Share Unobservable Input Investment Holdings Movements [Abstract]
Issuances	50	0
Sales	(42)	(2)
Maturities	0	0
Settlements	(4)	(11)
Calls	0	0
Total	4	(13)
Equity securities
Fair Value Investments Entities That Calculate Net Asset Value Per Share Unobservable Input Investment Holdings Movements [Abstract]
Issuances	8
Sales	(1)
Maturities	0
Settlements	0
Calls	0
Total	7	0
Mortgage loans on real estate
Fair Value Investments Entities That Calculate Net Asset Value Per Share Unobservable Input Investment Holdings Movements [Abstract]
Issuances	0	1
Sales	(1)	(1)
Maturities	0	0
Settlements	0	0
Calls	0	0
Total	(1)	0
Derivative investments
Fair Value Investments Entities That Calculate Net Asset Value Per Share Unobservable Input Investment Holdings Movements [Abstract]
Issuances		7
Sales		0
Maturities		(3)
Settlements		0
Calls		0
Total		4
Other investments
Fair Value Investments Entities That Calculate Net Asset Value Per Share Unobservable Input Investment Holdings Movements [Abstract]
Issuances	2
Sales	0
Maturities	(10)
Settlements	0
Calls	0
Total	(8)
Indexed annuity ceded embedded derivatives | Other Assets
Fair Value Investments Entities That Calculate Net Asset Value Per Share Unobservable Input Investment Holdings Movements [Abstract]
Issuances	27	26
Sales	0	0
Maturities	0	0
Settlements	(26)	(26)
Calls	0	0
Total	1	0
RILA, fixed indexed annuity and IUL contracts | Policyholder Account Balances
Fair Value Investments Entities That Calculate Net Asset Value Per Share Unobservable Input Investment Holdings Movements [Abstract]
Issuances	(234)	(249)
Sales	0	0
Maturities	0	0
Settlements	200	107
Calls	0	0
Total	$ (34)	$ (142)

XML

Fair Value of Financial Instruments - Changes in Unrealized Gains (Losses) Within Level 3 Financial Instruments Carried at Fair Value and Still Held (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Fair Value Assets And Liabilities Measured On Recurring Basis Level 3 Activity [Line Items]
Changes in unrealized gains (losses) included in net income	$ (1,217)	$ 2,356
Trading securities
Fair Value Assets And Liabilities Measured On Recurring Basis Level 3 Activity [Line Items]
Changes in unrealized gains (losses) included in net income	(3)	0
Equity securities
Fair Value Assets And Liabilities Measured On Recurring Basis Level 3 Activity [Line Items]
Changes in unrealized gains (losses) included in net income	(6)	(3)
Mortgage loans on real estate
Fair Value Assets And Liabilities Measured On Recurring Basis Level 3 Activity [Line Items]
Changes in unrealized gains (losses) included in net income	(1)	0
Derivative investments
Fair Value Assets And Liabilities Measured On Recurring Basis Level 3 Activity [Line Items]
Changes in unrealized gains (losses) included in net income	12	16
MRBs
Fair Value Assets And Liabilities Measured On Recurring Basis Level 3 Activity [Line Items]
Changes in unrealized gains (losses) included in net income	(1,299)	1,896
Reinsurance-related embedded derivatives
Fair Value Assets And Liabilities Measured On Recurring Basis Level 3 Activity [Line Items]
Changes in unrealized gains (losses) included in net income	(89)	206
Indexed annuity ceded embedded derivatives
Fair Value Assets And Liabilities Measured On Recurring Basis Level 3 Activity [Line Items]
Changes in unrealized gains (losses) included in net income	$ 169	$ 241

XML

Fair Value of Financial Instruments - Changes in Unrealized Gains (Losses) Included in OCI (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Fair Value Assets And Liabilities Measured On Recurring Basis Level 3 Activity [Line Items]
Unrealized gains (losses) included in OCI, net	$ 11	$ (9)
Corporate bonds
Fair Value Assets And Liabilities Measured On Recurring Basis Level 3 Activity [Line Items]
Unrealized gains (losses) included in OCI, net	(7)	(11)
ABS
Fair Value Assets And Liabilities Measured On Recurring Basis Level 3 Activity [Line Items]
Unrealized gains (losses) included in OCI, net	16	(1)
Hybrid and redeemable preferred securities
Fair Value Assets And Liabilities Measured On Recurring Basis Level 3 Activity [Line Items]
Unrealized gains (losses) included in OCI, net	0	2
Mortgage loans on real estate
Fair Value Assets And Liabilities Measured On Recurring Basis Level 3 Activity [Line Items]
Unrealized gains (losses) included in OCI, net	$ 2	$ 1

XML

Fair Value of Financial Instruments - Components of the Transfers In and Out of Level 3 (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net [Abstract]
Transfers Into Level 3	$ 96	$ 53
Transfers Out of Level 3	(10)	(123)
Total	86	(70)
Corporate bonds
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net [Abstract]
Transfers Into Level 3	22	22
Transfers Out of Level 3	0	(44)
Total	22	(22)
State and municipal bonds
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net [Abstract]
Transfers Into Level 3	0	0
Transfers Out of Level 3	0	(5)
Total	0	(5)
ABS
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net [Abstract]
Transfers Into Level 3	57	31
Transfers Out of Level 3	0	(23)
Total	57	8
Hybrid and redeemable preferred securities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net [Abstract]
Transfers Into Level 3	0	0
Transfers Out of Level 3	(10)	0
Total	(10)	0
Trading securities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net [Abstract]
Transfers Into Level 3	17	0
Transfers Out of Level 3	0	0
Total	17	0
Derivative investments
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net [Abstract]
Transfers Into Level 3	0	0
Transfers Out of Level 3	0	(51)
Total	$ 0	$ (51)

XML

Fair Value of Financial Instruments - Fair Value Inputs Quantitative Information (Details) $ in Millions	Mar. 31, 2025 USD ($)	Dec. 31, 2024 USD ($)
Assets
Fair Value	$ 88,297	$ 87,111
Market risk benefit assets	4,157	4,860
Liabilities
Market risk benefit liabilities	(1,306)	(1,046)
Corporate bonds
Assets
Fair Value	66,885	66,450
ABS
Assets
Fair Value	14,241	13,880
CMBS
Assets
Fair Value	1,830	1,665
Hybrid and redeemable preferred securities
Assets
Fair Value	273	254
Significant Unobservable Inputs (Level 3)
Assets
Equity securities	5	5
Market risk benefit assets	4,157	4,860
Embedded derivative asset	1,092	1,115
Liabilities
Embedded derivative liability	(10,860)	(12,402)
Market risk benefit liabilities	(1,306)	(1,046)
Significant Unobservable Inputs (Level 3) | Corporate bonds
Assets
Fair Value	190	187
Significant Unobservable Inputs (Level 3) | ABS
Assets
Fair Value	10	8
Significant Unobservable Inputs (Level 3) | CMBS
Assets
Fair Value	8	10
Significant Unobservable Inputs (Level 3) | Hybrid and redeemable preferred securities
Assets
Fair Value	39	19
Significant Unobservable Inputs (Level 3) | Other assets – ceded MRBs
Assets
Market risk benefit assets	2	2
Significant Unobservable Inputs (Level 3) | Other liabilities – ceded MRBs
Liabilities
Market risk benefit liabilities	$ (314)	$ (381)
Significant Unobservable Inputs (Level 3) | Minimum | Liquidity/Duration Adjustment
Assets
Equity securities, measurement input	0.045	0.045
Significant Unobservable Inputs (Level 3) | Minimum | Liquidity/Duration Adjustment | Corporate bonds
Assets
Fixed maturity AFS and trading securities, measurement input	0.000	0.000
Significant Unobservable Inputs (Level 3) | Minimum | Liquidity/Duration Adjustment | ABS
Assets
Fixed maturity AFS and trading securities, measurement input	0.014	0.019
Significant Unobservable Inputs (Level 3) | Minimum | Liquidity/Duration Adjustment | CMBS
Assets
Fixed maturity AFS and trading securities, measurement input	0.020	0.013
Significant Unobservable Inputs (Level 3) | Minimum | Liquidity/Duration Adjustment | Hybrid and redeemable preferred securities
Assets
Fixed maturity AFS and trading securities, measurement input	0.012	0.014
Significant Unobservable Inputs (Level 3) | Minimum | Lapse
Assets
Embedded derivative asset, measurement input	0.000	0.000
Liabilities
Embedded derivative liability, measurement input	0.000	0.000
Significant Unobservable Inputs (Level 3) | Minimum | Lapse | Other assets – ceded MRBs
Assets
Market risk benefit, measurement input	0.010	0.010
Significant Unobservable Inputs (Level 3) | Minimum | Lapse | Other liabilities – ceded MRBs
Assets
Market risk benefit, measurement input	0.010	0.010
Significant Unobservable Inputs (Level 3) | Minimum | Utilization of GLB Withdrawls | Other assets – ceded MRBs
Assets
Market risk benefit, measurement input	0.850	0.850
Significant Unobservable Inputs (Level 3) | Minimum | Utilization of GLB Withdrawls | Other liabilities – ceded MRBs
Assets
Market risk benefit, measurement input	0.850	0.850
Significant Unobservable Inputs (Level 3) | Minimum | Claims Utilization Factor | Other assets – ceded MRBs
Assets
Market risk benefit, measurement input	0.600	0.600
Significant Unobservable Inputs (Level 3) | Minimum | Claims Utilization Factor | Other liabilities – ceded MRBs
Assets
Market risk benefit, measurement input	0.600	0.600
Significant Unobservable Inputs (Level 3) | Minimum | Premiums Utilization Factor | Other assets – ceded MRBs
Assets
Market risk benefit, measurement input	0.800	0.800
Significant Unobservable Inputs (Level 3) | Minimum | Premiums Utilization Factor | Other liabilities – ceded MRBs
Assets
Market risk benefit, measurement input	0.800	0.800
Significant Unobservable Inputs (Level 3) | Minimum | Non-Performance Risk | Other assets – ceded MRBs
Assets
Market risk benefit, measurement input	0.003	0.003
Significant Unobservable Inputs (Level 3) | Minimum | Non-Performance Risk | Other liabilities – ceded MRBs
Assets
Market risk benefit, measurement input	0.003	0.003
Significant Unobservable Inputs (Level 3) | Minimum | Volatility | Other assets – ceded MRBs
Assets
Market risk benefit, measurement input	0.010	0.010
Significant Unobservable Inputs (Level 3) | Minimum | Volatility | Other liabilities – ceded MRBs
Assets
Market risk benefit, measurement input	0.010	0.010
Significant Unobservable Inputs (Level 3) | Maximum | Liquidity/Duration Adjustment
Assets
Equity securities, measurement input	0.045	0.045
Significant Unobservable Inputs (Level 3) | Maximum | Liquidity/Duration Adjustment | Corporate bonds
Assets
Fixed maturity AFS and trading securities, measurement input	0.043	0.031
Significant Unobservable Inputs (Level 3) | Maximum | Liquidity/Duration Adjustment | ABS
Assets
Fixed maturity AFS and trading securities, measurement input	0.014	0.019
Significant Unobservable Inputs (Level 3) | Maximum | Liquidity/Duration Adjustment | CMBS
Assets
Fixed maturity AFS and trading securities, measurement input	0.020	0.013
Significant Unobservable Inputs (Level 3) | Maximum | Liquidity/Duration Adjustment | Hybrid and redeemable preferred securities
Assets
Fixed maturity AFS and trading securities, measurement input	0.021	0.019
Significant Unobservable Inputs (Level 3) | Maximum | Lapse
Assets
Embedded derivative asset, measurement input	0.090	0.090
Liabilities
Embedded derivative liability, measurement input	0.090	0.090
Significant Unobservable Inputs (Level 3) | Maximum | Lapse | Other assets – ceded MRBs
Assets
Market risk benefit, measurement input	0.300	0.300
Significant Unobservable Inputs (Level 3) | Maximum | Lapse | Other liabilities – ceded MRBs
Assets
Market risk benefit, measurement input	0.300	0.300
Significant Unobservable Inputs (Level 3) | Maximum | Utilization of GLB Withdrawls | Other assets – ceded MRBs
Assets
Market risk benefit, measurement input	1.000	1.000
Significant Unobservable Inputs (Level 3) | Maximum | Utilization of GLB Withdrawls | Other liabilities – ceded MRBs
Assets
Market risk benefit, measurement input	1.000	1.000
Significant Unobservable Inputs (Level 3) | Maximum | Claims Utilization Factor | Other assets – ceded MRBs
Assets
Market risk benefit, measurement input	1.000	1.000
Significant Unobservable Inputs (Level 3) | Maximum | Claims Utilization Factor | Other liabilities – ceded MRBs
Assets
Market risk benefit, measurement input	1.000	1.000
Significant Unobservable Inputs (Level 3) | Maximum | Premiums Utilization Factor | Other assets – ceded MRBs
Assets
Market risk benefit, measurement input	1.150	1.150
Significant Unobservable Inputs (Level 3) | Maximum | Premiums Utilization Factor | Other liabilities – ceded MRBs
Assets
Market risk benefit, measurement input	1.150	1.150
Significant Unobservable Inputs (Level 3) | Maximum | Non-Performance Risk | Other assets – ceded MRBs
Assets
Market risk benefit, measurement input	0.022	0.020
Significant Unobservable Inputs (Level 3) | Maximum | Non-Performance Risk | Other liabilities – ceded MRBs
Assets
Market risk benefit, measurement input	0.022	0.020
Significant Unobservable Inputs (Level 3) | Maximum | Volatility | Other assets – ceded MRBs
Assets
Market risk benefit, measurement input	0.290	0.290
Significant Unobservable Inputs (Level 3) | Maximum | Volatility | Other liabilities – ceded MRBs
Assets
Market risk benefit, measurement input	0.290	0.290
Significant Unobservable Inputs (Level 3) | Weighted Average Range | Liquidity/Duration Adjustment
Assets
Equity securities, measurement input	0.045	0.045
Significant Unobservable Inputs (Level 3) | Weighted Average Range | Liquidity/Duration Adjustment | Corporate bonds
Assets
Fixed maturity AFS and trading securities, measurement input	0.019	0.017
Significant Unobservable Inputs (Level 3) | Weighted Average Range | Liquidity/Duration Adjustment | ABS
Assets
Fixed maturity AFS and trading securities, measurement input	0.014	0.019
Significant Unobservable Inputs (Level 3) | Weighted Average Range | Liquidity/Duration Adjustment | CMBS
Assets
Fixed maturity AFS and trading securities, measurement input	0.020	0.013
Significant Unobservable Inputs (Level 3) | Weighted Average Range | Liquidity/Duration Adjustment | Hybrid and redeemable preferred securities
Assets
Fixed maturity AFS and trading securities, measurement input	0.018	0.018
Significant Unobservable Inputs (Level 3) | Weighted Average Range | Utilization of GLB Withdrawls | Other assets – ceded MRBs
Assets
Market risk benefit, measurement input	0.920	0.920
Significant Unobservable Inputs (Level 3) | Weighted Average Range | Utilization of GLB Withdrawls | Other liabilities – ceded MRBs
Assets
Market risk benefit, measurement input	0.920	0.920
Significant Unobservable Inputs (Level 3) | Weighted Average Range | Non-Performance Risk | Other assets – ceded MRBs
Assets
Market risk benefit, measurement input	0.018	0.016
Significant Unobservable Inputs (Level 3) | Weighted Average Range | Non-Performance Risk | Other liabilities – ceded MRBs
Assets
Market risk benefit, measurement input	0.018	0.016
Significant Unobservable Inputs (Level 3) | Weighted Average Range | Volatility | Other assets – ceded MRBs
Assets
Market risk benefit, measurement input	0.143	0.145
Significant Unobservable Inputs (Level 3) | Weighted Average Range | Volatility | Other liabilities – ceded MRBs
Assets
Market risk benefit, measurement input	0.143	0.145

XML

Fair Value of Financial Instruments - Schedule of Mortgage Loans With Election of Fair Value Option (Details) - USD ($) $ in Millions	Mar. 31, 2025	Dec. 31, 2024
Fair Value, Option, Quantitative Disclosures [Line Items]
Fair value	$ 232	$ 232
Commercial
Fair Value, Option, Quantitative Disclosures [Line Items]
Fair value	232	232
Aggregate contractual principal	$ 263	$ 263

XML

Fair Value of Financial Instruments - Carrying and Estimated Fair Values of Financial Instruments (Details) - USD ($) $ in Millions	Mar. 31, 2025	Dec. 31, 2024
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	$ 270,346	$ 278,356
Liabilities	(16,061)	(18,301)
Mortgage loans on real estate
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	232	232
Other investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	483	392
Fair Value | Mortgage loans on real estate
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	20,373	19,647
Fair Value | Other investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	6,170	6,588
Fair Value | Policy loans
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	2,529	2,476
Fair Value | Cash and invested cash
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	4,284	5,801
Fair Value | Policyholder account balances and other liabilities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	(30,876)	(30,505)
Fair Value | Policyholder account balances – funding agreements
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	(508)
Fair Value | Short-term debt
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities		(299)
Fair Value | Long-term Debt
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	(5,356)	(5,304)
Fair Value | Funds withheld reinsurance-related liabilities – excluding embedded derivatives
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	(16,700)	(16,877)
Carrying Amount | Mortgage loans on real estate
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	21,326	21,083
Carrying Amount | Other investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	6,170	6,588
Carrying Amount | Policy loans
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	2,529	2,476
Carrying Amount | Cash and invested cash
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	4,284	5,801
Carrying Amount | Policyholder account balances and other liabilities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	(41,005)	(40,394)
Carrying Amount | Policyholder account balances – funding agreements
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	(500)
Carrying Amount | Short-term debt
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities		(300)
Carrying Amount | Long-term Debt
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	(5,868)	(5,856)
Carrying Amount | Funds withheld reinsurance-related liabilities – excluding embedded derivatives
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	(16,700)	(16,877)
Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	938	810
Liabilities	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Mortgage loans on real estate
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Other investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Fair Value | Mortgage loans on real estate
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Fair Value | Other investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Fair Value | Policy loans
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Fair Value | Cash and invested cash
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Fair Value | Policyholder account balances and other liabilities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Fair Value | Policyholder account balances – funding agreements
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Fair Value | Short-term debt
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities		0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Fair Value | Long-term Debt
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Fair Value | Funds withheld reinsurance-related liabilities – excluding embedded derivatives
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	0	0
Significant Observable Inputs (Level 2)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	257,843	265,955
Liabilities	(3,192)	(4,052)
Significant Observable Inputs (Level 2) | Mortgage loans on real estate
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Significant Observable Inputs (Level 2) | Other investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	468	369
Significant Observable Inputs (Level 2) | Fair Value | Mortgage loans on real estate
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	20,373	19,647
Significant Observable Inputs (Level 2) | Fair Value | Other investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	513	1,119
Significant Observable Inputs (Level 2) | Fair Value | Policy loans
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	2,529	2,476
Significant Observable Inputs (Level 2) | Fair Value | Cash and invested cash
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	4,284	5,801
Significant Observable Inputs (Level 2) | Fair Value | Policyholder account balances and other liabilities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	0	0
Significant Observable Inputs (Level 2) | Fair Value | Policyholder account balances – funding agreements
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	(508)
Significant Observable Inputs (Level 2) | Fair Value | Short-term debt
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities		(299)
Significant Observable Inputs (Level 2) | Fair Value | Long-term Debt
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	(5,356)	(5,304)
Significant Observable Inputs (Level 2) | Fair Value | Funds withheld reinsurance-related liabilities – excluding embedded derivatives
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	0	0
Significant Unobservable Inputs (Level 3)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	11,565	11,591
Liabilities	(12,869)	(14,249)
Significant Unobservable Inputs (Level 3) | Mortgage loans on real estate
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	232	232
Significant Unobservable Inputs (Level 3) | Other investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	15	23
Significant Unobservable Inputs (Level 3) | Fair Value | Mortgage loans on real estate
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Significant Unobservable Inputs (Level 3) | Fair Value | Other investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	5,657	5,469
Significant Unobservable Inputs (Level 3) | Fair Value | Policy loans
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Significant Unobservable Inputs (Level 3) | Fair Value | Cash and invested cash
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Significant Unobservable Inputs (Level 3) | Fair Value | Policyholder account balances and other liabilities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	(30,876)	(30,505)
Significant Unobservable Inputs (Level 3) | Fair Value | Policyholder account balances – funding agreements
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	0
Significant Unobservable Inputs (Level 3) | Fair Value | Short-term debt
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities		0
Significant Unobservable Inputs (Level 3) | Fair Value | Long-term Debt
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	0	0
Significant Unobservable Inputs (Level 3) | Fair Value | Funds withheld reinsurance-related liabilities – excluding embedded derivatives
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	$ (16,700)	$ (16,877)

XML

Contingencies and Commitments (Details) - USD ($) $ in Millions	Mar. 31, 2025	Dec. 31, 2024	Mar. 08, 2024
Commitments and Contingencies Disclosure [Abstract]
Loss contingency, estimate	$ 150.0
Loss contingency accrual			$ 147.5
Guaranty liabilities	63.0	$ 63.0
Premium expected to be collected	100.0	99.0
Estimated insurance recoveries	$ 37.0	$ 36.0

XML

Shares and Stockholders' Equity - Schedule of Preferred Share Authorized, Issued and Outstanding (Details) - shares	3 Months Ended
	Mar. 31, 2025	Dec. 31, 2024
Class of Stock [Line Items]
Preferred stock - authorized (in shares)	10,000,000	10,000,000
Preferred stock - issued (in shares)	40,000	40,000
Preferred stock - outstanding (in shares)	40,000	40,000
9.250% Fixed Rate Reset Non-Cumulative Preferred Stock, Series C
Class of Stock [Line Items]
Preferred stock - authorized (in shares)	20,000	20,000
Preferred stock - issued (in shares)	20,000	20,000
Preferred stock - outstanding (in shares)	20,000	20,000
Percent of non cumulative preferred stock	9.25%
9.000% Non-Cumulative Preferred Stock, Series D
Class of Stock [Line Items]
Preferred stock - authorized (in shares)	20,000	20,000
Preferred stock - issued (in shares)	20,000	20,000
Preferred stock - outstanding (in shares)	20,000	20,000
9.000% Non-Cumulative Preferred Stock, Series D | Series D Depositary Shares
Class of Stock [Line Items]
Percent of non cumulative preferred stock	9.00%
Not designated
Class of Stock [Line Items]
Preferred stock - authorized (in shares)	9,960,000	9,960,000
Preferred stock - issued (in shares)	0	0
Preferred stock - outstanding (in shares)	0	0

XML

Shares and Stockholders' Equity - Schedule of Preferred Stock Dividends (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Class of Stock [Line Items]
Dividend Per Share (in dollars per share)	$ 1,718.75	$ 1,718.75
Aggregate Dividend	$ 34	$ 34
Series C Preferred Stock
Class of Stock [Line Items]
Dividend Per Share (in dollars per share)	$ 1,156.25	$ 1,156.25
Aggregate Dividend	$ 23	$ 23
Series D Preferred Stock
Class of Stock [Line Items]
Dividend Per Share (in dollars per share)	$ 562.50	$ 562.50
Aggregate Dividend	$ 11	$ 11

XML

Shares and Stockholders' Equity - Changes in Common Stock (Details) - shares	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance as of beginning-of-year (in shares)	170,380,646	169,666,137
Stock compensation/issued for benefit plans (in shares)	314,520	350,750
Balance as of end-of-period (in shares)	170,695,166	170,016,887

XML

Shares and Stockholders' Equity - Reconciliation of the Denominator Calculations of Basic and Diluted EPS (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Stockholders' Equity Note [Abstract]
Net income (loss) available to common stockholders – basic	$ (756)	$ 1,188
Deferred units of LNC stock in our deferred compensation plans	0	3
Net income (loss) available to common stockholders	$ (756)	$ 1,191
Weighted-average shares, as used in basic calculation (in shares)	171,321,440	170,049,994
Incremental common shares from assumed exercise or issuance of stock-based incentive compensation awards (in shares)	2,765,580	1,096,272
Average deferred compensation shares (in shares)	0	688,480
Weighted-average shares, as used in diluted calculation (in shares)	174,087,020	171,834,746
Net income (loss) per share:
Basic (in dollars per share)	$ (4.41)	$ 6.98
Diluted (in dollars per share)	$ (4.41)	$ 6.93

XML

Shares and Stockholders' Equity - Components and Changes in AOCI (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Change in our unrealized gain on derivative instruments in accumulated OCI
Balance as of beginning-of-year	$ 8,269
Balance as of end-of-period	8,193	$ 7,546
Unrealized Gain (Loss) on Fixed Maturity AFS Securities and Certain
Change in our unrealized gain on derivative instruments in accumulated OCI
Balance as of beginning-of-year	(6,239)	(5,188)
Income tax benefit (expense)	(121)	71
Reclassification adjustment for gains (losses) included in net income (loss)	(90)	(55)
Income tax benefit (expense)	19	12
Balance as of end-of-period	(5,715)	(5,426)
Unrealized holding gains (losses) arising during the year
Change in our unrealized gain on derivative instruments in accumulated OCI
Changes arising during the year	744	(1,140)
Change in foreign currency exchange rate adjustment
Change in our unrealized gain on derivative instruments in accumulated OCI
Changes arising during the year	156	(103)
Change in future contract benefits and policyholder account balances, net of reinsurance
Change in our unrealized gain on derivative instruments in accumulated OCI
Changes arising during the year	(326)	891
Unrealized Gain (Loss) on Derivative Instruments
Change in our unrealized gain on derivative instruments in accumulated OCI
Balance as of beginning-of-year	638	375
Income tax benefit (expense)	(4)	(35)
Reclassification adjustment for gains (losses) included in net income (loss)	21	24
Income tax benefit (expense)	(4)	(5)
Balance as of end-of-period	637	486
Unrealized holding gains (losses) arising during the period - cash flow hedges
Change in our unrealized gain on derivative instruments in accumulated OCI
Changes arising during the year	173	64
Change in foreign currency exchange rate adjustment
Change in our unrealized gain on derivative instruments in accumulated OCI
Changes arising during the year	(153)	101
Market Risk Benefit Non-Performance Risk Gain (Loss)
Change in our unrealized gain on derivative instruments in accumulated OCI
Balance as of beginning-of-year	146	1,070
Adjustment arising during the year	403	(590)
Income tax benefit (expense)	(85)	126
Balance as of end-of-period	464	606
Policyholder Liability Discount Rate Remeasurement Gain (Loss)
Change in our unrealized gain on derivative instruments in accumulated OCI
Balance as of beginning-of-year	744	587
Adjustment arising during the year	(141)	147
Income tax benefit (expense)	30	(31)
Balance as of end-of-period	633	703
Foreign Currency Translation Adjustment
Change in our unrealized gain on derivative instruments in accumulated OCI
Balance as of beginning-of-year	(29)	(26)
Foreign currency translation adjustment arising during the year	5	(1)
Balance as of end-of-period	(24)	(27)
Funded Status of Employee Benefit Plans
Change in our unrealized gain on derivative instruments in accumulated OCI
Balance as of beginning-of-year	(296)	(294)
Adjustment arising during the year	(5)	1
Balance as of end-of-period	$ (301)	$ (293)

XML

Shares and Stockholders' Equity - Schedule of Reclassifications Out of AOCI (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Interest and debt expense	$ (80)	$ (81)
Net investment income	1,457	1,346
Realized gain (loss)	11	(434)
Benefits	(2,068)	(2,003)
Income (loss) before taxes	(949)	1,528
Federal income tax expense (benefit)	227	(306)
Net income (loss)	(722)	1,222
Reclassification out of Accumulated Other Comprehensive Income | Unrealized Gain (Loss) on Fixed Maturity AFS Securities and Certain
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Realized gain (loss)	(118)	(54)
Benefits	28	(1)
Income (loss) before taxes	(90)	(55)
Federal income tax expense (benefit)	19	12
Net income (loss)	(71)	(43)
Reclassification out of Accumulated Other Comprehensive Income | Unrealized Gain (Loss) on Derivative Instruments
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Interest and debt expense	3	9
Net investment income	15	15
Realized gain (loss)	3	0
Income (loss) before taxes	21	24
Federal income tax expense (benefit)	(4)	(5)
Net income (loss)	$ 17	$ 19

XML

Segment Information - Reconciliation of Income (Loss) from Operations by Segment to Consolidated Net Income (Loss) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Segment Reporting Information [Line Items]
Operating revenues	$ 4,685	$ 4,584
Interest credited	890	822
Interest and debt expense	80	81
Total federal income tax expense (benefit)	(227)	306
Reconciliation of total income (loss) from operations to net income (loss):
Net annuity product features, pre-tax	(1,092)	1,450
Net life insurance product features, pre-tax	42	(130)
Credit loss-related adjustments, pre-tax	(28)	(1)
Investment gains (losses), pre-tax	(103)	(81)
Changes in the fair value of reinsurance-related embedded derivatives, trading securities and certain mortgage loans, pre-tax	(90)	194
Other items, pre-tax	(35)	(186)
Settlement of cost of insurance litigation, before tax		(114)
Severance expense for workforce realignment, before tax	(6)	(49)
Transaction and integration costs for acquisitions or divestiture, before tax	(20)	(10)
Deferred compensation mark-to-market adjustment, before tax	(9)	(13)
Income tax benefit (expense) related to the above pre-tax items	270	(268)
Net income (loss)	(722)	1,222
Operating Segments and Corporate Non Segment
Segment Reporting Information [Line Items]
Operating revenues	4,685	4,584
Benefits and policyholder liability remeasurement (gain) loss	2,028	1,984
Interest credited	890	822
Commissions	557	499
General and administrative expenses	630	613
Interest and debt expense	80	81
Other	138	295
Total operating expenses	4,323	4,294
Total federal income tax expense (benefit)	48	46
Total income (loss) from operations	314	244
Other Operations
Segment Reporting Information [Line Items]
Operating revenues	52	27
Benefits and policyholder liability remeasurement (gain) loss	4	7
Interest credited	14	7
Commissions	0	0
General and administrative expenses	68	57
Interest and debt expense	80	81
Other	(2)	(6)
Total operating expenses	164	146
Total federal income tax expense (benefit)	(17)	(23)
Total income (loss) from operations	(95)	(96)
Annuities | Operating Segments
Segment Reporting Information [Line Items]
Operating revenues	1,198	1,269
Benefits and policyholder liability remeasurement (gain) loss	28	27
Interest credited	419	354
Commissions	298	254
General and administrative expenses	125	120
Interest and debt expense	0	0
Other	(12)	197
Total operating expenses	858	952
Total federal income tax expense (benefit)	50	58
Total income (loss) from operations	290	259
Life Insurance | Operating Segments
Segment Reporting Information [Line Items]
Operating revenues	1,587	1,541
Benefits and policyholder liability remeasurement (gain) loss	1,002	987
Interest credited	287	294
Commissions	99	113
General and administrative expenses	131	143
Interest and debt expense	0	0
Other	100	54
Total operating expenses	1,619	1,591
Total federal income tax expense (benefit)	(16)	(15)
Total income (loss) from operations	(16)	(35)
Group Protection | Operating Segments
Segment Reporting Information [Line Items]
Operating revenues	1,521	1,425
Benefits and policyholder liability remeasurement (gain) loss	994	963
Interest credited	0	1
Commissions	133	109
General and administrative expenses	222	208
Interest and debt expense	0	0
Other	44	43
Total operating expenses	1,393	1,324
Total federal income tax expense (benefit)	27	21
Total income (loss) from operations	101	80
Retirement Plan Services | Operating Segments
Segment Reporting Information [Line Items]
Operating revenues	327	322
Benefits and policyholder liability remeasurement (gain) loss	0	0
Interest credited	170	166
Commissions	27	23
General and administrative expenses	84	86
Interest and debt expense	0	0
Other	8	6
Total operating expenses	289	281
Total federal income tax expense (benefit)	4	5
Total income (loss) from operations	$ 34	$ 36

XML

Segment Information - Reconciliation of Revenue from Segments to Consolidated (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Segment Reporting Information [Line Items]
Operating revenues	$ 4,685	$ 4,584
Revenue adjustments from annuity and life insurance product features	227	(580)
Credit loss-related adjustments	(28)	(1)
Investment gains (losses)	(103)	(81)
Changes in the fair value of reinsurance-related embedded derivatives, trading securities and certain mortgage loans	(90)	194
Total revenues	4,691	4,116
Other Operations
Segment Reporting Information [Line Items]
Operating revenues	52	27
Revenue adjustments from annuity and life insurance product features	0	0
Credit loss-related adjustments	(8)	(2)
Investment gains (losses)	14	(66)
Changes in the fair value of reinsurance-related embedded derivatives, trading securities and certain mortgage loans	(11)	(8)
Total revenues	47	(49)
Annuities | Operating Segments
Segment Reporting Information [Line Items]
Operating revenues	1,198	1,269
Revenue adjustments from annuity and life insurance product features	209	(446)
Credit loss-related adjustments	(17)	(4)
Investment gains (losses)	(6)	19
Changes in the fair value of reinsurance-related embedded derivatives, trading securities and certain mortgage loans	10	(3)
Total revenues	1,394	835
Life Insurance | Operating Segments
Segment Reporting Information [Line Items]
Operating revenues	1,587	1,541
Revenue adjustments from annuity and life insurance product features	18	(134)
Credit loss-related adjustments	1	5
Investment gains (losses)	(109)	(29)
Changes in the fair value of reinsurance-related embedded derivatives, trading securities and certain mortgage loans	(89)	205
Total revenues	1,408	1,588
Group Protection | Operating Segments
Segment Reporting Information [Line Items]
Operating revenues	1,521	1,425
Revenue adjustments from annuity and life insurance product features	0	0
Credit loss-related adjustments	(2)	0
Investment gains (losses)	0	0
Changes in the fair value of reinsurance-related embedded derivatives, trading securities and certain mortgage loans	0	0
Total revenues	1,519	1,425
Retirement Plan Services | Operating Segments
Segment Reporting Information [Line Items]
Operating revenues	327	322
Revenue adjustments from annuity and life insurance product features	0	0
Credit loss-related adjustments	(2)	0
Investment gains (losses)	(2)	(5)
Changes in the fair value of reinsurance-related embedded derivatives, trading securities and certain mortgage loans	0	0
Total revenues	$ 323	$ 317

XML

Segment Information - Reconciliation of Net Investment Income from Segments to Consolidated (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Segment Reporting Information [Line Items]
Net investment income	$ 1,457	$ 1,346
Operating Segments | Annuities
Segment Reporting Information [Line Items]
Net investment income	452	379
Operating Segments | Life Insurance
Segment Reporting Information [Line Items]
Net investment income	624	622
Operating Segments | Group Protection
Segment Reporting Information [Line Items]
Net investment income	89	85
Operating Segments | Retirement Plan Services
Segment Reporting Information [Line Items]
Net investment income	251	244
Other Operations
Segment Reporting Information [Line Items]
Net investment income	$ 41	$ 16

XML

Realized Gain (Loss) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Fixed maturity AFS securities:
Gross gains	$ 4	$ 7
Gross losses	(122)	(61)
Credit loss benefit (expense)	(28)	(2)
Realized gain (loss) on equity securities	(5)	11
Credit loss benefit (expense) on mortgage loans on real estate	(1)	0
Credit loss benefit (expense) on reinsurance-related assets	1	1
Realized gain (loss) on the market-to-market on certain instruments	(55)	12
Indexed product derivative results	(69)	145
Derivative results	287	(548)
Other realized gain (loss)	(1)	1
Total realized gain (loss)	11	(434)
Mortgages
Fixed maturity AFS securities:
Realized gain (loss) on the market-to-market on certain instruments	(1)	1
Equity securities
Fixed maturity AFS securities:
Realized gain (loss) on equity securities	$ (5)	$ 11

XML

Federal Income Taxes (Details)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Income Tax Disclosure [Abstract]
Effective income tax rate reconciliation, percent	24.00%	20.00%

XML

Subsequent Events (Details) - Subsequent Event - Stock Purchase Agreeement - Bain Capital Prairie, LLC $ in Millions	Apr. 09, 2025 USD ($)
Subsequent Event [Line Items]
Collaborative arrangement, sale of stock, percentage of common stock	9.90%
Proceeds from collaborators	$ 825